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Section One
PROFESSIONAL AUDIT
PERSONAL STUDY PROGRAMME
Psvch D in Clinical Psychology:
Conversion Programme 
Name: Tanya Sichel
Date of Registration: 25 April 1994
Registration number: 3316009
1. Overall Aims and Objectives
As laid down by the course directives.
2.0 Academic
2.1 Aims
Prime aim:
To enhance academic competence in three specialist areas of clinical psychology so as to 
develop the services offered by the department or the profession.
Additional aims:
i) To provide a comprehensive overview of the breadth of current psychological and 
related literature within the substance misuse field: the boundaries and interactions.
ii) To critically evaluate, compare and contrast the diverse range of psychological 
theories, therapies and measures developed within this field: critical issues and 
concepts.
iii) To examine the possible applications of such theories, therapies and measures in the 
assessment and treatment of people who present with psychological difficulties
relating to substance misuse: applicability, usability and explanatory power.
2.2 Objectives
Prime objective:
To complete three critical academic reviews, one for each of the three specialist areas. 
Additional objectives:
i) To use the information gathered to form the basis of teaching sessions to colleagues
within the multi-disciplinary team.
ii) To underpin bids to purchasers for extra resources with well reasoned argument
highlighting theory - practice links.
iii) To use literature to provide a cogent and coherent rationale for the development of
new services within the existing drug treatment services.
iv) To present the academic reviews to the drugs services research advisory group with
recommendations for future potential research projects within the service as indicated 
by gaps in the existing literature.
2.3 Rationale
Camden and Islington Drugs Service is a busy, central London out patient treatment service 
offering a wide range of assessment and treatment options to a diverse, heterogenous drug 
using population. Providing a service to over 600 patients per month, the service has very 
little opportunity to spend time on research and development. The content of the academic 
reviews have been agreed with the lead academic and clinical consultants as useful both for 
individual and service development. The reviews will be available to all members of the 
team and will provide information on issues currently challenging the service.
2.4 Plan
The above aims and objectives laid down by the academic audit will be achieved as follows:
i) The aetiologv of stimulant drug abuse: implications and challenges for treatment.
ii) Changing high risk behaviours: the application of health education strategies to drug 
users.
iii) Critical issues in the field of sexual abuse with special reference to people who
misuse drugs.
3.0 Clinical
3.1 Aims
Prime aim:
To develop the services offered by the department or the profession.
Additional aims:
i) To develop a new treatment service for a specific population of drug users who
currently present with unmet treatment needs.
ii) To enhance the assessment and treatment options for drug users with psychological
difficulties related to their addictive behaviour.
3.2 Objectives
Prime objective:
To present a dossier on clinical activity that will describe service developments undertaken
and their psychological framework.
Additional objectives:
i) To increase personal understanding of the process of service development, ie. 
knowledge of existing treatment models, knowledge about the clinical population, 
writing a bid, providing a cogent proposal for the service with a clear clinical 
framework that can be evaluated.
3.3 Rationale
Camden and Islington Drugs Services offers a broad range of assessment and treatment 
options to a large number of inner city drug users. A recent service review highlighted a 
need to develop services for a growing population of users of stimulant drugs, (eg. cocaine, 
crack cocaine, amphetamine sulphate); currently, locally as well as nationally, such services 
do not formally exist. This group of drug users present with dependencies that appear to be 
underpinned psychologically rather than physiologically. This is supported by international 
literature which highlights the efficacy of cognitive - behavioural interventions with such drug 
users. The challenge exists for clinical psychology within the drugs treatment agency to 
develop such a service.
3.4 Plan
The above aims and objectives laid down by the clinical audit will be achieved as follows:
Title: Camden and Islington Drugs Services: Service Development proposal
A proposed out patient treatment service for people who abuse 
stimulant drugs
Service development proposal, including:
i) review of the existing treatment literature: what it shows, what it lacks;
ii) examination of the needs of the target population within Camden and Islington;
iii) overview of proposed service delivery model;
iv) service development bid;
v) treatment manual providing an overview of sessions within each stage of treatment.
4.0 Research
4.1 Aims
Prime aim:
Either to increase research competence so as to develop the services offered by the 
department or profession, or to increase the knowledge available to the department or the 
profession.
Additional aims:
i) To pilot, evaluate and write up a treatment service for people who use stimulant drugs
(see clinical dossier).
4.2 Objectives
Prime objective:
To develop a research dossier, part of which will be the original MSc dissertation, which will 
either make evident increased research competence or will present a contribution to 
knowledge.
Additional objectives:
i) To develop knowledge of qualitative and quantitative measures developed for the
evaluation of services and their application.
ii) To use the outcomes of research to improve service delivery of the proposed
treatment model.
iii) To use the research dossier to pull together work from the relevant academic and
clinical dossiers.
4.3 Rationale
Camden, and Islington Drugs Services propose to offer a comprehensive assessment and 
treatment service for stimulant drug users by 1995. In order to justify bids for the extra 
resources necessary, the proposed service should be piloted, thoroughly evaluated and written 
up. While this piece of work is conceptually very different to the original MSc dissertation, 
it will address issues that will expand on and develop the research skills acquired at that 
time. Where the first dissertation used a one group pre test/ post test correlational design 
(all quantitative statistics), this dissertation will require a more flexible and creative use of 
qualitative statistics. Furthermore the current NHS challenges for audit and quality standards 
will be met with an exercise looking at service design and evaluation of outcomes.
4.4 Plan
Title: The evaluation of an out patient treatment service for people who abuse stimulant 
drugs
A six month pilot treatment package of individual and group psychological therapy for 
stimulant misusers will be evaluated. Evaluation will include the areas of:
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standardised measures of psychological, health and behaviour change; 
clients’ perceptions of and attitudes towards treatment (focus group);
Additional information:
sample size: n = 10 - 15;
Facilitators: T.S. and L.M., clinical psychologists.
The treatment package will be developed and outlined in the clinical dossier.
5.0 Portfolio outline
The portfolio will contain three dossiers each made up of the academic, clinical and research 
requirements of the conversion programme. The general theme of the portfolio is substance 
misuse and related areas. Individual pieces of work from each dossier may 
link to or form part of a more detailed piece of work.
In summary the portfolio will contain:
a) Academic dossier
Three essays of 3,000 words each around the following three areas:
i) Stimulant drug use;
ii) Health education, behaviour change and drug users;
iii) Sexual abuse and drug use.
b) Clinical dossier
A 7,000 word service development proposal for a stimulant drug users treatment service will 
include work highlighting the stepwise development of such a multi-faceted process.
c) Research dossier
An evaluation and review of a pilot run of the proposed stimulant service (see above) using 
a number of qualitative and quantitative measures.
6.0 Suggestions for training events
6.1 Lectures and seminars
service evaluation: theory and practice 
sexual abuse
neuropsychology of substance abuse 
general psychiatry (DSM IV, drug therapies etc.) 
models of health education and behaviour change 
forensic psychology
6.2 Workshops
cognitive behaviour therapy with ’personality disorders’
therapeutic interventions with women who have been sexually abused
SPSS
6.3 Other
peer led seminars, ie. using the skills mix and experience within the group.
Signed.. ...............  ..Participant
Tanya Sichel 
Clinical Psychologist
Signed .........................Head of clinical department
Dr Charlotte Feinmann 
Senior Lecturer
Signed....................A.........................................................................................   .Course Director
Dr Graham Powell
' -  10 - Clinical Psychologist
RECORD OF CONTTNUTNG PROFESSIONAL 
DEVELOPMENT
Tanya Sichel
PsychD conversion course; April 1994 - October 1995
The PsychD conversion programme was fully funded by Camden and Islington Drugs 
services as part of their programme of staff continuing professional development (CPD). In 
addition it was agreed that CPD time should be allowed at two sessions per week in order 
to fulfill the demands of the PsychD programme. As described in the Personal Study 
Programme, the PsychD academic, clinical and research dossiers all relate to current service 
development priorities within Camden and Islington Drugs services (the outpatient treatment 
of stimulant drug misusers) and work from this PsychD programme will be applied to the 
clinical setting and used for staff training.
Further CPD activities during the period of registration include the following:
i) attendance at SPSS and qualitative statistical analysis workshops run by the
department of Psychology at Surrey University;
ii) lectures and seminars organised by the Academic Department of Psychiatry, UCL, 
eg.:
* the CBT treatment approach to psychosis;
* sexual abuse and eating disorders;
* Cognitive Analytic Therapy: a one-day workshop;
* Substitute prescribing in the European Union;
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iii) Substance misuse: psychological theories and therapies: one-week conference, 
Maudsley Hospital, London;
iv) The Addictions Forum: international conference, Birmingham, (speaker and 
attended other presentations);
v) Psychology Special Interest Group: Addictions (PSIGA) - local and national 
training days, eg.:
* the outpatient treatment of stimulant misuse: literature review
(speaker);
* assessment tools for addictive behaviour;
. * amphetamine prescribing: treatment efficacy and outcome;
* family therapy and addiction;
* managing benzodiazepine withdrawal;
vi) The First International Conference on Gay Men and Sexual Health, London, 
(speaker and attended other presentations)
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Section Two
ACADEMIC DOSSIER
13
THE AF.TTOT.OftY OF STIMULANT DRUG MISUSE; 
implications and challenges for treatment
Introduction
It is widely recognised that drug dependence must be viewed as a multifactorial phenomenon, 
where an interactionalist approach to explanations of dependence and use bridges 
pharmacological, behavioural and social scientific levels. However, although an 
interactionalist approach is required for research progression, aetiological theories are still 
discipline bound, falling within one of three broad categories: constitution, individual or 
context. Such broad distinctions are used for academic convenience in order to provide an 
ease of explanation and most contemporary aetiological explanations of human behaviour 
employ a biopsychosocial approach. Within this approach are a number of levels of 
explanation that span a continuum from a macro to a micro level of analysis (Fazey, 1979) 
encompassing environmental theories looking at sociocultural factors; individual levels of 
explanation looking at personality variables within a range of biological, psychological and 
social theoretical models; and constitutional levels of explanation exploring biophysiological 
functioning at a micro level, including genetic predisposition and the pharmacological 
properties of the drug.
The biopsychosocial approach to stimulant drug misuse provides a useful model for the 
identification of probable aetiological factors in the development of an addiction to or 
dependence on the stimulant drugs used. Addressing the question raised by Marlatt (1988):
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"is it possible to match treatment modality with specific etiological factors?" (pg. 476)
biopsychosocial aetiological models provide the foundations for the development of treatment 
interventions where the selection of specific treatment modalities that address these factors 
may logically follow from a consideration of their aetiology. One of the guiding principles 
behind the biopsychosocial model of addiction is that careful assessment determines which 
specific treatment interventions are necessary for individual patients (Donovan & Marlatt, 
1988).
However, when using broad levels of aetiological explanation within the applied field, 
difficulties occur due to the conflicting theoretical positions that may arise along with 
corresponding conflicts in the recommendations for treatment, for example, "some 
approaches favour a disease model of etiology, whereas others focus more upon acquired 
psychosocial factors" (Marlatt, 1988, pg. 475). An example of this for stimulant drug 
misuse, might be given by a biological aetiological perspective as in the treatment of post­
withdrawal anhedonia which may be explained as a result of neurochemical events in the 
brain (eg. Gawin, 1989), or, by a psychodynamic aetiological model, as being one of the 
many defenses and/or emotional states that result from self-regulatory deficits and the 
individual has yet to learn how to identify, label, process and manage negative feeling states 
without the use of stimulants (eg. Kohut, 1977). The latter can be treated with educational 
and therapeutic support however not evaluating patients for the provision of anti-depressant 
medication can constitute an ethical neglect of some patient’s needs or failure to acknowledge 
the former explanation. Clinical practice has shown that only a careful functional analysis 
of the using behaviour, ie. an individualised assessment of a patient’s history, past and
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current functioning, mental status, and responses throughout treatment, can determine when 
a strategy is to be recommended and for whom. Clearly this would indicate the need for an 
assessing clinician to hold a good overview of the aetiological models described within the 
stimulant drug literature and an eclectic and flexible approach to treatment; the following 
discussion shall attempt to provide an overview of these models within a biopsychosocial 
framework.
L Biological aetiological factors
Stimulant drugs can be seen as uniquely addicting drugs based on their neurochemical actions 
(Wallace, 1991). Acute tolerance, rebound depression or the "crash" and "craving" have 
specifically been attributed to neurotransmitter depletion and receptor supersensitivity that 
follows chronic use (Holman, 1994). The neurotransmitters involved for cocaine, 
amphetamine and ecstasy use are dopamine, noradrenaline and serotonin respectively, 
neurochemicals located in the reward/ pleasure, limbic systems of the brain and involved in 
the regulation of mood states, satiation and emotional lability. The neurochemical changes 
produced by chronic stimulant use also explain the withdrawal syndrome, which includes 
lethargy, depression, oversleeping and overeating, in addition to a neurochemically based 
need for more drug: craving. With chronic or repeated doses, the neurochemical 
mechanisms produce cravings that can interact with the conditioning or learned mechanisms 
(Jones, 1987). This occurs as the user self medicates the craving and over repetitive trials, 
establishing stimulant administration as a form of negative reinforcement, where withdrawal 
dysphoria is alleviated. Positive reinforcement occurs when the reward of the stimulant 
euphoria ensures the maintenance of continued use. Therefore it seems that physiological
changes in the brain regulate psychological processes (Gawin, 1989).
While many individuals appear to use stimulants safely, or "recreationally", the "cumulative 
neurochemical changes produced, combined with progressive psychological reliance on the 
drug, can lead even the most casual user to compulsive use" (Rosencan & Spitz, 1987, pg. 
15). Such an aetiological explanation provides the basis for pharmacological approaches to 
treatment where pharmacological adjuncts might best be used during the early initial stages 
of abstinence, for the withdrawal syndrome characterised by the intense cravings, or 
following a relapse and return to chronic using. Such interventions logically arise out of the 
explanation that chronic stimulant using leads to deleterious changes in the brain 
neurochemistry which may precipitate a resumption of use as self-medication of such 
neurochemical disruption.
2. Psychological aetiologies
il Behavioural aetiologies
Using a behavioural level of explanation by appreciating the etiology of stimulant misuse in 
conditioning phenomena and in exposure to a social environment saturated with the product, 
it is possible to consider the theoretical rationale for the utilisation of behavioural 
interventions.
Washton (1989a) highlights that in the case of chronic users "a point is reached where the 
drug no longer produces any pleasurable sensations at all - only unpleasant ones - but the
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compulsion to capture the vividly remembered, illusive high, propels a continuing futile chase 
for paradise lost" (pg. 23). This quote illustrates the strength of the operant response to using 
stimulants as a result of the positive reinforcement of euphoria. This conditioning response 
is strengthened further by the effects of tolerance (where only an increase in the dose will 
produce the desired effect), which creates a partial or intermittent reinforcement sçhtàuXt. 
The role of negative reinforcement within the operant - conditioning paradigm is explained 
by continued using behaviour becoming established to remove the aversive stimuli of the 
"crash", dysphoria and cravings. Treatment interventions that logically arise from these 
explanations would include work around alternative means of managing aversive states, eg. 
pharmacological adjuncts and therapeutic interventions; work to identify alternative sources 
of positive reinforcement; and using "crash" reminders as aversive stimuli.
The classical conditioning paradigm (Pavlov, 1927), provides another layer of etiological 
explanation within the behavioural model. This paradigm explains how a state of anticipation 
results from the numerous pairings of once neutral stimuli (the paraphernalia of using; the 
context of using, ie. a rave, crack-smoking den, before sex) with stimulant using and the 
euphoric effects experienced. The implications for treatment follow logically with the aim 
of extinguishing the conditioned responses as seen in interventions such as relapse prevention 
and associated cognitive-behavioural techniques.
ii) Psvchobiological: Affective and Personalitv Disorders
Psychopathology may modify patients’ response to treatment, treatment outcome, the 
symptom picture, and the course of the addictive disorder in terms of how rapidly the
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addiction develops (Meyer, 1986). Dougherty and Lesswing (1989) characterize the literature 
on the psychological features and psychopathology of stimulant users, in particular the 
cocaine user, as rather scant and conclude that as a result conjecture and misconceptions exist 
about aetiology and treatment. Such conjecture and misconceptions may arise as there is no 
consensus on the relationship between psychopathology and drug dependence (Blume, 1989). 
The confusion over this relationship is confounded by the added question of which comes 
first: psychopathology or substance misuse? This question was first posed by Meyer (1986) 
who points out that axis I and axis II psychopathology may serve as a risk factor for the 
development of an addictive disorder, psychiatric symptoms may develop in the course of 
chronic drug use and some psychiatric disorders emerging as a result of misuse, persist into 
abstinence. A further hypothesis cites the possibility that the agonist effects of the stimulant 
and subsequent withdrawal probably precipitate depression or that the stimulant is used to self 
medicate a premorbid disorder (Kleinman et al, 1990). Withdrawal from stimulant drugs 
manifests as depression, anxiety, guilt and low self esteem, but it is unclear as to whether 
these symptoms are a product of the neurochemical withdrawal or to the unmasking of an 
underlying primary mood disorder, or a response to the social, financial and occupational 
problems that follow chronic drug use (Mirin et al, 1986).
There have been a number of research studies addressing the existence of a predisposing axis 
I and axis II disorder as a variable in the aetiology of stimulant misuse. Using a structured 
diagnostic interview, Gawin and Kleber (1986) report that 54% of cocaine patients (n =  30) 
presented with an axis I  mood disorder, the breakdown being: 13 % with major depression; 
20% with dysthymic disorder ; and 17% with cyclothymic disorder; and one subject with 
ADHD (attention-deficit hyperactivity disorder). Support for this work comes from Weiss
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and Mirin (1986) where of their sample (n = 30) 53.3% presented with an axis I mood 
disorder; 9% with unipolar depression and 7 % with cyclothymic or bipolar disorder. Further 
studies support these findings with similar rates reported for axis I mood disorders (eg. 
Wallace, 1987). This finding may be significant as it represents a greater incidence of mood 
disorders than typically reported in other substance misusers (Rosecan & Spitz, 1987). 
However, the studies do not report the use of a comparison group and therefore the results 
must be questioned as to whether they are specific to crack smokers or similar to rates found 
in the general population. Such data must also be interpreted with caution as erroneous 
assessments of major depression or bipolar disorder may be made if the symptoms of the 
stimulant '!orash" and their time course are not significantly acknowledged. Furthermore the 
use of stimulants is depressogenic and again misdiagnosis of premorbid mood disorders may 
be made in error. Therefore it is clear that diagnosis of mood disorders should be deferred 
unless a clear corroborating history or longitudinal assessments during periods of no usage 
are made.
Stimulant misusers who self medicate mood disorders and behavioural disorders such as 
residual attention-deficit hyperactivity disorder, may have been at risk for the development 
of stimulant dependence because of their constitutional or biochemical predisposition. There 
is incomplete evidence of a clear link between early childhood ADHD and adulthood self- 
medication with stimulant drugs, however a possible relationship is supported by evidence 
of good outcomes for children with ADHD who have been prescribed a stimulant medication, 
eg. Ritalin (Taylor & Hemsley, 1995). Failure to identify and treat ADHD properly can lead 
to high levels of frustration for children, parents and teachers, alienation towards school and 
home, academic failure, antisocial behaviour and problems with the law. Antisocial
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behaviour commonly leads to substance misuse and the confidence-enhancing and other 
psychological properties of stimulant drugs would also be attractive for adults with such 
difficulties and resulting low self-esteem (Mannuzza et al, 1993).
Axis I I  disorders (personality or developmental disorders) have been shown in samples of 
cocaine patients. In a larger sample study (n = 128), Mirin and Weiss (1988) reported 
presentations of borderline personality disorder (14%); antisocial personality disorder (16%); 
histrionic personality disorder (21%); and narcissistic personality disorder (24%); this data 
is supported with similar findings by Wallace (1987). This evidence is important because 
an axis II diagnosis correlates with psychopathology and substantially influences treatment 
prognosis (Meyer, 1986).
Taken as a whole, the data reviewed may be summarised as highlighting characterological 
defects, narcissism, and DSM IV documentable mood and personality disorders in the 
stimulant misuser which supports a self-medication hypothesis beyond that supplied by the 
neurochemical models of chronic use. To appreciate the nature of the treatment challenge, 
the psychopathology of the stimulant misuser, whatever its origin, must be recognised as a 
significant dimension of the treatment challenge.
iii) Psvchosocial etiologies
Stimulant-related psychosocial deterioration may be understood from an aetiological 
perspective as "adding insult to preexisting narcissistic injuries rooted in childhood traumata 
experienced in dysfunctional families" (Wallace, 1991). Psychosocial data on a sample of
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stimulant misusers in treatment provides evidence that 91% had been exposed to 
dysfunctional family dynamics in childhood (Wallace, 1990b). In this context the 
’dysfunctional family’ is described as one which is characterised by abuse (verbal, physical 
and/ or sexual) and neglect, and the structural boundsaries between parent and child are 
transgressed.
The view of the trauma produced by stimulant related difficulties and severe personal 
deterioration as resulting in narcissistic injuries is supported by the work of Bean-Bayog 
(1986). In her work with alcoholics, Bean-Bayog recognises two types of situations: 
pathological states and stress or trauma, where the character is unable to carry out its 
functions of "maintenance of homeostasis, regulation of self-esteem, preservation of ego- 
identity and containment of fluctuation in affect" (pg. 335). It might seem, therefore, that 
the deficits in self-regulatory capacities seen in chronic stimulant misusers, may have 
followed from the trauma of addiction; the narcissistic injury and trauma following from the 
experience of severe stimulant related deterioration may add insult to those preexisting 
narcissistic injuries sustained as children in dysfunctional families. This explanation allows 
further clarity when trying to answer the question posed by Meyer (1986): which came first 
the psychopathology (chicken) or the addiction (egg). It appears that the reality of childhood 
trauma, the incidence of stimulant related trauma and personal deterioration permit the 
possibility that psychopathology may both precede and/ or follow the drug use: permitting 
both chicken and egg aetiologies.
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iv) Psychoanalytic explanations
There are a number of psychoanalytic theoretical perspectiyes that may offer an aetiological 
rationale for the deyelopment and maintenance of compulsiye stimulant drug misuse. The 
following discussion will focus on Kohut’s theory of self psychology (1971, 1977): a 
theoretical perspectiye that also goes some way to proyiding an explanation for susceptibility 
to addiction.
In order to accept parental shortcomings, the child establishes a grandiose and exhibitionistic 
image of the self: the grandiose self - "I am perfect”, which diminishes the trauma of 
maternal shortcomings (seen as ineyitable in all parent - child relationships). The idealised 
mother, the perfection known prior to the child’s realisation that there are maternal 
shortcomings, is transferred from the mother to a transitional object: the idealised parent 
imago. In time and with healthy psychological deyelopment, both the grandiose self and the 
idealised parental imago are integrated into the adult personality. Howeyer, if aboye and 
beyond these normal and unayoidable parental shortcomings the child suffers some seyere 
narcissistic traumas, the grandiose self does not merge with the releyant ego content and is 
retained; similarly, when corresponding traumatic disappointments in the admired adult 
occurs, the idealised parental imago is retained and does not become the necessary tension- 
regulating psychic structure for the adult. Traumatic disappointments in the once - admired 
parental figure may include physical or yerbal abuse, parental alcoholism and domestic 
yiolence. Eyidence indicates that ACA’s (adult children of alcoholics) and ACDF’s (adult 
children of dysfunctional families) are at greater risk of substance abuse, eg. the alcoholism 
rate for ACA’s is four times greater than the general population (Goodwin et al, 1973), and
in a large sample epidemiological study of crack smokers, 51% were ACA’s and 91% were 
ACDF’s (Wallace, 1990b). Such experiences lead to ’narcissistic personality disturbance’ 
which involves a susceptibility to substance misuse where the substance compensates for self- 
regulatory deficits (ie. self-regulation of tension and self-esteem) by performing those 
functions. Such vulnerabilities leave the adult substance misuser to utilise the psychoactive 
effects of the drugs to replace a defect in the psychological structure.
To summarise, Kohut’s (1971) theory allows a rationale for treatment by arguing that deficits 
in self-regulatory capacities characterise those who are addicts. Childhood experiences may 
have been-sufficiently traumatic not only to have established an adulthood pattern of 
functioning characterised by the breakthrough of material from a dysfunctional childhood, 
but also to have created an overall pattern of narcissistic disturbance characterised by poor 
regulation of tension and self-esteem, and occasional depression, emptiness and boredom. 
These deficits in the selfs capacity to perform regulatory functions are linked by Kohut 
(1971) directly to addiction, where the concept of self-medication extends to include 
difficulties with the regulation of self-esteem and may point to a predisposition to become 
dependent on chemicals owing to recurrent painful affect states that relate to defects in the 
ego and self-capacities, leaving the individual ill equipped to regulate and modulate feelings, 
self-esteem, relationships, and behaviour.
3. Social aetiologies
While escalation into compulsive-use patterns has alot to do with the neurochemical actions 
of stimulants and behavioural conditioning, the social environment certainly plays a role in
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promoting its continued use. The social environment must be negotiated by patients when 
they leave the treatment setting and therefore the role of social-environmental factors must 
be acknowledged in the aetiology and maintenance of use. Extending the self-medication 
paradigm, some users have self-medicated feelings of boredom, alienation and low self­
esteem that may have their origin in other significant social-cultural factors. This explanation 
is most relevant for the understanding of compulsive crack cocaine use where certain of these 
factors operate most strongly in the socialisation experiences of minorities and women: two 
groups for whom crack has become an equal opportunities drug, in contradistinction to 
cocaine powder, which has been mostly utilised by middle- and upper-middle class white 
males (Wallace, 1991).
These feelings of boredom, alienation and low self-esteem, may be distinct from those 
feelings characteristic of people presenting with a narcissistic psychopathology. However 
many users presenting with a history of such feelings, have actually suffered narcissistic 
injuries as a consequence of a socialisation process that does not include expectations of their 
success. This argument may be extended to a deeper, psychodynamic level of explanation, 
as discussed earlier, where such narcissistic injuries may also be rooted in a history of 
painful object relations with significant representatives and authorities that may be the basis 
for low self-esteem or a continued unconscious collusion in fulfilling low or negative societal 
expectations.
Other social factors with an aetiological function may include the role of the stimulant drug 
industry in the provision of employment and financial gain for groups with poor prospects, 
as seen, for example, in the crack industries among the minorities of central America. The
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social factors underpinning crack use are quite specific and while they may be extrapolated 
to some degree to the use of other stimulants, these other drugs also come with their own 
levels of explanation. The rave culture, for example, has provided a context for the use of 
ecstasy in particular where the context of using and the peer expectations of use in such a 
context provide a social and environmental level of explanation (Abbott & Concar, 1992). 
Furthermore, the strongly associated use of stimulant drugs within the gay club scene has 
also promoted a number of aetiological theories rooted in the social context particularly with 
the impact of AIDS on the sexual and social self-esteem of this population (Paul et al, 1994).
Conclusion
This discussion has attempted to provide an overview of the multiple aetiological factors that 
play a probable role in the development and maintenance of stimulant misuse, within a 
biopsychosocial model. The discussion has considered the theoretical rationale for the use of 
pharmacological adjuncts in the light of the aetiology of stimulant misuse as related to 
neurochemical disruptions in brain function. A consideration of psychoanalytic approaches 
provides the rationale for the use of psychoeducational and therapeutic interventions to 
remedy the psychological consequences of childhood development in dysfunctional families. 
These experiences can leave individuals susceptible to escalation from experimental and 
recreational use to dependent or addicted misuse, supporting an aetiology based in acquired 
psychosocial characteristics. Reviewing the principles of conditioning and the influence of 
other social - environmental factors supported an aetiology underpinned by behavioural and 
learning theory models of explanation. It was proposed that operant conditioning explained 
the experience of the stimulant euphoria as a form of positive reinforcement, the further and 
increasingly regular use being to alleviate the dysphoria of withdrawal as a form of negative
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reinforcement, and the role classical conditioning in creating conditioned stimuli in the 
environment which become triggers to continued use.
This discussion has highlighted the necessity of drawing on a biopsychosocial theory in order 
to adequately account for the multiple, interacting aetiological factors that underpin stimulant 
misuse. Such a discussion provides the foundation for an exploration of treatments which 
may be applied to promote the successful recovery of stimulant misusers with high - dose, 
high - frequency using patterns, childhood histories in dysfunctional families, predisposing 
biological and psychological personality factors, showing established patterns of self - 
medication within social environments where peer influence, socio-economic pressure and 
the ready availability of the drugs promote relapse.
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CHANftTNft HIGH RISK REHAVTOURS: the application of 
health education strategies to drug misusers
Introduction
There is growing evidence that in certain areas there is a levelling-off in HIV prevalence and 
a decline in the HIV incidence among injecting drug users (IDU’s) (Stimson, 1991; Des 
Jarlais, 1992). Nonetheless, in Europe and the United States, IDU’s are currently the 
second largest group of reported cases of AIDS (WHO, 1991). In the United Kingdom 
IDU’s make up 14 percent of the reported cumulative cases of HIV infection (Public Health 
Laboratory Service, 1992) and a drug-injecting partner is reported for over 60 percent of first 
generation cases of heterosexual transmission (Evans et al, 1992).
The following discussion will consider the most recent epidemiological evidence of HIV - 
related risk behaviours in IDU’s, with specific focus on the sharing of injecting equipment 
and sexual behaviour. Such evidence appears to indicate that while the reduction in injecting 
risk behaviours has been seen as one of the public health successes of this century, new 
populations at risk from both the injecting and sexual behaviour of TDU’s are being 
described. This new evidence will then be considered in the context of models of health 
behaviour and prevention , and the implications and challenges for behaviour change 
interventions with this population discussed. The key questions that arise are not only 
whether targeted behaviour change interventions are necessary but also which interventions 
are realistic and appropriate for this still at-risk population.
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Sharing injecting equipment
Widely recognised as one of the most conspicuous risks of HIV transmission among drug 
injectors is sharing injecting equipment, particularly syringes, which have been contaminated 
by infected blood. It has been argued that there is mounting evidence of drug injectors 
changing their drug use and injecting behaviour in response to HIV infection and AIDS with 
the incidence of sharing continuing to decline over time (Donoghoe et al, 1991), and with 
sharing becoming less the norm, less indiscriminate and more selective (Burt & Stimson, 
1993). Recent research in London cites the prevalence rates among IDU’s as varying from 
5.4 percent (Public Health Laboratory Service Working Group, 1991) to 12 percent (Strang 
et al, 1992) with most studies reporting a prevalence rate between four and five percent (Hart 
et al, 1989).
The most recent study, however, has found a 12.4 percent prevalence rate (Rhodes et al,
1993). This is the first study to employ multi-site sampling strategies which recruit drug 
injectors from a range of treatment and non-treatment community-based settings. The higher 
prevalence rate is accounted for by the 65 percent of the HIV-positive respondents in the 
sample who were drug injectors not in treatment and recruited from non-treatment settings. 
This finding may challenge the widespread perception that injecting behaviour has 
significantly shifted towards risk reduction. The main body of current prevalence and HIV 
risk behaviour research remains dominated by highly selective samples of drug injectors 
drawn primarily from drug treatment agencies (Samuels et al, 1992). In order to increase 
the reliability and validity of epidemiological indicators of HIV prevalence and risk 
behaviour, research needs to focus on the "harder to reach" drug injectors and simultaneously 
recruit samples from a variety of treatment and non-treatment settings (Rhodes et al, 1994).
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Taking such factors into account and acknowledging that there still exist vulnerable popula­
tions of IDU’s exhibiting high risk injecting behaviours, it would seem that the current multi­
site sampling research is highlighting certain target populations for behaviour change 
interventions. Rhodes’ recent study (1994) highlights that drug injectors in London and 
Glasgow are showing overall risk reduction in sharing equipment with 22 percent of the 
sample borrowing and 31 percent lending equipment at the rate of at least once a month. 
However, it is important to recognise that each borrowing event presents an element of HIV 
risk and although respondents described increased syringe cleaning behaviour (a behaviour 
cited in other studies as further evidence of risk reduction, eg. Strang et al, 1992; Stimson,
1991), when further questioned it became apparent that most rarely used bleach and usually 
only rinsed with water - an inefficient strategy for inactivating HIV; this finding has recently 
been replicated in other studies, e.g., Ross et al, 1994. A further issue, raised particularly 
by the Glasgow sample, was that there were increased rates reported for lending equipment 
outside immediate social networks, ie. sharing with those that they do not know: increasing 
opportunities for "efficient epidemiological mixing of the virus" (Rhodes 1994, pg. 422).
In a recent multi-site sampling study, Gossop et al (1993b) have highlighted a number of 
specific factors and processes as significant for sharing and which indicate specific 
populations at greatest risk. The major finding is that severity of dependence is associated 
with increased rates of passive sharing and that the more dependent poly-drug user appears 
to share in private settings or custody often when in withdrawal or intoxicated. Current 
criminality has been found to be an independent predictor of sharing in other studies and may 
indicate greater entrenchment in a risky lifestyle (Darke et al, 1994). The less dependent 
user shares less but is more likely to share with casual acquaintances in social settings, a
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finding which may relate to Rhodes et al, (1994) reference to epidemiological mixing. These 
differences in sharing partners and the injecting context clearly highlight the need for 
preventive efforts to be precisely targeted according to the degree of dependence.
A central feature of intervention policies is the provision of free, sterile equipment, usually 
from needle exchange schemes. However, recent evidence indicates that providing sterile 
equipment in this way may not be as effective as previously considered with indications that 
general availability is only useful if such availability extends to the time and place of the 
injection. Respondents in two major prevalence studies highlighted that drug injection is 
most likely to occur late in the day and at night, times when needle exchanges are closed and 
thus when sharing is most likely to occur (Gossop et al, 1993b; Ross et al, 1994). Indeed, 
services in Copenhagen and Amsterdam have responded to this problem by providing 
injecting equipment on a 24-hour dispensing machine basis.
Finally, a number of studies have highlighted that neither the risk perceptions of HIV nor 
general awareness of the issue were related to significant risk reduction (e.g. , Gossop et al, 
1993b; Darke et al, 1994). Klee et al (1990), also found that although there was a link 
between general health awareness and sharing behaviour, knowledge of AIDS was not signifi­
cantly associated with sharing. Donoghoe et al (1992) found syringe sharing to be related 
to social circumstances and lifestyle factors rather than to individual motivation, and Hartgers 
(1990) also suggested that risk reduction is strongly associated with social/environmental 
factors and weakly with health beliefs. This would indicate that education programmes may 
only be effective in the context of practical social/ environmental measures (Gossop et al, 
1993b). Furthermore, such evidence offers a direct challenge to the efficacy of prevailing
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models of behaviour change for this population which target individuals’ attitudes, beliefs and 
motivation systems; this will be discussed more fully later.
In summary, increased risks for sharing injection equipment in IDU’s are: severity of 
dependence and drug use profile; increases in the lending of equipment outside immediate 
social networks; unavailability of equipment at the time of injection; and environmental, 
situational and contextual determinants. Although evidence indicates a marked reduction in 
injecting risk behaviours, such a reduction may not be as significant as popularly argued 
while methodologically more reliable research highlights populations still clearly at risk of 
infection or transmission of the virus: often hidden populations not in contact with treatment 
settings.
Sexual behaviour
Estimating the risk on the basis of drug injecting and sharing behaviour covers only part of 
the epidemiological equation necessary to assess current and future HIV spread. HIV is, 
primarily, a sexually-transmitted virus. Of worldwide HIV infections, 70-80 percent are 
thought to be acquired through sexual intercourse (Chin, 1991). The majority of drug 
abusers are young and sexually active (Hart et al, 1989), with the heterosexual transmission 
of HIV in the United States being largely as a result of sexual contact with drug injectors - 
perhaps 87 percent of all heterosexually transmitted AIDS cases (Des Jarlais & Friedman, 
1987). It is now evident that heterosexual sex is now a more important risk factor for drug 
users than needle sharing (Gossop et al, 1993a).
Prior to the identification of HIV infection among drug injectors, very little research was
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done upon the sexual behaviour of drug users. To some extent, the risk of sexual trans­
mission of HIV among drug injectors has been eclipsed by this primary focus upon injecting 
behaviour (Strang et al, 1992). Although clearly there are groups at risk from their injecting 
behaviour, the shift towards risk reduction in the injecting area has led to an increased focus 
on the sexual risk behaviours of drug users and the findings highlight some worrying trends. 
The majority of all drug injectors are sexually active (White et al, 1993). Levels of 
heterosexual activity among drug injectors are comparable with those in the adult population 
as a whole although drug injectors exhibit a greater rate of partner change (Rhodes et al,
1994). A number of recent multi-site sampling studies consistently report low levels of 
condom use, particularly in private heterosexual encounters in couples who perceive 
themselves as having a long-term relationship (Gossop et al, 1994a; Rhodes et al, 1994). 
Couples also seem to exaggerate the importance of often lower utility precautions that they 
are taking, i.e., only taking partners who look "clean”, who they "trust" (White et al, 1993). 
These findings are similar to the general heterosexual population, as is the finding that 
condom use with casual partners is higher than with regular partners (Klee et al, 1991).
Severity of dependence has, again, been found to be a factor in the prevalence of this risk 
behaviour. Higher severity of dependence scores (SDS) in women were related to greater 
sexual activity (both vaginal and anal) and number of partners mostly due to the association 
of SDS and prostitution (Gossop et al, 1993a). More severely dependent and regularly 
working prostitutes showed greater condom use with sex clients but not with regular partners
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who they "trusted" and did not want to make "feel like a punter". (Klee et al, 1990). 
Severely dependent men who have sex with men are least likely to use condoms (Gossop et 
al, 1993a).
There also remains a significant risk of HIV transmission to the non-injecting partners of 
drug injectors, in particular women, significant proportions of whom never use condoms 
(Rhodes et al, 1994). Given the average rate of partner change, the high proportion of drug 
injectors with non-injecting partners and the infrequency of condom use within primary and 
casual relationships, such partners, particularly women, are substantially at risk. It seems 
that this is further compounded if they are partners of injectors not in contact with any form 
of treatment facility who, as discussed earlier, are more likely to be engaging in drug-taking 
behaviours that carry an increased risk of HIV transmission; indeed, the most recent 
prevalence study found that injectors not in treatment were almost twice as likely to be 
confirmed HIV-positive (Rhodes et al, 1994). Furthermore, many male IDU’s state that they 
would never volunteer to use a condom unless a woman insisted, highlighting further the 
risks to, and responsibilities of, women partners of IDU’s (Klee et al, 1990).
As has been found for injecting risk behaviours, the knowledge, beliefs, attitudes and 
interpersonal factors of IDU’s had little bearing on their decisions about condom use, with 
situational factors playing greatest importance: intentions to use condoms will be overridden 
by lack of availability at the time of intercourse (White et al, 1993). This is emphasised by 
the finding that reported use is substantially lower than intended use, most often due to 
having no condom available. Intention to use is found to be a most reliable predictor of 
behaviour if the individuals themselves are HIV positive; however, knowing someone who
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is HIV positive does not affect behaviour (e.g., White et al, 1993; Klee et al, 1992).
In summary, while a significant minority of IDU’s continue to share injecting equipment, 
greater numbers exhibit sexual behaviour at high risk for HIV transmission. Risk factors for 
this population include: severity of dependence; an increased rate of partner change; low 
condom use with the primary sexual partner; non-injecting partners, usually women, at 
greatest risk; and increased risk behaviours shown for non-treatment populations of IDU’s.
Models of health behaviour and prevention: implications and challenges
Behavioural research has, to date, provided a descriptive understanding of the psychological 
and social factors related to risk taking behaviour. However, after 12 years of this epidemic, 
there is an enormous gap in the research evaluating outcomes of targeted interventions to 
prevent virus infection and transmission (Kelly et al, 1993).
Explanations provided bv health behaviour models
The major role for preventive education is to create widespread consensus about the epidemic 
and positive strategies available to contain it. A health behaviour model useful in this context 
is the Protection Motivation theory o f Fear Appeals and Attitude Change (Rogers, 1975). 
This model emphasises the role of three critical cognitive responses to health messages: an 
appraisal of the severity of the disease; the expectancy of exposure to it; and a belief in the 
efficacy of the recommended coping response. The rationale is that behaviour change will 
not occur if values on any of these variables is zero. In relation to the data presented, it 
would appear that expectancy of exposure is, indeed, a prime determinant of behaviour. 
IDU’s have been inundated with preventive education focusing on injecting behaviour and
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HIV, while sexual contact is not often mentioned (Klee, 1990). Therefore while expectancy 
of exposure is high, the source of that exposure is less likely to be seen as sexual interaction.
This preventive issue of condom use presents a challenge given the now well documented 
resistance shown by the general heterosexual and IDU population to their use as a risk 
reduction strategy. The Theoty o f Reasoned Action (Fishbein & Azjen, 1975) provides a 
health behaviour model useful for the interpretation of this phenomenon. This model 
emphasises the role of the subjective norm (the influence of significant others) in behaviour 
change. Negative feelings towards condoms are well documented among both the IDU and 
general population (Evans et al, 1992). Within the IDU population it was the experienced 
and regularly working prostitutes that exhibited highest rates of condom use; within this sub - 
group there is evidence of real concern about the risks associated with sex and the consequent 
acceptance of condoms (Klee, 1990). However, these prostitutes are showing similar low 
levels of consistent condom use with non - commercial, primary partners, similar to the rest 
of the IDU and general populations. Sexual health campaigns have, it seems, got a long way 
to go in the promotion of condoms as part of loving, partner sex while the prevailing 
subjective norms will support the continuation of antipathy towards them.
Personal efficacy is also described as a key variable in behaviour change and is, again, 
relevant to this discussion. The Health Belief Model (Becker, 1974) highlights the value of 
personal efficacy in behaviour change and is supported by Azjen and Timko (1986) who 
found that perceived control over health related actions was strongly associated with self 
reports of those actions. With reference to drug using populations still most at risk from 
unsafe sexual and injecting behaviour, it is clear that for many, personal control in the
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context of the behaviour is significantly undermined by the context of that behaviour. Male 
prostitutes, widely seen as low regular condom users, represent one such vulnerable group 
where "risk practices are constrained and emergent from the immediate circumstances of the 
sexual encounter" (Bloor et al, 1992; pg 131).
Preventive intervention models
The examples given above of models of health behaviour are useful in the understanding 
of HIV related risk behaviours and IDU’s, but are not sufficient to inform the design of 
preventive campaigns. Moving from the theoretical to the applied fields, it might be useful 
to briefly describe some of the promising behaviour change approaches that have already 
been identified in the AIDS - HIV prevention and general health behaviour fields and are 
relevant to the at risk IDU populations.
Cognitive - behavioural skills training models work on the principles of social - learning 
theory and have shown good outcomes in the area of condom use among gay men. Group 
interventions teaching risk reduction skills including condom use, safer sex negotiation, 
sexual assertiveness when confronted with risk coercions, self - management of risk triggers 
and problem solving strategies, have shown substantial reduction in high risk sexual 
behavioural practices (eg. Kelly & St Lawrence, 1990; Valdiserri et al, 1989). Such models 
show promise but the good outcomes have only been shown with small samples of select 
groups of motivated volunteers, over brief follow up periods. Implementation and evaluation 
of such an approach among the IDU population would need to be translated into cost 
effective delivery formats capable of reaching large numbers of less highly selected samples.
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Populations at risk must be convinced of the value of attending such interventions, ie. the 
social consensus would need to be positive towards the value of the risk reduction strategy. 
Among the IDU population, it is clear that social consensus is greater for the perceived value 
of safer injecting practices than it is for safer sex. Social norm change models provide a 
useful framework for the design of such interventions which would aim to make sexual risk 
reduction socially normative within vulnerable populations (Coates, 1990). A number of 
models developed for use with American gay men show promise: eg. peer education (Bye, 
1990) and diffusion of innovation (Rogers, Peer education models utilise a
networking approach combining risk education and skills training lead by peer educators. 
The diffusion of innovation model similarly argues that population behaviour and perceptions 
can be influenced by innovative trends initially initiated and communicated by trend setters 
in the population, and which will diffuse and become normative over time. It has recently 
been argued in the British research literature that such interventions are the primary way 
forward in preventive work with IDU’s (Rhodes, 1993). Mass level interventions focused 
specifically on changing social norms have, again, to date only been attempted with gay men. 
Given the impracticality and expense of face to face interventions for curbing an epidemic 
that requires quickly reaching large numbers of people, research evaluating mass 
interventions is critical.
Such mass interventions have been designed and evaluated with positive outcomes in other 
areas of the health behaviour change field: eg. the Stanford City Projects aimed at 
cardiovascular risk reduction (Maccoby & Altman, 1988). Such campaigns utilise a 
multifaceted community mobilisation model and combine applications of print broadcast and 
other mass media; social marketing; peer lead modelling; environmental and policy changes;
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and empowerment and social structure change elements intended to promote maintenance of 
risk reduction after the intervention (Winett, 1989). Risk reduction observed in the injecting 
practices of urban IDU’s is probably due to such multifaceted, grassroots, community 
mobilisation campaigns incorporating many of these elements (Kelly et al, 1993). In the IDU 
community, such behaviour changes have been seen after extensive street outreach AIDS 
educational campaigns; encouragement of HIV testing; improved access to drug treatment 
services and the significant contribution of the needle exchange schemes. However, HIV 
prevention programmes targeting IDU’s have been slow to emphasize sexual risk reduction 
changes as well as changes in drug taking behaviour: recent research findings affirm the need 
to focus simultaneously on the encouragement of safer injecting practices and safer sexual 
practices (Rhodes et al, 1994). The evidence described highlights the urgent need to focus 
on the relationship between patterns of drug use, sexual activity and safer sex compliance 
(Rhodes & Stimson, 1994). The hidden populations, the ’hard to reach’ drug users and their 
sexual partners not in contact with treatment services, are a particular group at risk from both 
high risk injecting and sexual practices; proactive interventions combining treatment and 
outreach expertise are top priority.
Conclusion
Behavioural research in the area of IDU’s and HIV/ AIDS risk behaviours has been detailed 
and thorough, particularly within the area of injecting practices. While there has been some 
reduction in these practices, it is clear that preventive work needs to focus on specific 
populations still exhibiting high risk injecting and more generally on the sexual behaviours 
of the wider IDU population. However, the HIV epidemic is no longer new, and prevention 
priorities must now quickly change to those focused on intervention development. It would
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seem that the most pressing needs are for large - scale, fast - track evaluated fields of 
promising intervention models that more closely merge prevention research and prevention 
services and are capable of changing the course of the HIV epidemic rather than just 
documenting it.
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CRTTTCAL TSSTJES TN THE FIELD OF SEXIJAT. ARTTSR 
WITH SPRCTAT. REFERENCE TO PEOPLE WHO MISUSE 
DRUGS
Introduction
There is now a large body of literature identifying the trauma and adverse consequences of 
childhood sexual abuse (CSA). Among the most frequently observed correlates are substance 
abuse, low self esteem, impaired social skills, suicidal ideation, promiscuity and withdrawal 
(eg Brieve & Runtz, 1987; Gelinas, 1983). This paper provides an overview of the literature 
that highlights the relationship between adult substance misuse and CSA: looking at incidence 
and prevalence, functional explanations for this relationship and finally discussing 
implications for treatment and further research.
The relationship between CSA and substance misuse
Following the early work of Finkhelhor and his colleagues (1979) which put the issue of 
CSA on the research agenda, clinicians and other researchers began to explore the long term 
sequelae of such a traumatic early life experience. The relationship between CSA and 
substance misuse is an important research question, although direct causal links are difficult 
to ascertain (Coleman, 1987). Studies exploring this relationship tend to be of two types: 
clinical reports and interviews with imprisoned adolescents. The clinical populations include 
adolescents (eg Hernandez, 1990; Harrison et al, 1989), adult females (eg Swett et al, 1991; 
Ladwig & Andersen, 1989) and gay men and lesbians (eg Neisen & Sandal, 1990) under 
treatment for substance misuse.
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Numerous studies report adult substance misuse to correlate with CSA and neglect (Riggs et 
al, 1990; Dembo et al, 1988). Rates of CSA are high among chemically dependent 
adolescents in clinical populations (Rose et al, 1991; Burgess et al, 1987), with rates of 
incest at 7 - 9% and rates of extrafamilial sexual abuse at 13% (Cavaiola & Schiff, 1988). 
Both CSA and/or substance misuse occur more often among children whose parents 
themselves have histories of both or either (Burgess et al, 1987; Hawkins et al, 1985), and 
in many cases, parents’ substance misuse precedes abuse of their children (Daro, 1988). 
Among imprisoned substance misusers, the rate of sexual abuse has been estimated to be 
20%, highlighting the link, at times, with anti - social conduct disorders. In many cases 
substance misuse began in adolescence (Ladwig & Andersen, 1989), where, for example, in 
one study it was found that 59% of substance misusers were sexually abused adolescent girls 
(Singer et al, 1989). In adult clinical populations the number of female clients reporting CSA 
range from between 30 - 70% (Miller et al, 1987), while for men the proportions are 
substantially less ranging from 6.6-24% (Dembo et al, 1990).
Dembo and his colleagues have used intensive interviews in their pioneering work to study 
the effects of CSA on populations of imprisoned adolescents (Dembo et al, 1987, 1988 a & 
b, 1989, 1990). The findings from these studies are striking and consistent: sexual abuse has 
been highly correlated with drug and alcohol misuse as well as contributing to other forms 
of delinquent behaviours. This relationship is found with particular drugs: amphetamines, 
depressants, cocaine and marijuana (p < .001; Dembo et al, 1990). Such findings appear 
to be consistent across gender, over time and across samples. They conclude that CSA 
precedes and contributes to alcohol and other drug misuse by adolescents and adults, 
particularly marijuana and cocaine. This supports the earlier key study of Miller et al
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(1987), who found that female risk of alcoholism in later life is substantially effected by the 
experience of sexual abuse in childhood and early adolescence.
More recent studies have focused on the non - clinical population, in particular samples of 
adolescent girls surveyed in schools. Such non - clinical population surveys support the 
earlier research on clinical and imprisoned populations, where:
"significant but weak correlations have been found in this [adolescent girl] sample between 
sexual abuse and alcohol and some other forms of drug use, as well as other self - reported 
delinquent behaviours" (Watts & Ellis, 1993).
It would seem that this literature is almost entirely devoted to the woman who has been 
sexually abused, while research on male CSA has only recently begun (eg Reinhart, 1987) 
and this research has been difficult to conduct for several reasons. The fact that many boys 
are abused by men presents a problem to researchers given family secrecy around such 
incidence due to the stigma associated with homosexuality (Finkhelhor, 1984). Finkhelhor 
(1984) also suggests that boys may not report incidents of CSA because they are socialised 
to be self - reliant and not talk about their problems. Recent research addressing this 
problem has highlighted the similarity in presentation of boys/ men and girls/ women with 
histories of CSA: specifically, they show psychological distress, especially agitation, and are 
markedly suicidal; they have misused substances since a young age, at least in part to self - 
medicate their distress; and they have been in more serious trouble with the law than their 
peers (Harrison et al, 1990).
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Theoretical explanations
Theoretical explanations for the relationship between CSA and drug misuse have not been 
well developed. A useful explanatory model can be developed, however, between 
psychodynamic interpretations of personality development and a functional analysis of the 
substance misuse. One suggested mechanism is that experiences of sexual abuse leads to 
negative self - concept and self - imaging (Finkhelhor, 1979). Such negative emotions then 
may lead to depression and anxiety, emotions reported as significantly experienced by female 
substance misusers, while substance misuse is reported as being for the relief of these 
unpleasant feelings and usually began in early adolescence (Watts & Ellis, 1993).
Most adolescents experiment with alcohol and drugs. What usually mitigates against this 
experimentation developing into misuse is a sense of self - protection and good family 
relationships (Barrett & Trepper, 1991). In the abusive family, children’s voices are not 
heard, generational boundaries are not well defined and parents use children to meet almost 
all of their needs. The child may increase their drug use to increase self esteem and reduce 
isolation by belonging to a peer group which supports such activities without requiring the 
interpersonal closeness that can represent potential abuse. Some children report feeling 
different to other children as a result of their sexual abuse experiences (Ladwig & Andersen, 
1989) and may seek identity with groups of peers who are more deviant and for whom 
substance misuse is viewed as more normative. Furthermore, as this early pattern is laid 
down, the drugs themselves may become important coping strategies helping to avoid 
negative internal states and painful memories.
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Many of the subsequent consequences of CSA can be understood as the continuation of 
learned adaptive, coping and defence mechanisms developed as survival techniques around 
the time of the abuse but which become maladaptive in later life and adult relationships. 
Defensive responses and patterns of behaviour which occur in situations of high emotional 
arousal such as the fear and terror associated with sexual abuse, tend to be imprinted or 
learned at a deeper and more profound area of the personality (Dale, 1992). These defensive 
processes can then become an integral part of the developing personality and become 
enduring traits into adulthood.
CSA can be understood as having long term physical, emotional, cognitive, social and sexual 
consequences (Dale, 1992). The physical consequences are recognised by the wide range of 
largely involuntary physical and psychosomatic conditions that are known to be associated 
with CSA. Emotional pain may be manifested or displaced in almost any form of physical 
pain and the process of dissociation between mind and body is often highlighted as a common 
childhood coping strategy where the body is experienced as a separate ’out there’ entity, the 
mind remaining free while only the body is being abused. Drug use in adulthood may be 
part of a progression in this coping mechanism, encouraging adults to seek out the 
dissociation - causing effects of the drugs in a way similar to those in which they 
psychologically dissociated as children (Singer, 1990). Escapism, similar to dissociation, 
is often reported as another mechanism for coping where substance misuse may offer a 
chemically induced mechanism for forgetting, particularly in relation to the repression of 
disturbing images and ’flash back memories’ (Beckman, 1980).
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Physical sequelae of CSA may be in the form of enduring physical trauma or involuntary 
somatic responses to the abuse. Symptoms commonly reported include: sleep disturbance, 
chronic muscle tensions, headaches and migraines, eating disorders, genito - urinary and 
bowel problems, seizures and panic attacks. The symptom may hold symbolic importance 
to the individual or play an unconscious role, where retaining the symptom is an important, 
continued coping mechanism which may be best managed through a process of self - 
medication in adulthood. Furthermore, adults with a history of CSA may have such powerful 
self - destructive drives that they misuse substances not for relief but for punishment, 
symptom generation and perhaps even to toy with death.
These theoretical arguments are borne out by the Herman et al study (1986) of 206 women 
with a history of CSA. This study emphasises the long - term symptoms of CSA seen 
throughout the life span. The evidence is that often symptomatology presents as Post 
Traumatic Stress disorder with particular manifestations of social withdrawal and self 
injurious behaviours. While the abuse has been devastating to the ego structure and leaves 
the individual vulnerable to revictimization, the emergence of repetitive compulsion 
behaviours are likely to continue: reinforcing the victim role. Such behaviours are 
maladaptive coping mechanisms, a primary one being substance misuse. Such repetitive 
compulsion behaviours extend their influence to chemical dependency, compounding the 
issues necessary in addressing the original problem.
Implications for treatment
Given the long term physical, psychological, emotional and social correlates of CSA and the 
role of the substance misuse in the management of these difficulties, clearly the treatment of
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the substance misuser with a history of CSA needs special consideration. Rosenhow et al
(1988), studied substance misusers in treatment and found that the high prevalence of CSA 
was a contributing factor to both the aetiology and maintenance of the substance misusing 
behaviour, and that there was a higher occurrence of early relapse in individuals failing to 
disclose. Herman’s work (1986) supports this, concluding that untreated repetitive 
compulsion behaviours will lead to a higher probability of relapse. Chiavoroli’s recent work 
(1992) found that of a sample of sexually abused substance misusers in treatment, 25% 
presented a need for further treatment following failed detoxification, and of this subgroup, 
10% experienced relapse after their first admission into treatment. This study also 
highlighted 4he fact that disclosure in itself does not hold a better prognosis, since a 
significant proportion of relapsers who did disclose were "unable to disengage these 
maladaptive coping behaviours" (Chiavaroli, 1992). In general this research suggests that 
there is a need to address and encourage disclosure of CSA in persons receiving treatment 
for substance misuse in order to maximise treatment and enhance outcome.
This research suggests that clinicians should seek information regarding CSA. Frequently, 
substance misuse serves as an indication that some other issue is affecting an individual; the 
solution to the problem also holding functional significance as the symptom. This would 
highlight the importance of making clinical histories thorough and detailed in order to 
provide a background of explanation for the presenting behaviours. With an understanding 
of the functional representation of these behaviours, individuals may begin to identify more 
adaptive behaviours. However, research has shown that the extinction of behaviours long 
established as protection takes time, and therefore this process may require long - term 
therapy as well as involvement with other support services (Finkhelhor, 1984).
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Clearly this argument is based on the premise that such ’psychodynamic’ explanations for the 
relationship between substance misuse and CSA are correct. However, it is an issue that 
must be given careful consideration for a number of reasons. Firstly, the treatment of 
addictive behaviours is renowned for high rates of ’treatment failure’ or relapse, an issue 
which needs a greater depth of analysis and explanation than that given as rationale for the 
development of ’better models of treatment’. Secondly, assessment, an important part of the 
treatment process, needs careful review in the field of substance misuse where, it can be 
argued, the role of the ’symptom’ is, within the prevailing medical model and prescribing 
regimes, given too much primary significance. Finally, within the multi - disciplinary 
treatment setting, the clinician must assume responsibility for serving the whole person and 
not just one symptom of their behaviour.
Interventions
The international literature highlights that while recognition of the problem is increasing, 
very few agencies are actively applying and analysing interventions targeted at adult 
substance misusers with a history of CSA (eg. Barrett & Trepper, 1991; Chiavaroli, 1992). 
The first issue that agencies need to recognise is the necessity of identifying the issues of 
CSA. Many staff groups may feel inadequately trained or anxious about the way to question 
clients and how to manage the response they might receive. However, all the intervention 
itself requires is an empathie and compassionate therapist who provides a safe space for 
disclosure. It has been suggested that the therapist may say something like:
"In my experience, many women who had problems similar to yours had sexual relations 
when they were children, with an adult, quite possibly a family member. This might not
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make any sense to you now, but if over time you have a memory or feel safer telling me 
about any scary sexual experience, I want you to know that it is pretty common with
women.
(Barrett & Trepper, 1991).
The client may not disclose at the time but the subject is now in the open. At this point, it 
is imperative for the therapist to remember that denial helps the individual deal with the 
overwhelming intensity of the abuse and the deep sense of shame, while disclosure followed 
by retraction is now acknowledged to be a very common occurrence for similar reasons 
(Finkhelhor, 1979).
Following disclosure there are a number of interventions suggested in the literature. Barrett 
and Trepper (1991) have developed interventions for women based on a multiple systems 
perspective, divided into three stages: creating a context for change; challenging behaviours 
and expanding alternatives; and consolidation. The programme offers a combination of 
individual, partner, family and (if possible) family - of - origin sessions. Treatment length 
is a minimum of one year, most usually two, with the authors arguing that for such 
individuals, brief therapy is not an option given the layers of dysfunctional patterns of 
behaviour to be challenged and shifted. The authors argue that although it is easier to 
explain the origins of CSA within the traditional perpetrator - victim framework, the multiple 
systems model attempts to integrate the more salient features of the perpetrator - victim, 
family systems and ecosystemic explanations. Therefore, the model explains CSA as 
resulting from the interaction among various external, family and internal systems rather than
focusing on only one. In this way it is recognised that responsibility is not the sole cause, 
and in order to fully understand the cause and to effectively intervene, it is imperative to 
accept that "the complex interactions among various systems make a family more or less 
vulnerable to the development of incest" (Barrett & Trepper, 1991).
The Multiple Systems Model, (see figure 1), is an individual intervention model and is 
therefore resource intensive. Although it may not be ideal for use in traditional NHS drug 
treatment agencies, it certainly provides a useful framework for intervention. It is, however, 
important to acknowledge that this model is recently described and has only been validated 
via single case studies; to date there has been no large scale comparative study of outcome.
Group therapy has also been suggested for this population (Chiavaroli, 1992). Groups 
provide a way of sharing a secret in a supportive atmosphere that maximises bonding. 
Secrecy is central in CSA because the behaviour usually occurs in isolation. It has been 
observed in clinical practice that the child is often ashamed because the perpetrator may 
indicate that the activity is wrong and that the child is at fault but must keep the secret. The 
child may feel abandoned by the mother who may be seen as colluding with the abuser. 
Since the experience is associated with rejection by authority figures, the client may think 
that her/ his disclosure may be ignored, not believed or precipitate discharge from treatment. 
Transference issues with the therapist may be displayed in exaggerated feelings of anger and/ 
or idealisation, where s/he becomes the sadistic parent; such intense feelings may not only 
reduce the likelihood of disclosure but also encourage poor treatment progress as punishment 
to the therapist (Winnick et al, 1992).
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A survivors group offers the opportunity to be supporter as well as supported, it allows more 
painful memories and feelings to be ’normalised’ in the face of other group members’ 
experiences. Winnick et al (1992) describes such a group as part of an inpatient drug 
rehabilitation centre in New York. The weekly group of 15 women resulted in a significantly 
greater retention and graduation rate as compared to their peers in the centre. Members 
highlighted some key features that they found most positive about the group: reducing 
isolation; helping deal with denial; clarifying relations with children and significant others; 
and facilitating dealing with associated guilt and shame. The "impressive therapeutic 
progress of the survivors, which is attributable to the group, suggests the possible utility of 
such a group for other therapeutic communities and treatment programmes" (Winnick et al,
1992). This group has been reported as a descriptive study and outcome was determined by 
retention in treatment where women attending the group were more likely to complete the 
drug rehabiltiation programme. Results were reported qualitatively in the form of single case 
studies and group process and therefore it is not possible to draw firm conclusions about the 
efficacy of this approach. However the authors’ description of the group was clear and could 
easily be replicated in further studies. Given the tight resources of most drug treatment 
agencies, the group approach is immediately attractive.
A final treatment approach focuses on prevention, A survey of american adolescent females 
in grades seven to twelve in a suburban school system found significant correlations for CSA, 
drug misuse and delinquency (Watts & Ellis, 1993). The authors argue that identifying the 
extent of CSA in a community or school system will help to identify the need for counselling 
and other programmes that are designed to assist children through a recovery process. The 
sense in this is obvious: from a therapeutic point of view, as long as the underlying and
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highly stigmatising traumas are unresolved, it is unlikely that substance misuse and other 
problem behaviours can be either prevented or treated. Given that antecedents to substance 
misuse are set well before secondary school, prevention needs to begin at the middle junior 
stage. How realistic this is given current government policy on sex and drug education is 
debatable but, as we now i\ee with the crack problem in the inner cities, it would sensible for 
us to take notice of the american experience earlier rather than later.
Implications for future research
Future research must address the substance misuse histories of the perpetrator vs non - 
perpetrator members of the families, the time of onset of the CSA and substance misuse 
among the adolescent population, and whether or not the abused themselves were misusing 
substances at the time of the abuse. Little is known about the reasons abused individuals 
choose and use substances. Some may select drugs which counteract depression, anxiety and 
anger caused by the abuse, others may already have an underlying predisposition to misusing 
substances, as evidenced by the huge overlap between parental substance misuse and a history 
of CSA (Daro, 1988). For research purposes, the use of detailed interviews for data 
collection will be helpful. For clinical purposes, these findings suggest that screening 
adolescents and adults for a personal and family history of substance misuse and sexual 
abuse, whenever the others are documented, might be in order.
Conclusion
The evidence presented in this paper suggests that significant numbers of substance misusers 
in treatment may also have histories of CSA (eg Brieve & Runtz, 1987). Substance misuse 
represents a survival response and is only a superficial indication of the depth of the
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problem, sexual abuse. It has been found that individuals initially seek treatment for 
corollary behaviours, actually a disguised presentation of the CSA (Gelinas, 1983). In cases 
where CSA has not been identified further treatment of the behavioural correlates will be 
necessary, as high rates of relapse occur. Hence, the perpetuation of behaviours correlated 
with CSA continues as a survival response to the previous trauma. It is also evident that 
much is still needed to clarify the relationship between treatment offered and outcome. This 
would be helpful in providing a comprehensive explanation for and an understanding of the 
specific effects of CSA on the prognosis for recovery from substance misuse. Further 
research is necessary to provide information regarding the means by which to address issues 
in the course of treating substance misuse; it would arguably be appropriate for such research 
to be clinically based as the time for understanding and treating this complex and distressing 
experience of our clients is overdue.
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Section Three
CLINICAL DOSSIER
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INTRODUCTION
The prime aim of this dossier is to present work on developing current services offered by 
Camden and Islington Drugs services (C&IDS). This is achieved by presenting a newly 
developed treatment service for a specific population of drug misusers who currently present 
with unmet treatment needs.
The rationale for this service development is as follows. C&IDS offers a broad range of 
assessment and treatment options to a large number of inner city drug misusers. A recent 
review highlighted a need to develop services for a growing population of misusers of 
stimulant drugs, (eg. cocaine, crack cocaine, amphetamine sulphate); currently, locally as 
well as nationally, such services do not formally exist. This group of drug misusers present 
with dependencies that appear to be underpinned psychologically rather than physiologically. 
This is supported by international literature which highlights the efficacy of cognitive - 
behavioural interventions with such drug misusers. The challenge exists for clinical 
psychology within the drugs treatment agency to develop such a service.
This clinical dossier presents a service development proposal for an outpatient treatment 
service for people who abuse stimulant drugs. The complexities of the process of service 
development is reflected by the diversity of development tasks:
comprehensive service development proposal for management approval 
a bid written to region to fund such a service development
a selection of the clinical interventions planned session by session (presented as a 
treatment manual)
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This service was approved and the pilot first phase was run from October 1994 - April 1995. 
The pilot was concurrently evaluated and the results can be found in the research dossier of 
this thesis.
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INTRODUCTION
This document provides an overview of and rationale for an out patient treatment programme 
for stimulant drug misusers in Camden and Islington.
This statement paper provides an overview of the basic components of a treatment model 
effective with this population. It describes the target population, draws together current 
evidence of efficacious treatment programmes with this diverse group of drug misusers and 
outlines a treatment programme developed for the Camden and Islington Drugs Services. 
This is based on a review of the existing treatment literature (mostly from the American 
experience) and recent, limited experience accessing and treating (with some success) a small 
sample of this diverse group.
While this paper makes no claims to provide the definitive answers, it is hoped that the ideas 
expressed will provide a basis for the development of a new treatment programme within an 
already developing service. It can be argued that not only is this long overdue within Camden 
and Islington but also at a national level. This service development proposal is designed for 
a pilot run of the proposed treatment model, with the results from the evaluation enabling 
refinement prior to it becoming part of the range of treatment options on offer to users of the 
service.
The target population
Stimulant drug users are a growing population in Camden and Islington. While they may be 
seen as a homogenous group in terms of their drugs of choice eg cocaine, crack/free base
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cocaine, amphetamine sulphate (speed) and the stimulant-like hallucinogens: MDMA 
(ecstasy) and LSD (acid), either singly or in combination, their patterns of use are diverse, 
eg.
- Kings Cross working women using Crack
Islington young Afro-C^ibbean’s using Crack
Young heterosexual and homosexual adult poly drug users on the rave scene.
It is widely recognised that these drug misusers exhibit a number of high risk behaviours ie 
high risk sex and high risk injecting (eg. Klee, 1992). Historically they have presented a 
challenge to drug treatment services due to their relative inaccessibility and also, in part, 
because of there being no universally recognised treatment regime of substitute prescribing 
as there is for the opiate misuser.
Nationally the percentage of new stimulant drug misusers has risen by 100% from 1987 - 
1991 (over a similar period there was a 55% rise in heroin misuse). Stimulants are misused 
by 25% of all drug users however recent estimates indicate a higher prevalence at 30% for 
NETRHA. Reported amphetamine use locally has increased by 175 % with over 60% of the 
users injecting. While their modal age group is 20-24 years, a substantial proportion 
(approximately one-quarter) are under 20. Reported cocaine misuse has shown a dramatic 
increase of 210%, most due to an increase in reported use of cocaine freebase: by 1992, 63 % 
of all reported cocaine misusers were known to be using crack. The most striking change, 
locally, is the increase in reports of ecstasy use: by 676% between 1990 - 1992, 35% being 
below the age of 20 (all data: Institute for the Study of Drug Dependency, 1992).
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The local picture
Locally there are acknowledged problems with particular vulnerable populations, especially: 
the Afro-Caribbean population, pregnant women and in GUM clinics. In a recent study of 
196 attenders at an HIV clinic: 48% had misused amphetamine and 44% cocaine, in contrast 
only 7% had a history of heroin (opiate) abuse (St Mary’s Hospital, 1994). At a national ard 
local level, therefore, there exists a huge unmet need for a growing and vulnerable group of 
drug users; in support of this, the National Audit of Drug Misuse in Britain (ISDD, 1992) 
concludes its report on the increase in reported stimulant misusers, with the following:
"This increase in reported [stimulant] use may indicate that services’ attempts 
to attract the client group are beginning to bear fruit, although what service 
they will be able to offer to these users remains to be seen. "
General classification; "uppers"
"Uppers" is the term used to describe the group of substances that are central nervous system 
stimulants. They force the release of neurotransmitters, especially dopamine, the effects 
being increased heart rate, high blood pressure, quicker respiration, restlessness, dilated 
pupils, talkativeness, irritability, reduced appetite, thirst and variable euphoria. Problems 
occur due to the depletion and disruption of neurotransmitter balance and can result in 
paranoia, muscle tremors, aggression and depression. Other problems include 
malnourishment, dehydration and death via overdose, eg. due to uncontrolled heart rhythms, 
convulsions, hypertension, heart attacks, strokes, psychotic episodes and coma.
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Stimulants can be natural, ie, coca leaf, tobacco leaf, coffee bean, in refined form: cocaine, 
nicotine and caffeine (respectively). Synthetic stimulants include amphetamines and diet 
pills. Amphetamines are the second most widely abused illicit drug in the UK and come in 
the form of amphetamine sulphate (Benzedrine), dexamphetamine (Dexedrine) and 
methamphetamine (ice); a class B drug, they are class A if used for injection. Cocaine 
hydrochloride (powder) and freebase (crack) are class A drugs. The hallucinogenic 
amphetamines, methylenedioxyamphetamines, are the ’rave’ drugs: MDMA, MDEA, MDA 
(’ecstasy’); swallowed, snorted or injected, they are class A. Anabolic steroids are 
prescription only drugs and are mainly abused by sportsmen and women. The alkyl nitrites 
are not controlled drugs and are used (snorted) mainly on the dance scene, eg. amyl nitrite, 
butyl nitrite and isobutyl nitrite (’poppers’). Tobacco is used by approximately 38% of UK 
adults, while caffeine, in the form of tea, coffee etc., is the most widely used stimulant.
Cocaine is commonly seen in two forms: cocaine HCL (hydrochloride) ie: coke, charlie, 
snow and freebase cocaine ie, crack, base, rock; the difference comes in production and use. 
Cocaine HCL is either snorted, chewed or injected and these were the principal routes of use 
until the mid 1970’s when street chemists converted cocaine HCL to cocaine freebase in 
order to try and purify the street drug from its many cuts or dilutents. "Freebase" cocaine 
has a higher melting point and can be smoked without destroying the psychoactive properties.
There are two principal methods to make "freebase". The first, developed in the mid 1970’s 
uses highly flammable or toxic chemicals, ie. ether, to remove the HCL molecule (the 
"acid") from the base and form the crystals of freebase. The second technique, developed 
in the early 1980’s, is called "cheap basing" or "dirty basing" and uses baking soda and heat
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to create "rocks" of "crack". Crack comes in smaller amounts, there is a large market for 
it and the profits are great. Smokeable cocaine gives a greater "high" and a more rapid rush 
however the effects quickly wear off (within 60 minutes) and withdrawal begins. These 
phenomena are associated with the increase in violent crime and unsafe sex via prostitution 
linked to an urgent need to buy further rocks.
Amphetamines are very similar to cocaine the main difference being that they are longer 
acting, take more time to metabolise and are cheaper to buy. As Benzedrine and Dexedrine, 
it can be swallowed, snorted or injected and, more recently, smoked in the form of "ice": 
methamphetamine.
Working on the neuronal pathways of the nervous system, stimulant drugs have the effect 
of increasing the release of dopamine and noradrenaline into the synaptic gap. In order to 
cope with this the body starts to produce more of the neurotransmitter. Furthermore, 
stimulant drugs also inhibit the reuptake process and destroy the enzymes that break the 
neurotransmitters down (eg. acetylcholinesterase). Dopamine is thought to be the most 
important neurotransmitter involved in stimulating nerve - impulse transmissions within the 
brain’s reward - pleasure centre. Normally, a certain amount of dopamine is released as 
needed to maintain a normal mood, mental state and feelings of pleasure (satiation). The 
neurotransmitter noradrenaline, works in the limbic pathways of the brain and is involved 
in the regulation of emotional responses and muscle tension.
The forced release of these neurotransmitters by the ingestion of the stimulant drugs, ie. 
cocaine and amphetamine, has a number of effects:
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i) Stimulant users describe feelings of euphoria and intense pleasure after using: "the 
high". This can be explained by the increase in production of neurotransmitters 
associated with pleasure and well - being.
ii) In order for the neurones to cope with the increased flood of neurotransmitter, they 
grow more branches (dendrites) to receive it. This also has the effect of increasing 
the amount of neurotransmitter being released and therefore more stimulant is needed 
in order to achieve a ’high’ (see Tolerance, below).
iii) The increase in the release of neurotransmitters, no enzymes to break it down and no 
reuptake process means that the chemical ’bridge’ across the synaptic gap is not 
destroyed once the nerve impulse has passed over it. Therefore, the nerve impulses 
continue to fire across neurones, a further explanation for the feelings of increased 
stimulation and euphoria.
iv) The continued firing of the impulse across neurones can also lead to more serious 
complications eg. convulsions affecting the heart and respiration and possibly leading 
to death.
The characteristic 'crash' will occur after such large amounts of neurotransmitter
have been released and the body is in temporary shortage. This shortage is understood to 
be one explanation for the ’crash’ followed by the stimulant ’high’. The ’crash’ usually lasts 
between 30 - 60 minutes while the body produces more neurotransmitter, and because the 
neurotransmitters involved: dopamine and noradrenaline, are involved in maintaining mood,
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users often report tiredness, irritability, anxiety and depression during the ’crash’. These 
feelings lead the user to crave more drug which will artificially provide relief from the 
symptoms. The intensity of the ’crash’ varies from person to person, is often dependent on 
the amount of drug used, the length of time of use and how regularly, and the method of 
using: IV and freebase will deliver more drug to the brain, more quickly and therefore the 
user can expect a higher ’high’ and a more intense ’crash’.
Tolerance is seen when a user needs to increase the dose of drug in order to get the same 
effect as a lower dose previously gave them. Often users will get to doses that at the 
beginning of their using careers would have been extremely toxic or even lethal for them. 
Users will also therefore become tolerant to the ’high’ and report that eventually they will 
no longer experience it. This can be explained in part because the neurones have grown 
more dendrites (branches) to accommodate the increased flow of neurotransmitter and 
eventually the body cannot produce enough neurotransmitter to satisfy all the dendrites. 
Users will continue to use the drug even though they no longer experience the ’high’ because 
the body is programmed to expect it and in order to alleviate the depression that will occur 
if they do not use. There are also a number of psychological reasons for why a user will 
crave drugs and will continue to use despite no longer experiencing the pleasure experienced 
with the earlier days of using: these will be discussed later.
Kindling is the one effect of stimulant drugs that the user will not develop tolerance to over 
time. The ability of a stimulant drug to induce a brain seizure or convulsions will increase 
over time with greater use and doses. In other words, a user may become more sensitive 
to the seizure inducing properties as usage continues. This effect can and does end in death.
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The literally fatal error is that increasing doses can be taken and because they seem to have 
less effect on the user (tolerance), the mistaken belief is that all effects of higher doses are 
less dangerous. Animal studies indicate that over time, certain neurones in the central 
nervous system become more sensitive to the effects of a stimulant drug and will therefore 
fire more readily with each exposure to the drug. This will also mean that at low doses, 
some long term users will report an increased sensitivity to the unpleasant effect of the drugs, 
eg. depression, restlessness etc.
The long term ^e c ts  with chronic use are seen over time when the body is unable to replace 
the neurotransmitters that are artificially released in greater quantities than normal by the 
drugs. This will lead to an inability to experience any pleasure or to feel interested in any 
pleasurable activity (anhedonia). There is simply no dopamine, for example, available in the 
reward - pleasure centre of the brain to stimulate the individual towards such activities. The 
drugs then begin to provide the user with the very opposite effects to those enjoyed in the 
early days of using: depression, irritability and anxiety replaces euphoria, instead of 
increased energy there is chronic fatigue, paranoia and withdrawal replace social confidence 
and spontaneity, mental alertness is replaced by poor concentration, confusion and shortened 
memory span, and any sexual desire and enhanced performance becomes impotence or 
complete loss of any sexual interest at all. The using becomes a vicious cycle because the 
drug used to try and get rid of the negative effects is actually the cause of them. Even when 
users are aware of the trap that they are in, they will often report a helpless compulsion to 
continue to use, as they have forgotten any way of living outside of their compulsive and 
chronic drug use which by now has become their sole reason for living.
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Treatment overview
The literature
The literature concerning stimulant dependence, based on the US experience with cocaine, 
advocates abstinence as a treatment goal. There is no evidence that tapered withdrawal is 
preferable to abrupt cessation. They also recommend abstinence from other mood altering 
drugs eg. alcohol and cannabis, based on clinical experience that their use most commonly 
preceded relapse. While there have been no studies of the application of a harm reduction 
framework (reduced consumption rather than abstinence) the advent of AIDS has highlighted 
the important goal of reduction of HIV transmission, eg. not sharing needles. Teaching safer 
sex practices is also important especially as low dose use of stimulants can stimulate libido 
and is associated with an increase in unsafe sex (Klee, 1992).
A number of addiction researchers have suggested that open-ended non-directive "generic" 
psychotherapy methods are not useful in treating cocaine dependency. The hypothesis that 
spontaneous cessation of drug use will occur if insight is gained into underlying 
psychodynamic problems is inaccurate (Rawson et al, 1991).
A package of cognitive - behavioural techniques within a broad spectrum treatment 
programme has been positively indicated with this population. These techniques include 
cognitive restructuring (the modifying of individuals’ beliefs about their drug use into more 
realistic forms), problem solving skills, social skills and assertiveness training, motivational 
interviewing and relapse prevention (where the individual is taught to recognise high risk 
situations for induced drug craving and is trained in techniques for coping).
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Key components of treatment
The key components of treatment are highlighted as being: motivational interviewing and 
relapse prevention within a group therapy approach. At the outset of treatment, ambivalence 
may be experienced in a number of ways, primarily to the cessation of cocaine use and to 
the treatment itself. Prochaska and DiClemente (1984) have described this state of conflict 
as being characteristic of the first stage of a cycle of change. The model of change aids the 
conceptualisation of the stages of change that an individual goes through in her/ his attempts 
to give up/ gain control over a problem behaviour (see Appendix A, research dossier). 
People suffering from addictions are often in the early stages of change: precontemplation 
or contemplation. Precontemplators are those who use the least change strategies and 
traditionally such individuals have been seen as having problems of denial or lack of 
motivation. Alternatively, a precontemplator can be described as an individual who is highly 
motivated to continue their behaviour, not change it (Tober, 1989). Gontemplators are those 
individuals who are considering the need to do something about their behaviour, they will 
be currently using drugs but feel dissatisfied with the situation and may be experiencing 
conflict between the positive and negative aspects of their drug use. Motivational 
interviewing comprises a set of therapeutic techniques which aim to stimulate and supervise 
the contemplation and decision making of the client. At this initial stage of contact, the 
therapist should aim to create an atmosphere in which the client motivates themselves which 
can be achieved by offering the opportunity to increase awareness of the nature and 
consequences of the behaviour. This would include an awareness of the motives for the 
behaviour and possibilities for change.
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Many clinicians have integrated relapse prevention techniques in their cocaine out patient 
treatment programmes (eg. Rawson, 1990; Washton, 1987). The techniques involve teaching 
about conditioned cues and cravings and using the knowledge to understand the high risk 
situations to using (internal and external) and means of coping with them. Cognitive work 
enables the identification of thoughts, feelings and behaviours associated with using situations 
and challenging and shifting cognitive distortions, rationalisations and dysfunctional beliefs 
associated with using. The model also allows for a non - judgemental and pragmatic 
approach to relapse. Individuals who ’slip’ during recovery are encouraged to use the 
incident as a learning experience and prevent the occurrence of major relapse episodes.
Group therapy has been described as the core of an outpatient treatment programme for 
stimulant users (Washton, 1989). The popularity of group therapy is due in part to its cost 
effectiveness in agencies where increasing numbers of people are making demands on 
services without the necessary increase in staff resources. Furthermore, it is well 
documented that the group setting provides an environment conducive to behaviour change 
where behaviours are reinforced or extinguished with greater potency than in an individual 
session (Douglas, 1976).
The success of group therapy with stimulant users is enhanced by the provision of concurrent 
individual sessions. While the groups will provide the core of the treatment programme, they 
are not usually sufficient to address the full range of individual problems and issues 
experienced by each individual member. Individual therapy enables general group 
experiences to be related to individual issues in greater depth and also allows for the analysis 
of personal issues which may be of a more sensitive nature and difficult to share in the group
environment. Furthermore, given the structured and task orientated nature of the groups, 
individual reflection may not always be possible. Some treatment models adopting this 
combination of individual and group modalities suggest a continuity in therapists offering 
both types of treatment, the rationale being that it allows coordination between the two 
experiences and can have "very potent synergistic effects... accelerating the treatment and 
recovery process" (Washton, 1989, pg. 160). There is no empirical evidence to support this 
and it is important to acknowledge that this recommendation is made by therapists working 
in private and well resourced services in America. For the purposes of a treatment 
programme within a busy National Health Service environment, it would be important to 
achieve continuity between therapists offering treatment forms but cannot be seen as 
essential.
Treatment considerations
The intensely reinforcing properties of these drugs are a major contributing factor to high 
rates of drop-out and relapse in treatment. Successful outpatient treatment uses a 
biopsychosocial approach and is underpinned by a structured framework combining 
behavioural techniques, cognitive strategies, education, family involvement (if indicated), self 
help groups, urine testing and follow-up. Evidence from American treatment programmes 
designed around this model is encouraging eg. in one programme of 127 patients entering 
treatment 65% completed a 6-12 month programme and 75% were drug free at a 1-2 year 
follow-up (Washton et al, 1989).
There is a significant positive relationship between length of time in treatment and drug free 
outcomes. The neuro-behavioural model separates treatment into two phases: phase I (0-6
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months): the stages of recovery and phase II (7-12 months) maintaining abstinence and 
lifestyle changes (Rawson et al, 1991). Washton (1989) divides a year long treatment 
programme into 4 stages:
* Stage 1 : Stabilization and crisis intervention (2 weeks)
* Stage 2 : Early abstinence (months 1+2)
* Stage 3 : Relapse Prevention (months 3 to 6)
* Stage 4 : Advanced Recovery (months 6 to 12)
All authors emphasize several key features of the treatment programme: 
highly structured: clear framework
external structures
treatment: stepwise in clearly defined stages with sequential focus on specific tasks 
and goals
clear rules of treatment eg. addressing issues such as abstinence and attendance 
(presented in the form of a treatment contract, signed by patient and therapist)
length of treatment: minimum 6 months; optimal 12 months
While out-patient programmes are more cost-effective and the problems of generalisation 
from the in-patient to out-patient environment does not exist, in-patient treatment is thought 
to be warranted in certain cases, eg:
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severe polydrug dependence
where severe withdrawal is anticipated
medical complications requiring close observation or treatment
psychiatric complications (eg. psychotic, suicidal)
absence of social supports
undesirable living conditions
failed out-patient treatment.
82
Camden and Islington Drugs Services: 
Service Development proposal
An integrated out patient treatment programme for people who
misuse stimulant drugs
Described below is an outpatient treatment plan for people who misuse stimulant drugs. The 
programme runs for a minimum of 6 months where each participant is expected to commit 
to every stage of treatment. This treatment programme will be based on cognitive - 
behavioural, relapse prevention theory and techniques. There will be a combination of 
individual and group work which will be collaborative, didactic and directive. Participants 
will set individual and group goals between sessions and there will be widespread use of 
handouts for information and exercises. This proposal will be piloted with an initial cohort 
of 12 -15 stimulant drug users and the results of the evaluation will be used to refine the 
treatment service before it becomes generally available to users of Camden and Islington 
Drugs Services.
ASSESSMENT
Aims:
i) to utilise a biopsychosocial perspective in the comprehensive, multi- disciplinary and 
holistic assessment of the stimulant using patient;
ii) to screen out patients inappropriate for an intensive out-patient programme.
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Objectives:
i) to establish early engagement and therapeutic relationship with the patient;
ii) to gather the relevant clinical data in order to formulate a comprehensive case history:
biopsychosocial assessment including MSE;
iii) to collect pre-treatment baseline data using stiindardised quantitative questionnaires;
iv) to elicit the patient’s motivations and goals for treatment and establish their place
within a ’cycle of change’(cf Prochaska & DiClemente, 1984).
v) to provide the patient with an overview of the treatment plan;
vi) to assess the ability of the patient to work in groups;
vii) to take urine samples at each initial contact.
Month 1: THE MIOTIVATION TO CHANGE
Treatment at this stage will include the following:
i) Weekly, 50 minute individual sessions with an allocated therapist. The aim of these 
sessions would be to provide the opportunity to address specific treatment issues and 
to relate group experiences to individual needs.
ii) Random urine testing. If the client reports any stimulant use a urine sample will not
be taken and a positive result will be marked in the notes.
iii) Weekly attendance at two groups (maximum participants: 12)
Group involvement will be compulsory as part of the whole treatment package. The groups
will be closed. The groups will be structured and combine teaching, handouts, large and
small group exercises and general discussion. Individual issues will be addressed as part of
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the learning experience of the group but patients will be able to address them in greater depth 
with their individual therapist.
a) Educational Group;
Aim: to educate patients about the nature of stimulants and stimulant use and to orient 
them to the treatment programme. By the end of the group sessions, patients should 
have a general knowledge of these issues with insights into their individual 
relationship with the drugs. The group will address:
overview of treatment; contract signing; working in groups and group rules; 
teaching and workgroup sessions on the pharmacology, psychology and social 
aspects of cocaine use.
b) Decision Making Group:
Aim: to facilitate the movement of individuals though ’the cycle of change’ from the 
contemplation to the action stage. The group will include:
the use of motivational interviewing theory and techniques; 
teaching around problem solving and decision making; 
the use of decision making matrices etc. 
the setting of clear, realistic and achievable individual goals.
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By the end of this first month stage of treatment, patients will have achieved the following:
i) an increased knowledge and individual formulation of their drug use;
ii) a set of early individual goals which will include:
- a commitment to abstinence;
- to stop using for one week;
- a commitment to the next stage of treatment.
Months 2 & 3: EARLY ABSTINENCE
Treatment at this stage will continue to include the following:
i) Weekly, 50 minute individual sessions with an allocated therapist.
ii) Random urine testing.
iii) Weekly attendance at two groups (maximum participants: 12)
a) Early Relapse Prevention Group (8 sessions);
Aim: to educate the patients in the philosophy of relapse prevention and to enable 
each patient to do a microanalysis of their using behaviour and begin to make 
concrete action plans relating to the specifics of their using behaviour.
The group will include:
relapse prevention exercises to identify external cues and internal feeling 
states;
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teaching about classical conditioning: cravings and cues;
specific (general and individualised) action plans: coping with triggers, cues,
cravings and urges;
use of the following model (Annis, 1982 b & c):
High risk situation 
for relapse
Cognitive appraisal 
of past performance
Efficacy
Expectation
Inventory o f drinking Cognitive Appraisal
situations Questionnaire
NB. Questionnaires will be modified as appropriate.
Situational
Confidence
Questionnaire
b) Lifestvle/ Dailv Functioning Group (Fridav afternoons; 8 sessions);
Aim: to enable patients to understand specific times of vulnerability to relapse and 
plan alternative activities and coping strategies. Please note that the timing of this 
group is prior to the weekend, a time where many stimulant misusers are at high risk 
to relapse. The group will address: 
scheduling time;
alternative activities and positive addictions;
alcohol and secondary drug use;
daily/ leisure activities;
relaxation and stress/ anger management.
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By the end of the second and third months of treatment, patients will have achieved the 
following:
i) A general understanding of Relapse Prevention and the ability to generalise the basic
principles to the specifics of their drug using behaviour.
ii) A microanalysis of their using behaviour.
iii) A preliminary set of coping strategies and goals for change.
iv) A commitment to long term abstinence.
Months 4 - 6: MAINTAINING ABSTINENCE
Treatment at this stage will continue to include the following:
i) Weekly, 50 minute individual sessions with an allocated therapist.
ii) Attendance at one weekly group:
Advanced Relapse Prevention Group (12 sessions);
Aim: to use a psychoeducational approach to Relapse Prevention to address the long 
term cognitive and behavioural needs of maintaining abstinence. The group will 
include:
extinguished exposure to cocaine and cocaine cues;
self monitoring of high risk situations and associated cognitive and behavioural
coping strategies;
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recognition of conditioned cocaine craving and the development of strategies 
for coping with craving;
cognitive therapy addressing issues such as Apparently Irrelevant Decisions, 
cognitive reframing, negative automatic thoughts, distorted beliefs and 
rationalisations etc.;
preparation for emergencies and coping with a relapse to stimulant use; 
stabilising lifestyle functioning and developing alternative activities.
By the end of this stage of treatment, patients will have achieved the following:
i) Maintained abstinence and successfully coping with slips.
ii) Shifted focus to a drug free lifestyle.
Months 6 - 12: offer reduced input with a reduction in the frequency of individual sessions. 
At this stage, focus will be on maintaining a drug free lifestyle and preparing to leave 
treatment.
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THE BID
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TITLE: DEVELOPING A PROGRAMME FOR
HOMOSEXUAL, BI SEXUAL AND OTHER
MEN WHO HAVE SEX WITH MEN WHO
MISUSE STIMULANT DRUGS
PROVIDER: C & ICHST DRUGS SERVICES
EVIDENCE OF NEED:
Stimulant drug users are a growing population in Camden and Islington. This group may be 
seen as a homogenous group in terms of their drug choice; cocaine, crack/free base cocaine, 
amphetamine sulphate (speed) and the stimulant-like hallucinogens: MDMA (ecstasy), and 
LSD (acid), either singly or in combination, their patterns of use are diverse.
Nationally, the percentage of new stimulant drug misusers has risen by 100% from 1987 - 
1991 (over a similar period there was a 55% rise in heroin misuse). Nationally, stimulants 
are misused by 25 % of all drug users however recent estimates indicate a higher prevalence 
at 30% for NETRHA. Locally there are acknowledged problems with attenders at GUM 
clinics. In a recent study of 196 attenders at an HIV clinic 48% had misused amphetamine 
and 44% cocaine and in contrast only 7% had a history of heroin (opiate) misuse.
There is increasing anecdotal evidence that there is a growing subgroup of homosexual men 
who misuse stimulant drugs. The most common pattern of poly-drug misuse is the
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combination of stimulants with alcohol on the dance clubs/rave scene. Their drug use 
commonly beings as weekly 24 - 35 hour binges; research evidence indicates that an early 
binge pattern has a significant chance of developing into more sustained use and recent 
experience in Camden and Islington backs this up. In addition to the well documented 
mental and physical health risks, it is widely recognised that these drug users exhibit a 
number of high risk behaviours ie. high risk sex and high risk injecting. Historically they 
have presented a challenge to drug treatment services due to their relative inaccessibility and 
also, in part, because of there being no universally recognised treatment regime of substitute 
prescribing as there is for the opiate misuser.
A pilot project has been established at James Pringle House because of the increasing 
recognition of the number of homosexual male attenders who misuse stimulant drugs. These 
men perceive themselves as ’recreational’ drug users and therefore do not feel comfortable 
with any suggestion that they should access drug services for help or advice. This has 
highlighted that GUM services are an important point of access to these clients. The project 
has adopted a liaison/advocacy model of treatment where clients are initially assessed by a 
clinical psychologist and liaison psychiatrist, engaged into treatment at the GUM service with 
which they are familiar and then move to Drug Services (The Hampstead Road Centre) for 
ongoing treatment.
The project has been running for 10 months and is coordinated by a clinical psychologist 
working in a split post: HIV/AIDS/GUM and Drugs Services. It had been highly successful 
both in terms of the increasing numbers of homosexual men being accessed and treatment 
outcome. This success has been partly due to the advocacy/liaison model adopted.
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DESCRIPTION/OBJECTIVES
It is proposed that the pilot project is formally established and extended. The objective of 
this project would be to treat problematic drug use and hence sexual risk behaviour in this 
client group.
Cognitive - behavioural techniques within a broad spectrum treatment package have been 
shown to be effective with this population. These techniques include cognitive restructuring 
(the modifying of individuals’ beliefs about their drug use into more realistic forms), problem 
solving skills, social skills and assertiveness training, motivational interviewing and relapse 
prevention (where the individual is taught to recognise high risk situations for induced drug 
craving and is trained in techniques for coping). Key features of the treatment programme 
would be:
highly structured: clear framework
external structures
treatment: stepwise in clearly defined stages with sequential focus on
specific tasks and goals 
clear rules of treatment eg. addressing issues such as abstinence, attendance 
(presented in the form of a treatment contract, signed by patient and therapist) 
length of treatment: minimum 6 months; optimal 12 months
Treatment is labour intensive and combines individual and group work based on an 
abstinence model while also addressing harm reduction issues. Optimally, clients would visit 
the service more than three times a week.
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The service would combine core treatment sessions at the Hampstead Road Centre and
sessions spent at local GUM services accessing this client group. Time dedicated to audit
and research would be intrinsically linked to service development.
MEASURES OF SUCCESS:
1. Number of homosexual men seen.
2. Number of homosexual men who have achieved and maintained abstinence of all
stimulant drugs at discharge.
3. Number of homosexual men who have maintained abstinence of all stimulant drugs 
at 6 months and 18 month follow up.
4. Significant differences found on baseline, pre- and post-treatment data, taken from
standardised questionnaires.
BUDGET DETAILS
0.5 WTE Clinical Psychologist 10,900
Non staff (training/travel) 300
Total 11,200
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THE TREATMENT MANUALS
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EDUCATION 1 
Introduction to treatment
a) Organisational issues
introductions: - "the name game” (in pairs) TS
group rules (brainstorm on flip chart) LM
treatment contract: read, clarify and sign }
overview of the treatment programme: } OHP
*
stages of treatment } TS
times of treatment }
rationale for treatment }
b) Why are we here?
what are stimulants: }
* the drugs } brainstorm with
* the categories } group
how they are used } LM
prompts:
* what are the main stimulant drugs 
* what are their effects 
how can you use them*
use OHP for overview after group feedback
what do I use... .what do I want to stop using (discuss in pairs = > share with group) 
how do we understand abstinence
c) Ownwork TS
drug diary } discuss the rationale for
activities diary } self monitoring
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EDUCATION 3 
Addiction and withdrawal
a) Review ownwork; TS
on a scale of 0 - 10: how far is your life built around, effected by your drug use
how far do you consider this a good thing (0 -10)
b) The biology of addiction and withdrawal; TS
lecture, Q & A format using flipchart to describe neuronal function etc. : (see attached 
information handout)
* the neuronal system * tolerance
* neuronal transmission * kindling
* the crash * long term effects
* stimulant effect on: dopamine, noradrenaline
= > match all above with how it feels ie. linking in psychology with the biology
= > graph: initial effect vs. sustained use
c) Psychological aspects of addiction; LM
concepts to discuss:
* introduce cognitive model:
thought = > feeling = > behaviour 
: I am bored = >  I feel wound up = > I use cocaine
: I am a failure = > I feel sad = > I use cocaine
= > link in with above biological explanations eg.: craving and related thoughts, feelings
and behaviours
* belief systems:
: downward arrow: ask someone to give a T = > F = > B example from their
own experience: do downward arrow 
= > highlight underlying beliefs and their effects
d) Conclusion; TS
present a model linking the biological and psychological factors discussed
e) Ownwork; LM
read handout: explain to a friend/ partner
do own biology - psychology matching exercise (handout given)
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MOTIVATIONAL 1 
The Process of change
a) Feedback from first group LM
any questions re: programme, structure, rationale or rules
any general comments re: the group itself 
review drug diaries and leisure diaries:
* how much have you used * what % of your time has been taken up by:
- using - scoring - thinking about using 
= > WHERE AM I NOW: the process of change 
= > HOW READY AM I FOR CHANGE
b) Readiness for change TS
how do we understand change: thinking back:
* when did change first start * how did this feel
* was it a constant steady process into treatment, has it been fluctuating
* describe the process of fluctuation psychologically: (ambivalence) 
present Prochaska & DiClemente (1984) model:
* a way of conceptualising change
* why is it important: useful for self - monitoring, enables the understanding of
change as a long term process, realistic goal setting
* comments and feedback
the Readiness to Change Questionnaire
* score in group, preliminary discussion for each individual, encourage to bring 
information for further discussion to individual session
c) Where am I going LM
give worksheet = >  to do in session, can discuss with each other = > encourage it 
to be immediate, brief answers
group discussion and feedback
d) Summary and review TS
where am I now, where am I going, how ready am I for this change:
* each individual makes a statement to the rest of the group
e) Ownwork TS
set one manageable goal for next week re. leisure time
Pro’s vs. Con’s: using/ not using
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MOTIVATIONAL 3
Problem solving turning stumbling blocks into stepping stones
a) Review ownwork LM
what problems accompanied the goal setting exercise:
* generate list from group * pull out NAT = > underlying beliefs:
+ve value = developing a fulfilling relationship:
T = "setting goals around relationships is stupid"
B = "I am an unloveable person so what’s the point"
b) Group goals
brainstorm list of group goals: into broad categories
brainstorm problems associated with one category: list specific problems
c) Problem solving TS
rationale for problem solving: group suggestions
give handout and read through together: highlight the five stages of problem solving 
practice with group: one problem highlighted earlier
pair work: take one problem = >  brainstorm = >  problem solve = >  group 
feedback
d) Cognitive distortions LM
techniques for dealing with cognitive distortions/ negative auto, thoughts when goal
setting and problem solving:
: eg.: "what’s the point in setting goals when my life is a mess"
: "I’ll never be drug free so I might as well give up on sorting out my life"
= > highlight:
* B & W (all or nothing) thinking * catastrophic thoughts
* review evidence for the thoughts * techniques: - positive self talk
- distraction - cognitive challenges
e) Feedback and review
f) Ownwork TS
exercise from Education 2 session (areas of my life grid):
* set goals around each area * problem solve around all goals
* catch neg. auto thoughts * practice challenges/ +ve self talk
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LIFESTYLES 1 
Introduction to sessions
a) Introduction TS
Kate Young (OT) = > group
aims of module; links with previous sessions. Biopsychosocial model. Process of 
Change model etc.
b) Theory - practice links KY
discuss current stage of change for each group member
use of life grids (from motivation 2 session):
* where are you now = > where do you want to be
* what are the obstacles in achieving those aims (brainstorm)
* what skills will you need (brainstorm)
= > end formulation: changing a from a drug lifestyle = > a more functional lifestyle can 
be a difficult transition because:
i) how do you substitute the positive functions of drug taking
ii) people often find that lifestyle skills become ’rusty’ and out of practice after a long
period of a drug lifestyle
c) The wall - an exercise KY
discuss the object of the exercise: "the wall" that drugs build up against life 
problems: substituting the bricks
large wall drawn out on flip chart paper x 2: each member write on each brick a 
positive function of drug - taking: eg. identity, excitement, buzz, sex etc.
on identical wall ask members to think about an activity/ situation/ circumstance 
which could potentially replicate each feeling = > give a few options for each brick: 
ranging from small and easy to more ambitious activities, projects etc.
feedback: * what are the short - medium - long term goals TS
* where are the specific problems: problem solve
d) Relaxation KY
a key feature of positive lifestyle management is managing stress = >  intro, to 
relaxation
e) Ownwork TS
make own lists of "wall" activities using ideas discussed in the group 
set self one, small manageable activity, task from list to do each day
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LIFESTYLES 3 
Activities and balance
a) Ownwork review TS
role prioritising exercise: overview and feedback
weekly activity diary:
* compare week one of treatment to last weeks 
= > what’s changed/ what’s similar: achievements made
b) Shoulds and wants KY
discuss the concept of shoulds : wants - linking in with above exercise 
= > key issue = balance: + +  + shoulds = deficit of pleasure = > increased 
vulnerability to relapse
explicit model: shoulds vs. wants
look at activity schedules: using two colours of marker pen - highlight S : W 
calculate daily ratio of S : W = > congratulate on days of balance
c) Discussion session: shoulds (hassles) TS
= > take a day where there seems to be a predominance of shoulds : wants
i) are they all vital?
ii) which could be taken out/ avoided?
iii) which could be coped with in a manner that doesn’t exacerbate it’s demands
ivX what wants could be added to the day to make the overall structure more balanced? -
use the pleasurable activity list (ownwork: session 1)
d) Relaxation session KY
extended relaxation session: relaxation can =  a want when life seems overwhelmed 
by shoulds (demands/ hassles/ stresses)
taking time out for relaxation can be an important part of the balance of the daily 
routine
spend 30 minutes on relaxation session
e) Ownwork TS
pull together past 3 sessions:
* plan a week of balanced (S:W) activities
* include pleasurable activities each day (from own list)
* set week target around achieving goals set around priority role (session 2)
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LIFESTYLES 5 
Assertiveness and confidence 2
a) Review ownwork TS
highlight specific difficult situations in hierarchy: discuss skill application to situations 
at the lower end of the hierarchy
b) Blocks to open communication, assertion and negotiation KY
i) Distancing techniques: all have the effect of distancing on e from the other person: 
" above" or "out of harms way", eg.:
* judgemental stance * ordering/ threatening/ moralising
* avoiding the other’s concerns * being unemotional/ logical
== > discussion: * choose to use above = self protection; * unthinking use of above =
hinderance when wanting a more open communication
ii) Negative thinking: TS
an examination of the negative automatic thoughts (NAT’s) that accompany situations 
requiring an assertive stance:
* the situations (use ownwork hierarchies)
* belief systems underlying NAT’s (use downward arrow technique)
* resulting communication difficulties
= > points for discussion:
- evidence for and against beliefs - the self fulfilling prophecy:
= > exercise:Thought: "I’ve got to meet someone new. I’ve got nothing to say"
Feeling: Anxious, over perception of other’s reaction to you ("they just blinked 
therefore I must be boring to them")
Behaviour: inability to speak
c) Assertiveness self - rating questionnaire KY
purpose of exercise: anxiety re. not being assertive = > ’phobic’ avoidance of 
situations = > increase in anxiety + no evidence of coping abilities
discuss assertiveness as defined by contexts
d) Relaxation KY
e) Ownwork TS
assertiveness self - rating scale
plan for situations where assertive skills are required: rate perform and review for 
next time
practice relaxation skills
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LIFESTYLES 6 
Stress and Anxietv
a) Review - Assertiveness 2 KY
communication blocks - negative thinking
difficult feelings = > managing them prior to crisis
b) Stress and Anxietv; an overview TS
define stress/anxiety: links (brainstorm)
present interactional model of stress 
the biological basis of stress and anxiety
the arousal curve: using stress positively (optimal performance etc.)
c) Stress and Anxietv; barriers to functioning KY
problematic stress and anxiety: current examples:
* shoulds : wants imbalance
* phobic avoidance of interactions (generalisation of the avoidance of HRS)
* social phobia
* unrealistic goal setting
= > generate current examples:
* the warning signs
* the situation(s)
* coping strategies: - adaptive - maladaptive
* manifestations: T = > F = > B
= > eg: - cognitions - inc HR, sweating - staying in
d) Practical management skills TS
Cognitions: - distraction - challenging - +ve self talk
Behaviour: - breaking the cycle - small manageable goals
Feelings: - relaxation
e) Relaxation session KY
f) Ownwork KY
monitor stress levels (diary)
relaxation time each day
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EARLY RELAPSE PREVENTION GROUP 1 
Education
a) What is relanse; an overview LM
cycles of change and relapse: overhead and explanation
relapse is defined by making the decision to stop using and then returning to previous 
drug using habits. Everyone has stopped for a day.
why do people relapse? Brainstorm and link to biopsychosocial model. M e
links to what it means to be an "Addict". Question traditional view ie simple linear 
model of addiction.
Exercise: Someone from the group share a situation where they relapsed: use of diaries = > 
structure the "relapse" in terms of the cognitive model = > T = > F = >  B.
b) Cognitive Model of Relanse; HRS = > trigger = > craving =  >  using TS
Exercise: Each person present a relapse (use diaries). Others break it down into model. 
Connect to the Thoughts - Feelings - Behaviour model that they know =  > on flipchart 
paper = > modify relapse situation
- looking at the specific analysis of the components of relapse and (HRS, triggers, cravings, 
lapses) and to identify possible coping strategies = >  brainstorm: triggers; cravings
- Introduce High Risk Situations: rationale for examining them in more detail including 
precursors to HRS.
c) HRS and Relapse Prevention; Relanse Prevention as a Fire Drill LM
= > why is RP useful: what can we learn
- increase self awareness / learn coping skills / links to lifestyle balance.
d) Ownwork TS
- complete Inventory of Drug Taking Situations. (Return for scoring in following LifeStyle 
Group ready for next session).
- Drug Taking Diaries. Identify one common HRS experienced in the week.
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EARLY RELAPSE PREVENTION 4 
High Risk Situations 3 - Relapse
a) Review ownwork LM
overview of concept: relapse chains (road maps)
review SCQ and IDS: highlight specific relapse issues: what are you learning
b) Relapse Fantasies TS
using chain (road map principles) draw out a future imagined relapse chain scenario
identify: HRS, dysfunctional thinking {ihonghts), self efficacy specific
resulting behaviour and coping skills - present or absent.
= > from this exercise set up discussion of: LM
c) Seeminelv Irrelevant Decisions (Setups)
= > self sabotaging acts created when exposed to drugs in a way that appears to 
absolve an individual of responsibility and they "have to use" = >  describe: 
cognitions =  > patterns of behaviour
link to Lifestyle Balance (part of lifestyle session: discussion over last two weeks re. : 
shoulds vs. wants) = > eg a form of setup is having enormous stresses to cope with 
so that person deserves to use ie self deprivation = > instant gratification.
= > Exercise : each person describe a setup (highlight the importance of self monitoring
and forward thinking). Link to:
d) Coping with HRS TS
= > coping as a form of action to cope with a HRS. Coping as a response to HRS. Coping
can be divided into:
Skills training, to cope with lapses etc
Cognitive reframing - identifying T - F - B - questioning thinking patterns.
Global changes - Link to lifestyle group.
= > focus on: cognitive reframing: techniques:
* distraction * challenge * +ve self talk * identify alternatives
= > Brainstorm: Five specific HRS - identify coping or potential coping strategies for each
one. Categorise coping skills in terms of the three common HRS.
e) Ownwork LM
write out a High Risk Situation and list all potential coping strategies
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EARLY RELAPSE PREVENTION 5 
Cravings - 1
a) Review TS
review the week; highlight particularly any cravings experienced
planning for Xmas: progress over the week
b) Cravings; Psvchological model TS
how Cravings can occur in HRS:
* when do they occur in the relapse chain
* understand in terms of components: T = > F = > B; psychol. + physiol.
classical conditioning model: * overview of model (Pavlov)
* how does this translate to the craving experience (cue laden [HRS] envmt)
- Exercise: Brainstorm triggers of cravings: * rate for intensity/frequency
* list hierarchical order 
= > recognise that they become less frequent/ intense over time (extinction)
= > link to "urge surfing"
c) Recognising cravings LM
Exercise: Identify coping strategies:
* current coping strategies * additional coping strategies
Discuss:
COGNITIVE eg: Distraction
* describe surrounding * using talking * remove from HRS (cue laden)
* competing activities: cognitive/ behavioural
BEHAVIOURAL EG: Flashcards
* write out key coping statements (do in session)
Activity scheduling
* planning for Xmas etc.
Relaxation training
d) Planning for Xmas LM
e) Ownwork TS
planning for Xmas: focus on cravings & cravings diary
design cue card
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EARLY RELAPSE PREVENTION 7 
Coping with a lapse
a) Review Ownwork TS
present Flashcards prepared for when craving
highlight individual differences: experience and manifestation of craving
b) Relapse plan LM
Relapse fantasies
Relapse rehearsal
coping strategies prepared: imaginai rehearsal
challenge cognitive distortions:
* Abstinence Violation Effect
* Lapse = learning experience
* magnification of positive drug related experience
* catastrophic interpretations: all or nothing (B/W) thinking
c) Cognitive Dissonance TS
review of pro’s : con’s of using : not using strategy
cognitive dissonance = > conflict = > anxiety = > increased risk of using
understanding the signs of cognitive dissonance = > managing anxiety (relaxation, 
controlled breathing etc.)
d) Draw up Relapse Plan LM
Positive coping statements
* Remove self from situation
* Seek supports
* Alternative rewards
* Review lapse: What can be learnt. How / why did it happen.
e) Ownwork TS
prepare for review session: RP review in relation to Xmas
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CONCLUDING REMARKS
This service development proposal has been approved by management as a service priority 
1995 - 1996. This is partly based on a recognition of the need for such a long overdue 
service and also due to the success of the pilot service and support for the efficacy of the 
cognitive - behavioural approach. Recently, the bid submitted for a further half - time 
clinical psychology post to develop this service has been approved.
The challenge now exists to attract stimulant misusers to a service which is traditionally 
viewed as an outpatient opiate treatment service. Furthermore, given the heterogeneity of 
the stimulant using population, it is now necessary to look at ways in which the current, 
traditional cognitive - behavioural model can be refined and developed in order to meet the 
diverse needs of this drug misusing population.
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Section Four
RESEARCH DOSSIER
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ABSTRACT
Clinical Psychology has limited resources while demand for the mental health services is 
increasing. One way to alleviate this pressure on services is by adopting preventive models 
based on a one-to-many service delivery approach in order to supplement the traditional 
service delivery model based on a one-to-one approach. The mass media provide one 
resource for preventive campaigns and, in the area of health, have produced impressive 
results. This study addressed the efficacy of the televisual media as a potential resource for 
the development and delivery of preventive models of mental health. The programme 
evaluated was "Overcoming Fear," a ten minute programme from the innovative BBC 
preventive mental health television series, YOU IN MIND. Participants were asked to 
complete two questionnaires before and after viewing the programme. The impact of the 
programme, which dealt with the subject of anxiety, was assessed by examining the 
mediating role of a number of viewer individual difference variables on impact. Results 
indicated that the programme increased viewers level of knowledge about anxiety and had 
greatest impact on older women with clinical levels of anxiety, low pre-viewing levels of 
knowledge about anxiety and who were psychologically minded in terms of an ability to 
access and identify their own feelings and had the capacity for behavioural change. The 
impact of the programme was prescriptive, ie. facilitating the adoption of positive coping 
strategies, rather than exploratory, ie facilitating personal insight and problem clarification. 
Viewers reported intentions to perform a number of general and specific coping behaviours. 
There were marked self/ other differences. These findings are discussed in the context of the 
relevant literature and in terms of the potential and limitations of the use of the televisual 
media for mental health promotion.
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INTRODUCTION
"The application of Psychology to the behavioural and psycho-social dimensions is one of 
very few fundamental influences on the health and well-being of the population...more 
resources should be allocated...to introduce the serious possibility of preventing illness and 
promoting and enhancing health." (Kat, 1989, pp 434).
"Clinical Psychology in crisis.. .the most obvious symptom is, indeed, the manpower shortage 
the profession is facing...the figures have serious implications about the kind of service 
which can be delivered." (Brown & Loftus, 1988, pp 393).
Historically, the mental health field has aimed to understand the complexities of 
psychological function and dysfunction and to develop strategies to enhance the former and 
contain or minimise the latter. However, given the enormity of such a task, there can never 
be sufficient numbers of skilled health care providers to meet all the mental health needs of 
the population. Indeed, as indicated above, there is growing recognition within the clinical 
psychology profession that: there are too few resources to deal with mental health problems 
as defined, distribution of these resources is inequitable and that mental health energies are 
disproportionately allocated to the management of "end state" conditions, ie. those most 
resistant to change and which demand high levels of longer term input (Goldston, 1984). 
Mental health professionals are beginning to accept that preventive models are needed to 
supplement traditional treatment models (Albee, 1982), the challenge, therefore, is to harness 
all available (be they relatively limited) resources in order to maximise productive
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achievement; readiness for primary prevention in mental health is thus growing (Cowen, 
1982).
The traditional service delivery model is based on a one-to-one format with an individual 
therapist treating an Individual or a group of individuals, the presenting problems usually 
being entrenched (ie. a late treatment focus) and with the mental health professional adopting 
a passive-receptive stance by waiting for the patient to come for treatment (Jason, 1977b). 
In contrast a Preventive model is based on a one-to-many format (ie. being mass or group 
orientated) with the objective being to enhance psychological health and forestall the 
development of psychological problems in a proactive manner.
Recent epidemiological studies have shown that demand for mental health services is 
exceeding supply and that while it is acknowledged that the traditional treatment model has 
its place in the delivery of mental health services, if all clinical psychologists and 
psychiatrists were to adopt only this model, the extension of the service would only be 
approximately 2% of the population in need, thus demand would never be met (Jason & 
Bogat, 1983). Furthermore, it has been shown that there is inadequate delivery of current 
services to the economically disadvantaged who are often hesitant to seek out therapy (cf the 
Yavis Syndrome; Savage, 1968), which they currently have to do under a service delivery 
model with a passive-receptive stance. A final criticism of the traditional service delivery 
model which is relevant to this discussion is that by being based around a medical model, it 
results in clinical psychology being too closely allied to psychiatry and the medical setting.
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Preventive interventions can be classified into three types: primary, secondary and tertiary. 
Primary preventive interventions aim to prevent the onset of disorders by modifying risk 
factors, secondary, to identify incipient problems and attempt their reversal and tertiary, to 
focus on restoring or remediating areas of competence in individuals with longstanding 
dysfunctions (Caplan-Moskovich, 1982). Mental Health Education (MHE), as one area of the 
preventive service, aims to promote mental health through facilitating the acquisition of 
knowledge, attitudes and behaviour patterns that enhance and maintain psychological health. 
This can be achieved through proactive, mass orientated interventions targeted at a variety 
of groups, using a variety of formats, covering a broad range of topics and implemented at 
any time.
The mass media are one resource used for preventive campaigns, mostly in the area of 
health. Recent examples include the North Karelia study which successfully reduced the 
smoking habits of an addictive population (McAlister et al, 1980) and the Stanford Three 
Community Study which aimed to reduce the risk factors for coronary heart disease, with 
impressive results (Maccoby et al, 1977). The recent HIV/AIDS media campaigns further 
support the use of the mass media for the promotion of preventive models of health. The 
literature indicates that such approaches increase knowledge and facilitate attitude change 
(Gilmour, Riddell, Russell & Fordyce, 1989) and may lead to certain positive behaviour 
changes (Reader, Carter & Crawford, 1988). Even at a general level of promoting awareness 
and agenda-setting, such interventions are extremely useful (Edgar, Hammond & Freimuth, 
1989).
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Qualitative evidence from a recent Thames television late night therapy programme "A 
Problem Aired", indicates the success of this form of televisual modelling of seeking 
professional help for mental health problems which ranged from hoarding and anxiety to 
sexual abuse and family relationship difficulties. During the first series, more than 1,600 
information sheets were requested and many callers were put in touch with appropriate 
mental health agencies (McIntosh, 1992). However, as recently quoted in the Independent 
Broadcasting Commission report on television and mental health (Wober, 1991), "our 
(quantitative) knowledge of the possible therapeutic uses of television is nil." (Tan & Tan, 
1985).
Given the need for the development of preventive models of mental health to supplement the 
traditional treatment models (Albee, 1982), the televisual media with its far reaching 
influence, efficiency, reliability and relative cost-effectiveness seems to be a resource well 
suited to this area. However, given that television is an underused resource by mental health 
educators (McAlister, 1982), it is interesting to note that when individuals were asked to 
choose their "two or three main sources of health information", television was the second 
most cited source (Mills, 1979). The mass media are a central element in the lives of most 
individuals living in the industrialised world, providing a wealth of information outside our 
immediate experience. The broadcast media is probably the most powerful of all the mass 
médias in terms of its potential to reach greater audiences in one exposure; 97.1 % of UK 
households own a television and in 1990, the average viewing time was 3.5 hours per person 
per day (Saatchi & Saatchi, 1991). For some time, there has been the general belief that the 
media has a powerful influence to persuade and affect the opinions, beliefs and attitudes of 
the viewer, indeed the debate over the responsibility owned by the mass media for the
118
increasing levels of societal violence and sexual permissiveness is well documented in the 
literature (eg. Whitehouse, 1967; Eysenck & Nias, 1978). Similarly, given the amounts of 
money spent yearly by manufacturers advertising their products on television, consumer 
behaviour appears to be shaped by such media exposure. Therefore, if the media does 
produce such appreciable effects on the viewer, surely television can be used to promote or 
simulate socially useful ends (Comstock & Lindsay, 1975).
The use of the televisual media for promoting mental health education requires careful 
thought, planning and design. The recent (1990) Broadcasting Act calls for research on the 
effects of television programmes on viewers’ attitudes and behaviour. This area of research 
is applicable to psycho-educational television programmes (ie. those discussing mental health 
issues) which can be designed as preventive interventions. As clinical psychologists, we not 
only have the skills to consult on the development of these programmes but we are also 
highly trained in the areas of research and evaluation. Television is the resource available to 
our profession for the promotion of clinical psychology and for use in the area of preventive 
intervention.
Understanding the impact of television
In order to capitalise on this resource, it is first necessary to understand the factors that 
mediate the impact of television on the individual. The next discussion will now review the 
literature on the psychological impact of television on the viewer in the context of mental 
health educational programmes. The following section will review the limited literature about 
two important, individual difference variables which may mediate the impact of such 
television programmes: psychological mindedness (PM) and pre-exposure levels of
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knowledge. Finally, the rationale and specific aims of this study will be discussed.
The process of media effects can be conceptualised in a stimulus response or conditioning 
model (McQuail, 1991), which can be represented as follows:
single message— > individual receiver— > reaction
This simple model has to be modified in order to take into account a number of other 
variables in the process such as: selective attention, interpretation, response and recall 
(McQuail, 1991). The literature describing the media effect often refers to this process as the 
"bullet" or "hyperdermic" theory but this has been criticised as over-estimating the possibility 
of effect and the vulnerability of the viewer to influence. Therefore, a number of 
modifications are necessary, importantly those accounting for individual differences ie. 
personality, attitude, intelligence, level of prior knowledge, interest and demography. 
(DeFleur, 1970). Furthermore, there are a number of mediating factors that need to be taken 
into account which have been broadly identified as source, content, channel, receiver and 
destination (McGuire, 1973).
The Ecological Approach (Gibson, 1986) provides a useful model for research which aims 
to understand the impact of television and allows for an acknowledgment of the many 
mediating variables involved in this process, such as those highlighted above. Initially 
developed within the field of visual perception, this model is applicable to research on 
television and highlights two factors to consider: the organism (ie. the viewer and his/her 
perceptual processes and personality variables) and the environment (ie. television and the
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content of mental health programmes described in terms of their selective appeal). Thus the 
influence of television is conceptualised as an interaction between the nature of the organism 
or viewer exposed and the nature of the information displayed.
The effects of television on the viewer can be broadly split into three areas: Cognitive (ie. 
knowledge and opinion), Affectual (ie. attitudes and feelings) and Behavioural (ie. actions), 
and are arranged in this order in the Effect Hierarchy (Hovland, 1949). Learning of 
information from the television could occur without related attitude change and attitudes can 
change without related behaviour change (Trenaman & McQuail, 1961). In research in this 
area, the three must, therefore, be considered separate stages that a viewer is likely to 
undergo when watching a programme depending on his/her current position in the Effect 
Hierarchy for programmes of that nature. Therefore, when investigating the impact of 
specific programmes on a viewing population, the three stages must be measured separately.
It seems from the literature, however, that many evaluative studies have ignored this model 
by conceptualising outcome in terms of only behaviour change, the final stage in the Effect 
Hierarchy (Hovland, 1949). Therefore of viewers do not show attitude or behaviour change, 
these studies discount the value of the intervention. At this point it would be useful to include 
the Theory of Reasoned Action (Fishbein & Ajzen, 1975; Ajzen & Fishbein, 1980) as a 
means of justifying the inclusion of the above three stages as separate measures of 
programme impact. This theory states that individuals act on the basis of their beliefs and 
available information and that behavioural intention is the best predictor of how individuals 
will behave. Intention to behave is underpinned by beliefs about the consequences of the 
behaviour and about the social norms surrounding that behaviour. The social norm (called
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the subjective norm) is influenced by what significant others think about the behaviour. 
Together, attitude and subjective norm influence intention, which in turn directs behaviour. 
Therefore, it would seem to be most appropriate to measure intention to behave as a 
predictor of impact and then follow this up in a longitudinal study with an assessment of 
actual behaviour performed. However many evaluative studies have concentrated on changes 
of behaviour and have thus had disappointing results: an intention may be an immediate 
result of an intervention with behavioural change occurring in the longer term.
Preventive mass media campaigns have produced mixed results, for example the literature 
provides numerous examples of unsuccessful preventive interventions in the area of the 
addictions (McAlister, 1982). There are a number of factors accounting for these generally 
inconclusive studies. An initial reason may be these evaluations focus on immediate 
behaviour change as the accepted outcome measure which, as discussed above, ignores the 
stages of the Effect Hierarchy (Hovland, 1949) and inappropriately expects immediate 
behavioural change. Most of these studies have focused on behaviours, such as the 
addictions, that are extremely difficult to treat even using the one-to-one traditional treatment 
model, and are usually presented as end-state conditions; an expectation of behavioural 
change following a preventive mass media intervention seems naively optimistic. 
Furthermore, these evaluations may be of a single media intervention which may not be 
sufficient to effect any change where a multi-media approach or a media intervention plus 
a clinical intervention may be most appropriate.
This issue of appropriate and sensitive outcome measurement was highlighted in a study of 
the YOU IN MIND series (Barker, Pistrang, Davies Shapiro & Shaw, 1990). YOU IN
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MIND was a series of seven ten minute programmes developed in consultation with a number 
of British mental health professionals. The results of the study provided preliminary evidence 
for the benefits of a mass-media approach to preventive mental health. The impact of the 
programme was measured using items from the Therapeutic Impact Content Analysis System 
(TICAS) (Elliott, James, Reimschuessel, Cislo and Sack, 1985), a number of targeted 
behaviours that the viewer intended to perform after viewing and repeated measures of 
coping and help seeking. Individual difference measures were Psychological Symptomatology 
and Demographic. Baseline data was taken at the start of the series and then one year later. 
In conclusion, the authors suggested a number of recommendations for further research 
which suggested a need for a more specific examination of the processes underlying change 
in a media based preventive intervention. These recommendations have begun to be addressed 
in the present study, and prior to outlining the rationale and aims, the discussion will focus 
on two individual difference variables: Psychological Mindedness (PM) and level of pre­
exposure knowledge about the programme subject. These variables are particularly relevant 
to an examination of the impact of a psycho-educational programme on the viewer.
Individual difference variables: psvchological mindedness (PM) & pre exposure knowledge 
level
The original YOU IN MIND series study concluded with a specific recommendation for an 
examination of the series impact on members of the audience according to their psychological 
mindedness (PM) (Barker et al, 1992). It was argued that this is important theoretically 
because it addresses fundamental processes underlying psychological change in the psycho- 
educational context; this study aims to address this issue.
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PM is popularly construed as ’reading between the lines of behaviour’ and relates to the 
extent to which an individual has the ability to: "see relationships among thoughts, feelings 
and actions with the goal of learning the meanings and causes of his, or others, experiences 
and behaviours." (Appelbaum, 1973). First coined in the area of psychoanalysis in the 
1960’s, PM was traditionally viewed as a patient variable in the outcome of therapy: greater 
PM facilitating greater impact of therapy on the individual (McCallum & Piper, 1990). The 
literature indicates that PM is a capacity composed of related abilities which are relatively 
enduring and show individual qualitative differences, eg: self observation, confidence in 
controlling and modulating affects and integration and synthesis. Insight, reflectiveness, 
introspectiveness, appraisal and awareness are defined as products arising from the PM 
process. Recent research has indicated that PM is acquired (Hatcher et al, 1990) and is a 
complex set of cognitive abilities that show a pattern of related development in childhood. 
There are some indications that PM is related to culture (ie. where insight may become part 
of spiritual development), but not to IQ or socioeconomic status (eg Appelbaum, 1973).
Early assessments of PM were used to evaluate the suitability of a patient for psychoanalysis 
(Conte et al, 1990). More recently, however, PM has been used as a way of evaluating the 
effectiveness of interventions, eg. a health education campaign aimed at the chemically 
dependent (Rogalski, 1987). In this way, PM will be used to evaluate the impact of the 
mental health education programme used in this study. There are, however, no previous 
studies which use PM in the media context and therefore, at this stage, it is only possible to 
speculate as to its role in mediating the effects of mental health education programmes. As 
was described earlier, PM is related to processes of insight and reflectiveness and therefore 
given an intervention, be it psychotherapy or a media based mental health television
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programme, an individual who is psychologically minded may use any new information 
which is personally relevant to enhance their psychological functioning.
The differential impact of the intervention by pre-exposure knowledge level can be explained 
in two ways: that either high pre-knowledge or that low pre-knowledge facilitates greater 
impact. Both these possibilities are supported in the literature. The Elaboration Likelihood 
Model (ELM) of persuasion (Petty & Cacioppo, 1986) would predict that the intervention 
would have greater impact on viewers with greater prior knowledge of the subject material 
than those with little or no prior exposure knowledge. The rationale is that positive impact 
is mediated by a positive attitude towards the subject and that an individual’s dominant 
response to a persuasive message, if it is consistent with their existing attitude, is to generate 
pro-message arguments which, in turn, promote persuasion. This effect is suggested to be 
further enhanced if the message-recipient views the source of the information as credible (Wu 
& Shaffer, 1987). The argument follows that individuals with a greater pre-viewing 
knowledge on which to base pro-arguments would also exhibit more positive intentions after 
the intervention. This is further supported by Chaiker’s notion of heuristic responses to 
persuasion (1980), whereby message-recipients with little or no prior knowledge would fail 
to consider the information seriously if they use the heuristic "I’ve never heard of/ 
considered this before, therefore it can’t be important".
The opposing argument states that an intervention may have less impact on message 
recipients with greater prior knowledge. These informed individual’s may have already 
formed positive beliefs advocated by such educational materials and have already rejected the 
negative beliefs that the material discounts (eg Davidson, Yantis, Norwood & Montano,
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1985). The theory of decelerating set-size effects (Anderson, 1965,1967) further supports this 
argument by stating that the introduction of new beliefs about the subject-focus of the 
intervention would have greater impact on the less knowledgeable individuals because they 
had relatively fewer beliefs at the outset; new beliefs are "averaged with existing ones" 
resulting in greatest impact. This argument is supported by two recent studies evaluating the 
impact of a health education campaign: Sherr (1987), found that changes in knowledge 
resulting from an AIDS media campaign were due to filling in knowledge gaps rather than 
adjusting knowledge errors and Steffen (1990), who found that a health promotion campaign 
about the Testicle Self-Examination (TSE) had greatest impact on men with little or no prior 
knowledge about the subject.
Rationale and Aims of the studv
The study aimed to examine the impact of psycho-educational television within the Ecological 
Model (Gibson, 1986), and focused specifically on the organism, ie. the viewer. The 
programme evaluated in this study was "Overcoming Fear", which was part of the YOU IN 
MIND series. This programme, which addressed the subject of Anxiety, was selected for 
evaluation for two reasons. Firstly, on original screening (in 1987), this particular 
programme attracted the highest viewing audience of the series (10.9 million), and secondly 
because anxiety states account for between 6 and 27 percent of all mental health problems 
requiring treatment (Marks & Lader, 1973). With a one year point prevalence rate of 
between 0.5 and 3 percent (Clark, 1990), with onset usually precipitated by a life event, 
accounting for between 8 and 14 percent of clinical psychology out-patients (Lader & Marks, 
1971), and thus a condition with a high demand on the limited mental health resources, 
anxiety is an appropriate psychological disorder to be addressed within a preventive model.
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The variables included in the study will be discussed in detail below; for a fuller description 
of the YOU IN MIND series, see the Method section.
As discussed earlier, one of the aims of a preventive intervention is to facilitate knowledge 
acquisition: to educate and inform. However the process of knowledge acquisition is affected 
by a number of factors eg. broadcasting related such as: visual format, sequencing of 
material, vision-text relations and a number of viewer individual differences such as 
motivation, demographic variables and pre-viewing levels of knowledge about the subject of 
the intervention. In this study, knowledge acquisition will be measured and the effect of pre­
viewing levels of knowledge about Anxiety on programme impact will be evaluated.
The individual difference measures used were psychological mindedness (PM) and level of 
pre-exposure knowledge. Psychological symptomatology and demographic variables were 
included in this study although they were not found to be significantly related to impact in 
the original Barker et al (1992) study. The inclusion of the former is justified in this study 
because PM has been used in the literature as a variable in conjunction with individuals 
presenting for therapy, ie. possessing clinical levels of psychological symptomatology. PM, 
therefore, may only mediate programme impact within a clinical (viewing) population. 
Anxiety is a psychological condition which is most usually presented in women between the 
ages of 16 and 40 years (Rapee, 1985), and therefore sex may also be an important variable 
in the impact of the Anxiety programme.
The impact of the programme was measured using two measures: the TICAS system, 
developed by Elliott et al in 1985, and the intention of the viewer to perform a number of
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targeted behaviours relating to specific coping strategies. The TICAS system provides a 
framework for rating clients’ experiences of immediate, in-session effects of significant 
therapist interventions. The therapeutic impacts presented, eg. Insight and Awareness, are 
"relevant to many of the central theoretical constructs in the major theories of psychotherapy " 
(Elliott et al, 1985; pp. 628) and are also, at a face level, related to the construct of PM, 
discussed above for use in the same context. The primary impact variables can be broadly 
categorised as three stages in the change process effected by psychotherapy: Insight (ie. 
directing individuals toward reflectiveness and introspection). Problem Clarification (ie. 
aiding the individual towards a better understanding of common psychological conditions, 
such as Anxiety) and Problem Solution (ie. giving individuals a range of new and alternative 
coping strategies relating to these difficulties); the former two stages can be further 
conceptualised as exploratory and the latter stage as prescriptive (ie. relating to specific 
coping). They are relevant stages in the understanding and resolution of psychological 
difficulties relating to the self or to significant others. These Impact variables were shown 
to be an appropriate measure of series impact (Barker et al, 1992) and thus will be used, with 
some modification (see Method section for a full description), in this study.
The targeted behaviours impact measure is also replicated from the Barker et al (1992) study. 
These are specific, such as joining a self-help group, and more general coping behaviours, 
such as trying new ways to cope. The measure is of the intention of the viewer to perform 
the targeted behaviour; the rationale for this has been discussed earlier with reference to The 
Effect Hierarchy (Hovland, 1949) and the Theory of Reasoned Action (Fishbein & Ajzen, 
1975; Ajzen & Fishbein, 1980).
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Research Questions
The study addressed several research questions:
1. Does a psycho-educational television programme about anxiety increase 
viewer’s knowledge ie. is there a difference between pre-viewing and post­
viewing levels of knowledge?
2. What was the impact of the programme in terms of: (a) the Elliott et al 
(1985) dimensions and (b) self-reported intention to perform targeted 
behaviours (Barker et al, 1992)7 This question is a replication of Barker et 
al’s (1992) study, however the measures will be used to assess immediate, 
post-viewing impact.
3. Do certain individual difference variables mediate the impact of the 
programme independently or in combination. The variables examined were: 
Psychological Mindedness (PM), prior knowledge and psychological 
symptomatology. Demographic variables, specifically sex, age, education, 
employment, ethnic origin and marital status, were also included.
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METHOD
The Series
The following description of the series is taken from the original series study (Barker et al, 
1992).
YOU IN MIND was a series of seven, ten minute programmes on mental health which was 
produced by the BBC and first broadcast in the UK on BBCl at 6:15 pm on Sunday evenings 
between 22 February and 19 April 1987. The average viewing audience for the series was 
6.7 million, representing approximately 13% of the UK adult population (British Audience 
Research Bureau [BARB], 1987).
Each programme addressed one mental health issue and mostly using ’ordinary people’ who 
had experience of the difficulties discussed, used a broadly cognitive-behavioral approach. 
The programmes were positive in tone and content and illustrated self-help coping strategies 
appropriate to the problem. Mental health professionals and GP’s appeared only rarely. 
Graphics and subtitles were used to emphasise key points. A free back-up booklet (Davies 
& Mason, 1987), available on request, gave further information about the topics covered and 
listed resources such as mental health agencies and self-help groups available nationally and 
locally depending on the county of the viewer requesting the booklet.
The programme titles were:
1. The Tranquilliser Trap.
2. Being Assertive.
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3. Overcoming Insomnia.
4. Overcoming Fear.
5. Overcoming Depression.
6. Expressing Feelings.
7. Change.
The programme evaluated in this study was ’Overcoming Fear’, which dealt with anxiety and 
panic attacks. It was selected for evaluation because it attracted the largest viewing audience 
of the series: 10.9 million.
Participants
The participants in the present study were volunteers from two settings: a Community Centre 
in North London and a General Practice in Hertfordshire. The Community Centre serves a 
cross section of the population and volunteers came from a number of groups and clubs 
attended by both sexes from the ages of 12 (the Youth group) to 75 (the elderly club). The 
General Practice sample consisted primarily of staff members (n=24) rather than 
patients(n=1) as there had been a number of difficulties in recruiting practice patients as 
volunteers for the study. The majority of the staff members in the General Practice sample 
were Administration staff (n = 16) and the rest were the practice doctors and nurses (n = 
8).
The study was advertised in both settings by posters and leaflets which explained the general 
nature of the study, what would be required of participants, ie. filling in two questionnaires 
before and after watching a ten minute programme, the length of time required for
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participation and a choice of a number of daytime and evening screening/data collection 
times. Participants chose which screening/data collection time they wished to attend by 
signing an attendance form. Participants unable to provide their own transport v/ere either 
visited in their home or at the community centre on the day of their club meeting. Of the 87 
people who volunteered, 80 (91%) participated. All questionnaires completed were useable. 
The 80 respondents (50 women and 30 men) had an age range of 12 - 78, with a mean age 
of 39 years. None of the respondents had previously viewed the programme, but 4 (5.0%) 
remembered the series.
Procedure
Data collection at the screenings took place in small groups. Participants arriving at the 
screening were each given the first questionnaire which was labelled with a code number. 
Before they began, they were directed to read the front sheet which explained the nature of 
the study and concluded with a consent form. Participants filled in the first questionnaire 
which took about twenty minutes and then watched the television programme, which lasted 
ten minutes. At the end of the programme participants filled out the second questionnaire and 
after completing this, they were given the opportunity to ask questions about the study.
Overview of Research Design
This study used a one group pre-test/ post-test design (Cook & Campbell, 1979), to examine 
changes in levels of knowledge about anxiety after having watched the programme. The study 
also used a correlational design to examine the relationship between individual difference 
variables and impact. The individual difference variables measured were: psychological 
mindedness, level of knowledge about anxiety, psychological symptomatology and
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demographic data. Overall reaction to the programme was measured by a questionnaire 
assessing impact and a questionnaire assessing intention of the viewer to follow-up the 
programme with a number of targeted behaviours relevant to the management of anxiety.
Measures
The two questionnaires, pre- and post-viewing, contained a number of measures: both 
standardised instruments and measures designed specifically for this research. In addition, 
participants were given the opportunity to make any written comments about the programme 
or study at the end of the post-viewing questionnaire.
Pre-post Measure: Knowledge about Anxietv This twelve item questioimaire was designed 
to assess respondent’s knowledge about anxiety, the subject covered in the programme. The 
twelve items were generated from twelve key points about anxiety covered in the programme 
and the booklet. Six of the questions were about coping behaviours, eg. "it is best to avoid 
things that make us anxious", "taking tablets is the only way to manage severe anxiety", 
while the other six items were statements about the condition itself, eg. "chronic anxiety is 
a disease", "anxiety is a natural reaction". Respondents answered ’True’ or ’False’. In order 
to minimise response bias, half of the items were worded so that "True" was correct and half 
were worded so that "False" was correct. An informal validity check was performed by 
fifteen clinical psychologists working in the field of Adult Mental Health who were 
independent from the study. They were asked to rate the questionnaire for face validity: their 
comments were of a positive nature and did not indicate a need for any additions or 
amendments.
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Post Viewing Reactions These measures were adapted from those used by Barker et al, 1992. 
General Impact
The impact of the programme was assessed using six items derived from Elliott et al’s (1985) 
Therapeutic Impact Content Analysis System (TICAS), which was developed for use in 
psychotherapy process research. Respondents were asked how much they agreed or disagreed 
with statements about the programme. The items focused on three variables with respect to 
the respondent and people known to them, the Primary Impact Variables:
a) INSIGHT: "it made me realise something new about
myself/someone I know".
b) PROBLEM CLARIFICATION: "it gave me a clearer
understanding of my own/other peoples problems".
c) PROBLEM SOLUTION: "it helped me see what to do about a
problem I have/ someone else’s problem. "
In addition to these six items, there were five items assessing three other TICAS categories :
a) REASSURANCE: "I found it reassuring "; "it helped me feel
more confident in being able to cope with my problems. "
b) AWARENESS: "it helped me confront a problem I did not
want to admit I had/someone I know had".
c) UNWANTED THOUGHTS: "it made me think about things that
I did not want to think about".
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Finally, four broadcasting related items assessing relevance and identification with the 
participants in the programme were addressed. Responses to all items were on a four-point 
scale: Agree a lot/ Agree a little/ Disagree a little/ Disagree a lot.
Targeted Behaviours 
Respondents were asked:
"As a result of watching this programme, do you intend to do any of the following?".
The fourteen item checklist aimed to capture behaviours that were targeted by the 
programme, eg "join a self-help group", "seek professional help for your problems". 
Respondents were asked how much they intended to do each of the targeted behaviours for 
themselves or encouraging someone they know to do them. Response categories were: Yes/ 
Maybe/ Not Sure/ No.
Individual Difference Measures The following measures were combined into one 
questionnaire that participants were required to complete before viewing the programme.
Psychological Mindedness (PM)
PM was measured using the Bronx Municipal Hospital Centre PM Scale (Conte et al, 1990). 
This scale was used due to its integration of the multiple operational definitions of PM and 
its cogent nature. Literature reviews of the scale indicate good face validity. The scale is 
currently unpublished and was used with permission of the author.
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Respondents were asked to indicate how much they agreed or disagreed with 45 statements. 
Responses were on a four-point scale: Agree a lot/ Agree a little/ Disagree a little/ Disagree 
a lot. Each of the 45 items fall into four sub-categories:
- willingness to talk over one’s-problems: PM-Talk;
- access to one’s feelings and their identification: PM-Identification;
- capacity for behavioural change: PM-Change;
- interest in why people behave in the way that they do: PM-Others.
Reliability analyses of the whole scale and each of the sub-scales were performed with the 
present sample. The reliability analysis performed on the whole scale showed it to have good 
internal reliability with an alpha coefficient of 0.80. The reliability analysis on the sub-scales 
showed their alpha coefficients to be moderate, ranging from 0.50 - 0.73. The sub-scales 
were also inter-correlated, and the correlation coefficients of PM-Talk, PM-Identification and 
PM-Change ranged between 0.35 and 0.48 and thus these scales could justify use as separate 
measures of the construct, PM. There was a higher correlation between the PM-Others and 
PM-Change subscales (r=0.61). However, PM-Others was retained as a separate subscale 
as it was potentially important in the analysis of any Self-Other differences in the impact 
measures.
Level of Knowledge about Anxiety
The level of knowledge about anxiety scores from the pre-viewing questionnaire were used 
to evaluate the role of this individual difference measure on the impact of the programme.
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Psychological Symptomatology
Twelve items were taken from the Symptom Checklist (SCL-90-R; Derogatis, 1977), a 90- 
item questionnaire designed to measure how much people feel they suffer from some 
common psychological complaints: eg. "feeling blue", "heart pounding or racing". The 
twelve items consisted of four items from each of the Anxiety, Depression and Somatisation 
subscales where items having the highest factor loadings on each subscale were chosen. Çince 
the distributions of responses were negatively skewed, as would be expected from using a 
clinical symptom scale in a general population survey, they were grouped into three ranges: 
zero, moderate (0.25-0.75) and high (1.00-4.00); the high scores approximate to a ’clinical’ 
range. The three sub-scales were found, however, to be highly inter-correlated with 
correlation coefficients ranging between 0.37 - 0.68. Therefore, it was decided that the items 
from the Anxiety sub-scale (furthermore referred to as SCL-Anx) were only used for the 
purposes of the present study, being the most relevant to the subject material of the 
programme.
Instructions to the respondents were: "...indicate how much discomfort that problem has 
caused you in the past month, including today. " Responses were on a five-point scale ranging 
from: "Not at all" to "Extremely".
Demographics
The pre-viewing questionnaire concluded with a number of standard demographic questions 
which were taken from those used by the BARB for their nationwide broadcasting research. 
Age, sex, education, employment, ethnic origin and marital status were included in this 
study.
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RESULTS
Pre-post measure
Level of knowledge about Anxiety The first research question addressed the uptake of 
knowledge about the programme subject: anxiety. There was an increase in knowledge scores 
after viewing the programme: (t(79)=-2.18, p <  .05). Table 1 shows that the levels of pre­
viewing knowledge were moderately high and that after viewing they shifted from the low 
to the moderate level of knowledge with very little change amongst the highest scores.
Post viewing reactions
The general impact variables and the targeted behaviour variables showed a number of low 
to moderate correlations which were not considered high enough to justify collapsing all the 
variables into a global measure. Therefore, overall impact of the programme was measured 
by separate analyses of both the general impact scores and the intention to perform targeted 
behaviours scores.
General Impact The four response categories were collapsed into two for ease of 
presentation, with "Agree a lot" and "Agree a little" collapsed into a Agree category and 
"Disagree a little" and "Disagree a lot" collapsed into a Disagree catagory.
There were a number of differences found in terms of the primary impact variables of 
Insight, Problem Clarification and Problem Solution, in relation to self and other people. The 
programme was reported as having greater impact on the problems of others rather than on
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the viewers themselves (F(l,79) =30.34, p<  .001) and overall differences in the impact 
variables were significant (F(2,78)=5.91, p<  .01). The pattern of impact also differed for 
self and other (F(2,78)=5.23, p <  .01), with impact on the self-related items being greatest 
for Insight, then Problem Clarification and finally Problem Solution, while for the other- 
related items the impact was greatest on Insight, then Problem Solution and finally Problem 
Clarification.
The distribution of scores on each item of the programme impact rating scale are presented 
in Table 2. These data indicate that a majority of the viewers (75.0%) agreed that the 
programme was reassuring and one quarter (25.0%) of them found that it made them think 
unwanted thoughts. The content of the programme appeared to be personally irrelevant to the 
nearly one half (47.5%) of the viewers, with only about a quarter (26.3%) of them 
identifying with the people appearing in the programme, however over half (65.4%) of the 
viewers found them similar to people they knew.
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Table 1.
Histograms of Pre- and Post-viewing levels of knowledge
Pre-viewing
SCORES
4 . 0 0
5 . 0 0
6 . 0 0
7 . 0 0
8 . 0 0
9 . 0 0
1 0 . 0 0  
1 1 . 0 0  
1 2 . 0 0
I....... .1.   .......I__
5 10 15
Histogram frequency
.1
20
.1
25
Post-viewing
SCORES
7 . 0 0
8 . 0 0
9 . 0 0
1 0 . 0 0
1 1 . 0 0
1 2 . 0 0
 1 . . . . . . . . . 1.........1
8 12 16 
Histogram frequency
.1
20
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Table 2.
Programme Impact Ratings
ITEM AGREE DISAGREE
01. Realise something new: S 28 (35.0%) 52 (65.0%)
02. Realise something new: O 46 (57.5%) 34 (42.5%)
03. Understand problem: S 34 (42.5%) 46 (57.5%)
04. Understand problem: O 59 (73.8%) 21 (26.2%)
05. What to do: S 39 (48.8%) 41 (51.2%)
06. What to do: O 53 (66.3%) 27 (33.7%)
07. Confront problem: S 21(26.3%) 59 (73.7%)
08. Confront problem: O 20 (25.0%) 60 (75.0%)
09. Feel more confident 39 (48.8%) 41 (51.2%)
10. Reassuring 60 (75.0%) 20 (25.0%)
11. Unwanted thoughts 20 (25.0%) 60 (75.0%)
12. Irrelevant 38 (47.5%) 42 (52.5%)
13. Identify: S 21 (26.3%) 59 (73.7%)
14. Identify: O 53 (66.3%) 27 (33.7%)
15. Participants well chosen 61(76.3%) 19 (23.7%)
16. Good graphics and diagrams 73 (91.3%) 7 (8.8%)
NOTE:
S = Self;
O = Other;
INSIGHT = items 01 + 02;
PROBLEM CLARIFICATION = items 03 + 04; 
PROBLEM SOLUTION = items 05 + 06. 
AWARENESS = items 07 4- 08.
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Targeted Behaviours The four response categories were collapsed into two for ease of 
presentation, with "Yes" and "Maybe" collapsed into a Yes category and "Not Sure" and 
"No" collapsed into a No category.
As shown in Table 3, the intended behaviour most highly endorsed was the general coping 
item: try new ways to cope, both in terms of the respondents themselves (60.0%) and for 
someone they knew (52.5%). Of the specific coping behaviours, buying booklets about 
anxiety was the most highly endorsed item, both for the self (27.5 %) and for others (42.5 %), 
followed by talking to someone new both for the self (20.0%) and for others (37.5%). A 
minority of viewers said they intended to seek professional help and ring the Samaritans 
(12.5%). The least endorsed intended behaviour by the viewers, was to attend a self-help 
group for themselves (7%).
Although, on the more general targeted behaviour, finding new ways to cope, the intention 
for self (60.0%) and other (52.5 %) was high and almost equal, there was a marked self/other 
difference on the more specific targeted behaviours that viewers intended to perform. Each 
of the behaviours: joining a self-help group, attending classes or workshops, buying booklets, 
seeking professional help, talking to someone new and ringing the Samaritans, were most 
highly endorsed for someone they knew rather than for themselves.
Individual Difference Measures
Intercorrelations of Predictor Variables The three primary individual difference variables 
examined in this study were Psychological Mindedness(PM), pre-viewing level of knowledge
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about Anxiety and Psychological Symptomatology (SCL-Anx). Before analysing the 
individual mediating effects of these variables on the general impact of the programme, they 
were inter-correlated. The correlation matrix shows a number of inter-correlations (see Table 
4): the three PM sub-scales (Talk, Change and Identification) were positively correlated as 
would be expected. It also showed that SCL-Anx and PM-Change were negatively correlated, 
indicating that the most highly anxious viewers were those with the least capacity for 
behavioural change. Knowledge about anxiety was not found to be related to PM-Talk, PM- 
Change and PM-Identification or to SCL-Anx.
Psvchological Mindedness (PMI Only two significant correlations were found between the 
PM sub-scales and the programme impact items. In both cases, PM-Identification was 
positively correlated with Insight: other, (r=0.26; p < .01) and unwanted thoughts (r=0.32; 
p < .01). However, both these correlations are low and in general, PM seems to have no 
effect on the reported impact of the programme. Similarly, there were no significant 
correlations found between intention to perform the targeted behaviours. As a high Self-Other 
difference had been found on these items, it was decided to also correlate PM-Change and 
PM-Others with these items in order to examine whether these PM sub-scales, relating to 
Self and Other respectively, could account for the difference. No significant correlations were 
found.
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Table 3.
Intention to perform Targeted Behaviours.
BEHAVIOUR YES NO
01. Self help group: S 6 (7.5%) 74 (92.5%)
02. Self help group: 0 26 (32.5%) 54 (67.5%)
03. Classes or workshops: S 8 (10.0%) 72 (90.0%)
04. Classes or workshops: 0 26(32.5%) 54 (67.5%)
05. Seek professional help: S 10(12.5%) 70 (87.5%)
06. Seek professional help: 0 29 (36.3%) 51 (63.7%)
07. Talk to someone new: S 16(20.0%) 64 (80.0%)
08. Talk to someone new: 0 30 (37.5%) 50 (62.5%)
09. Try new ways to cope: S 48 (60.0%) 32 (40.0%)
10. Try new ways to cope: 0 42 (52.5%) 38 (47.5%)
11. Buy booklets: S 22 (27.5%) 58 (72.5%)
12. Buy booklets: 0 34 (42.5%) 46(57.5%)
13. Ring Samaritans: S 10 (12.5%) 70 (87.5%)
14. Ring Samaritans: 0 23 (28.8%) 57(71.3%)
NOTE:
s = self;
o = other.
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Table 4.
Intercorrelations of the Individual Difference Variables. 
KNOW SCL-ANX PM-TALK PM-IDENT
KNOW 1.00
SCL-ANX -.13 1.00
PM-TALK .25 -.05 1.00
PM-IDENT .00 -.16 .35** 1.00
PM-CHANGE .09 -.35** .45** .48*
1-tailed signif: * - .01; ** - .001 
NOTE:
KNOW = Pre-viewing knowledge about Anxiety;
SCL-ANX = Psychological Symptomatology (SCL-90-R: anxiety sub-scale); 
PM-TALK = Psychological Mindedness: Talk sub-scale;
PM-IDENT = Psychological Mindedness: Identification sub-scale; 
PM-CHANGE = Psychological Mindedness: Behavioural Change sub-scale.
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Pre-viewing level of knowledge about Anxietv Knowledge about Anxiety before viewing the 
programme was positively correlated with a number of the Self related impact items: Insight 
(r=0.33; p < .01), Problem Clarification (r=0.33; p < .01), helping to confront own problem 
(r=0.29; p<.01) and unwanted thoughts (r=0.29); p<.01). Given the direction of the 
scores, this indicates that the programme had greatest impact on these items for viewers with 
the lowest pre-viewing knowledge about Anxiety scores. There were no significant 
correlations between pre-viewing level of knowledge and any of the intended behaviour 
items.
Psvchological Svmptomatologv Since the SCL-Anx scores were highly skewed, a Kendalls 
Tau statistic was used to investigate the correlations. There was a significant association 
between SCL-Anx and three of the self-related impact items: Insight (t=-2.30; p <  .05); 
Problem Clarification (t=-2.26; p < .05) and Unwanted Thoughts (t=-2.67; p <  .05). Given 
the direction of the scores, this indicated that the programme had the greatest impact, on the 
above items, on viewers with more psychological problems associated with anxiety.
Multiple Regression The regression analyses were computed on the twelve programme impact 
items relating to the Elliott et al (1985) items and two of the targeted behaviour items that 
were found to be the most highly endorsed for Self and Other. Only variables that entered 
into the equation are shown (see Table 5). Six predictor variables were entered into the 
equation: pre-knowledge, PM-Identification, PM-Change, Education, Age and Sex.
For Insight about self and other and Problem Clarification about self, the two significant 
predictor variables were low pre-knowledge about anxiety and high PM-Identification. For
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Problem Solution for self: high Education and high PM-Change. For Awareness for other 
: high age and high PM-Identification. The single significant predictor variable for Problem 
Solution for others, feeling reassured and the programme being of no relevance was high 
Age. For Unwanted Thoughts the only predictor variable was high Education. For the two 
intended targeted behaviours, only try new ways to cope with someone else’s problem had 
a significant association with a predictor variable: Sex (Female).
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DISCUSSION
This study provides evidence that a short television programme about a common 
psychological disorder can have positive effects on a viewing population. This gives 
preliminary support for the use of television as a medium for preventive mental health 
interventions. The results will be discussed in relation to the research questions that were 
addressed at the outset of the study. The discussion will then close with a broader appraisal 
of the implications of these results and with recommendations for future research.
Knowledge Uptake
The issue of knowledge uptake was the first research question and it was found that after 
viewing, participants knew more about anxiety than they did before they watched the 
programme. This result indicates that, at a very general level, television is an effective 
medium for the dissemination of information about mental health issues. This also lends 
support to the Effect Hierarchy (Hovland, 1949), which argues that the impact of such a 
media intervention can occur on three separate levels: Cognitive ie. knowledge and opinion, 
Affectual ie. attitudes and beliefs and Behavioural.
As one of the objectives of a preventive intervention is to enhance psychological functioning 
through the adoption of positive coping strategies, then knowledge uptake must be a 
necessary precursor of eventual behaviour change (McQuail, 1991). This study did not, 
however, address the issue of attitude change (ie. the impact of the programme on the 
Affectual level of the Effect Hierarchy) and therefore it is not possible to know whether such 
a change accompanied the uptake of knowledge. However, evidence from media-based
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preventive interventions in the area of HIV/AIDS education indicates that attitudes and 
opinions show slight change after knowledge uptake (Gilmour et al, 1986). Another study 
found that as well as immediate knowledge increase, one-third of viewers showed positive 
behaviour change at a two week follow-up (Reader, Carter & Crawford, 1988). These results 
optimistically indicate that after exposure to a preventive intervention an increase in 
knowledge may be followed by progress through the next two stages of the Effect Hierarchy. 
This must be interpreted with caution, however, as these studies were concerned with health 
rather than mental health campaigns. However given that the existing literature on media 
preventive interventions is sparse, the initial results from this study plus the supporting 
literature provide positive preliminary evidence for the use of the televisual media in 
preventive mental health.
Impact of the programme
The measure of the general impact of the programme indicated that for the viewer 
themselves, the prescriptive components of the programme (ie. relating to problem solution 
and new coping strategies) had greater impact than the exploratory components (ie. relating 
to insight and problem clarification). However in relation to someone the viewer knew, the 
programme had greater impact on the exploratory components rather than the prescriptive 
components. In other words, viewers were more likely to use the problem solution aspects 
of the programme for themselves and the exploratory aspects of the programme in relation 
to people they knew.
These results differ from those found by Barker et al (1992) where viewers of the series were 
more likely to use the programme information for the exploratory processes rather than the
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prescriptive content. These conflicting results might indicate differences in immediate (as 
measured in this study) as opposed to long term impact (as measured in the Barker et al, 
1992 study). At long term follow up (ie. one year post-exposure), the majority of viewers 
may not recall the specific prescriptive information and may only recall the more general 
exploratory features of the programme. Immediate recall may be of the more prescriptive 
elements of the programme. Furthermore, this study evaluated one programme in a series 
whereas Barker et al (1992) evaluated the whole series. The impact of one programme may 
be more prescriptive whereas overall series impact may be of a more general exploratory 
nature because viewers are less likely to recall the individual prescriptive elements of each 
programme which dealt with different mental health topics. Finally, given that this study was 
conducted in conditions which were removed from those in which a viewer would normally 
watch the programme (ie. in groups of strangers, filling in questionnaires etc.), it may be 
that participants were paying greater attention to the fine detail of the programme (for the 
purposes of filling in a questionnaire) and therefore gained more from the prescriptive 
elements. Processes of reflection may only occur in an environment where the viewer feels 
safe, in the same way that a individual undergoing psychotherapy needs a safe environment; 
indeed, the Barker et al (1992) participants viewed the programme in their homes.
Finally, this programme had greater impact on how viewers perceived the problems of others 
rather than how they perceived their own problems. This is a replication of the findings of 
the Barker et al (1992) study and the same reasons that were given then can be supported by 
this study. The first reason may be arithmetical, ie. that it is far more likely for viewers to 
know someone else with problems related to anxiety than it is for them to be suffering from 
the psychological problems themselves. The second reason takes a psychological stance and
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postulates that it is possible that viewers are defensive and deny that they suffer from any 
problems.
The theory of Cognitive Dissonance (Festinger, 1957) may help to understand why viewers 
might be defensive about having any psychological problems themselves. This theory states 
that the need for individuals to experience a consistent world is a strong motivating factor 
that shapes our behaviour. Therefore, if we detect inconsistencies in our beliefs, we suffer 
conflict: cognitive dissonance. In order to resolve the conflict that may have arisen for some 
viewers in this study, who may have gained new insights into their psychological difficulties 
associated with anxiety, they rationalise these unwanted thoughts as being relevant to 
someone they know. Indeed, as will be discussed more fully later on in this discussion, the 
impact of the programme on individuals who did gain new insights into themselves was 
accompanied by unwanted thoughts. These thoughts may be a result of cognitive dissonance 
and are thus resolved by being rationalised as belonging to someone else.
The other measure of impact, viewer intention to perform targeted behaviours, indicated that 
the viewers intended to adopt positive coping strategies. The majority of viewers reported 
that they intended to try new ways to cope, for both themselves and people they knew; this 
was the most general of all the items. Viewers were less likely to commit themselves to the 
specific coping strategies but did report an intention to use them for people they knew. It 
may be that an immediate assessment of impact does not allow the new information gained 
about positive coping strategies to be assimilated by the individual. Therefore while intending 
to adopt adaptive coping strategies, the viewer is unable to identify immediately which of 
those suggested in the programme would be the best for them.
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However, even taking the smaller percentages of viewers who reported an intention to try 
one of the specific coping behaviours for themselves, when one extrapolates the sample size 
of this study (n = 80) into the total viewing population of this programme (n = 10.9 
million), the programme could result in a considerable clinically significant intention to 
change behaviour. It is impossible to project the numbers, that this would mean in terms of 
real behaviour change and several issues would need to be taken into account, for example, 
the issue of over-reporting. Also, as stated in the Theory of Reasoned Action (Fishbein & 
Ajzen, 1975; Ajzen & Fishbein, 1980), intention to behave results in real behaviour change 
in conjunction with beliefs about that behaviour and the subjective norm (ie. what significant 
others think about the behaviour); these issues were not measured in this study, and would 
need to be taken into account when assessing the amount of positive behaviour change that 
resulted from the "Overcoming Fear" programme; the most reliable assessment would be a 
long-term follow-up. However, for example, 12.5% of the sample indicated an intention to 
seek professional help for themselves and, even taking the above arguments into account, this 
could result in a significant increase in referrals for clinical psychology for the treatment of 
anxiety in a number of viewers of that programme.
A small number of viewers reported both seeking professional help and ringing the 
Samaritans as an intended behaviour for themselves. It is interesting to speculate that mental 
health professionals are perceived as playing a similar role to the Samaritans. Given that the 
recent advertising for the Samaritans showed individuals in acute states of breakdown and 
nearing suicide, it is fair to speculate that the public image is most likely to be of a crisis 
intervention service. Mental health professionals may be perceived, by both the public and 
the referral agencies, in a similar role. This argument is supported by the point made in the
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introduction to this study, where one of the criticisms of the traditional service delivery 
model was that it was had a late treatment focus, therefore the majority of referrals were 
"end state" and entrenched (Jason, 1977b). Therefore, as well this study providing evidence 
that the media is a positive resource to the preventive field, clinical psychologists might 
consider using the media to promote a service which is not solely for crisis intervention.
Individual difference variables which mediate impact
The following discussion addresses the final research question about the mediating effects of 
a number of individual difference variables, either independently or in combination, on the 
impact of the programme. The variables examined in this study were psychological 
mindedness (PM), knowledge about anxiety, psychological symptomatology and demographic 
variables. The findings support the assertion that the media effect is a complex interaction 
of individual difference variables (DeFleur, 1970).
The individual difference variable of specific interest in this study, PM, was not found to be 
a significant independent factor mediating the impact of the programme. The only 
relationship found was between an ability to access and identify one’s own feelings and 
impact in terms of gaining insight into someone else and experiencing unwanted thoughts. 
The former relationship is surprising because it would seem more appropriate for individuals 
with such a capacity to gain new insights into themselves. This result may be related to 
cognitive dissonance, a concept noted earlier in the discussion of self/ other differences in 
impact. In this case, an individual with a greater capacity to access and identify their own 
feelings, may find that the programme gives them new insights into themselves, but they may 
not feel immediately comfortable with accepting the fact that they are accessing feelings that
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relate to personal psychological difficulties. In order to alleviate the cognitive dissonance that 
arises, they rationalise such feelings as belonging to someone they know. Therefore, in the 
context of this study, a viewer, highly psychologically minded in this way, may identify with 
the difficulties associated with anxiety, experience cognitive dissonance and thus explain the 
new insight as being associated with someone they know. The argument is supported by the 
fact that these individuals also reported unwanted thoughts which may have been a feature 
of the cognitive dissonance.
It would seem, therefore, that PM may be part of a larger and more complex interaction of 
personality variables and therefore in itself an insufficient measure of the processes going on 
in such a context. This is supported by the results of the multiple regression which indicated 
a number of interactions between pre-exposure levels of knowledge, psychological 
symptomatology and demographic variables on the impact scores; this will be discussed more 
fully below. It may also be that there exists a curvilinear relationship between PM and impact 
where the programme may have least impact on individuals with low and high PM scores: 
the former group being disinterested in a programme addressing such issues and the latter 
group having already addressed the issues raised. It may be, then, that individuals with a 
medium level of PM are those for whom the programme has the greatest impact.
As PM is a construct that has been operationalised as a measure of patient suitability for 
psychotherapy, it may be unrealistic to expect it to mediate the short-term impact of a brief 
psycho-educational programme. Psychotherapy is a longer term process and it may be that 
individuals high on PM benefit from a psychological intervention over a longer time period, 
giving them time to reflect on issues raised, gain new insights and use them to resolve
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psychological difficulties and enhance their psychological functioning and coping. A ten 
minute programme may therefore not do justice to the conditions required for PM to mediate 
the impact of a psychological intervention. Furthermore, as was highlighted in the literature 
review of this construct, PM is an ability acquired over time and therefore it may have been 
useful to measure pre- and post-viewing levels of PM in order to assess whether PM 
increased, as was found with the Rogalski (1987) study of a preventive mass media 
intervention with the chemically dependent, PM increased. An increase in PM may 
precipitate the use of this construct in mediating the effect of such a programme.
It is also possible that the measure of PM used in this study is not an adequate 
operationalisation of the construct. The measure is newly developed and at the time of this 
study was not yet published. Therefore although it shows good internal reliability, it has not 
yet undergone the necessary validity checks. Similarly, the PM-Identification sub-scale, 
which was found to relate to gaining a new insight into someone else’s problems, may in 
itself not be a reliable measure of the ability to access and identify one’s own feelings and 
may also measure an ability to do this for a significant other.
The level of pre-viewing knowledge about anxiety was found to be an important variable 
mediating the impact of the programme. Consistent with predictions based on the decelerating 
size effect (Anderson, 1967), which postulates that a preventive intervention would have 
greatest effect on less knowledgeable individuals, this programme had substantially greater 
impact on viewers with little pre-exposure knowledge about anxiety. This is supported by the 
argument that knowledgeable viewers already held the advocated beliefs and therefore would 
not use the intervention (Davidson et al, 1985). These findings contradict the Elaboration
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Likelihood Model (ELM) of persuasion, which suggests that the programme might have 
greatest impact on viewers with higher pre-exposure levels of knowledge. This results of this 
study are supported by those of Steffen (1990), who found that a health promotion campaign 
about the Testicle Self Examination (TSE) had greatest impact on men with little or no prior 
knowledge about the subject.
This finding also relates to the Effect Hierarchy (Hovland, 1949) reviewed in the 
introduction. Viewers with little pre-exposure knowledge, may have entered the Effect 
Hierarchy at the first stage: Cognitive, which relates to knowledge and opinion. With 
additional psycho-educational programmes, the viewers may move further up the Effect 
Hierarchy, adjust their attitudes and feelings about mental health issues and eventually adopt 
strategies for behavioural change. This point also relates to the earlier criticism about 
evaluative studies of preventive interventions that focus solely on behavioural change as an 
indicator of impact; the viewers in this study who made some cognitive changes but did not 
show the necessary behavioural changes, would have been classified as a group for whom 
the programme had no impact.
Psychological Symptomatology was associated with certain impacts. Viewers with high levels 
of anxiety gained more insight into their own difficulties, found that the programme clarified 
the issues about these difficulties and experienced unwanted thoughts (ie presumably were 
not reassured). These results are expected given that preventive interventions are aimed at, 
and will be used by, individuals with personal experience of the condition discussed. It seems 
that this programme facilitated personal exploration of the difficulties (ie. insight and problem 
clarification) for individuals with high levels of anxiety, rather than facilitating behavioural
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change and problem solution; exploration is a necessary precursor of change which may only 
occur after a period of assimilation of the new insights gained.
Viewers with high levels of anxiety also experienced unwanted thoughts as a result of the 
programme. These thoughts may accompany insight and problem clarification and be a factor 
inhibiting problem solution until individuals feel more able to accept that they have 
psychological difficulties in relation to anxiety. The difference between these results and 
those of the Barker et al (1992) study, which found no association between psychological 
symptomatology and impact, may be that in the latter impact was measured one year after 
viewing the programme. It is conceivable that in that time individuals with high levels of 
anxiety may have dealt with their difficulties in some way, which they may not attribute, in 
retrospect, to the impact of the programme.
An examination of combinations of individual variables, yielded a rough picture of the 
audience for whom this programme had greatest impact. Impact of this programme on the 
viewer themselves, in terms of gaining new insights and clarifying the problems, was found 
to be greatest for older individuals who possessed high levels of anxiety, who had little pre­
viewing knowledge about anxiety and who had the capacity, related to PM, to access and 
identify their feelings. In terms of problem solution, the same pattern of associations exists, 
except the PM capacity associated with accessing and identifying feelings is substituted by 
the capacity for behavioural change, as would be expected. Impact of the programme for the 
viewer in terms of people known to them was found to be greatest for the older female 
viewer, with little pre-viewing knowledge about anxiety and a capacity to access and identify 
their own feelings.
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Implications of the study
This study provides further support to the limited evidence that the televisual media is an 
important, cost-effective and highly flexible resource suited to the development and 
presentation of preventive models of mental health. At a very general level, programmes 
such as "Overcoming Fear" put mental health issues on the personal and social agenda 
(McCombs & Shaw, 1972) and increase viewers’ knowledge. In terms of the levels of 
preventive intervention discussed earlier (Caplan-Moskovitch, 1982) this programme is most 
probably a secondary preventive intervention, ie. to identify incipient difficulties and attempt 
their reversal, and thus provides support for the use of television at this level of preventive 
intervention. This does not provide specific support for the use of television at the primary 
(modifying risk factors) and tertiary (restoring levels of competence in individuals with 
longstanding dysfunction) levels of intervention. However, given the general nature of these 
results in terms of the individual difference variables mediating impact, it is probably 
possible to generalise them across these other levels of intervention. Such programmes appear 
to have positive impacts, in both a prescriptive and exploratory manner, on a target group 
of individuals who possess a combination of specific individual difference variables, some 
of which were addressed in this study.
As highlighted at the outset of this study, research of this nature requires careful design and 
planning in order to understand the complex interactions of the processes that underlie change 
in the psycho-educational context. By adopting an Ecological approach (Gibson, 1986), it has 
been possible in this study to begin to separate out some of these variables by conceptualising 
impact as an interaction of two general factors: the organism (the viewer) and the 
environment (the programme). The results of this investigation on the organism provide
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evidence of a number of individual differences that mediate the effect of such a programme. 
However, these are just a small fraction of all the possible individual difference variables that 
may be significant in the interaction, for example motivation, recall, attitudes and beliefs, 
etc.. Further research is needed before a picture of the different target viewing groups that 
would benefit from such exposures emerges. Furthermore, there is a huge area of potential 
research in the context of the environment, ie. television and the nature and content of 
broadcasts. Visual format, sequencing of material and vision-text relations are some examples 
of the mediating variables involved, and by establishing the range of such factors, it would 
eventually be possible to design programmes for different purposes, ie. information giving, 
attitude or behaviour change (Maccoby, Rossi & Freeman, 1986).
It may be eventually possible, therefore, to possess a body of knowledge that highlights the 
possible combinations of variables in this process and use these in the design of mental health 
television programmes for specific target groups of viewers and presented in specific 
environments. Examples of these might be short films about the role of clinical psychology 
which could be shown in GP waiting rooms, self-help videos about a variety of common 
mental health difficulties which would be of a more prescriptive nature and films about ways 
of coping with health-related psychological difficulties that could be shown on in-patient 
wards. Therefore, as stated in the mass media literature, it is important, whatever the content 
or purpose of the media communication, to examine the conditions and processes that 
mediate between exposure and its outcomes (Cumberbatch & Howitt, 1989).
As discussed earlier, there were a number of differences in the results of the original series 
study (Barker et al, 1992) and this study. One of the major factors influencing these was the
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great time difference for the measurement of the impact of the programme: in the former 
study at one year and in this study, immediately after viewing the programme; a comparison 
of these results is useful. Immediate impact seems to be of a more prescriptive nature, ie. 
in terms of the problem solving elements of the programme. Long-term impact seems to be 
of a more exploratory nature ie. viewers are able to assimilate the knowledge and reflect on 
its relevance to themselves or to people they know but report less impact on the prescriptive 
elements of the programme. These findings highlights the importance of time of presentation 
of a media preventive intervention. In order to achieve the immediate impact, the intervention 
is either followed up regularly, and therefore provides a number of exposures enabling 
individuals to work through the Effect Hierarchy (Hovland, 1949) and use insights to 
problem solve, or concludes with good telephone facilities for viewers to use in order to 
speak to a trained mental health worker about their difficulties and how to begin to address 
them.
These results may also indicate that one television programme is not sufficient to enable 
individuals to address all the issues that may be relevant to them and that preventive 
interventions should be presented using a combination of approaches. This was found in the 
successful North Karelia preventive intervention (McAlister et al, 1980), where the smoking 
habits of a population decreased after their exposure to an intensive preventive health 
campaign presented through a number of channels, eg. television, written literature, group- 
directed professional interventions. Information presented over a period of time through a 
combination of channels, allows the prescriptive information to be regularly followed up, 
while the longer time period enables the selection and assimilation of information in an 
exploratory capacity. Furthermore, different approaches would require the individual to
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attend to the information on a number of psychological levels and thus reduce the risk of 
habituation to the information. Indeed once the effects of a variety of channels of presentation 
of preventive mental health interventions are better understood, the objectives of the 
interventions can be matched to the channel best suited for their presentation.
There are a number of specific recommendations for future research that can be generated 
from this study. The results indicated that there could be a significant number of viewers 
who, after exposure to this programme, intended to adopt some positive coping behaviours, 
for themselves or for someone they knew. In terms of evaluating actual changes that 
occurred, a long term follow-up would be necessary. The measures adopted were entirely 
self-report and in order to fully evaluate the immediate and long-term impact of such 
programmes, other measures would be needed. However, before investing in such ambitious 
and costly multi-measure, long-term studies, it is necessary to establish the general 
characteristics of the organism and the environment that mediate impact. A more general 
criticism of this study relates to the sample. The sample size was small and, in general, the 
participants in the study had low levels of anxiety and therefore did not represent the target 
viewing group for whom the programme would have personal relevance.
This study presents findings that indicate that television is a potentially valuable resource to 
the clinical psychology profession in the area of preventive mental health. Psycho-educational 
television programmes can potentially facilitate positive psychological change and may result 
in a reduction in referrals for "end state" conditions" and an increase in awareness of the 
clinical psychology profession. It has also been recently stated in an Independent Television 
Report that the image of the mentally ill in the mass media is far removed from the
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characteristics established by the mental health professionals and instead of mediating 
between the experts and the public, media imagery pulled the public image away from the 
experts and in the direction of traditional prejudices (Gerber, 1982). Therefore even for 
viewers who may not use the information for the management of their own or other people’s 
psychological problems, the effects of such programmes may be to normalise, destigmatise 
and decatastrophise the general societal perceptions of mental health issues. There are still 
many research questions to address however, and as the results of this study indicate, the 
audience member is not a blank page on which the media can write their prescriptions for 
belief or behaviour; audiences are not passive recipients but active participants in a 
communication exchange given the mediation of a number of individual variables, 
ie.knowledge and predispositions.
Since the media play a critical role in facilitating the adoption of adaptive and maladaptive 
behaviours, a role for preventive psychologists might be active participation in the design of 
media-based interventions (Jason & Klich, 1982). As television is better understood we, as 
mental health professionals, will make better use of it in terms of the development and 
presentation of preventive models of mental health and for the promotion of the clinical 
psychology profession.
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APPENDIX
BROADCASTING STUDY
Thank you for agreeing to participate in this study.
Before we start let me briefly introduce myself and the aims, of 
this research. My name is Tanya Sichel and 1 am a p s y oh pip g is t 
working in the N.H.S. This study is part of a MSc degree in 
clinical psychology. - ;
Your help is required as television viewers. 1 am researphing 
the effects of psycho-educational television, ie: television
programmes which deal with psychological issues. My aim is to 
assess whether these programmes are useful to the viewing public 
and have any particular short or long term benefits.
In order to do this 1 will ask you to first fill out a fairly
detailed questionnaire, then watch a ten minute programme ;
"Overcoming Fear" taken from the BBC series : YOU IN MIND. After
viewing you will then fill out a second, shorter questionnaire.
You will notice that I am asking your for you personal details.
This is because in approximately six weeks time I shall be 
contacting you to follow up y o u r  o p i n i o n s  about the programme.
Your personal details will not be used ip any other w a y v ^  all 
the information you provide is confidential. No one person 
taking part in this study will be identified by name and your 
answers will be used for research purposes only.
There are no right answers to most of these questions^ I am only
interested in your opinions. Please do answer all questions and
when this is difficult please indicate the answer nearest to what 
you feel.
' ' '
After you have finished doing the study, 1 should be happy to 
answer any questions you may have. Once the study is completed 
(by August, 1992) copies of the results will be available.
This study is not harmful in any way and should cause you no 
discomfort. If, however, you object to any particular questions 
you may choose not to answer them and may leave the study at any time
Thank you, again, for your co-operation.
NAME: Mr/Mrs/Miss/Ms          • • •
ADDRESS :................................. ................... ............
TELEPHONE NUMBER: ...............
SIGNATURE: .....................I,
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TO BFGIN WITH, HERE ARE SOME QUESTIONS ABOUT YOUR PARTICULAR 
VIEWING PREFERENCES.
(i)
Below are a number of categories describing types of television 
programmes. Please indicate the three you are most likely to watch 
THE MOST;
PLEASE RING AS APPROPRIATE:
Documentary and Features 1
Comedy 2
Religious 3
Soap Opera 4
Thriller 5
Science and Nature 6
Current Affairs 7
Mini Series 8
Drama 9
Situation Comedy 10
Film 11
Chat Shows 12
(ii)
Below are 
television 
MOST:
a number of ways of describing different types of 
programmes. Please indicate the three you enjoy THE
PLEASE RING AS APPROPRIATE;
Informative 1
Exploring new ideas 2 
Exciting 3
Frightening 4
Funny 5
Interesting 6
News related 7
Looking at other peoples lives 8
Gossipy 9
Sad 10
Giving advice 11
Looking at other peoples problems 12
Other (please write in) 13
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THE PROGRAMME YOU WILL WATCH IS CALLED "OVERCOMING FEAR"
AND LOOKS AT ANXIETY.
Twelve statements about ANXIETY are listed below. Please
indicate whether or not you think each statement is True or 
False.
PLEASE RING AS APPROPRIATE True False
1. It is best to avoid things that make us anxious.
2. People suffering from severe anxiety cannot change 
the way they are.
3. We all cope with anxiety in different ways
4. Chronic anxiety is a disease.
5. Lots of quick, deep breaths help anxiety 
disappear.
6. Prolonged anxiety can cause madness.
7. Positive thinking can help to manage severe 
anxiety
8. Anxiety is a natural reaction.
9. Taking tablets is the only way to manage 
severe anxiety.
10. Anxiety affects the mind and body.
11. Learning to relax is helpful when trying to 
manage severe anxiety.
12. Anxiety usually causes physical harm.
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HERE IS A LIST OF PROBLEMS AND COMPLAINTS THAT PEOPLE SOMETIMES 
HAVE. PLEASE INDICATE HOW MUCH DISCOMFORT THAT PROBLEM HAS 
CAUSED YOU DURING THE PAST MONTH, INCLUDING TODAY.
PLEASE RING ONE 
NUMBER NEXT TO 
EACH PROBLEM
Not at A little Quite
all bit Moderately a bit Extremely
1. Nervousness or 
shakiness inside
2. Pains in lower 
back.
3. Feeling lonely.
4. Feeling blue.
5. Heart pounding 
or racing.
6. Soreness of 
your muscles.
7. Feeling hopeless 
about the future.
8. Feeling weak in 
parts of your body.
9. Thoughts and 
images of a 
frightening nature.
10. Heavy feelings 
in your arms or 
legs.
11. Feelings of 
worthlessness.
12. The feeling 
that something bad 
is going to happen 
to you.
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FORTY FIVE STATEMENTS ARE LISTED BELOW. PLEASE INDICATE HOW MUCH 
YOU AGREE OR DISAGREE WITH THE FOLLOWING STATEMENTS:
PLEASE RING AS APPROPRIATE 
OR EACH STATEMENT
1. I would be willing to talk 
about my personal problems if 
I thought it might help me or 
a member of my family.
2. I am always curious about the 
reasons people behave as they 
do.
3. I think that most people who 
are mentally ill have something 
physically wrong with their 
brain.
4. When I have a problem, if I 
talk about it with a friend,
I feel a lot better.
5. Often I don't know what I'm 
feeling.
6. I am willing to change old 
habits to try a new way of 
doing things.
7. There are certain problems 
which I could not discuss 
outside my immediate family.
8. I often find myself thinking 
about what made me act in a 
certain way.
9. Emotional problems can some­
times make you physically 
sick.
10. When you have problems, 
talking about them with other 
people just make them worse.
11. Usually, if I feel an 
emotion I can identify it.
12. If a friend gave me advice 
about how to do something 
better. I'd try it out.
Agree Agree 
a a
lot little
Disagree Disagree
a
little
a
lot
4
4
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Agree Agree Disagree Disagree
a a a a
lot little little lot
13. I am annoyed by someone, 
whether they are a doctor or 
not, who wants to know about my 
personal problems. 1
14. I find that once I develop a 
habit it is hard to change, 
even if I know there is another 
way of doing things that might
be better. 1
15. I think that people who are 
mentally ill often have problems 
which began in their childhood. 1
16. Letting off steam by talking 
to someone about your problems 
often makes you feel a lot
b e t t e r .  1
17. People sometimes say that
I act as if I'm having a certain
emotion (anger for example)
when I am unaware of it. 1
18. I get annoyed when people 
give me advice about changing
the way I do things. 1
19. It would not be difficult for 
me to talk about personal 
problems with people such as 
doctors or clergymen. 1
20. If a good friend of mine 
suddenly started to insult me, 
my first reaction might be to 
try to understand why they were
so angry. 1
21. I think that when a person 
has crazy thoughts, it is often 
because they are very anxious
and upset. 1
22. I ’ve never found that talking 
to other people about my worries 
helps much. 1
23. Often, even though I know that 
I'm having an emotion, I don’t
know what it is. 1
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Agree Agree Disagree Disagree
a \ - ia: a ■ - ' ' a
lot little little lot
24. I like to do things the way 
I've done them in the past. I 
don't like to try to change my 
behaviour much.
25. There are some things in my 
life that I would not discuss 
with anyone.
26. Understanding the reasons you 
have deep down for acting in 
certain ways is important.
27. At work, if someone suggested 
a different way of doing a job 
that might be better. I'd give
it a try.
28. I've found that when I talk 
about my problems to someone 
else, I come up with ways to 
solve them that I hadn't 
thought of before.
29. I am sensitive to the 
changes in my own feelings.
30. When I learn a new way of 
doing something, I like to try 
it out to see if it would work 
better than what I had been 
doing before.
31. It is important to be open 
and honest when you talk about 
your troubles with someone you 
trust.
32. I really enjoy trying to 
figure other people out.
33. I think most people with 
mental problems have probably 
received some kind of injury 
to their head.
34. Talking about your worries to 
another person helps you to 
understand your problems better.
35. I'm usually in touch with 
my feelings.
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Agree Agree Disagree Disagree
a a a a
lot little little lot
36. I like to try new things, even
if it involves taking risks. 1 2 3 4
37. It would be very difficult for 
me to discuss upsetting or 
embarrassing aspects of my 
personal life with people even
if I trust them. 1 2  3 4
38. If I suddenly lost my temper 
with someone, without knowing 
exactly why, my first impulse
would be to forget about it. 1 2 3 4
39. I think that what a person's 
environment (family etc) is like 
has little to do with whether
he develops mental problems. 1 2 3 4
40. When you have troubles, 
talking about them to someone
else just makes you more confused. 1 2 3 4
41. I frequently don't want to 
delve too deeply into what
I 'm feeling . 1 2  3 4
42. I don't like doing things if 
there is a chance that they won't
work out. 1 2  3 4
43. I think that no matter how 
hard you try, you'll never really 
understand what makes people
tick. 1 2  3 4
44. I think that what goes on 
deep down in a person's mind is 
important in determining whether
they will have a mental illness. 1 2 3 4
45. Fear of embarrassment or 
failure doesn't stop me from
trying something new. 1 2  3 4
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FINALLY, BEFORE YOU WATCH THE PROGRAMME, PLEASE FILL IN SOME 
QUESTIONS ABOUT YOURSELF. THIS IS TO ENSURE THAT A CROSS SECTION 
OF THE VIEWING PUBLIC TAKE PART IN THIS STUDY.
SEX: V
Male 1
Female 2
AGE GROUP:
1 6 - 1 9 1
20 - 29 2
30 - 49 3
5 0 - 6 4 4
65 - 69 5
69+ 6
AGE FULL TIME EDUCATION FINISHED:
16 years or under 1
17 or 18 years 2
19 years or over 3
EDUCATIONAL QUALIFICATIONS: PLEASE WRITE IN:
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EMPLOYMENT:
Full-time Employment 
Part-time Employment 
Full-time Education 
Unemployed 
Retired
Housewife/husband
ETHNIC ORIGIN: 
White
W. Indian/Guyanese
Indian
Pakastani
Bangladeshi
Chinese
African 7
Arab 8
Mixed Origin 9
Other 10
MARITAL STATUS:
Married 1
Living with someone 2
Single 3
Divorced or separated 4
Widowed 5
Thank you for completing this questionnaire. Please ensure that
you have answered every question.
Shortly you will watch a ten minute programme; "Overcoming Fear"
and after that you will be asked to fill in a shorter questionnaire.
Thank you for your co-operation.
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YOU IN MIND 2
THIS QUESTIONNAIRE IS TO BE FILLED OUT AFTER YOU HAVE WATCHED THE 
PROGRAMME: OVERCOMING FEAR.
TO BEGIN WITH, HERE ARE SOME GENERAL QUESTIONS LOOKING AT WHAT 
YOU THINK ABOUT THE PROGRAMME THAT YOU HAVE JUST WATCHED.
Please indicate how much you agree or disagree with the following 
statements :
PLEASE RING AS APPROPRIATE 
FOR EACH STATEMENT
1. It made me realise 
something new about myself.
2. It made me realise 
something new about other 
people.
3. It gave me a clearer under­
standing of my own problems.
4. It gave me a clearer under­
standing of someone else's 
problems.
5. It helped me see what to 
do about a problem I have.
6. It helped me to see what to 
do about other peoples'problems.
7. It helped me to confront a 
problem I did not want to 
admit I had.
8. It helped me to confront a 
problem I did not want to 
admit someone I know had.
9. It helped me feel more 
confident in being able to 
cope with my problem.
10. I found it reassuring.
11. It made me think about 
things that I did not want 
to think about.
Agree
a
lot
Agree Disagree Disagree
a
little
a
little
a
lot
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Agree Agree D isagree  D isagree
12. It did not address anything 
relevant to my life.
13. The people in the programme 
were similar to me.
14. The people in the programme 
were similar to people I know.
15. The participants were well 
chosen.
16. The graphics and diagrams 
were easy to follow.
a a a
lot little little
a
lot
4
4
4
B
As a result of watching the programme, do you intend to do any of 
the following?
PLEASE RING AS APPROPRIATE. YES
1. Join a self-help group 
yourself. 1
2. Encourage someone you know
to join a self-help group. 1
3. Attend classes or workshops. 1
4. Encourage someone you know to 
attend classes or workshops. 1
5. Seek professional help for
your problems. 1
6. Encourage someone you know to 
seek professional help for their 
problems. 1
7. Talk to someone you haven't 
talked to about your problems 
before. 1
8. Encourage someone you know to 
talk to someone they haven't 
talked to about their problems 
before. 1
9. Try new ways of coping with
your problems. 1
MAYBE NOT SURE NO
4
4
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YES MAYBE
10. Try new ways of coping with 
someone else's problems.
11. Buy booklets or leaflets on 
the subject.
12. Encourage someone you know to 
buy booklets or leaflets on the 
subject.
13. Ring the Samaritans yourself.
14. Encourage someone you know to 
ring the Samaritans.
15. Other (please write in)
NOT
SURE
NO
HAVING JUST WATCHED A PROGRAMME ABOUT ANXIETY PLEASE READ AGAIN 
THE TWELVE STATEMENTS ABOUT ANXIETY WHICH ARE LISTED BELOW.
Please indicate whether or not you think each statement is 
True or False; some of your answers may have changed.
PLEASE RING AS APPROPRIATE True False
1. It is best to avoid things that make us 
extremely anxious.
2. People suffering from severe anxiety 
cannot change the way they are.
3. We all cope with anxiety in different ways.
4. Chronic anxiety is a disease.
5. Lots of quick, deep breaths help anxiety 
disappear.
6. Prolonged anxiety can cause madness.
7. Positive thinking can help to manage 
severe anxiety.
8. Anxiety is a natural reaction.
9. Taking tablets is the only way to manage 
severe anxiety.
2
2
2
2
2
2
2
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True False
10. Anxiety affects the mind and body. 1 2
11. Learning to relax is helpful when trying to
manage severe anxiety. 1 2
12. Anxiety usually causes physical harm. 1 2
Thank you for filling in this questionnaire. Please make sure 
you have answered all the questions.
If you have any comments please make them in the space below:
You will be contacted in approximately six weeks time to answer 
some follow-up questions.
Please make sure you hand both your questionnaires in together. 
Thank you very much for your co-operation.
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ABSTRACT
This study evaluated an outpatient treatment programme for stimulant drug misusers based 
in a Central London outpatient NHS setting. The design of the programme was broadly 
cognitive-behavioural, specifically using motivational, educational, lifestyle and relapse 
prevention components and was conducted over a six-month period in a step-wise, structured 
manner. Qualitative and quantitative measures were taken in order to evaluate outcome and 
the general issue of the treatment efficacy of this model for such a population. Given the 
small initial sample size (n=5) and subsequent drop-out’s from treatment, the quantitative 
data was presented in single case study form. The qualitative data was provided by a pre­
treatment focus group attended by all of the initial sample.
Although there are limitations to the generalisability of the data to treatment populations, the 
results are promising and provide preliminary support for the use of cognitive behavioural 
interventions for the treatment of stimulant misusers on an outpatient basis. Such support 
is shown on a number of dimensions provided by the data. The single case study outcome 
not only indicates marked changes in drug using and related behaviours from baseline to end 
of treatment but also that there are specific changes on particular dimensions relating to the 
treatment focus of the time ie. relapse prevention or motivational work, therefore also 
supporting the efficacy of the psychological construct underpinning each phase of treatment. 
The focus group highlighted a number of interesting issues which also provide support for 
the treatment intervention in a non-empirical way. The results are discussed in terms of 
future service development and the implications for the outpatient treatment of stimulant 
misusers. Issues of access and retention in treatment and patient - treatment matching within 
a heterogenous population are highlighted and discussed in the context of resource 
implications and future programme development and evaluation.
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LO INTRODUCTION
This research has been funded by Camden and Islington Community Health Services Trust 
Drugs Services and forms part of the Surrey University Psych D conversion programme 
(April 1994 - September 1995). As part of the Psych D conversion programme, this research 
is additional to the original MSc dissertation: The role of the televisual media in preventive 
mental health: an investigation (Sichel, 1992: MSc, London University). While this piece 
of work is conceptually very different to the original MSc dissertation, it will address issues 
that will expand on and develop the research skills developed at that time. Where the first 
dissertation used a one group pre test/post test correlational design (all quantitative statistics), 
this dissertation has required a more flexible and creative use of qualitative statistics. 
Furthermore, the current NHS challenges for audit and quality standards will be met with an 
exercise looking at service design and the evaluation of outcomes.
hi INTRODUCTION TO THE RESEARCH
1.1.1 Stimulant misuse treatment in the 1990's
Camden and Islington Drugs services wishes to develop a comprehensive assessment and 
treatment service for stimulant drug misusers by the end of 1995. This service must be 
piloted and evaluated.
The U.S. cocaine/ crack epidemic initiated in the 1980’s caused problems for the treatment 
system which struggled to cope with the challenge of how to define treatment. Most of the
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strategies for the treatment of cocaine and later amphetamine abuse, were adapted from 
treatment approaches that were developed for heroin addiction and alcoholism (Rawson et 
al, 1991). These adaptations have involved the integration of cocaine treatment programmes 
into those already existing for other drug and alcohol abusers; attempts to develop treatments 
that are conceptually parallel to existing addiction models, but that address the specific 
problems created by the physiological effects of stimulants; and the creation of new models 
of treatment that have used knowledge from clinical research on alcohol and drug addiction, 
but have never been used as mainstream approaches (particularly the integrated outpatient 
treatment models).
The recognition of such issues by the British addiction research and treatment communities 
has only begun recently with an awareness of the national increases in the amounts of 
stimulant drugs both used and seized. Opiate users in existing treatment programmes are 
increasingly reporting the use of crack cocaine as part of a poly-drug use profile, and the 
single or poly-stimulant misuser is now seeking treatment in greater numbers (The National 
Audit of Drug Misuse in Britain: ISDD, 1992). The British addictions field has to address 
these issues; however, similar to the U.S. experience, the challenge exists in the definition 
of treatment for stimulant users whose treatment needs are qualitatively different from the 
traditionally understood opiate user.
1.1.2 The application of research to clinical populations
Shore (1989) points out that the purpose of research is to inform practice from a base of 
reliable knowledge, however often research has and is used as a means of avoiding action.
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As well as the traditional research goal of hypothesis testing, Shore argues that other research 
approaches such as demonstration projects, descriptive studies, clinical research, exploratory 
investigations and action research can all generate valid data and contribute to our dealing 
with problems such as those being addressed in this study. For Shore "binding ourselves to 
hypothesis tes ting as the sole valid research technique not only represents a perversion of the 
concept of research (the systematic, objective testing and confirmation of knowledge) but has 
ethical and practical implications as well" (pg 482).
The swift replication, evaluation and implementation of programmes that seem to work is 
crucial. Hypothesis testing may be seen as scientifically more ’watertight’, however to deny 
treatment to vulnerable populations because no ’valid’ research justifies spending money on 
an approach may be unethical. Treatment must be made available that replicates models of 
proven efficacy. While responsible policymakers, administrators, and mental health 
professionals must do all they can to make proven and promising treatments available now, 
the need is to incorporate outcome evaluation components (Wallace, 1991).
The present study is the evaluation of an integrated, cognitive - behavioural outpatient 
treatment model for stimulant drug abusers. The programme is designed around models of 
treatment that have shown promising results in the American treatment field. There has, to 
date, been no systematic evaluation of such a treatment programme on offer in the NHS. 
This study aims to evaluate the development of such a treatment package for stimulant drug 
misusers attending an NHS outpatient treatment service: studying the process of care in order 
to evaluate outcome.
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1.2 REVIEW OF THE STIMULANT LITERATURE
1.2.1 The Stimulant drugs
The stimulant drugs fall into at least three major categories including the various forms of 
cocaine, a number of formulations of amphetamine, as well as other stimulant-like drugs 
including methylphenidate (Ritalin) and prescription weight reduction pills. Included in this 
category are the amyl nitrites, anabolic steroids, nicotine and caffeine. For a full description 
of this class of drugs and their biochemical effects, see the clinical dossier, pg. XX.
1.2.2 Prevalence and demographic factors of stimulant use
Throughout history stimulants have been used both symbolically and as part of the daily life 
of most people. Today, caffeine is probably the most commonly used stimulant throughout 
the world. Stimulants are used in a number of ways for a variety of reasons, particularly 
controlled use as a means of remaining awake and alert, e.g., for the better performance of 
an occupational task. This is to be contrasted with recreational or compulsive use by 
individuals who use the drugs mainly for the psychological effects caused, rather than as a 
means to an end.
Amphetamines are the second most widely used illicit drug after cannabis; used both as a tool 
by occupational groups (e.g., long-distance drivers) and as a mood enhancer by those who 
take the drugs for recreation. Preliminary results from a study of amphetamine users in the 
UK in 1991 showed that nearly three-quarters were male and were generally younger and
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more sociable than heroin users. It is argued that amphetamine injectors are at greater risk 
of HIV infection; only 10 percent were contacted through a treatment facility and more than 
two-thirds had shared injecting equipment during the six months prior to interview (Klee, 
1992). Police drugs seizures are also a good indication of illicit use: between 1981-1991, 
police seizures of all drugs trebled, while amphetamine seizures increased by a factor of six 
(Home Office Statistical Bulletin, 1992).
Cocaine snorting was popular in the late 1970s and 1980s and seen as a measure of 
individual and societal affluence with users generally white, "thirty-something yuppies". The 
cost of cocaine in the UK prevented its use as a "street" drug up until the mid-1980s after 
which changes in marketing methods, media advertising and the introduction of "crack" 
resulted in heroin users adding cocaine to their inventory of drugs and its use as a primary 
drug by young, socially-marginalised groups who had not previously used opiates (Hartnoll 
& Power, 1986).
The social profile of stimulant misusers would appear to be very similar regardless of the 
drug involved. Studies of amphetamine or cocaine misusers in Japan, Sweden, the USA and 
the UK all show a similar socio-demographic breakdown. The majority of users are from 
lower socio-economic groups, aged 20-35 years and between two-thirds and three-quarters 
are male (e.g., Klee 1992; Bachman, 1990). The majority of stimulant misusers also report 
heavy use of a variety of other drugs, including alcohol and cannabis, which may exacerbate 
their problems.
193
The local picture supports the perceived increase in stimulant use at a national level and will 
be described in detail in section 1.3 below.
1.2.3 Approaches to the treatment of stimulant misuse
1.2.3.1 Modalities of treatment
Treatment strategies were devised to provide the proper support structure for facilitating 
cocaine abstinence during the early years of the U.S. epidemic. From these efforts, a group 
of cocaine abuse treatment strategies have emerged, and these include: integrated outpatient 
treatments; cognitive and behavioural strategies; 28 day inpatient programmes; therapeutic 
communities; twelve step programmes; pharmacological interventions; complimentary 
therapies. The following discussion will review those strategies relevant to the aims of this 
study. It is important to note that references to cocaine in particular appear because the 
current treatment research has primarily focused on the cocaine misuser.
1.2.3.2 Integrated outpatient models for the cocaine misuser
Outpatient psychotherapeutic techniques are extremely varied in their approach to the 
treatment of cocaine misuse. There is growing recognition that some approaches appear to 
have significant value in assisting recovery (Kertzner, 1987). Millman (1986) has described 
the value of providing educational information within a cognitively based therapy strategy 
with cocaine users. Other cognitive techniques, such as cognitive labelling, teach users about 
conditional cues and craving and aim to enhance feelings of control over and understanding
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of behaviour (Galanter, 1983). Rounsaville et al (1985) have reported success using a variety 
of directive strategies to assist coping with interpersonal deficits that may contribute to 
relapse. In all of these cognitive approaches, the clearly defined goal is abstinence; there is 
no evidence that tapered withdrawal is preferable to immediate abstinence.
The general therapeutic gains in other emotional or behavioural areas which enhance the 
maintenance of change are seen as secondary to abstinence. Some proponents of in-depth 
psychotherapy with cocaine users believe that therapy needs to extend deeper than issues of 
abstinence and that addressing these underlying issues is essential to good long-term outcome 
(Schiffer, 1988). However a number of addiction researchers have argued that 
psychotherapy intended to address only underlying dynamics without providing specific 
remedial assistance for stopping cocaine use, is contraindicated in treatment (Rawson et al, 
1991; Resnick & Resnick, 1984). The following discussion of individual therapy techniques 
will, therefore, focus on cognitive behavioural interventions initially on integrated outpatient 
treatment models and then particularly on the specific components of such models.
h  Washton’s Rehab Model
Arnold Washton has developed a structured outpatient treatment approach combining 
behavioural techniques, cognitive strategies, information, family involvement, self-help 
groups and urine testing (Washton, 1987, 1989; Washton and Stone - Washton, 1990). 
Washton reports that such a combination of procedures appears to provide "middle class 
patients" with a set of strategies assisting abstinence and positive lifestyle changes. He 
reports that of 127 middle class patients who entered treatment, 65 % completed the 6 - 12
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month programme and 75% were drug free at follow up (Washton et al, 1986). He argues 
that there is a significant positive relationship between length of time in treatment and drug 
free outcome. The beauty of Washton’s model lies in its clarity of detailed description 
provided in the excellent clinical text on his methods (Washton, 1989). He describes 
sequential stages of treatment:
Stage 1 (first 2 weeks): stabilisation and crisis intervention
Stage 2 (months 1 & 2): early abstinence
Stage 3 (months 3 - 6 ) :  relapse prevention
Stage 4 (open-ended): advanced recovery
within which therapy sessions and urine samples are scheduled three times per week for three 
months and followed by two sessions and two urines per week for the final nine months. 
The majority of the sessions are group therapy. Early treatment focus is the provision of 
information and behavioural strategies aimed at the achievement of abstinence, with a 
subsequent shift of emphasis toward relapse prevention issues. Washton’s programme 
focuses on the concept of ’addictive disease’ and requires abstinence from all mood altering 
substances. Another key component is the focus on the ’critical interaction’ between sexual 
behaviour and cocaine use: the former a conditioned cue for the latter. Washton has not yet 
produced a structured treatment protocol that can be replicated and evaluated in a systematic 
manner.
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h  The Neurobehavioural Model
The term "neurobehavioural" indicates the focus of this model on ’neurochemical 
normalisation’ and behavioural strategies aimed at promoting long term recovery. Rawson’s 
model is described as "an initial attempt to structure information, support and encouragement 
across a series of stages that are experienced by cocaine misusers as they progress through 
the first six months of their recovery" (Rawson et al, 1991, pg 117). These stages are:- 
The withdrawal stage: 0 - 1 5  days post - cocaine
The honeymoon stage: 16-45 days post cocaine
The wall: 46 - 120 days post - cocaine
Adjustment: 121-180 days post - cocaine
Resolution: 181 +  days post - cocaine
For each stage, the patient is aware of expected behavioural, emotional, cognitive and 
relationship difficulties that will arise. The goal of treatment is to provide a framework 
within which cocaine misusers:
1) achieve abstinence;
2) remain in treatment for 12 months;
3) learn about issues critical to addiction and relapse;
4) receive direction and support from a trained therapist;
5) receive education for family members;
6) join self help groups;
7) receive monitoring by urine testing.
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The programme lasts 12 months and includes 52 individual sessions in the first 6 months, a 
12 week educational group, a 4 week group focusing on structuring weekends and leisure 
time, a 20 week relapse prevention group, seven couples sessions in the first six months, 
weekly random urine tests, analysis of relapse episodes and membership of AA/NA. An 
unusual aspect of this model is the intense focus on the use of individual sessions with 
secondary group therapy (the reverse to Washton’s programme). These are forty - five 
minute, focused cognitive-behavioural sessions using techniques of self monitoring within a 
broadly socratic, directive and collaborative approach as suggested by the cognitive therapists 
(eg. Beck et al, 1993). Relapse prevention is one of the topics covered in the group sessions 
and is directed by the work of Marlatt and his colleagues (1985). The effectiveness of this 
programme has been studied within a pilot and an open trial study; the results from both are 
promising. Subjects reported lower rates of cocaine use than those attending hospital-based 
or a no treatment group. There appeared to be a positive relationship between alcohol 
consumption and relapse of cocaine use. The overall outpatient programme was given 
significantly higher patient satisfaction ratings (Rawson et al, 1986). These studies were 
conducted using quasi-experimental designs and participants were self selected so therefore 
the conclusions are limited, however there is a strong suggestion from the findings that the 
materials and clinical strategies are useful in assisting the achievement of cocaine abstinence.
Motivation
The work of Washton and Rawson and colleagues formalises and standardises two models 
of outpatient cocaine dependency treatment. The models appear to have demonstrated the 
capacity to engage and retain substantial numbers in treatment, implying that the levels of 
motivation for treatment of this self selected sample would be high, particularly with a charge
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of up to $6,000 to attend the programme. This issue poses a problem for the design of 
programmes within agencies where patients are not required to pay and where issues of 
motivation are likely to be a more critical focus at the onset of treatment. Addressing 
treatment ambivalence within a motivational framework may be an additional component not 
described in the America literature; this issue will be explored further later on. Furthermore, 
Washton describes a "middle-class" patient population who may be better educated and 
therefore better able to make use of the socratic, cognitive-behavioural approach.
Kev features of treatment
Before moving onto the specific treatment components and in order to conclude this section 
it is important to highlight what are emerging as key features of an outpatient treatment 
model. An abstinence - based, structured programme with clearly marked treatment phases 
that are sequential seems essential. A combination of cognitive and behavioural techniques 
applied within individual and group sessions which include/aw/fy members as appropriate. 
In general the programmes should attend to the biological, psychological and social factors 
underlying the dependence following a biopsychosocial model. Furthermore, model 
treatments should recognise the circumscribed population or type of patient for whom the 
treatment works, acknowledge the phase o f treatment or recovery it should be
administered and include relapse prevention. Urine testing, complimentary and 
pharmacological interventions are useful adjunctive strategies.
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1.2.3.3 Components of Treatment
In general, the main components of treatment for stimulant misuse are:
i) Motivational interviewing
ii) Relapse Prevention
iii) The Behaviour Therapies
iv) Pharmacological interventions "
II The motivational work aims to help individuals to develop and sustain high levels of 
motivation for abstinence. Such work combines education and motivational 
interviewing addressing the ambivalence experienced by most users when first 
entering treatment.
III Relapse Prevention, a set of cognitive-behavioural therapy techniques, appears to be 
particularly useful when treating stimulant misusers; stimulant misusers, using drugs 
with such strong reinforcing properties, show a high relapse rate after treatment 
(Schuckit, 1994). Theoretically, this can be associated with conditioned 
environmental stimuli that increase craving. Relapse prevention interventions focus 
on the individuals’ high risk situations and mood states and then offers management 
strategies tailored to meet individual patient needs.
1111 Behavioural interventions are developed around learning theory models of
dependence. Addressing similar issues as the Relapse Prevention techniques, i.e. 
conditioned cues and cravings, the strategies attempt to reverse or extinguish the
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associations made between drug and environment (classical conditioning) and the 
reinforcing properties of the drugs themselves (operant conditioning).
iv) Pharmacological interventions for the treatment of stimulant misuse are being 
developed in order to provide a ’methadone’ equivalent for stimulant misuse treatment 
(Rawson et al, 1991). Research work has primarily focused on the treatment of 
cocaine misuse and such medications would aim to achieve one or more of the 
following: reverse cocaine overdose reactions; alleviate symptoms of the cocaine 
"crash" in early withdrawal (i.e., depression, anxiety, craving, etc.); facilitate 
maintenance of continued abstinence beyond the withdrawal period.
The following section addresses each component in more detail.
1^  Motivational Interviewing
Most individuals seeking help for substance misuse are initially very ambivalent about 
change. Ambivalence may be experienced in a number of ways, primarily to the cessation 
of the stimulant misuse and to the treatment itself. It is critical that ambivalence is addressed 
as a first stage in the process of change in order for the patient to experience themselves as 
an active participant in their treatment.
Prochaska and DiClemente (1986) have described this state of conflict as being characteristic 
of the first stage of a cycle of change. The Process of Change model aids the 
conceptualisation of the stages of change that an individual goes through in her/his attempts 
to give up/gain control over a problem behaviour (see Appendix A). People suffering from
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addictions are often in the early stages of change: precontemplation or contemplation. 
Precontemplators are those who use the least change strategies and traditionally such 
individuals have been seen as having problems of denial or lack of motivation. Alternatively, 
a precontemplator can be described as an individual who is highly motivated to continue their 
behaviour, not change it (Tober, 1989). Contemplators are those individuals who are 
considering the need to do something about their behaviour, they will be currently using 
drugs but feel dissatisfied with the situation and may be experiencing conflict between the 
positive and negative aspects of their drug use.
Using this model it can be argued that before it is appropriate to start a treatment 
programme, individuals must reach the stage of active change at which stage a number of 
change directed therapeutic procedures are available (Miller, 1983). Therefore in order to 
successfully engage in treatment and increase the probability of a successful outcome, the 
client has to be motivated.
Motivational interviewing comprises a set of therapeutic techniques which aim to stimulate 
and supervise the contemplation and decision making of the client. The most important 
motivational techniques are (van Bilsen, 1987; Miller, 1983, 1985):
(i) creating an empathie atmosphere of unconditional positive regard for the client;
(ii) giving the client clear and concrete feedback about their behaviour, motives and 
personal situation;
(iii) structuring and providing choice alternatives concerning the addictive behaviour and 
related problems;
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(iv) keeping regular contact with the client;
(v) actively listening to the client.
To carry out motivational interviewing, therapists require a wide repertoire of therapeutic
skills. They must be able to use reflective, proactive, and directive interventions, to 
empathise with the client but also utilise restructuring when required. Clinical success comes 
from using these skills in a flexible, integrated manner. At this initial stage of contact, the 
therapist should aim to create an atmosphere in which the client motivates themselves which 
can be achieved by offering the opportunity to increase awareness of the nature and 
consequences of the behaviour. This would include an awareness of the motives for the 
behaviour and possibilities for change. Evaluations of this technique in relation to the 
treatment of stimulant use would be included in the review of the Relapse Prevention 
literature described below.
2. Relapse Prevention
Relapse prevention techniques fall within the general category of cognitive-behavioural 
methods and seek to address the significant problem of relapse in substance misuse disorders 
through the development of self control strategies. Although developed as a treatment for 
problem drinking, relapse prevention is theoretically applicable to the spectrum of substance 
misuse disorders and has begun to receive empirical support in clinical trials for a variety of 
classes of substance misuse including problem drinking, smoking and poly-substance misuse 
(Carroll et al, 1991).
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Relapse prevention is described as being particularly suited to the treatment of cocaine 
misuse. For example, while many cocaine misusers manage short periods of abstinence, 
successful long term maintenance of change seems to be dependent upon the effective 
management of cocaine craving (Carroll et al, 1991). Relapse prevention includes techniques 
intended to faciltee the identification and reduction of subjective craving for cocaine through 
the recognition of high risk situations for cocaine misuse and craving and the development 
of effective coping behaviours and urge control strategies.
There are several elements of relapse prevention which make it particularly suitable for 
outpatient treatment. Emphasis on symptom control is essential where cocaine is likely to 
remain accessible to the abuser. A second feature of relapse prevention is that it is a flexible 
approach. This is essential given the marked heterogeneity among populations of same-drug 
users. Relapse prevention can be integrated, with ease, into a variety of treatment modalities 
and approaches. As an active, directive approach, relapse prevention facilitates the 
development of skills to control substance misuse which, in turn, enhances feelings of self- 
efficacy. Over-represented among populations of treated substance misusers are individuals 
with "borderline" personality characteristics - characteristics usually associated with greater 
need for clear boundaries, structure and support (Linehan, 1993). Finally, relapse prevention 
provides the patient with a broad repertoire of generalisable skills.
Only recently have researchers begun to evaluate the relapse prevention approach for the 
treatment of cocaine abuse. Carroll (1991) describes a comparative trial of relapse 
prevention and interpersonal therapy (IPT) for cocaine users with the question "is this 
treatment (relapse prevention) at least as good or better than other therapies in current use
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with this population (IPT)?" (pg. 231). The results were positive for clinicians who had 
intuitively thought that a) psychotherapeutic techniques alone and b) relapse prevention 
techniques specifically, were well indicated for the treatment of cocaine misuse. Subjects 
assigned to relapse prevention were more likely than subjects in IPT to a) attain three or 
more continuous weeks of abstinence (57 vs 33%) b) be classified as recovered at the point 
of treatment termination (43 vs 19%) and c) complete treatment (67 vs 38%). There was 
a significant difference by treatment group when subjects were stratified by severity of 
substance misuse: more severe users receiving relapse prevention being significantly more 
likely to achieve abstinence (54 vs 9%) and be classified as recovered (54 vs 0%). This 
finding was further explored in the same author’s later comparison of relapse prevention and 
pharmacotherapy (Carroll et al, 1994). Again, results indicated that higher-severity patients 
had significantly better outcome when treated with relapse prevention while lower-severity 
patients responded best to desipramine (a tricyclic antidepressant). Furthermore, depressed 
subjects showed a greater reduction in use than non-depressed subjects and responded 
significantly better to relapse prevention. A final study compared relapse prevention and 
twelve step approaches. No real differential effects of treatment type on cocaine misuse over 
time were found, however relapse prevention subjects showed better retention in treatment 
and better maintenance of post treatment change at 6 months follow up (Wells et al, 1994).
To conclude, relapse prevention theory offers a promising range of techniques for the 
treatment of the cocaine misuser; this conclusion can probably be generalised to stimulant 
misusers in general given the shared biopsychosocial properties of this group of drugs. 
Recent studies indicate relapse prevention is helpful for treatment retention, long term 
maintenance of change and particularly for greater severity, depressed users. These studies
205
also highlight the heterogeneity of this drug using population where the flexibility of relapse 
prevention models is particularly useful. Clearly further research in needed and it may be 
useful to pursue this in a stepwise manner: to develop and refine a given model of treatment, 
to establish the efficacy of that treatment in reducing cocaine and other stimulant drug misuse 
and to identify sub-populations for whom the treatment is most effective. Once efficacy has 
been established within a certain sub-group of clients, matching studies can be undertaken 
to evaluate whether efficacy is specific to that subgroup (Wells et al, 1994).
& The Behaviour Therapies
The development of behavioural strategies as a treatment approach is based on the principles 
and conceptual framework of behaviour analysis and behaviour pharmacology; the general 
behavioural principles operating in the case of stimulant drugs being operant behaviour 
maintained by the reinforcing effects of the drugs themselves. Support for this model stems 
from reliable empirical observations that laboratory animals self-administer most of the same 
drugs that are misused by humans (eg. Henningfield et al, 1986). From such observations, 
it appears that stimulants can override even the most basic individual biological drives, 
including the basic instinct to survive: hungry monkeys will choose cocaine over food, 
ultimately dying of starvation or overdose; rats given unlimited access to cocaine will self- 
administer such massive doses that 90 percent die from overdose within thirty days 
(Washton, 1989). Neither a prior history of drug exposure nor physical dependence are 
necessary for these drugs to function as reinforcers and maintain ongoing pattern of drug 
administration.
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The behavioural model of stimulant drug abuse has permitted researchers to effectively 
extrapolate and apply to drug dependence scientific principles already available from research 
on other types of operant behaviour and has highlighted the links between environmental and 
pharmacological variables in the reinforcing effects of drugs (Goldberg & Stolerman, 1986). 
The applications of such principles are described in studies reporting the use contingency 
contracting cue exposure and aversion therapy.
(a) Contingencv Contracting
One of the first treatment reports in the stimulant treatment literature described the 
use of contingency contracting procedures (Anker & Crowley, 1982). This technique 
assumes that users can abstain if they are properly motivated to stop (i.e., have 
sufficient contingencies). This first study evaluated a treatment consisting of 
establishing a written contract agreement between the patient and the treatment staff 
specifying a punishment contingency for use. Such an "all or nothing" contingency 
was viewed by 52 percent of subjects as "unacceptably severe". There was a 
significantly high rate of abstinence over a three-month period, however, the subjects 
being "middle and upper-middle class clients" had something valuable to lose in the 
contracts and are not representative of the majority of such users entering the 
treatment system. Furthermore, at eight months follow-up, more than 50 percent of 
subjects had relapsed. More recent work has recommended a number of possible 
modifications in the contract that might improve compliance, ie. the use of the 
positive contingency (Kleber & Gawin, 1984). The most recent example of such an 
approach within the outpatient setting is where contingency management procedures
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were used to reinforce abstinence (using retail vouchers) and drug use resulted in the 
loss of positive reinforcement (Higgins et al, 1994). Results indicate that the treatment 
was acceptable to patients, it retained them in treatment, engendered clinically 
significant levels of cocaine abstinence and could be adapted to deal with other forms 
of substance abuse common with this population. Such contingency contracting 
appears to be a very valuable therapeutic adjunct when patients are ambivalent about 
abstinence: a useful motivational tool.
Higgins (1994) describes a programme with contingency contracting at its core but 
including relationship counselling, relapse prevention, and skills teaching and lifestyle 
and employment management. This highlights that contingency contracting has use 
as a motivational technique in combination with the previously described cognitive 
behavioural techniques.
(b) Cue Exposure
Substance misusers associate the use of the drugs with a wide range of environmental 
stimuli: drug paraphernalia, bars, drug-using friends, money and sexual activities, 
become associated with the use of the drugs themselves. Cravings result from the 
triggering effects of such external stimuli. The establishment of these conditioned 
stimuli for craving occurs by the process of classical conditioning. Relapse by drug 
abusers is frequently preceded by exposure to these conditioned stimuli (Rawson et 
al, 1990). One way of eliminating the conditioned response to these cues is by an 
extinction procedure that exposes the drug misuser to the cues repeatedly without
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permitting the subsequent self-administration of the drug. Classical conditioning 
principles suggest that the repeated exposure to the cues without accompanying drug 
use should result in a weakening of the conditioning ultimately allowing exposure to 
cues with no resultant craving.
The most recent and comprehensive evaluation of this intervention has been by 
O’Brien and colleagues (1990). This group evaluated the usefulness of cue exposure 
as an added procedure to inpatient treatment programmes. A group of cocaine 
misusers were given nine trials of exposure to varied cocaine use stimuli and self 
reported cravings, heart rate, skin temperature and respiration were monitored. 
Results indicate that response to the cocaine stimuli decreased over time which 
demonstrated the extinction of the conditioned response with the experimental setting. 
It is not clear how generalisable this effect would be on discharge, however, subjects 
involved in such a trial were retained in aftercare longer than subjects who were not, 
and showed less cocaine use at urinanalysis. The results would indicate that although 
it is unlikely that cue exposure will be a stand-alone treatment intervention, it may 
be a useful component of a co-ordinated inpatient treatment experience. Use in the 
outpatient setting may be contraindicated, because the craving produced by the trials 
may lead to relapse upon leaving the clinic; indeed there are no studies of out-patient 
cue exposure trials to date.
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(c) Chemical Aversion Therapy
Chemical Aversion Therapy has been used in the treatment of alcohol addiction 
(Smith, 1982) and marijuana (Morakinyo, 1983). The theoretical role of aversion is 
as part of a multimodel treatment programme focusing on addiction as a neuro- 
behavioural disease. Aversive counterconditioning works within the same theoretical 
frameworks as presented for contingency contracting and cue exposure, ie. operant 
and classical conditioning paradigms. It is not a substitute for support for life- 
enhancing behaviour, rather it suppresses the undesirable behaviour, while other 
modalities support positive alternatives. Aversion therapy is à recognised and 
accepted part of a multimodal treatment programme for alcoholism (Frawley & 
Smith, 1990).
The only research report concerning specifically on aversive counterconditioning is 
Frawley and Smith (1990). Taking cocaine snorters it was argued that such ingestion 
behaviour may be successfully linked to the aversive stimulus of nausea. The goal 
of the research was to provide treatment for patients with cocaine dependence only 
or with alcohol and cocaine dependence and to determine the possibility of integrating 
chemical aversion therapy into the multimodal treatment protocol. The results were 
impressive. Ninety-five percent were followed up at six months with 56 percent of 
the cocaine only group and 70 percent of the cocaine and alcohol group showing total 
abstinence. At eighteen months these figures were 37 percent and 50 percent 
respectively. This treatment approach was also shown to have high patient 
acceptability. It is important to note that the sample size was initially only twenty
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subjects. Furthermore, subjects were also provided with two "counselling groups" 
per day and regular individual sessions which would clearly account for some of the 
treatment outcome.
Conclusion
In summary, research on behavioural approaches to the treatment of cocaine abuse has shown 
positive results. However, the behavioural techniques are often embedded among other 
cognitive - behavioural supportive techniques and interventions. Therefore such interventions 
are most helpful as part of an integrated cognitive - behaviour therapy treatment programme.
4  ^ Pharmacological approaches
There are many precedents for pharmacotherapy approaches in the treatment of other 
addictions and mental health difficulties, e.g., methadone and naltrexone for heroin addiction, 
antidepressants for depression, and neuroleptics for schizophrenics. Therefore, it would be 
a valuable contribution to identify medications that aid in the management of stimulant 
misuse. However, the current literature reveals no pharmacological agent that has been 
demonstrated in large double-blind controlled clinical trials to be significantly better than 
placebo for stimulant dependent people.
Dopamine (DA) boosting agents reverse the marked depletion of the functioning of the DA 
pathways which result from chronic cocaine misuse. Early trials of the agent bromocriptine 
(Parlodil) were relatively promising, however, more recent studies have not replicated early 
findings (e.g., Kranzler & Bauer, 1992). Other controlled trials on agents that block the DA
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reuptake process, e.g., mazinidol, have also shown poor results, while further trials on the 
antipsychotic drug flupenthixol (Gawin et al, 1989) and the DA boosting agent amantadine, 
have also not been promising (Schuckit, 1994).
Buprenorphine is a mixed opiate agonist/antagonist which has been tested for treating poly 
drug (IV opiate/cocaine) misusers. The DA reward system of the brain is also responsive 
to opiate effects and several animal and human studies indicate that the level of stimulant 
intake in opiate misusers decreased in trials of this agent. Buprenorphine also causes a 
dampening of the body’s response to cocaine. There are, however, no large sample, 
longitudinal double-blind controlled trials of this drug and clearly further research is needed 
(Schukit, 1994).
Antidepressant medications alter levels of noradrenaline and serotonin: neurochemicals 
affected by stimulant misuse. The use of such agents would aim to diminish the mood 
swings experienced after abstinence due to the depletion of these neurochemicals. Again, 
earlier promising studies, e.g., on the tricyclic antidepressant desipramine, have not been 
supported by more recent large sample, double-blind trials (eg. Kosten et al, 1992). More 
recent work on the serotonin-specific digtni fluoxetine indicates increased subjective responses 
to cocaine but further research is needed (Schukit, 1994).
Carbamazepine. the antiepileptic agent, has been studied for its hypothesised use in blocking 
some of the longer-term sensitising, or kindling, effects of stimulants (Halikas et al, 1992). 
Recent open trials have looked positive for cocaine dependence, however, the longer trials 
all indicate high rates of subject drop-out (Schuckit, 1994).
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Substitute prescribing, i.e., administering a drug of the same class as that being misused, has 
also been investigated. Most studies have focused on methylphenidate (Ritalin) but none has 
demonstrated any superiority to placebo (Schuckit, 1994).
1.2.4 Summary and conclusions
There is no clear best treatment for stimulant misuse. However the implementation of 
combinations of approaches currently developed with evaluation may be useful. General 
recommendations are:
(i) Integrated outpatient treatment models appear to be promising with some types of 
cocaine misuser. Current evidence suggests good outcome with middle-class 
misusers, but poorer outcome with those less affluent. Treatment outcome data are 
necessary to fully assess the value of such approaches.
(ii) Cognitive - behavioural strategies are currently being tested in some well designed 
experimental evaluations. Recent outcome studies support the efficacy of relapse 
prevention and behavioural techniques for the treatment of some populations of 
cocaine misuser.
(iii) Desipramine appears to facilitate cocaine abstinence following the first several weeks 
of abstinence and may provide a useful adjunctive therapy in combination with the 
integrated psychotherapeutic approaches. Other pharmacologic treatments are not yet 
established.
(iv) As the treatment system continues to evolve, programme evaluation components are 
essential to the understanding of stimulant abuse treatment. This would include the
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inclusion of all single and poly-stimulant drug misusers (ie. amphetamine and ecstasy 
misusers) in treatment evaluations apart from just the cocaine misuser as is the case 
with current research. Measurements including urinalysis and treatment retention as 
well as measures of client satisfaction will provide important feedback for the 
development of an empirically based treatment system. Therefore, it would seem that 
the most useful approach at present would be to initiate pilot programmes based upon 
the best available information and to evaluate their impact. This challenge has been 
set by a number of the major researchers in this field (eg. Rawson et al, 1991) and 
is being attempted by this study.
hi THE HAMPSTEAD ROAD CENTRE OUTPATIENT STIMULANT 
TREATMENT PROGRAMME
The outpatient programme has been designed around the integrated models of outpatient 
treatment showing efficacy in the American literature (see section 1.2 for a review of the 
literature). The programme will run for a minimum of 6 months where each participant is 
expected to commit to every stage of treatment. This treatment programme is based on 
cognitive - behavioural, relapse prevention theory and techniques. There is a combination 
of individual and group work which will be collaborative, didactic and directive. Participants 
set individual and group goals between sessions and there is widespread use of handouts for 
information and exercises.
The clinical dossier of this PsychD portfolio describes the service development of this 
treatment programme. The dossier includes a description of the target population, an
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overview of the class of drugs being treated, and a full description of the programme 
including a treatment manual (a session by session breakdown of the group sessions).
lA SUMMARY AND CONCLUSIONS
1.4.1 Rationale and aims of the study
The provision of treatment services for stimulant drug misusers has become a service 
development priority for drugs services in this country. Given established patterns of 
prescribing for the traditionally treated opiate misuser and given that there is no validated 
prescribing regime for the stimulant misuser, treatment services have to explore models of 
intervention provided by disciplines other than medicine. In the U.S., clinical psychology 
has taken the lead in the development, evaluation and implementation of treatment services 
for stimulant drug misusers. Such programmes are abstinence orientated and use cognitive - 
behavioural techniques, particularly relapse prevention and motivational interviewing. 
Preliminary outcomes are good, however the populations evaluated pay for their treatment 
and are generally more affluent and better educated than the typical single or poly stimulant 
drug misuser in this country. Nonetheless, such models provide useful frameworks for the 
development and implementation of an outpatient stimulant drug treatment service in a central 
London NHS outpatient setting. This study aims to evaluate the efficacy of such a newly 
designed outpatient programme based on existing models described in the treatment literature; 
outcome will affect future service development.
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1.4.2 Research questions
The research will be concerned with detailed examination of the following areas:
i) Does involvement in treatment lead to abstinence/decreased drug use?
ii) Are there associated mental health changes and what are they?
iii) Are there associated lifestyle changes and in what areas?
iv) How far can these changes be explained by specific and/or non-specific components 
of the treatment programme?
v) What are the patients’ expectations of treatment?
vi) Does the treatment process meet the expectations of the patients?
vii) What implications does the outcome of this research hold for the treatment of 
stimulant misusers and the design and evaluation of future programmes?
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2.0 METHOD
2. 1 SUBJECTS
Recruitment
As this was the pilot of a new treatment service, recruitment of subjects was an issue given 
that the Drugs Services were historically perceived as an opiate treatment service and 
therefore did not attract large numbers of stimulant-only misusers, the population required 
for this study. Furthermore, stimulant misusers do not perceive themselves in need of 
treatment given the myths around ’recreational drug use’ and therefore were even less likely 
to present at a drug clinic for help. In order to recruit, therefore, a number of statutory and 
non - statutory drug agencies and GP’s were contacted with information about the programme 
and the research and a request for referrals. Prospective clients were given information 
sheets and asked to contact the outpatient drugs services if interested in an assessment for a 
place on the programme.
Assessment
The assessment interview took place over two, one hour periods, spaced a week apart: this 
allowed the client to ask questions at the second interview and for urine to be tested between 
the interviews in order to confirm stated drug use. In addition, the client was given a 30 
minute appointment for a mental state examination with a team psychiatrist (in line with 
clinic policy). All assessment interviews were conducted by one psychologist using a 
standardised format of information collection agreed with a colleague who then discussed all 
cases prior to a decision about inclusion on the programme being made.
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Inclusion and exclusion criteria
Clients were expected to show primary dependence on stimulant drugs (as defined by DSM 
IV); dependence on any other class of drug requiring substitute medication (eg. opiates, 
benzodiazepines) was not acceptable given the potentially confounding effects on treatment 
and outcome (ie. receiving a prescription while attending an abstinence orientated 
programme). Clients with a frank psychiatric illness or a degree of dependence that 
contraindicated outpatient treatment would be referred on to the appropriate in or outpatient 
setting. Clients who wanted substitute prescribing, who clearly were not abstinence 
orientated or did not seem appropriate for a group intervention were also excluded.
Clients excluded
Of nine subjects assessed, four were not offered places on the basis of the above described 
criteria and received the following: two were referred on for an inpatient detoxification given 
their presenting mental state; one did not wish to become abstinent and was re-referred back 
to a voluntary agency for counselling and advice around controlled use; and one felt that their 
drug problem was not in need of treatment and wanted one information session which was 
given.
Clients included
Five clients were offered places on the programme. Two had been referred from outside the 
service and three were in-service referrals. Table 1 provides an overview of the 
demographic characteristics of all clients assessed for the programme.
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2. 2 DESIGN
2.2.1 Qualitative analysis of the programme
In order to evaluate the design and efficacy of a new treatment programme, data collection 
should not only provide empirical information allowing comparisons across individuals over 
time (ie. showing changes made throughout the progress of treatment), but also information 
that highlights the attitudes, opinions and perceptions of treatment, given by the clients for 
whom the treatment is being designed (Kreuger, 1994). Clearly, within the structure of the 
purchaser - provider NHS and with the increased influence of the consumer (the client) 
within services, such information is of primary importance to service providers. Qualitative 
data in the form of taped, facilitator-led interviews with the consumer group (a focus 
group), provides a method of data collection that has become increasingly respected as part 
of an experimental design.
The focus group approach, involving all participants in treatment, will be used before and 
after the outpatient stimulant treatment programme in order to examine their opinions and 
views as consumers before and after the intervention. Each group will be taped and data 
analysed using a transcript - based method. The post-intervention group will be held 
providing there are sufficient participants to form a ’group’ for discussion (ie. minimum of 
3) and will depend on the dropout rate throughout treatment.
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Table 1;-Siimmarv of Characteristics of Patients Assessed for the Out-Patient
Programme
m AGE SEX ETHNIC
GROUP
DRUGS USED LENGTH 
OF USE
PREVIOUS
TREATMENT
PSYCH
HISTORY
CURRENT 
MENTAL STATE
OUTCOME
N 37 M WHITE
UK
CANNAEIS (D) 
ALCOHOL (D) 
COCAINE (D) 
ECSTASY (E)
22 YRS 
20 YRS 
IS YRS 
8 YRS
YES
ANALYTIC
PSYCHOTHERAPY
DEPRESSION
ADHD
SEXUAL
AEUSE
DEPRESSION
ANXIETY
PARANOIA
AGGRESSION
I
DE 28 M WHITE
UK
CANNAEIS (D) 
LSD(0) 
AMPHETAMINE 
(D)
COCAINE (E) 
ECSTASY (E)
15 YRS 
13 YRS 
13 YRS
16 YRS 
6 YRS
NONE SELF HARM 
AGGRESSION
DEPRESSION
ANXIETY
PARANOIA
AGGRESSION
I
DO 34 M AFRO
CARRIE
CANNAEIS (D) 
COCAINE (0) 
CRACK (D)
17 YRS 
9 YRS 
5 YRS
NONE VIOLENCE
PHYSICAL
AEUSE
PARANOIA
ANXIETY
AGGRESSION
I
DA 33 M WHITE
IRISH
ALCOHOL (D) 
COCAINE (D)
16 YRS 
4 YRS
NONE PARENTAL
ALCOHOLISM
PARANOIA
ANXIETY
AGORAPHOEIA
AGGRESSION
I
M 25 F AFRO
CARRIE
CRACK (E) 5 YRS REHAE OD X I 
PHYSICAL 
AND SEXUAL 
AEUSE
DEPRESSION
PARANOIA
ANXIETY
AGGRESSION
I
J 31 M WHITE
UK
COCAINE (D) 
AMPHETAMINE 
(D)
ECSTASY (D) 
LSD(0) 
ALCOHOL (D)
12 YRS 
12 YRS 
7 YRS 
15 YRS 
12 YRS
REHAExS O D x 6  
SEXUAL 
AEUSE 
SELF HARM 
DEPRESSION
SUICIDAL
IDEATION
DEPRESSION
PARANOIA
ANXIETY
E
(REFER 
ON TO IN 
PATIENT)
S 29 M AFRO
CARRIE
CRACK (D) 2 YRS NONE OD X I 
DEPRESSION
SUICIDAL
IDEATION
DEPRESSION
PARANOIA
ANXIETY
AGGRESSION
E
(REFER ON 
TO IN 
PATIENT)
P 24 M WHITE
UK
ECSTASY (0) 
COCAINE (O) 
AMPHETAMINE 
(0)
2 YRS 
2 YRS 
2 YRS
NONE ADHD ANXIETY
PARANOIA
E
(REFER ON 
TO VOL. 
AGENCY 
FOR 
ADVICE)
T 23 M WHITE
UK
ECSTASY (0) 6MTHS NONE NONE ANXIETY E
(CLIENT
DECISION)
Key: O = Occasional I
D = Daily E
B = Binge ADHD
Include in Programme 
Exclude from Programme 
A t t e n t i o n a l  D e f i c i t  
Hyperactivity Disorder
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2.2.2 Quantitative analysis of the programme; a group approach
This study has a repeated measures design, with global, target and process measures taken 
at intervals relating to stages of treatment. Given the small group size (n = 5), the Friedman 
test, a non-parametric equivalent of a repeated measures ANOVA, would be used to detect 
changes over time. However, given the small n, statistical power would be small and 
therefore the interpretation of results would have to be made with caution due to the risk of 
making a Type II error.
2.2.3 Quantitative analysis of the programme: The Single Case Studv - methodological 
issues
Given the small n in group size and the fact that as a new programme with limited access to 
clients, drop-out’s may occur and leave even fewer participants, it is important to consider 
an alternative design: the single case study. A prospective clinical trial would be the best 
approach for the evaluation of this programme but because of the acknowledged difficulties 
of recruiting and retaining clients for new programmes, single case studies are increasingly 
accepted as evidence of the efficacy of treatment.
Single case methods have been discussed as being useful aids to "satisfying a clinician’s 
everyday curiosity about clients" (Morley, 1989). Such curiosity would include questions 
about the aetiology and maintenance of problems, treatment effects and efficacy and issues 
relating to the outcome. Such a methodology also provides a flexible and logical way of 
evaluating clinical activity.
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Considering the presentation of the data of this study within a single case framework is 
clearly necessary given the possible circumstances of and changes in the group population 
over time; there are also a number of advantages to this method. The original group size 
was small (n=5), given limited access to subjects such a number would have provided group 
data with limited statistical power. Furthermore such group - based research has the problem 
of generalising from group data to the individual where a functional relationship shown in 
group data is not necessarily reflected in an individual. Similarly, the individual differences 
which must be highlighted at this early stage of treatment design and evaluation are clearly 
lost when group data is collapsed.
The data represents three levels of measurement of change over time: standard/global 
measures; individual target measures; process measures. In the discussion of this treatment 
programme, an attempt will be made to look at levels of change at various stages of 
treatment and to hypothesise links with the psychological constructs key to the particular 
stage of treatment. Possible limitations to this approach will also be discussed.
2 3  MEASURES
2.3.1 The Focus Group
A focus group is a carefully planned, facilitator - led discussion group conducted with 
approximately 6 - 1 0  people. The aim of the focus group is to obtain perceptions on a 
defined area of interest in a permissive, non-threatening environment with participants 
sharing ideas and influencing each other through their responses (Kreuger, 1994).
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The technique of focus group interviewing has been developed within private sector market 
research where decision makers realised the limited utility of the traditionally used face to 
face interviews and questionnaires. The focus group offered a unique qualitative approach 
providing a richness of data by allowing for group interaction and greater insight into why 
the attitudes, perceptions and opinions of participants are held. For this reason, it has been 
found that focus groups can improve the planning and design of new programmes, 
preferences for new or existing products, provide means of evaluating existing programmes, 
and produce insights for developing market strategies. A focus group can be used before, 
during or after the programme or service provided.
The researcher serves several functions, using an inductive process, in the focus group: 
moderating, listening, observing and eventually analysing. The inductive researcher derives 
understanding based on discussion as opposed to testing or confirming a preconceived 
hypothesis or theory. The moderator will use predetermined, open-ended questions derived 
from a pre-planned interview guide and analysed in a natural, logical and spontaneous 
sequence. The moderator places no pressure on the group to have it reach a consensus - 
instead attention is placed on understanding a thought process used by participants as they 
consider the issues of the discussion. The discussion, usually lasting about an hour and 
facilitated by a person not directly involved with the service being evaluated, is taped and 
then analysed using a transcript- based method.
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2.3.2 Treatment evaluation
The measures taken fall into three broad categories and are outlined below; copies of all 
measures can be found in Appendix B.
1. Standard/Global measures ie. those that have been developed for known populations
and problems. For this study, such measures used were:
i) The Opiate Treatment Index (OTP
(Darke et al, 1992)
The OTI provides a comprehensive, standardised set of measures for the evaluation of opiate 
treatment. The index is multi-dimensional in nature reflecting the broad range of health, 
legal and social problems associated with problematic drug use.
The six independent outcome domains are:- drug use; HIV risk taking behaviour; social 
functioning; criminality; health status; and psychological adjustment (measured by the 
General Health Questionnaire [GHQ]). In all scales the higher the score, the greater the 
degree of dysfunction. With the exception of the social functioning scale, all questions are 
concerned with behaviour in the month prior to the date of completion. The variables are 
continuous rather categorical, in order to maximise the sensitivity to actual behaviour change. 
The OTI has proven reliability and validity.
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Despite its name, the OTI does not only assess the opiate dependence of the individual but 
provides scores for eleven different drug categories and poly drug use. Furthermore, it 
examines the recent behaviour of the individual over a range of outcome domains, focusing 
on actual behaviour change. Such a scale was felt to be appropriate for the evaluation needs 
of this study: offering domains of measurement within a biopsychosocial context and 
appropriate for repeated measures of an individual’s behaviour change over time.
ii) The Halikas - Crosbv Drug Impairment Rating Scale for Cocaine 
tHCDIRS-C).
(Halikas et al, 1991)
The purpose of the HCDIRS-C rating scale is to provide a reliable and valid measure of the 
impact of cocaine use upon life functioning. The scale is a 25-item clinical rating scale, 
administered in the context of a semi-structured interview. The scale measures the impact 
of cocaine use and its effects upon daily functioning, relationships, other alcohol and drug 
use, cocaine withdrawal symptoms, adverse effects associated with use, optimism about the 
future and self-esteem. Impairment is assessed for the previous week making it ideal for 
regular administration in clinical efficacy trials. The scale has proven reliability and validity.
iii) The Severitv of Dependence Scale (SDST 
(Gossop et al, 1992)
This is a short, five-item self-completion scale which has been developed so that it can be 
easily and quickly administered. It can be used to measure the degree of dependence upon
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Therefore, while the wording was altered to meet the needs of the drug user - the scoring 
and graphing remained the same.
The Inventory o f Drinking Situations (IDS) is a 100-item questionnaire designed to assess 
situations in which a client drank heavily over the past year. These items collapse into eight 
categories of relapse divided into two major classes:
a) Personal states: negative emotional states; negative physical states; positive emotional
states; testing personal control; urges and temptations.
b) Situations involving other people: Interpersonal conflict; social pressure to drink;
pleasant times with others.
The Situational Confidence Questionnaire (SCQ) is also a 100-item questionnaire designed 
to assess self-efficacy in relation to an individual’s perceived ability to cope with a high-risk 
using situation. The 100-items of the SCQ parallel those of the IDS and the individual can 
then make meaningful comparisons between the two over time. The questionnaires also 
provide useful prompts to relapse prevention work.
3. Process Measures ie. measures used to monitor treatment sessions.
i) Goal Setting
Goal setting forms an important part of the cognitive-behavioural approach. It involves
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agreeing with the patient detailed, specific goals for each of the problem areas which are 
going to be worked on, as well as setting up intermediate subgoals. As well as a behaviour 
change strategy, goal setting provides an atmosphere of ongoing self-monitoring and feedback 
of progress on a more regular basis than that provided by the standard/global or individual 
target measures. Setting goals also emphasises the possibility of change and begins to focus 
the patient on future possibilities rather than simply on symptoms or problems. Defined 
goals also help impose structure on treatment: highlighted as an important aspect of an 
outpatient stimulant treatment programme. Finally, setting goals provides the opportunity 
for an evaluation of outcome related directly to the individual’s presented problems.
Goal setting is an integral component of cognitive-behaviour therapy providing focus on 
sequential goals set throughout treatment. Such a system provides an impetus for between 
session individual work, a method for self monitoring and measuring change and a 
structured and containing means of plotting the stages of progress towards long term change 
which initially may feel formidable and unattainable. The principles of goal setting can be 
described using a mountaineering metaphor:- in order to reach the summit, the successful 
climber will plot a route by stages and focus on each stage at a time rather than trying to use 
the summit as a guide: clearly this allows for problem solving at each stage and the
possibilities of changing the route when insurmountable obstacles or hazards present 
themselves along the way.
The use of diaries and activity schedules are key to the goal setting system. In the 
educational and motivational sessions (T2), the lifestyle and early relapse prevention sessions 
(T3) and the later relapse prevention sessions (T4), such behavioural strategies were used as
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different types of drugs and focuses upon the central component of dependence: the user’s 
feelings of impaired control or compulsion to keep taking the drug. The scale has proven 
reliability and validity. Its relevance to this study was to enable an examination of the 
perceived change in dependence over time in relation to other more global changes in drug 
use and life functioning.
iv) The Beck Depression Inventorv (BDIT 
(Beck et al, 1961).
The BDI is a 21-item self-rating scale which allows rapid assessment of overall 
symptomatology and can be routinely completed by patients before each session, or used as 
a repeated measure. Scores may be categorized as: less than 10 = not depressed; 10- 
19=mildly depressed; 20-25= moderately depressed; 26 or more = severely depressed. 
This scale has proven reliability and validity. Given that depression is a recognised symptom 
of long term stimulant use, an assessment of changes over time in treatment is appropriate 
for this study.
2. Individual Target Measures ie. measures focusing on more specific aspects of
individual change over time in treatment.
i) The Readiness to Change Questionnaire (RCO)
(Rollnick et al, 1992).
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part of the process of treatment at that time. After an initial two week period of self 
monitoring focusing on the daily use of time with particular focus on the ratio of daily 
’shoulds versus wants’, there would be a twice weekly system of goal setting and review. 
Goals would be specific and task orientated with clearly defined outcome criteria; the short 
term weekly goals being planned within a longer term sequence leading to medium term and 
ultimately long-term goals.
As shown in Table 2, goal setting as a process measure would be done at each stage of 
treatment with goals set and then reviewed at the beginning and end of each treatment stage 
respectively.
M  PROCEDURE
The levels of measurement described above and their relation to stages of treatment over 
time, are summarised in Table 2. The four periods of mesurement relate to the stages of 
treatment: T l: measurement at baseline; T2: measurement at the end of stage on of stage one 
of treatment (month 1); T3: measurement at the end of stage 2 of treatment (months 2 and 
3); T4: measurement at the end of stage 3 of treatment - end of treatment (months 3 - 6 ) .  
Interventions at each stage of treatment are as follows:
Tl: baseline: no intervention prior to measurement;
T2: weekly individual, and group motivational and educational sessions;
T3: weekly individual, and group lifestyle and early relapse prevention sessions; 
T4: weekly individual and advanced relapse prevention sessions.
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This 12 item questionnaire has been designed to assess excessive drinkers ’readiness to 
change’ and assign them to one of the stages in the Prochaska and DiClemente model (1986). 
The instrument is short and easy to administer and allows allocation of an individual to a 
particular stage of change based on their self report. The individual rates their agreement 
or disagreement to a number of statements on a 5 point Likert scale. The judgements apply 
to different stages of change and the overall score is calculated. Previous studies have 
highlighted the usefulness of this instrument as a repeated measure during treatment periods 
of motivational work and the positive effects of the feedback on behaviour.
ii) The Inventorv of Drinking Situations (IDSl and the Situational Confidence
Questionnaire (SCO).
(Annis, 1982b & c).
These scales, although originally developed for problem drinkers are applicable to any 
substance misusing situation. Both scales allow for a highly individualised microanalysis of 
drinking behaviour within high-risk situations for relapse. These scales are appropriate as 
individual target measures within the context of a relapse prevention programme because it 
has been repeatedly demonstrated that global measures do not have the same predictive power 
for particular behaviours as do situation-specific person measures (e.g. Endler, 1975). The 
rationale is that a microanalysis of each high-risk using situation in terms of the individual 
resulting behaviour in that situation will be a strong predictor of the individual’s actual 
behaviour in that situation. Although originally designed for use by problem drinkers, the 
principles of relapse prevention underpinning these questionnaires are those developed by 
Marlatt and colleagues (1984) and are used widely within the field of substance misuse.
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The standard/ global questionnaires are either administered in the form of a semi - structured 
interview: OTI and HCDIRS - C or self completion: SDS and BDI. The target measures are 
self completion: RCQ, IDS and SCQ. Each process measure, (related to goal setting) is self 
completion.
Table 2;- Measures taken at each stage of treatment
TIME BASELINE
(Tl)
TREATMENT 
STAGE 1 (T2)
TREATMENT 
STAGE 2 (T3)
TREATMENT 
STAGE 3 (T4)
Measures
Taken
Standard/
Global
-OTI 
- HCDIRS-C 
-SDS 
-BDI
-OTI 
- HCDIRS-C 
-SDS 
-BDI
- OTI
- HCDIRS-C
- SDS 
-BDI
-OTI
-HCDIRS-C
-SDS
-BDI
Individual
Target
-RCQ -RCQ
-IDS
-SCQ
-RCQ
-IDS
-SCQ
(Review) (Review)
Process -GOAL
SETTING
-GOAL
SETTING
-GOAL
SETTING
KEY: OTI
HCDIRS-C
SDS
BDI
RCQ
IDS
SCQ
Opiate Treatment Index
Halikas Crosby Drug Impairment Rating Scale - Cocaine
Severity of Dependence Scale
Beck Depression Inventory
Readiness to Change Questionnaire
Inventory of Drinking Situations
Situational Confidence Questionnaire
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M  FOCUS GROUP
3.1 RATTONAT.E AND ATMS OF THE FOCUS GROUP
The focus group provides an opportunity to evaluate the proposed outpatient programme from 
a qualitative perspective. While quantitative data offers standardised and focused measures 
of progress through treatment and allows for a measure of change over time, the focus group 
offers a less structured evaluation of the service with greater flexibility of questioning and 
response (Kreuger, 1994). As part of this service evaluation, the focus group was included 
as a measure in order to achieve the following:
i) to utilise a qualitative method of data collection as a part of the overall service 
evaluation;
ii) to explore the attitudes, opinions and perceptions of treatment of the service users 
themselves outside of the structure and limits imposed by the questionnaire methods 
of measurement;
iii) to investigate particular themes or issues related to treatment design: the similarities 
and differences in the perceptions of service user and service provider;
iv) to enable the group to meet in a safe, non-threatening environment and share common 
anxieties and expectations prior to the onset of treatment.
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M  METHOD
3.2.1 Participants
The five focus group participants were stimulant misusers who had been assessed and 
accepted for the six month outpatient treatment programme. The purpose of the focus group 
had been explained to all participants as a voluntary exercise as part of the evaluation process 
of the treatment programme; participants understood that choosing not to attend the group 
would not affect their treatment in any way. All participants elected to attend.
The participant characteristics are summarised in Table 1, section 2.1. For a more detailed 
explanation of the selection criteria and assessment procedures, see section 2.0.
3.2.2 Procedure
The group moderator. Dr. Jane Gibbons, was a trainee clinical psychologist on specialist 
placement at the Drugs Services prior to qualifying. Dr. Gibbons had recently submitted a 
focus group research thesis as part of her PsychD qualifications (UEL).
Dr. Gibbons and this author met on five occasions prior to the focus group interview, where 
the nature and content of the treatment programme was discussed. The Interview Schedule 
was developed during discussions around the aims of the treatment programme and the study.
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The themes contained in the pre-group interview guide were:-
1. The Process of Change
2. Components of treatment
3. The treatment programme
These three themes were selected as key service evaluation issues that would provide an 
overview of factors significant in the proposed programme: issues of motivation and early 
access and entry into treatment; components of the programme itself; key issues of treatment 
for potential service users. Each theme generated a series of open-ended questions which 
would be used to guide the discussion.
The participants arrived for a one-hour taped discussion group with Dr. Gibbons in a large 
group treatment room at the Hampstead Road Centre. This author was not present in the 
group discussion, as it was felt that this might influence participants towards more desirable 
comments about the treatment programme, given this author’s association with their ongoing 
treatment. Once over, the participants left expecting to meet again as a group for the first 
group treatment session, two days later.
Dr Gibbons and this author immediately debriefed after the group. This author was 
particularly interested in Dr Gibbons’ impressions of the group dynamics and functioning 
throughout the discussion and any implications that this might have had for treatment. The 
tape was checked, copied and transcribed verbatim prior to analysis.
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3.2.3 Materials
Materials used for the focus group were:-
The Interview Schedule (see Appendix C)
Consent forms highlighting the confidential nature of the study and the taping: to be 
signed by each participant 
A tape recorder and blank tape.
3.2.4 Data Collection
Participants were welcomed into the room and seated in chairs arranged in a circle around 
the tape recording equipment. Introductions were made, consent forms signed and the focus 
group began. Dr. Gibbons used the Interview Schedule and questions were ordered in a 
logical sequence, focusing on critical issues of concern (key themes). All questions were 
open-ended and probe or follow-up questions were used to expand issues raised by the 
participants. Participants who were experiencing difficulty in making their comments within 
the general discussion were encouraged in order to minimize the domination of the discussion 
by a few individuals. Dr. Gibbons restricted any verbal or non-verbal reinforcement during 
participant discussion and did not offer personal opinions on any of the issues raised. Other 
verbal techniques used as appropriate were: reflecting back (to maintain a logical sequence 
of questions), clarifying (if points made did not seem clear) and paraphrasing (particularly 
as a means of summary when moving the discussion onto the next question or theme).
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M  RESULTS
3.3.1 The Analysis
The analysis procedure used was a transcript-based analysis where the transcript of the taped 
discussion was used together with the moderator field notes and the debriefing discussion 
between the moderator and this author. The transcript and held notes were then read one 
category at a time (corresponding to the three major themes generated from the interview 
guide). Emerging themes were categorised and then coded using a series of index cards 
which allowed for cross-referencing of overlapping themes. The data was then sorted under 
the three themes by coded category, data not included (ie. not relevant to the themes under 
investigation) was rejected, and then the first draft report Was prepared. Draft reports were 
read and subsequently discussed by the moderator and this author and revisions made as 
appropriate.
3.3.2 Data collected and presented
The data collected and presented in the following discussion was from the pre intervention 
focus group only. Given the small number of participants for the programme (n = 5) and 
subsequent drop-ouf s (see section 4.1 for a fuller discussion) only one participant completed 
the six month programme. Clearly a post intervention focus group could not be conducted 
with less than three participants and therefore it was not done. The issues surrounding this 
will be discussed later on in greater detail in the discussion, section 3.5. The raw data is 
included in Appendix C.
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The following statement of results is presented under subheadings which relate to the major 
themes identified from the pre-treatment focus group data.
L THE PROCESS OF CHANGE
a) Models of motivation and decision making
As discussed earlier (section 1.2), models of addiction described in the context of the 
integrated outpatient treatment of stimulant misuse have adopted a biopsychosocial 
perspective, viewing problematic drug use less as the symptom of an illness and more as an 
example of the wider activity of drug taking. From an assessment and treatment perspective, 
it appears to be most useful to see it in its widest social and psychological context and its 
effects in many areas of life. The Staues o f Change model (Prochaska & DiClemente, 1986) 
has led to an acceptance of the fluctuating nature of motivation and behaviour change. The 
five stages of change are: precontemplation, contemplation, action, maintenance and relapse 
(see Appendix A).
Efforts to examine the treatment of addictions are incomplete without considering the issue 
of motivation. Miller and Rollnick (1991) address this issue, explaining that most users are 
genuinely ambivalent about changing rather than weak-willed, resistant or characteristically 
flawed. The authors’ view motivation as a "state of readiness or eagerness to change, which 
may fluctuate from one time or situation to another" (pg. 14).
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Prochaska and DiClemente (1986) caution that the process of change is very complex. They 
explain that "most individuals do not progress linearly through the stages of change" (pg. 5). 
Alternatively, they offer a "revolving door model" (pg. 6), based on the assumption that 
individuals make multiple revolutions around the circle of stages prior to achieving their long 
term goals. This model is described as a transtheoretical model (Tober, 1990), a useful 
heuristic for the assessment and treatment of drug abuse and it is interesting how this 
professional model of behaviour change has significant overlap with lay models expressed 
by the group participants. (This model is discussed in greater detail in section 1.2.3.3).
The data does seem to support the notion that there are stages of change and that progress 
through such stages is non-linear. The participants discussed such issues at the beginning of 
the focus group when explaining their reasons for and progress into treatment. The major 
themes were: the shift from precontemplation to contemplation and the ambivalence 
experienced in the stage of contemplation. Each will be discussed in turn, below.
i) The shift from precontemplation to contemplation
This shift was experienced in a number of ways and participants highlighted a number of 
précipitants to the ’realisation’ that they were experiencing problem drug use and needed to 
seek professional help. Initially highlighted were the increasing biological, psychological and 
social problems that accompanied escalating stimulant misuse and realisation of problem drug 
use usually occurred with the cumulation of such problems impeding any quality of life or 
resulting in a crisis situation:
N: "I lost it... and I lost my career... I’ve just been doing just about enough to survive...
and a few months ago I lost my girlfriend, well she left me"
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DE: "I can’t fulfill my potential... I’m not enjoying it... it’s the first time I’ve felt really
unhealthy - it ain’t doing what it used to do to me... before, if someone wants to 
come up to me and say I’ve got a problem with drugs, it would be like whoa, slow 
down, you’re off your cloud man. I’m having a good one... but I’m not anymore."
DA: "It’s just like a habit isn’t it, you just want to keep doing it., you’re not getting the
same thing out of it. "
N: "The first day I was in Bangkok I got arrested, um, for, um, well I thought I’d
bouglit some coke but in fact I’d bought some heroin... and I was puking my guts up 
for sixteen hours... and Mr. Dickhead took it back to the dealer to try and get my 
money back, and I got arrested and I spent three months in Thailand on the run 
without a passport or anything... and that really sort of brought it home to me, you 
know, just how silly it was to be so dependant on it... on a stimulant drug. "
Compounding these difficulties, it appears that participants were also realising that their own 
strategies for change were not working: highlighting even further their loss of control in the 
face of their drug use:
DA: "You don’t know how much you need it until you try and get off it... Before I used
to say I could easily kick it, then when I tried to give it up, then I couldn’t do it... 
I stopped for a full week... then after that week on Friday I’d go out with me mates 
and then after two beers sitting in the pub they’d say ’here’s a line, there’s a line’; 
I’d say no to the first couple of lines then after that I just got back on
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N: "I don’t take that much at the moment because I’ve restricted myself financially...
and the reality is that I’m terrified of earning money because I know... when I earn 
money again, unless I’ve actually got rid of this compulsion of taking cocaine and E’s 
then I’m gonna be straight back in it but in a much bigger way. "
M: "I’ve tried [to stop] so many times and it doesn’t work you know what I mean."
Although the process of shifting from precontemplation to contemplation may be the result
of a cumulative set of aversive experiences with the drugs used, the point of shifting: ’the
moment of realisation’, appeared to be a more instantaneous experience:
DE: "It didn’t take me a long time to think ’oh I need to go and get help’, the minute I
thought it I came down here, I never thought about it before, it never crossed my 
mind to come to one of these places."
N: "And for me it was the minute I realised that what was stopping me from working...
before that I blamed it on all sorts of other things like being insecure and not being 
talented"
DA: "I went to the doctor’s ... I took so much during that week I just felt really shit, really
bad, I thought ’I’ve had enough of it, let’s go and do something about it now’."
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The shift from precontemplation to contemplation is traditionally understood as being a point 
where psychological conflicts about the using behaviour increase; interventions at this point 
would aim to enhance decision making and encourage the individual to weigh up the 
arguments for and against change. Such questionning and conflict is clearly an 
uncomfortable cognitive state for the individual and is accompanied by ambivalence - this 
will be discussed in detail below. The following quote offers a good summary of the 
preceding discussion about the point of movement through the first two stages of the ’cycle 
of change’:
DO: "...and it’s basically when this realisation hits, you think to yourself, I mean it goes
on for a period and you keep lying to yourself saying ’oh there’s nothing’, and then 
realisation hits you something like God, you look around you, you see what’s 
happening and then you take a look at yourself and you think: ’this is not me you 
know’. And you’re trying to, you’re in a constant battle with yourself trying to 
understand why you’re doing this.."
ii) Contemplation and ambivalence
The stage of contemplation is described as when individuals are willing to examine the 
problems associated with their substance misuse and consider the implications of change 
although they are likely to be ambivalent and in a state of conflict about change itself 
(Prochaska et al, 1992). The data supports the notion of ambivalence, particularly as 
illustrated in the series of exchanges following a moderator open question about what 
participant’s hoped to achieve from attending the programme. The discussion following the 
question illustrates how clients who have presented for treatment may still not be clear as to
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their longterm treatment goals, and that acknowledgement of the need for treatment is not 
automatically linked with a decision to stop the problem behaviour. In part this might be 
associated with clients not being clear as to the possibility of controlled drug use following 
a chronic habit, however the exchanges between clients also highlight the ambivalence that 
accompanies contemplation and is clearly a state of indecision, confusion and psychological 
vulnerability:
DA: "Well, to get off the drugs."
DE: "Yeah, to stop using them, I think that’s pretty obvious really."
M: "Or just control it or something"
DO: "I’d like to understand. "
N: "Yeah, maybe to be able to use drugs recreationally again, as opposed to it being an
addiction... I mean that’s not a goal because I mean that I think you’re saying ’I still 
want to be an addict but’. "
M: "I know but if you put yourself back and say ’right, I want to come out of here and
not use it’, that’s a load of bollocks really, innit."
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Such ambivalence is summed up with the following:
N: "The difference is that I don’t want to give up now, I want to give up in six months,
but you know what I mean, I know I’m gonna have to."
The issue of conflict is then further expanded on and the ideas expressed highlight the 
similarity between contemplative conflict and the psychological construct cognitive 
dissonance. Proposed by Leon Festinger (1954), the theory of cognitive dissonance states 
that people are motivated to keep their cognitions (beliefs, attitudes, opinions and values) 
consistent. If the relationship between their cognitions becomes inconsistent, it causes 
psychological distress which is called "dissonance". Since this state is psychologically 
unpleasant, it produces a motivation to change either the attitude or action that is responsible 
for the dissonance. The more important the attitudes and behaviour involved in the 
dissonance producing situation, the stronger will be motivation to change the situation to 
produce consistency. In terms of behaviour change, such a state is clearly a necessary 
precursor to making such change and, as illustrated below, fits in with the Stages of Change 
model (Prochaska & DiClemente, 1986) where contemplation precedes the action stage:
DO: "But subconsciously you’re saying ’I want to give up’ but mentally and physically
where your body’s already been in that cycle, you’ve gone through that cycle... so 
it’s... I’ve come here really to understand one, what’s the attraction to the drug and 
why, like, not because you can’t say no, because you can say no..."
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N: "No you can’t, well I can’t."
DA: "I can’t say no, you can’t say no can you?"
DE: "You’ve got to want to say no haven’t you? If you want to say no you’ve got to say
no, haven’t you... if everyone... in an ideal world we could split ourselves into two 
people and one says: ’look, you’re not doing anymore’... but it doesn’t work like that 
does it?"
A feature of ambivalence is the non-acceptance of the extent of the problem: the 
psychological construct denial. Such a mechanism exists as an essential buffer against the 
shock of knowing or accepting the extent of the damage that an individual has done and is 
doing to themselves, and furthermore protects against the fear presented by the need for 
change: an unknown, threatening and seemingly unobtainable state. The data illustrates such 
a coping mechanism when a participant avoids or denies the addictive nature of cocaine by 
attributing it to other substances mixed into the powder. This may reflect a desire not to 
acknowledge the increasingly dependent behaviour that develops over the time of regular 
using as well as the difficulty in accepting that in order to resolve current using difficulties, 
cocaine use would have to cease. This denial is quickly picked up by another participant 
who is clearly more able to acknowledge the contribution of the substance to the dependent 
behaviour and associated difficulties:
244
DO: "It’s not so much the drug that you get addicted to it’s what’s mixed with it that’s
more the body addiction. I mean if you had straight cocaine then... well then as soon 
as it’s mixed with something, then that’s the mixture..."
N: "No, no, I think you’re avoiding the issue, I think that you’re addicted to cocaine.,
it’s okay to be addicted, but it’s addictive it’s as simple as that."
DO: "Each of us are in a different position, different stages of..."
M: "Because you’re dealing with things and you feel paranoid... if it was clean and
like... then you wouldn’t get that addiction you get."
N: "I find the reason you’re paranoid is because you’re taking too much of it."
M: "Yeah, okay."
bl The psychological construct of addiction
The group also spent some time discussing the concept of addiction and their debate raises 
the issue of the use of terminology and the framing of drug dependent or addictive behaviour 
in treatment: does the construct of addiction induce helplessness or aid motivation for 
change? The professional literature has been debating this issue surrounding the use of 
terminology in the field of substance abuse/misuse, particularly around the terms addiction 
and dependence, for years and a consensus is difficult to reach given the multi- disciplinary
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perspectives in the field. Prevailing models of addiction highlight the differing theoretical 
approaches to the treatment of substance misuse depending on the definition of the construct 
of addiction that is offered by that model. The oldest model, the moral model would define 
addiction as a sign of a weak or flawed character. The disease model has traditionally been 
seen as viewing addiction as a disease over which addicts have no control. In an 
enlightenment models the individual is responsible for having become addicted but is seen as 
needing to turn recovery over to a higher power; the Twelve - Step (Alcoholics Anonymous 
or AA) philosophy often combines both these models. Finally, the compensatory model 
views addiction as caused by learning and biological variables but sees the individual as 
capable of overcoming addiction through the use of active compensatory strategies. 
Washton’s rehab model discusses the need to understand addictive disease and challenges the 
notion that "telling drug addicts that they have a disease will simply give them... a ’cop out’ 
from personal responsibility" (Washton, 1989, pg. 49). Similarly, the neurobehavioural 
model offers a neurochemical perspective on cocaine addiction (Rawson et al, 1990).
When the group were asked for their views on the construct addiction, the most noticeable 
aspect of the discussion is that there is no direct reference to a biological or disease 
underpinning use. One participant highlights the daily pattern of using that indirectly points 
to the use of the drugs for self medication, ie. alluding to biological needs for daily 
functioning developed by long-term drug use:
DE: "Addiction for me means I wake up in the morning and I can’t do anything until I’ve
had my spliffs... and then I’m alright to deal with people, then by, what, the 
afternoon I start thinking about I might go and have a beer and - you know what I
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mean - have a toot or whatever, by the evening I meet up with a bunch of people and 
we’re going to go out and there’s nothing to do but go out on a buzz... that’s 
addiction... I’m defining it for myself. Obviously until you start coming down, 
everything’s much better when you’re doing it... everything’s normal... everything’s 
right."
However, the conversation about addiction quickly turns to an exploration of the symbolic 
importance of the drug and the role it plays in the individual’s life:
N: "I think for me, addiction means when the most important thing to you is the drugs
that you’re taking, more important than your relationships, more important than your 
work... that’s how I define that I’m addictive."
This then leads into the main focus of the discussion: the functional significance of the drug, 
as a way of defining addiction. Addiction holding a less biological but more emotional and 
psychological meaning to the drug user, either as a means of medicating emotional pain:
DO: "... when I’m depressed or I use it as an excuse... like another cloak, like putting on
another coat... you know... like where I’m hurting inside, like you got no-one who 
can understand you... no-one’s taking any interest in you..."
or avoiding the emotional pain altogether:
N: "It’s a way of not dealing with problems"
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DO: "It’s an escape really"
DE: "Yeah you just bypass everything, don’t you"
However, although the user understands the meaning of their use (ie. addiction as being seen 
from a compensatory model perspective), the perception by those around them is Judgemental 
and rejecting, (ie. from a moral model perspective). At this point, the group has highlighted 
a bind that using drugs can cause, and also an explanation for the maintenance of using: the 
function of the using, ie. avoidance of rejection and emotional pain, in turns leads to further 
rejection and therefore greater emotional pain - ie.:
REJECTION USE
This highlights the notion of addiction as a self-perpetuating and self-fulfilling construct.
DO: "but then when people do see you they see you with the drugs and they say ’ah,
what’s wrong with you, you’re on drugs’... but instead of finding out why you’ve 
resorted to the drugs..."
DE: "Yeah, they just pass you off..."
DO: "... they just pass you off, and then you get more involved because that’s... it’s
easier to deal with that than to deal with, um..."
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N: "The emotional problems causing you to be addictive in the first place, yeah."
Is the concept of addiction necessary? The following quote comes towards the end of the 
focus group but the speaker is clearly alluding to a series of exchanges earlier on when the 
concept of addiction was raised and challenged (see quotes given above in illustration of the 
construct denial). It appears that for some the concept of addiction and acknowledging 
’being addicted’ represents a real acceptance of the problem (the difference between 
precontemplation and contemplation), however for others, not thinking in terms of this 
construct as a way of understanding one’s own problem does not necessarily represent an 
avoidance of the issue or denial.
DO: " ... we’re all being honest with ourselves, saying look, we have got a problem,
whether you feel you’re addicted to it or if you feel you’re not, we’ve all got a 
problem, the problem is the powder, and we want to try and deal with it, or at least 
be able to control it instead of it controlling us."
It can be seen from the data so far that participant’s experiences of their drug using 
behaviour and related difficulties cumulate over time to result in an awareness of the problem 
nature of the behaviour and an acknowledgement of the need for change. This data supports 
the Stages of Change model (Prochaska & DiClemente, 1986) and participant’s were 
describing their pre- treatment decision making in terms of the stages outlined in the model 
as precontemplation and contemplation. The participants also describe how each stage is 
accompanied by significant psychological experiences, eg. ambivalence, denial and conflict 
(similar to the construct of cognitive dissonance) that will affect the behavioural outcome.
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This data therefore highlights an overlap between professional models of behaviour change 
and individuals’ experiences. This is further underlined within a discussion of the concept 
of addiction and relates to the issue of the labelling and attribution of behaviour. 
Participants were mixed in their views as to whether a concept like addiction removes or 
stimulates responsibility for change. This theme will be discussed in greater detail below 
when the issue of understanding behaviour and its causes will be discussed in relation to 
treatment.
2. COMPONENTS OF TREATMENT
Following the model of change, the discussion progressed in a logical manner from specific 
issues of the problem behaviour and aspects of change to issues relating to the change process 
itself and initially, what participants were hoping to gain from treatment. This is the next 
major theme of the discussion where participants offered perspectives on factors necessary 
to facilitate behaviour change. Interestingly, the discussion centred on factors which might 
broadly be described as cognitive - behavioural in nature and reflect the components of 
treatment that have been highlighted in the literature as efficacious in the treatment of 
stimulant drug use (for a full discussion of this literature, see section 1.2.3.3).
a) Understanding self; explanation and attribution
Knowledge around the drug and the self in relation to the drug was highlighted as being one 
of the key issues for treatment. Such concepts relate to the educational and cognitive aspects 
of the motivational and preliminary relapse prevention interventions. The act of explaining
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is common when people are faced with the unexpected, and this seems particularly true when 
the unexpected involves illness, accidents or misfortune (Weiner, 1985b). This issue has 
already been explored in the context of the usefulness of the construct of addiction.
Explanations involve the labelling of experience and the attempt to make sense of it in terms 
of what people already know about the world around them. When they have determined 
what sort of event they are dealing with they can attribute to it a cause or a combination of 
causes. Individuals will be concerned with whether this cause is internal or external to them, 
whether it is temporary or permanent, and whether it is controllable or uncontrollable. There 
is now reasonable evidence to suggest that explanations mediate a variety of responses to 
illness and accidents and, furthermore, attributions for progress in changing behaviour will 
contribute to maintaining that change (Brewin, 1988).
The following quotes summarise the main issues raised in the group. They highlight the 
notion of knowledge and insights gained in treatment as being part of a process of change, 
a learning curve where understanding forms the foundations of long - term behaviour change. 
Behaviour change is seen less as being part of gaining insights into past psychological issues 
but more about the here and now approach offered by problem solving and decision making 
in the context of information gained: treatment aiding a rational approach to change.
DO: "This understanding the drug and understanding yourself... it’s all part of the same
package, it’s like following a circle, you understand the drug, then you understand 
what’s the drug doing to you, then you have to understand what you have to do to 
stop one being two, two being three, etc., etc.."
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DE: "Like get a bit of perspective, I mean same with any problem, if you get any rational
person, it doesn’t matter if they’re a user or not, you can give them a problem, any 
problem, and give them sufficient amount of information to solve the problem then 
everyone will have a better chance of doing it... so I think that’s what I’m here for, 
to get some perspective I mean ’cos at the end of the day you’ve got to help yourself 
anyway."
b) Relapse Prevention
The biological, psychological and social effects of long-term stimulant misuse combine to 
leave misusers feeling anxious and paranoid, depressed, chaotic and afraid. Such experiences 
can leave the rational person feeling irrational and out of control; the participants respond 
to this with a need for help with understanding and to gain a perspective on themselves and 
the drugs they use. However theoretical models of behaviour change argue that 
understanding and knowledge about the problem behaviour is, in and of itself, not enough 
to facilitate long-term behaviour change and other strategies, eg. Relapse Prevention, are 
needed; (for a detailed discussion of models of behaviour change in relation to drug use, see 
review essay II, in the academic dossier of this PsychD folio). It is interesting to find that 
this issue is also raised as part of this theme in the focus group discussion, where stopping 
is not the issue, but staying stopped (maintaining abstinence and preventing relapse) is - ie. 
that willpower alone is not enough. This is concordant with the cognitive - behavioural 
model of stimulant treatment which includes relapse prevention as a major treatment 
component. Furthermore, as the following quote also highlights, the containing nature of the 
focused, structured cognitive - behavioural approach, not only aids understanding but
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reassures the catastrophic belief that madness would be an inevitable outcome of 
unsupervised treatment - the madness relating to the current anxious and paranoid states 
experienced by the participants; (the reference in this context is to Friern Barnet - an old, 
infamous longstay inpatient psychiatric hospital).
DE: "Fve probably got the willpower to turn round and say I’m not going to do bM ,
blah, blah anymore, but it’s what comes with it what’s stopping - what I haven’t got 
a clue about , you know and I’d rather know what’s that’s going to be about. I’d 
rather know the obstacles that I’m going to have to approach. You know, stopping 
is staying stopped, you know? That’s the thing... you’ve got to have a certain 
amount of information to know what’s going on or you’re just going to charge off 
again, aren’t you, with a new set of problems... you could stop and you might end 
up being a patient at Friern Barnet’s or something within a week, if you didn’t know 
what was going on. "
The data exploring components of treatment continues the theme first raised in the discussion 
around the concept of addiction, ie. the labels and attributions given to health behaviour and 
its relation to behaviour change. Understanding the drug and its use in relation to the self 
is seen, by the participants, as key to the first stage of their change directed behaviour. This 
need for understanding supports the stimulant treatment models which highlight the need for 
educational and decision making work to combine with early motivational work in order to 
facilitate the movement into a decision making stage and for abstinence to occur. Once that 
decision has been reached, participants then highlighted the need for support with maintaining 
abstinence as key to the next stage of treatment; this issue relates to the notion of relapse
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prevention which participants saw as a skill based technique that would not only facilitate the 
maintenance of the change state but also prevent the loss of rationality and new problem 
formation. Again, based on the experiences of the participants, the data provides support for 
the professional models of treatment.
& THE TREATMENT PROGRAMME
Clearly when evaluating a treatment programme it is necessary to look at the expectations 
of the clients and whether such expectations are fulfilled. Such a discussion also allows 
clients to highlight aspects of treatment that are priority to them at the outset and this may 
have implications for retention in treatment, quality of service delivery and client satisfaction. 
Also, such a discussion prior to treatment may allow clients to feel some ownership of the 
programme and responsibility for outcome given the value placed on their opinions. 
Participants highlighted four major issues: mechanisms for engaging in treatment; thoughts 
on the group approach to treatment; and confidentiality; the concept of abstinence.
af Mechanisms for engaging in treatment
A key feature of an outpatient treatment programme from the participants’ perspective is 
quick access. This relates particularly to the time of the shift from precontemplation to 
contemplation when clients clearly feel vulnerable and in need of containment given the 
nature of the psychological state of contemplation, eg. cognitive dissonance. The risk, at 
this stage, would be that the client would give up on their decision for treatment while on 
a waiting list. Clearly this is an issue facing all drug users who decide to enter treatment as
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most treatment agencies operate a waiting list, however stimulant users seem to present at 
a stage of acute physical and mental health crisis and at a time when prolonged using could 
have more serious consequences. The following illustrates the participants’ perceptions:
N: "There seems to have been a very long time in the assessment period leading up to
this course... that’s bothered me because having made the decision all I want to do 
is get on with it. "
DO: "I felt let down because you’ve come... it’s enough to commit yourself to come to
one of these places and say ’okay. I’ve got a problem and I need to get it sorted so 
I need help’, so you come to the experts, but then when they make a decision with 
you... like if you can’t go to them at that time, and then it goes on and on and on, 
the longer the period in between what you were supposed to do and the gap in 
between, it’s like, where do you turn to?"
DA: "I come here, I come all the way here and we had to make another appointment for
next week, and you think ’oh fuck it’: after all that time you come here and you feel 
let down, so I went out and bought some more Charlie (cocaine) and... "
It could be argued that a waiting list has positive functions and can act as a motivational tool, 
ie. strengthening commitment to change. None of those assessed for this programme 
dropped out while on the waiting list, however the sample size was small. However, for 
stimulant users who then enter an abstinence orientated programme where substitute 
prescribing is not a treatment option, this may compound the psychological difficulties
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experienced in the contemplative state. Clearly, once having acknowledged the extent of 
their problem use and the need for treatment, clients feel vulnerable and needy - requiring 
immediate access to treatment and frequent sessions:
N: "An hour isn’t enough every week for me personally, I need to talk longer than that. "
Models of treatment do highlight the need for high frequency contact particularly at the 
beginning of treatment, however this statement also clearly reflects the feelings of 
vulnerability and neediness in individuals who are coming to terms with the chronic nature 
of their difficulties.
bf The Group Approach
One of the key components of the outpatient programmes for stimulant misusers described 
in section 1.2.3, is the central role of group therapy. Washton (1989) summarises the main 
advantages of group therapy as "...[to] provide members with a strong sense of identity and 
belonging, a unique opportunity for accelerated progress through guided feedback, continuity, 
role modelling, peer pressure, didactic and experiential learning, and the acquisition of 
problem solving skills. The group places high value on self - disclosure, active participation, 
compliance with group norms (eg. abstinence, punctuality, attendance, honesty), and facing 
rather than avoiding problems. " (pg. 145).
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The participants in the focus group discussion, despite having never met as a group 
previously, all seemed to place similar high value on the group therapy approach. Again, 
the discussion also highlighted the overlap between professional and lay perspectives on 
models of and approaches to treatment. Issues particularly highlighted as useful were:
the sense of belonging:
DE: "The thought of a group is good for me because it’s the one thing you’re not going
to get anywhere... maybe that’s something I’m longing for anyway - to belong to
something that..."
N: "To know that you are not completely isolated... I personally feel incredibly isolated,
the more my drug habit came on the more isolated I became, and so you find that
there are fewer and fewer people that you can actually talk to about it. "
the feeling of support:
N: "To give and receive support from each other. "
DE: "Yeah, ... it’s like when you was a kid outside the headmaster’s office, if there were
a few of you there, you’d just wait for your whack, if you were on your own, it
would be like , ’what?! I don’t need all this"
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the role of positive modelling:
N: "Once we’ve actually got into the programme and some people have actually given
up, it would be good to see that they have managed to give up, you know, and 
therefore maybe I can. "
the positive function of peer pressure:
N: "Being in a group is really good, much better than on an individual basis, because I
find that on an individual basis you become terribly self indulgent and self-pitying. "
DE: "And deceptive. "
N: "Yeah,, and if there’s a group., if you’re being analysed and look a little bit deeper,
and if you’ve got other people looking at you, you’re going to be more thoughtful 
about what you’re actually saying... you might also be more guarded about what 
you’re saying, but for me personally it stops the fantasy going on. "
to find alternative perspectives:
DE: "As he was talking a minute ago, a lot of what he was saying was not exactly what
I was thinking, but made me think about something else, you know? And it’s just 
good to knock heads together. "
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DO: "It’s triggering little switches..."
This final point is then linked in with the notion of stages of change that had been highlighted 
much earlier in the focus group discussion:
DO: "My hope is like to understand you, to understand you, to understand you, to
understand you, ’cos we’re all at different stages... and we’re all here for different 
reasons, so if one’s at a worse stage than another person, one’s at a lesser stage, it’ll 
be easier to deal with what they’re going through because they’re getting it first hand 
from somebody who is a bit further up the ladder, you see?"
çl Confidentiality
Towards the close of the focus group discussion, the group spent some time discussing their 
concerns about the programme. The overriding anxiety was related to the issue of 
confidentiality. The main issue was around the legal implications of their drug related 
behaviour but more generally about being ’found out’. This is a very real fear often 
expressed by clients new to treatment:
N: "I’m a bit worried about the confidentiality of it... it frightens me because I don’t
believe that the NHS has a secure record on medical records... they get out... and
we’re admitting to crimes, some of us are admitting to dealing, it’s all there in the
bloody records... it would be better if we were totally anonymous... if we worked on 
the first letter of our name or something. "
259
However, there also appeared to be a more paranoid aspect to the fantasies expressed which 
may also have related to the specific psychological effects of long-term stimulant use, ie. in 
particular paranoia, acute anxiety and catastrophic thinking and interpretation:
DO: "I mean, I could sit here talking to you all day, but as long as no-one knows who I
am, then what I say they can’t put a name to that voice, I suppose like if they were 
really technical they could do it, like through voice analysis and that... but these 
hospitals are so accessible to., like.. aliens I will call them, digging for
information..."
N: "Well, I’ll give you another scenario; you get a junkie out needing a fix who breaks
in the window... and they rummage around the office, and you know, maybe chuck 
some files out of the window or something... you know I don’t think there’s this 
conspiracy of someone out to get us, it’s that thing of a haphazard event, and you 
know, someone finding the file and ’phoning this person up and saying ’We found 
this file outside this drug centre’ and then suddenly everything’s in public demand... "
Dealing with anxiety (real or imagined) and paranoia is something that stimulant users accept 
as a part of their using experience. Such an issue may relate to the difficulties in accessing 
such a population for treatment programmes: secrecy and anonymity being important and 
necessary aspects of the stimulant misusers behaviour:
DE: "Once you’re using, you become very secretive and you got, you know... I like
having the door shut, and for you something like this, it’s obviously frightening."
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^  The concept of abstinence
A final treatment factor that was raised in the discussion was that of abstinence. Abstinence 
is clearly a difficult concept to imagine achieving when chaotic, out of control drug use has 
been a way of life for a significant amount of time. This treatment programme also is 
located in a Drug Dependency Unit in a hospital based setting. Such a setting is clearly 
associated with medical intervention and obviously opiate users attending the clinic are 
prescribed medication as a primary intervention. Such issues for individuals used to self 
medication, would clearly present challenges to them accepting a programme which provides 
no substitute medication and is working towards abstinence. Primarily the thought of being 
abstinent is obviously very frightening:
N: "I can’t envisage a situation where I will never take any sort of drug again; I can’t
see that, I really can’t, and if that’s the aim then I’m gonna, it’s gonna fail."
It also seems to represent an image of conformity and a loss of individuality:
DE: "Let’s just say we all end up walking out of here like robots, at the end of six months
knowing that we’re never going to touch anything again, that causes another whole
heap of problems... I can’t understand this abstinence, but if I’m going to totally stop
everything, where am I going to be?"
It seems, therefore, that using is a non conformist statement and although they are all chaotic 
users and have previously identified the escalating problematic effects of their behaviour,
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being a user, in and of itself, represents control in a system where actions and behaviour are 
dictated. This would also indicate the investment in the role of being a drug taker: a non­
conformist anarchist for whom the drug use provides an identity and measure of control 
through personal choice:
DE: "We are told what hours we can drink... and we’re told how much cigarettes we can
bring home... I mean when you go and buy drugs there is nobody who is sitting there 
saying: ’No, no, no you’re not buying three grammes today, take one’; it doesn’t 
happen, it’s your environment, you’re in control of it completely. "
Abstinence, therefore, is not just about stopping the use of drugs but also represents a loss 
of identity and a joining into the ranks of conformity: highlighting the central role of drug 
use in the life of the regular and long term user, who has ’forgotten’ how to define 
themselves in any other way:
DO: "Drugs, from drink to cigarettes to hard drugs, it’s part of your lifestyle, it’s part of
everyone’s lifestyle it’s just there... if someone says No to me. I’d say Yeah, and I’d 
do the opposite, I mean like cigarettes... I don’t do as much because it’s legal, same 
with drink... if cannabis was legal I wouldn’t puff as much as I do because it’s 
illegal... so I’m defying by what I’m doing. I’m defying... seriously, drug taking is 
the only time that you can have a little bit of privacy. "
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A final point raised in the discussion relates to another aspect of abstinence: the risk of 
substitute addiction. It is interesting to note that in this discussion, similar to the discussion 
focusing on the concept of addiction, there is no emphasis on the biological aspects of the 
construct ie. abstinence representing withdrawal etc., and the focus is still firmly on the role 
of the drug in the life of the user and what the loss of that would mean; abstinence is about 
understanding the functional significance of the drug and resolving underlying issues and 
replacing the significance without developing substitute addictions:
N: "It also has to deal with the problems - not just the problem of taking drugs - the
problems with why you’re taking drugs, because the trouble is if you cure yourself 
of taking A, B and C, at the end of the day you’ll turn to D, E, and F, if you haven’t 
solved the original problems in the first place, that make you want to take it in the 
first place. "
The issues raised by the participants about the treatment reflected their experiences of 
assessment and their understanding of how the programme would be conducted. The issues 
raised were particularly interesting from a service provider perspective where access and 
confidentiality were stressed as priority for clients new to treatment. The discussion around 
these issues also highlighted the anxieties and, to some degree, paranoia that the participants 
were experiencing prior to starting treatment and as a result of their longterm use. Working 
within a group was positively welcomed and again the data highlighted the overlap between 
professional and lay perspectives on the usefulness of an approach to treatment. The concept 
of abstinence was raised as a significant factor about the treatment programme and the 
discussion ended in a similar context to it’s beginning with ambivalence about change
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reflected in its tone and content. The loss of the drug from the users lifestyle in the context 
of abstinence was also raised, however, and insightful models of maintaining change 
behaviour, ie. not developing substitute addictions, were shown.
M  DISCUSSION AND CONCLUSIONS
The focus group discussion has clearly provided data rich in content and detail and highlights 
the utility of the qualitative method. The most striking aspect of the major themes, to be 
discussed in detail below, is the consistent overlap between professional and lay models of 
treatment and related issues. This is enhanced by other indirect aspects of the focus group, 
in particular, its role in the formation of the treatment group and as an initial intervention 
particularly in the area of motivational work where participants challenge each other and 
offer a range of perspectives and opinions. Each of these points will be discussed separately 
below.
3.4.1 The Major Themes
Behaviour Change
When discussing issues related to models of motivation and decision making, the data appears 
to highlight the overlap between professional and lay models of behaviour change. The 
participants highlighted how change is not a unitary concept, nor is it a linear event but 
rather a series of experiences culminating in the realisation that a problem exists: the shift 
from precontemplation to contemplation. This then results in a state of cognitive dissonance
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or conflict as to the appropriate action to be taken, if any at all is necessary, and the data 
highlights the split between cognition (acknowledging the problem) and behaviour (continuing 
to use or repeated attempts at abstinence followed by relapse). In support of this, the notion 
of the conflict between conscious and subconscious/ rational and irrational is raised. The 
data then illustrates the ambivalence that accompanies contemplation and the role of denial 
in the state of cognitive dissonance; at this point we also see the richness of data offered by 
a focus group discussion where participants act out their ambivalence and denial within a 
series of challenges and exchanges questioning the construct of addiction.
Compensatorv versus disease models: the cognitive - behavioural approach
The discussion around the construct of addiction provided the first insight into the non- 
biological focus of the participants. Traditionally, opiate drug users can expect substitute 
prescribing as part of treatment and it is interesting to find that the stimulant users do not 
even query the fact that this is not available for them. The constructs of addiction and later 
on abstinence, are both described and discussed in terms of the functional significance of the 
drugs and the role they play in the user’s life: both constructs being defined in terms of 
psychological/ emotional need rather than as a biological construct. The group discussion 
around addiction seems to match the compensatory model of addiction which is the model 
most closely aligned to the cognitive - behavioural programmes proposed for the treatment 
of this population. There was some discrepancy in whether there is a need for the concept 
of addiction, where for some it represented an acknowledgement of the problem, while for 
others, a denial or escape into helplessness; therefore it seems that such a construct is as 
useful to the individual as they want to make it. The construct of abstinence brought up a
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number of feelings which matched the ambivalence around behaviour change highlighted 
early in the group discussion, but also reinforced the compensatory model perspective of the 
group. Reluctance to stop all use was associated with loss of identity and fears of conformity 
and being controlled by the system: these issues reinforce the value of a multi-modal 
treatment perspective that focuses on lifestyle functioning and the need to replace the role of 
drugs in order to extinguish them from daily functioning. This leads into the issue of the 
real possibility of substitute addictions developing upon abstinence and clearly as well as 
looking at factors underlying use, such substitute addictions need to replace the value of the 
drugs for the individual in a positive and adaptive manner: themes that provide the primary 
focus of the lifestyle sessions in stage 2 of the treatment programme.
As well as showing concordance with the compensatory perspective, more specifically it 
seems that participants were also raising the key factors for treatment as being those which 
are cognitive - behavioural in emphasis. The use of ’will power’ is seen as insufficient for 
managing the drug misuse with factors such as ’understanding’, ’perspective’, ’staying 
stopped’ and adopting a rational, contained approach being seen as the most important. Such 
concepts seem to relate to issues around education and knowledge, a functional analysis of 
the drug use and related motivational issues and the relapse prevention approach within a 
contained and structured programme, respectively. Furthermore there seems to be a very 
positive endorsement of the inclusion of the group approach, with participants highlighting 
similar positive factors of working within groups that are described in the treatment 
literature: a further overlap of the professional and lay perspective. Models of treatment 
described earlier propose such interventions as most efficacious in the treatment of stimulant 
drug misuse and again we see the overlap between professional and lay models of beneficial
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treatment interventions. The effects of stimulant drugs in the long term leave users feeling 
chaotic, disorientated and paranoid: the rational person becomes undermined and any 
potential coping mechanisms for change, lost. Cognitive - behaviour therapy, with it’s 
focused, goal-orientated approach, seems to offer containment and support to the recovering 
rational person. Therefore it seems that we might be providing participants with the model, 
structure and focus that they intuitively feel they need given their psychological and social 
vulnerabilities at the outset of treatment.
Access to and retention in treatment
Such vulnerabilities relate to the next major theme of the discussion: access issues. There 
was a very clear consensus that immediate access to treatment is key for these drug users. 
The reasons for this clearly link with the issue of the shift from precontemplation to 
contemplation and the resultant psychological discomfort arising out of that. Waiting lists 
may not be appropriate for such a population as waiting could result in a shift back into 
precontemplation/ denial and drop out from the waiting list. Furthermore it appears that 
stimulant users present at more chronic stages in their using careers, ie. when they are 
showing patterns of uncontrolled use, social difficulties and psychological distress, which 
make them priority for immediate access to treatment on the basis of these factors alone. 
However, it is apparent that those who did wait for treatment, did not drop out while on the 
waiting list so it could be argued that the wait, while difficult, was managed and may have 
strengthened motivation for change. This is a key issue for service providers who face the 
difficult task of accessing such a population to begin with and clearly would wish to minimise 
potential for drop out once engaged with a treatment programme. Larger samples would be
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necessary in order to explore this issue further.
A final issue that relates more to retention in treatment rather than access is that of 
confidentiality, an issue discussed at some length with no prompting from the moderator. 
This issue is central to all therapeutic relationships and one to be addressed at the onset of 
treatment. Such a discussion between a new patient and therapist allows for an exploration 
of the safety and boundaries of treatment and for an expression of the vulnerability felt in 
such a unique relationship given issues of self-disclosure, therapist anonymity etc. 
Furthermore in a group setting issues of ambivalence and fear about the safety and 
containment of the group are usefully expressed and explored. This discussion, however, 
has also highlighted the added aspect of stimulant paranoia which exacerbates such feelings 
and difficulties. This issue has implications for accessing patient populations and retaining 
them in treatment programmes and clearly special care must be taken to ensure feelings of 
safety in the client group. The expected treatment anxiety overlaid with suspicion and 
paranoia may prove a further psychological obstacle reinforcing the conflict and ambivalence 
for treatment that is too great to manage and results in denial and resistance to change.
3.4.2 The application of the Focus Group to research
The value of the Focus Group as a research tool
The advantages of the focus group approach have been highlighted in section 2.3.1 and it 
seems clear that these advantages apply to the group conducted for this research: a socially 
orientated research technique capturing real-life data in a social environment, possessing
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flexibility and relative low cost. A question arising out of focus group research relates to 
the validity of the results. Validity is the degree to which the procedure really measures 
what it proposes to, and it can be assessed in a number of ways including face validity (ie. 
do the results look valid) and predictive or convergent validity (ie. the degree to which the 
results are confirmed by future behaviours, experiences or events). The data presented here 
appears to show high face validity, with participants sharing ideas, challenging each other 
and generating some firm conclusions about treatment issues: the goal of the focus group 
from the outset. The participants were honest and shared some difficult and painful 
experiences and insights that may not be available from individual interviews, questionnaires 
or other data sources. The predictive validity of the data can be established, to some degree, 
by comparison with the quantitative outcome data; this point will be addressed further in the 
general discussion section of this research (section 5.0).
One disadvantage of the use of this technique for this particular study is the fact that the 
author and main analyst of the data is the same person who designed and principally ran the 
programme; such an overlap of roles may cause difficulty in the objective assessment of 
qualitative data, ie. the analyst seeing what they want to see. In order to overcome this issue 
the moderator, who had no further involvement or investment in the programme, was 
involved in the early analysis of the raw data and the reviews of subsequent drafts of the 
results.
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The Focus Group as an intervention
An advantage of using the focus group approach prior to treatment onset, apart from for data 
collection purposes, is its value as an intervention in and of itself. From a motivational 
perspective, it appears that the discussions often generated some differences of opinion and 
as the group progressed, participants felt more able to challenge each other. A good example 
of this is given in the results section during the discussion around contemplation and 
ambivalence, where there is a direct challenge to a participant who sees the adulterants in the 
powder as the addictive substance and the challenger highlights that this illustrates an 
avoidance of accepting addiction and addictive behaviour as an individual responsibility. 
This is clearly a powerful statement, particularly when coming from a peer, a fellow user, 
rather than a professional. Another advantage was the effect on group bonding prior to 
treatment onset. This was apparent particularly towards the end of the discussion when there 
was an increase in personal disclosure and a greater use of ’we’ statements compared to the 
’I’ statements used at the beginning of the discussion. This indicates that the group began 
to bond in the face of their shared difficulties and goal of overcoming them.
The behaviour of the Focus Group participants
The behaviour of the participants during the group also provides some interesting, non­
specific data. Three participants in particular: N, DE and DO spoke most often and most 
at length and were often involved in detailed, three - way discussions. The input of M and 
DA was limited to short, concrete comments mostly made when invited to by the moderator 
and furthermore, they both left the focus group early saying they had other appointments.
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Also M was the only female participant and may have felt inhibited within a conversational 
group predominated by men. It is difficult to draw any firm conclusions from the behaviours 
of all participants, however it is interesting to note that M and DA were the first two drop 
outs from treatment (after one session). N, DE and DO all engaged in treatment, however 
DO dropped out after five sessions and erratic attendance due to clear feelings of 
ambivalence. N and DE both attended treatment regularly, with DE dropping out after three 
months and having achieved abstinence and N staying on until the end and discharge; the 
drop outs are discussed in greater detail in section 4.1.
3.4.3 Implications for treatment
This Focus Group has provided data both interesting and reassuring to the treatment 
provider. It seems that participants and professionals are ’talking the same language’ with 
the numerous overlaps that have been highlighted between professional and lay models of 
treatment. The participants highlight the need for focused, goal directed interventions in line 
with the proposed cognitive - behavioural programme; furthermore they specifically allude 
to components of treatment they would find useful that relate to issues of motivation, 
education, lifestyle functioning and relapse prevention: the key components of this 
programme. More generally there also seems to be a confirmation of the professional 
perspectives on behaviour change given by the participants experiences in relation to 
precontemplation and contemplation. This has implications for issues of access and retention 
given the immediacy of presentation and need for treatment. Related to this are issues of 
safety that are clearly important to people using illicit drugs, committing crimes and 
increasingly paranoid and suspicious in their behaviour: this may provide some insight into
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the fact that stimulant misusers are notoriously seen as the ’hard to reach’ population; 
advertising for services may need to emphasise issues of confidentiality and separateness 
from the law. The issue of fast access may indicate that treatment services need also to look 
at providing ongoing, rolling programmes which minimises waiting for treatment and thus 
reduces the risks of drop out while on the waiting list; clearly this last point has very real 
resource implications and could be easily argued for all drug misusers applying for treatment.
3.4.4 Recommendations for future research
This qualitative data collection technique has clearly provided a unique and useful approach 
to the overall evaluation of the new service available to stimulant users. It would have been 
especially interesting to have been able to compare and contrast the data collected prior to 
treatment with a post treatment focus group discussion, however, given the drop outs, this 
was not possible and clearly should be put on the agenda for future service and treatment 
evaluation, not only of this programme but others within the clinical setting. A modification 
for future research would be to keep the moderator and the principle data analyst as separate 
to the programme designer and co-ordinator, thus reducing any possibility of experimenter 
bias. A further recommendation relates to some of the issues raised in the data which 
appear to show participants as having a less biological and more psychosocial approach to 
their using behaviour: in line with the proposed models underpinning the cognitive - 
behavioural treatment interventions. It would be interesting to compare groups of different 
classes of drug misusers, ie. opiates, stimulants, benzodiazepines, etc., and see if those who 
use drugs for which there is a known and established regime of substitute prescribing, would 
frame their using behaviour within the more medical or disease orientated models; a
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particularly interesting group, from this perspective, would be the poly-drug misusers, 
particularly the mixed stimulant/opiate users. Finally it seems that the focus group could also 
be useful applied within the clinical setting as an intervention as well as a research tool, in 
order to aid the process of group bonding prior to the onset of treatment.
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4.0 TREATMENT EVALUATION
M  INTRODUCTION
1) Progress of treatment
After the assessment of nine subjects for the outpatient programme, five met inclusion 
criteria and were offered places; all five accepted, however there were subsequent drop outs: 
M, DO and DA dropped out during stage 1 of treatment and DE dropped out after 
completing stage 2 of treatment, leaving N as the only subject to complete the six-month 
outpatient programme.
ill Drop outs from treatment (n = 3^
It is of interest to consider the different patterns of presentation of the clients and possible 
reasons for dropouts. Two of the early drop outs, M and DA, occurred after only attending 
one group session. Their presentation at the focus group (speaking very rarely, appearing 
very ambivalent about treatment, both leaving the focus group early) and subsequent late 
arrival and early leaving of the initial treatment groups indicated that they may have been 
intimidated by the group approach but also more ambivalent about change; furthermore, a 
significant factor for M may also have been the fact that she was the only female participant 
within a group of men. M also highlighted childcare difficulties due to the requirement of 
such high frequency attendance for the programme. The other drop out, DO, had 
erratically attended occasional group and individual sessions, subsequently dropping out due 
to ill health. DO had been pushed into treatment by a worried partner who may have been 
more motivated for change than DO himself - his ambivalence was evident in his erratic
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attendance and, when this issue was raised in an individual session, he elected to drop out
and reapply for treatment when he ’felt ready’.
iiil Engaged in treatment (n = 2)
DE engaged well with treatment and showed strong commitment throughout stages 1 and 2
(months 1-3). He achieved abstinence early (by week 5 of treatment) and successfully 
maintained abstinence apart from one ’slip’ during week 8. Following a seasonal break 
between stages 2 and 3 of treatment, DE started to attend less regularly and eventually 
dropped out. At this time, he reported that he felt that the treatment had ’worked’ and felt 
that other issues in his life (eg. getting back to work, decorating his new flat) took 
precedence over treatment programme attendance. He was abstinent (as confirmed by 
urinalysis), had been re-housed out of a hostel and had started working again as a session 
musician. Follow-up data, returned by post at the end of the treatment programme, indicated 
that he was still drug-free and working regularly.
N engaged with the six-month programme until the end. It is difficult to assess the effect 
of drop outs by other group members on his progress, but he did complete treatment. As 
discussed in section 2.0, the single case study is accepted as data useful for the evaluation 
of clinical interventions. Given the drop outs and acknowledged difficulties with recruitment 
for a new treatment programme, N’s data shall form the basis for the following single case 
study that shall be submitted as part of the treatment evaluation. Clearly, this is a departure 
from the stated aims of this research, and interpretation of the results from a single case will 
need to be made with caution in terms of conclusions made about the efficacy of the 
treatment programme; the implications of this will be discussed more widely later.
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4.2. THE CASE; N
The following single case study describes the treatment progress and outcome of the one 
member of the original group of treatment participants, who completed the six month 
oui'patient programme. The results will be discussed in the context of the individual’s change 
over time and the main issues of investigation are:-
Has the client improved?
How far can the improvement be seen as a result of the treatment?
Does the treatment have a specific effect or do the non-specific components of the 
treatment account for the change?
Is such a treatment more effective than no treatment?
Does the treatment work for the reasons given in the theoretical rationale?
What implications do the results of this single case hold for the design, 
implementation and evaluation of further out-patient treatment programmes for 
stimulants users?
4.2.1. Method
Subject
Patient presentation
N is a 37 year old white, British male who presented for treatment with a 15 year history of 
regular stimulant drug use. At the initial interview, N was very anxious and fidgety. He
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seemed very ambivalent about presenting at a drug dependency unit ("I’m not a junkie") and 
was adamant that he had not committed to the concept of abstinence (this issue may be 
related back to his qualitative data reported in section 3.0, the focus group; he seemed 
contemplative about change).
Drug historv: presenting complaint
At the time of presentation N was using cocaine, ecstasy, cannabis and alcohol on a regular 
basis and magic mushrooms and LSD on an occasional basis. His use was constrained by 
finances, however, he reported that he would use up to 3g of cocaine powder per day if he 
could afford to. He snorted or swallowed all his drugs.
Previous treatment episodes
N had never presented for help with his drugs problem before and his only other therapy 
experience was a six month period of analytic psychotherapy four years previously. This 
period of therapy was related to depression arising from the collapse of his business and the 
ending of long term relationship which, he said, he did not link to his escalating drug 
problem at the time but in retrospect thought this was a major factor of his lifestyle 
difficulties and depression of that period.
Familv and personal historv
N described a complex and problematic early life featuring multiple foster homes marked by 
sexual and physical abuse within the foster siblings (both abuse directed towards him and 
from him to others), truanting and delinquency. He had one child, a daughter, (the mother 
was one of his foster sisters), who was adopted from birth and with whom he has had no
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contact since that time, 22 years ago. N had some contact with two foster brothers and a 
very acrimonious relationship with his foster mother (the foster father had died 6 years 
previously). At the time of the interview he was coping with the deterioration of a 
relationship which he highlighted as being mainly related to his drug use and this seemed a 
major motivation for treatment. He discussed his sexuality as heterosexual and also reported 
transvestitism which he felt compelled towards but felt uncomfortable with particularly in the 
context of his childhood sexual abuse by older foster brothers.
Family and personal psvchological historv
Prior to the 15 year period of escalating drug use, N reported periods of depression: his 
"black moods". He described these as being related to the longer term issues of childhood 
abuse and neglect and his conflicts about his transvestitism. He also reported a childhood 
history with features of attentional deficit hyperactivity disorder (ADHD): inability to 
concentrate, problems settling at school, short attention span and easily bored. He reported 
no significant family psychiatric or psychological history, however he did describe his foster 
mother as "highly strung and neurotic".
Current psvchological functioning
N presented with a number of mental and physical health problems which related to his long 
history of stimulant misuse: poor diet and sleep pattern, anxiety and occasional paranoid 
ideation (particularly contingent on a binge), inability to relax, agitation and pronounced 
mood swings with an increase in aggressive outbursts, panic attacks and hyperventilation. 
He also reported increasing social isolation relating both to the paranoid ideation and his 
worsening depression and a sense of increasing hopelessness and helplessness. A clinical
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diagnosis of depression was confirmed at mental state examination with a team psychiatrist. 
Compounding and intrinsic to these issues were a number of social and financial difficulties: 
from a lucrative and successful career in photography, N had been unemployed for 4 years 
and was bankrupt living in arrears in rented accommodation and had sold most of possessions 
to fund his drug habit.
Reasons for treatment
N listed his main reasons for treatment as follows:-
1. To deal with the depression and anxiety;
2. To "get my life together": resume work, sort out his financial difficulties;
3. To control or stop (not clear which) his chronic drug use;
4. To try and save his relationship.
Formulation and summary
N was a bright, insightful man with a history of chronic simulant drug misuse and a number 
of related physical and mental health difficulties. He showed marked tolerance to the drugs 
and was clinically depressed. The use of drugs began as an occupational aid to his long 
photographic sessions and was also related to the glamour of the job. There were also 
indications that he used the drugs to self - medicate depression accounted for by both 
proximal (the use itself and related mental, physical and social problems) and distal (the 
complex and traumatic early history) factors. There may also be a link between the early 
history of ADHD and self medication with stimulants. He was clearly motivated for change 
but ambivalent as to what form that change might take. Following a discussion of the range 
of treatment options, N wanted to pursue outpatient treatment and was not keen on the
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inpatient options. Urine analysis was positive for cocaine, E, cannabis and alcohol. N was 
offered a place on the outpatient programme, baseline measures were taken and a start date 
confirmed. It was agreed within the clinical team that there were no immediate medical or 
psychological concerns that would prohibit a wait for a treatment to begin.
Design
As discussed in section 2.2, the design of the evaluation is a repeated measures design at 
four time intervals: baseline (beginning of treatment: Tl); end of treatment stage 1 (end of 
month 1: T2); end of treatment stage 2 (end of month 3: T3); end of treatment stage 3 (end 
of month 6; end of treatment: T4).
Measures
The measures taken fall into three broad categories:
1 • Standard/Global measures ie. those that have been developed for known populations
and problems. For this study, such measures used were:
i) The Opiate Treatment Index (OTII (Darke et al, 1992)
ii) The Halikas-Crosbv Drug Impairment Rating Scale - Cocaine (HCDIRS-C). (Halikas 
et al, 1991)
iii) The Severitv of Dependence Scale (SDSl. (Gossop et al, 1992)
iv) The Beck Depression Inventorv (EDIT (Beck et al, 1961)
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2. Individual Target Measures ie. measures focusing on more specific aspects of
individual change over time in treatment.
i) The Readiness to Change Questionnaire (RCO). (Rollnick et al, 1992)
ii) The Inventorv of Drinking situations (IDS) and the Situational Confidence 
Questionnaire (SCOT (Annis 1982b & c)
3) Process Measures ie. measures used to monitor treatment sessions,
i) Goal Setting
The development of these measures and their relevance to the evaluation needs of this study 
has been described in greater detail previously in section 2.3.
4.2.2 Results
This section shall describe the changes that occurred over the course of N’s treatment. Data 
from each measure will be dealt with separately and an attempt will be made to provide 
overall conclusions. Data will be represented graphically and analysed visually. According 
to Morley (1989), describing Baer (1977):
"the thrust of single case research in the field of applied behavioural analysis is to detect 
effects that are strong, consistent and dependable. He argues that graphical representation 
of the data will ensure that only these effects are detected whereas weak effects which may 
be statistically significant will be ignored. In statistical terms Baer argues that visual analysis 
of the data will ensure that Type I errors are minimised (ie. concluding that an effect is
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present when it is not) but there is a corresponding increase in the likelihood of Type II 
errors (failing to detect any effect when it is present)." (pp. 257).
In the case of small magnitude or variable pattern which may still be statistically significant, 
the data will not be taken as supportive of change due to treatment.
Data was collected from N as described in section 2.4. Table 3 represents Q scores for each 
drug class as measured by the OTI. The Q score is a measure of the daily average of use 
over the past month.
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Table 3;- OTI - change in scores over time
OTI scores
Baseline
T im e! Time 2 Time 3 Time 4
Polydrug (total) 6.0 5 3 3
Stimulant drug (total) 2 2 1 0
Opiates 0 0 0 0
Alcohol 1.1 0.9 0.2 1
Cannabis 7 3 1 1.3
Amphetamines 0 0 0 0
Cocaine 1.4 0.3 0.1 0
Tranquilisers 0.6 0 0 0
Barbiturates 0 0 0 0
Hallucinogens 0.2 0.1 0 0
Inhalants 0 0 0 0
Tobacco 7 5 7 7
HRBS 16 0 0 0
SOCIAL 24 14 17 17
CRIME 2 0 0 0
HEALTH 10 8 7 5
GHQ 25 2 1 1
A (somatic) 6 0 0 0
B (anxiety) 6 2 0 1
C (social dysfunction) 6 0 0 0
D (depression) 7 0 1 0
NOTE: HRBS 
GHQ :
HIV Risk Behaviour Scale 
General Health Questionnaire
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1. Global Measures
1) The OTI
The Q scores obtained on the OTI measures are presented in Table 3. These results are 
illustrated in Figure 1. As can be seen from Figure 1, change in drug use scores showed 
a dramatic decrease over time, from baseline (Tl) to the end of treatment (T4). By the end 
of treatment stimulant, tranquilliser and hallucinogen use had ceased, there was an overall 
reduction in cannabis use, and alcohol and tobacco use remained constant. Overall these was 
a striking difference in pre and post treatment polydrug and stimulant drug use total scores. 
As opiate and inhalant use was 0 at baseline and showed no change, these categories will not 
be discussed further or represented in Figure 1.
As shown in Figure 2, there was an immediate and dramatic reduction in the HIV risk 
behaviour scores. In relation to the clinical category scores of the OTI, these scores shifted 
from the high range risk category at T l to no risk behaviour being exhibited between T2 and 
T4.
There was an initial reduction in the social score which reflects social functioning ie. 
relationships, accommodation, employment. In relation to the clinical categories for OTI 
scores, the score at T l was above average (in the direction of poor social functioning), with 
a marked shift at T2 to a low score and finally at T3 and T4 to below average (see Figure
2). N’s crime score is also represented in Figure 2. The crimes commited involved fraud 
and tax evasion. The graphical representation highlights the striking change from a score at
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Figure 1: C h a n g e s  in OTI drug use  s c o r e s  over  t ime
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Tl which was within the average range, to scores from T2 to the end of treatment indicating 
a maintained shift to no criminal behaviour.
The steady reduction in health scores over time, illustrated in Figure 2, indicate steady and 
positive improvements in overall health. The scores shown in Table 3, indicate an overall 
shift from an average score at T l, to a low score at T4. Health gains were related to a 
normalised sleeping and eating pattern and regular primary health care visits. There were 
striking changes in the GHQ scores over time, as shown in Figure 3. The most pronounced 
difference was seen between Tl and T2 when scores on all four scales decreased 
dramatically: shifting from the average clinical category to the low category. The changes 
were then maintained over time with only a small increase in anxiety scores at the end of 
treatment.
b) Additional questionnaires: HCDIRS-C: SDS: BDI
Table 4;- Additional Questionnaires - change in scores over time
Questionnaire Baseline 
Time 1
Time 2 Time 3 Time 4
HCDIRS-C 44 20 21 16
SDS 12 6 5 0
BDI 25 12 15 7
NOTE:
HCDIRS-C
SDS
BDI
Halikas Crosby Drug Impairment Rating Scale - Cocaine 
Severity of Dependence Scale (short version)
Beck Depression Inventory
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Figure 3: Changes in GHQ scores over time
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i) HCDIRS-C
Overall there was a striking reduction in scores over time indicating a reduction in problems 
associated with cocaine use. As seen in the OTI scores, greatest change occurred between 
Tl and T2 and may reflect significant psychological and drug related changes made at the 
time. Scores between T2 and T4 remained fairly constant and the new scores indicated 
difficulties with the psychological effects of maintaining abstinence (ie. cognitive intrusions, 
cravings etc.) and also the residual effects of withdrawal over time (ie. normalising sleep and 
mood etc.) as would be expected.
ii) SDS
Again, in line with other scores discussed, there was an overall marked reduction in 
dependence scores with the greatest shift seen between T l, and T2. The scores at T2 and 
T3 reflect the intrusive thoughts of using present at that time which would be expected 
during early abstinence. At T4 (the end of treatment) and after a lengthy period of not using 
(approximately 20 weeks), there were no features of dependence reported.
iii) BDI
Depression scores indicated moderate clinical depression at T l (baseline) with a marked shift 
to mild depression at T2 and T3 and no clinical depression present at the end of treatment 
(T4).
Overall, as illustrated in Figures 1 - 4, all global scores showed striking reductions 
indicating positive health and behaviour changes. All scores shifted most dramatically 
between Tl and T2, corresponding to N becoming abstinent during that period. With such
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Figure 4: C h a n g e s  in addit ional  q u es t ionna i re  s c o r e s
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a marked reduction in drug use, it would be expected that associated mental and physical 
health changes would take place and this was reflected in the marked shifts in related scores, 
in the same direction, during the same time periods.
2. Individual Target Measures
i) The Readiness to Change Questionnaire (RCOi.
As described earlier, the RCQ indicates an individual’s position within the Prochaska and 
DiClemente ’Cycle of Change’ model (1986). At Tl (baseline; pre-treatment), N fell into 
the contemplation category but he shifted markedly into the action stage at T2 and remained 
there for the rest of the treatment period.
ii) The IDS & SCO
The IDS measures degree of risk of a number of key high risk personal and inter-personal 
states while the SCQ measures degree of confidence with being able to cope with the 
demands placed by such a high risk situation. Table 5 shows the IDS & SCQ scores for 
N at T3 and T4: the time periods prior to and after the intensive relapse prevention work. 
As shown in Figure 5, comparison of the two time periods clearly indicate a change in 
perceived risk situations and individual coping mechanisms in such situations over time, 
however, before the differences are discussed each time period will be taken separately.
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Table 5:- The IDS and SCO scores at T3 and T4; ore and post the relapse 
prevention component of treatment
HIGH RISK
SITUATION/
STATES
T3 PROBLEM INDEX T4 PROBLEM INDEX
IDS SCQ IDS - SCQ IDS SCQ IDS - SCQ
1. Unpleasant 
emotions
60 18 42 35 55 -20
2. Physical 
discomfort
29 12 17 2 52 -50
3. Pleasant 
emotions
62 36 26 60 55 5
4. Testing 
control
28 5 23 3 60 -57
5. Urges/ 
Temptations to 
Use
40 22 18 25 62 -37
6. Conflict with 
others
39 10 29 8 74 -66
7. Pressure 
from others to 
Use
55 18 37 2 25 -23
8, Pleasant 
times with 
others
60 30 30 35 55 -20
NOTE: Personal states
Interpersonal states
1 -5  
6 -  8
Measurements taken at T3 highlighted personal and interpersonal states where N would be 
at greater risk of using: unpleasant emotions; pleasant emotions; pressure from others to 
take drugs; pleasant times with others. Some extra explanation about the implications of 
these scores is needed in order to understand N’s experience. The interpretation of these 
scores is adjusted by considering the matching SCQ score and calculating the difference 
between the two: ie. a high IDS and SCQ score on the same state would indicate greater 
risks for using when in the situation/state but a greater sense of self efficacy in terms of 
coping with those risks - thus leaving a challenging but manageable state. At T3 therefore
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we find that unpleasant emotions and pressure from others to take drugs are situations/states 
where the difference between presenting risk and perceived ability to cope with such risks 
are greatest. This provided very useful information to N who was clearly most vulnerable 
when unhappy and amongst others - he knew that his strategy for coping with low mood had 
been finding other, using friends in order to "get off our faces and forget the crap" and 
confirmation of this enabled individual sessions to focus oh such maladaptive coping 
strategies and look at alternatives. The exercise also allowed an appreciation of adaptive 
coping mechanisms already in place and although the risks for all situations/states 
outweighed perceived ability to cope, the information highlighted coping mechanisms to be 
developed and provided some reassurance to N who was in the difficult and helpless early 
days of abstinence.
By T4 the situation had clearly changed and this might reflect, to some degree, the impact 
of ongoing relapse prevention work, continued abstinence and successfully coping with slips 
and normalising mental and physical states. In all but one situation/state the difference 
between perceived risk and perceived ability to cope with that risk had shifted - with coping 
outweighing risks present.
Pleasant emotions still presented a degree of risk slightly greater than perceived coping and 
related to the enduring belief that: "cocaine was the champagne drug of success and
celebration", and provided valuable information about continued vulnerability to relapse 
even after 5 months of abstinence.
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Figure 5: IDS and SCQ scores :  Change over  time in 
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3. Process Measures: Goal Setting
a) Tl: Knowledge about drugs
N set a goal for the first stage of the treatment that felt manageable, non-threatening to his 
contemplative state and fit with the group session focus at the time: to increase his 
knowledge about stimulant drugs. This goal supported the psychological constructs of the 
early stages of treatment (ie. knowledge forming a basis for decision making and early 
behaviour change) and N’s own perceived needs at the time. A simple multiple choice quiz 
(Appendix D) was given as a repeated measure at the beginning and end of T l. The quiz 
focused on specific biopsychosocial aspects of stimulant drug use.
A pre-intervention score of 33% correct shifted to 94% correct after stage T l: clearly 
demonstrating an increase in knowledge.
b) T2 & T3:- Lifestvle goal setting
In T2 (the lifestyle and early relapse prevention sessions) and in T3 (the later relapse 
prevention sessions), diaries and activity schedules were used as part of the process of 
treatment at that time. After an initial two week period of self monitoring focusing on the 
daily use of time with particular focus on the ratio of daily ’shoulds versus wants’, N started 
a twice weekly system of goal setting and review.
Some goals eg. the specific behavioural tasks were easier to achieve than others. By the end 
of T2, N was exercising on a daily basis, had established a regular sleep-waking pattern and 
had achieved a good balance of shoulds (eg. writing a CV, visiting financial advisors) and
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wants (eg. visiting museums and art galleries) throughout his week, hence establishing 
structure and daily routine. Goals relating to more specific personality and interpersonal 
issues were more difficult but offered experiences rich in feedback relating to areas of 
personal development necessary; a goal relating to stopping a dealer ’dropping by on the off 
chance’ highlighted issues relating to lack of assertiveness and poor communication skills. 
Goals would then be reviewed in the context of some cognitive and behavioural work around 
such areas of development.
4. Medication
Five weeks into treatment N stopped using drugs. After twelve days, he presented at an 
individual session in a tearful and agitated state describing symptoms of sleeplessness, 
agitation and worsening mood consistent with the features, both biological and psychological, 
of early abstinence. After a session exploring strategies for managing such symptoms it was 
felt appropriate for N to be re-assessed by the team psychiatrist who had previously 
conducted his initial mental state examination. Following this assessment, N was prescribed 
Bromocriptine: 2.5 mg per day and Nitrazepam: 10 mg nocte for 2 days and then further 
Bromocriptine: 2.5 mg on alternate days for 8 days and Nitrazepam: 5 mg nocte for 8 days. 
The Bromocriptine would offer symptom relief from the early stimulant withdrawal and the 
Nitrazepam would aid in establishing a night-time sleep pattern. At the end of this ten day 
period of prescribing, N reported a reduction in symptoms, a stabilising sleep pattern and 
did not require further medication throughout the rest of treatment.
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In summary, overall there was a positive behaviour change shown from baseline (Tl) to the 
end of the treatment (T4). Problem drug use, particularly stimulant use, had stopped and 
there were related positive changes in risk behaviour, social functioning, physical and mental 
health. There were also positive changes in motivation and perception of relapse risk and self 
efficacy over time and target goals set at each stage of treatment were accomplished. 
Medication was used for symptom relief following a period of abstinence and scores 
following the period after prescribing had ceased indicate that positive behaviour changes 
were unchanged and continued to strengthen. Each of these results will be discussed in 
greater detail below.
4.2.3 Discussion and Conclusions
The results on all three levels of measurement indicate significant changes between baseline 
(Tl: pre-treatment) measurement and measurement at the end of treatment (T4). The most 
significant changes were seen between Tl and T2 and then either further shifts in scores or 
a maintained level was seen until the end of treatment. The significant Tl - T2 shifts in 
scores can be explained by early abstinence from cocaine at week 5, with continued scores 
showing ’slips’, as would be expected in the newly abstinent, rather than continued using.
The OTI: drug use and related areas of functioning
By the end of treatment, N was no longer using cocaine or ecstasy, his main problem drugs, 
and showed associated cessation in hallucinogen and tranquilliser use. Cannabis use 
(associated, like the tranquilliser use, with medicating the alerting effects of the cocaine) had 
significantly reduced. Alcohol and tobacco use remained fairly stable throughout treatment
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with no meaningful changes seen across T1 - T4: the OTI scores reflect low use on both 
(an average of 7 cigarettes per day and approximately one unit of alcohol per day) neither 
of which are excessive or could be seen as substitute dependencies. N aimed to attempt to 
stop smoking cigarettes but felt that coping with abstinence from the other drugs used was 
still his primary focus. It is interesting to note that tranquilliser use, which was contingent 
on stimulant use, (ie. the tranquilliser being used to counter the alerting effects of the 
stimulants) ceased prior to abstinence in cocaine use.
These results highlight two disadvantages with the OTI scoring system: firstly, baseline 
scores only show use in the preceeding month and N had reported a recent reduction in use 
due to lack of funds - so the baseline score does not truly reflect the chronic nature of his 
use. Secondly abstinence, defined by a O Score on the OTI, is when there is no use at all 
in the previous month: this conflicts with the relapse prevention model which considers 
intermittent use after a period of abstinence as being abstinence accompanied by ’slips’. In 
real terms, N considered himself abstinent by week 5 and this is reflected by the significant 
reduction in cocaine use between T1 and T2 - the score in T2 reflecting occasional slips 
rather than continued use as would be expected in the days of early abstinence.
The cannabis use showed a marked reduction over time with a slight increase between T3 
and T4. This, together with the tobacco and alcohol scores may reflect end of treatment 
anxiety - this could be monitored at follow-up. Indeed, apart from the expected separation 
anxiety at the end of treatment, N was also facing homelessness prior to re-housing which 
was clearly causing him some stress. Overall, however, in real terms these scores reflect 
low levels for all three substances.
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The drug score changes were accompanied by striking shifts in scores on other OTI 
subscales: indicating concurrent positive health and mental health changes. Again, the 
changes seen were most marked between T1 and T2 coinciding with the most significant 
change in drug use. HIV risk behaviours were completely extinguished by T2, highlighting 
positive health behaviour change which was regular condom use with casual partners. N 
identified cocaine and ecstasy use as being associated with an increase in casual sexual 
partners due to the context of using (ie. at clubs, raves); the reduction in risk behaviour 
would also reflect the reduction in the stimulant use over time due to an avoidance of the 
high risk situations (ie. clubs) associated with using.
Social functioning stabilised steadily throughout treatment. This indicates an overall 
improvement in social functioning over time in treatment with the slight increase in scores 
towards the end of treatment possibly reflecting the ongoing re-housing difficulties due to 
bankruptcy. Improvements were reported by N in his family relationships (a reduction in 
conflict) - particularly his relationship with his mother, and he had started in part-time 
employment. Individual sessions were used to look at all aspects of N’s relationships, 
particularly with women and also the relationship of these issues with his transvestitism.
Physical and mental health as measured by the Health OTI scale and the GHQ respectively, 
both showed dramatic positive shifts again particularly between T1 and T2. The changes 
seen again are related to the reduction in drug use and associated mental and physical health 
changes expected. The educational sessions seemed to motivate a real concern for health 
once the short and long term effects of chronic stimulant use had been highlighted and this 
may be related to the sudden shift in scores at this time in treatment, coinciding with a
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marked reduction in stimulant use which had particularly related to such health difficulties. 
The slight increase in the GHQ measurement of anxiety at the end of treatment (T4) again 
probably reflects ending issues and current social difficulties of the time.
The additional global questionnaires
All the above changes were supported by the HCDIRS - C, the SDS and the BDI where 
problems associated with stimulant use, dependence on drugs and depression all reduced 
dramatically in the period T1 - T2, corresponding to early abstinence and then showed the 
pattern throughout the rest of treatment expected from an individual maintaining abstinence. 
The HCDIRS -C questionnaire would undoubtedly provide useful data if used regularly at 
follow-up and from this early pattern of scores, it could be hypothesised that scores would 
gradually further reduce over time as psychological functioning around abstinence and 
relapse prevention was reinforced by long term behaviour change. The scores on the GHQ 
and the BDI for depression are as would be expected given the depression characteristically 
experienced in the immediate period following early abstinence due to a depletion of 
dopamine. The marked reduction, as well as being linked to stabilisation of the biological 
mechanisms associated with the management of mood, may also be related to improved 
psychological functioning given the treatment intervention and early treatment containment 
experienced at the time. At the end of treatment the scores indicated no clinical depression 
present.
The scores on all the global questionnaires show dramatic and positive physical and mental 
health changes with scores at T1 indicating levels of poor functioning and clinical concern 
to scores by T4 showing abstinence in problematic drug use, marked reduction in other drug
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use and the associated physical and mental health changes expected in relation to such 
changes. The direction and pattern of change in all scores support each other, with most 
marked changes seen between T1 and T2: the onset of abstinence. Furthermore, changes 
seen may also be explained by changes in mental state and psychological functioning 
associated with the broader psychological concepts relating to behaviour change. One 
explanation may be a shift from the contemplation to the action stage between T1 and T2 
at a time when treatment focused exclusively on educational and motivational issues. The 
marked changes in scores reflected in all four global measures correspond with each other 
at each stage of change, ie. GHQ and BDI change in scores both reflecting increasing 
stabilisation of mood; reduction in dependence scores (SDS) and problems associated with 
cocaine scores (HCDIRS - C) corresponding with overall reduction in the use of drugs. The 
interpretation of these scores in relation to the treatment of stimulant users will be discussed 
more widely later.
The target and process measures
While it is not appropriate to suggest that these changes can all be explained by the treatment 
programme per se, it is interesting to find that individual target and process measures which 
were repeated before and after targeted interventions underpinned by specific psychological 
constructs, also showed marked positive changes. The measures taken before and after the 
educational and motivational sessions and also the early relapse prevention sessions, showed 
marked changes in readiness to change, knowledge about drug use and relapse management 
strategies respectively. Such changes are unlikely to be accounted for by chance alone and 
it seems appropriate to assert that these results are not only related to the associated changes 
seen on the above described global measures, but also support the treatment focus of the
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time: with psychological functioning shifting in accordance with the psychological construct 
underpinning the particular period of treatment. This is particularly supported by the shift 
from contemplation to action occurring at the time when the treatment focus was 
motivational and educational work and, subsequently, early abstinence occurred.
These results are not surprising in light of the shifts in scores described earlier on the global 
rating scales with significant positive health and behaviour changes shown between T1 and 
T2 alongside associated reduction or cessation of drug use. These results strengthen the 
earlier hypothesis that the changes between T1 and T2 which were maintained over time 
were, in part, explained by a shift in motivation to change which, in turn, was explained by 
the treatment focus (educational and motivational) during that period. With the increase in 
knowledge, N reported that the biological and psychological information challenged his 
resistance to change when he was faced with the consequences of long term use. Such a 
knowledge intervention seemed to have facilitated the decision-making process and might 
have contributed to the motivational shift from contemplation to the action stage; indeed one 
week into T2, N became abstinent for the first time in 15 years.
The maintenance of change between T2 - T4 may be explained, to some degree, by the 
relapse prevention intervention at that time as indicated by the shift in IDS & SCQ scores 
and the relapse prevention intervention that took place between the two times of 
measurement. The indications are that the relapse prevention component of the programme 
provided information and support over a time when abstinence was maintained and cognitive 
control and adaptive coping mechanisms were developed. The measures themselves 
provided meaningful feedback to N who was involved in plotting and interpreting the graphs
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and allowed targeted focus on specific components of relapse prevention relevant to his 
situation.
It is most difficult to describe and evaluate the success of the process strategy: goal setting. 
To attempt an empirical evaluation of success in terms of the outcome of the goals set (ie. 
counting the ratio of goals achieved to those not) is meaningless given the richness of data 
provided by goals that were not successfully attained. It is clear that clinically such a system 
fit well within the structured nature of the programme and offered containment of anxieties 
that clearly accompanied thoughts of long term change. Also within the context of broader 
mental health changes, a systematic, focused and goal directed approach clearly had benefits 
as a depression and anxiety management strategy. The diaries and schedules also provided 
regular feedback to N who was able to review achievements and areas of personal growth 
as stages in the process of his long term change.
Medication
Abstinence was achieved with no medical intervention. Medication was prescribed for a 
short period (ten days) following twelve days of no use and in order to provide symptom 
relief from the expected biological and psychological withdrawal experienced at time. This 
short period of prescribing can be seen as separate from the achievement of early abstinence 
and adjunctive to the maintenance of this abstinence. There was no use immediately 
following the end of prescribing and positive health and behaviour changes continued in the 
direction established prior to the use of any prescribed medication. These results would 
indicate, therefore, that medication for symptom relief was an intervention complimentary 
to the psychological programme and was not primarily accountable for the onset of
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abstinence nor the impressive long term maintenance of this state and the associated positive
physical and mental health changes seen. Furthermore the effectiveness of the drugs
prescribed as placebo versus pharmacological is unclear, however such a short period of
*
prescribing may indicate the placebo effect as important for anxiety management.
Overall, therefore, these results provide support for the structured, focused relapse 
prevention component of such a programme and highlight the positive contribution provided 
by the feedback of such process measures when placed in the context of the treatment focus 
of the stage of treatment at that time. It is important to note, however, that the results are 
only relevant to the individual measured and generalisations to treatment populations cannot 
be made.
Implications for the treatment of stimulant misuse
There would, therefore, be sufficient evidence to suggest that the changes seen pre and post 
treatment were, to some degree, associated with the treatment received. It would be difficult 
to explain the changes as being by chance alone, given the marked and striking differences 
in all areas of functioning which support each other in time and the progress of N. The fact 
that all measures showed change in the same direction also adds strength to the argument 
that treatment is responsible, and with treatment targeting the specific areas where dramatic 
changes were then seen, it is unlikely that some other factor could account for this pattern 
of results. Furthermore it is highly unlikely that after 15 years of chronic use and repeated 
unsuccessful attempts at cutting down or stopping, that such significant changes would have 
occurred purely by chance.
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These results therefore would not only support the efficacy of the intervention in terms of 
addressing the primary stimulant problem but also the related biological, psychological and 
social issues. Also it supports the use of specific cognitive - behavioural interventions (eg. 
motivational, educational, relapse prevention and lifestyle) during the treatment programme 
and within a structured framewoik with a specific treatment focus at each stage relating to 
an overall process of change.
The implications for treatment can now be considered in relation to the key research 
questions raised in section 4.2. It is clear that the client has improved in all areas of 
functioning, ie. drug use and related biological, psychological and social aspects. In terms 
of how far the improvement can be seen as a result of the treatment, the discussion earlier 
has highlighted factors which lend strong weight to the argument that treatment played a 
significant role in the changes seen: all scores shifting markedly in the same direction and 
within time frames corresponding to each other and the treatment focus of the time. The 
additional support provided by the target and process measures, indicates that the treatment 
seemed to have specific effects on the individual’s behaviour with measures of the 
psychological constructs underpinning the treatment focus of the time, showing marked 
changes before and after the specific intervention; this point also provides support for the 
question as to whether the treatment works for the reasons given in the theoretical rationale. 
It might also be hypothesised that some non-specific components of the treatment could also 
account for the change with issues such as the containment offered by a high frequency, 
structured programme providing additional, meaningful support; the post intervention focus 
group may have provided some insight into this and other important non-specific components 
of treatment, however, for reasons explained in section 3.3.2, it was not possible to conduct
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this group and therefore there is no direct evidence for this hypothesis.
The question of whether such a is treatment more effective than no treatment is very difficult 
to answer in the context of this research. There was no matched control as it would have 
been unethical to deny an individual with similar difficulties immediate access to treatment. 
It might be argued that the dramatic changes demonstrated during the treatment period, 
which were striking and marked in comparison to the previous 15 year history of chronic 
drug misuse and repeated failed attempts to cut down and stop without treatment, may 
provide some support that treatment affected outcome; clearly, however this can only be 
demonstrated by the use of a matched control or by following up the early drop outs.
Limitations of the data presented
This last point: the absence of a matched control, is clearly a limitation to the data presented 
however this limitation to the interpretation of the data is modified by the strength of change 
on all measures, in the same direction at time periods corresponding to the treatment focus 
of the time. However, these results clearly cannot be used in any argument about longterm 
change as it was not possible to present follow-up data. Such data will be collected and 
considered when implementing further programmes. Furthermore, it will also be useful to 
follow-up on the drop outs from treatment, the absence of such data here also a limitation 
of the study.
Cognitive behaviour therapy has often been criticised for being a treatment bias towards 
more educated clients. A criticism of Washton’s work (1984) is that he treats populations 
of ’middle-class’ , stimulant misusers who can afford the high cost of his programme. Such
306
a patient population may fit into the profile of those who the critics of CBT argue are most 
likely to engage in and benefit from such an intervention. It is clearly important to 
acknowledge that this intervention appeared to show efficacy with N: a bright, articulate and 
motivated individual who was literate and found the self-monitoring, diary and schedule 
keeping manageable and non-threatening. The application of this model to other individuals 
can only be speculated, however the principles of CBT could be used in the same way but 
the methods of application modified to fit the needs of the patient; such a flexible approach 
is part of the CBT model and also, it could be argued, good clinical practice: matching 
treatment application to the needs of the patient.
Recommendations for future treatment evaluation
The final research question is what implications the results of this single case hold for the 
design, implementation and evaluation of further out-patient treatment programmes for 
stimulants users? The results have provided support for the work of Washton, Rawson and 
others who have recently been describing the efficacy of cognitive - behaviour therapy and 
the specific techniques of motivational interviewing and relapse prevention with this 
population. This study has provided the opportunity to evaluate such a programme in the 
context of one individual with good outcome and clearly it would be appropriate and useful 
to continue to evaluate this approach with other single cases, with contrasting demographic 
profiles in order to see if replication is possible. Investigation of the drop outs, particularly 
the later drop out, would provide an opportunity to explore the issue of length of time in 
treatment. Furthermore, future research must attempt to evaluate this approach in the 
context of a group study as originally planned and improved access to clients should make 
this possible.
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While overall these findings are very promising and provide support for the efficacy of this 
intervention with the single client, N, they do not support the efficacy of a single treatment 
for all stimulant misusers; Instead some important points are highlighted. The early drop 
outs and later drop out of a newly abstinent client underscores the significance of the 
heterogeneity among stimulant users, as patient characteristics such as severity of use, 
demographic profile and psychopathology may influence treatment seeking, treatment 
retention and treatment effects. Further studies need to explore patient- treatment matching 
and the development of specialised treatments for clinically distinct sub-groups of stimulant 
users (including those excluded by the criteria of this study), and the complexity of the 
relationship between treatment retention and outcome.
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5.0 DISCUSSION
This study evaluated an outpatient treatment programme for stimulant drug misuse based in 
a Central London outpatient NHS setting. The design of the programme was broadly 
cognitive-behavioural, specifically using motivational, educational, lifestyle and relapse 
prevention components and was conducted over a six-month period in a step-wise, structured 
manner. Qualitative and quantitative measures were taken in order to evaluate outcome and 
the general issue of treatment efficacy for such a population. Given the small initial sample 
size (n=5) and subsequent drop outs from treatment, the quantitative data was presented in 
single case study form. The qualitative data was provided by a pre-treatment focus group 
attended by all of the initial sample.
The results are promising and provide preliminary support for the use of cognitive 
behavioural interventions for the treatment of stimulant users on an outpatient basis. Such 
support is shown on a number of dimensions provided by the data. The single case study 
outcome not only indicates marked changes in drug using and related behaviours from 
baseline to the end of treatment but also that there are specific changes on particular 
dimensions relating to the treatment focus of the time ie. relapse prevention or motivational 
work, therefore also supporting the efficacy of the psychological construct underpinning each 
phase of treatment. The focus group highlighted a number of interesting issues which also 
provide support for the treatment intervention in a non-empirical way. There was a clear 
overlap between professional and lay models and perceptions of treatment where participants 
supported the goal focused interventions as most useful for them at this stage. Issues of 
motivation as a precursor to behaviour change were immediately highlighted as significantly
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important at the outset of treatment and the notion of change being a stage-wise process was 
discussed. Before considering the implications of all data collected, it would be useful to 
focus specifically on the research questions posed in section 1.4.2. in order to review the 
data more specifically.
5.1 The Research Questions
5.1.1 Changes in Drug Use
Although the participants at the focus group stage were very ambivalent about changing their 
use and particularly about the notion of abstinence, the single case study data highlights how 
one individual with a chronic history of long-term stimulant drug misuse, was first abstinent 
within five weeks of programme attendance. (The other participant to achieve abstinence did 
so around the same time but dropped out of the treatment, still drug free, half way through 
the programme). In the single case, all stimulant use had stopped at discharge when 
abstinence had been maintained for approximately 20 weeks; other drug use contingent on 
stimulant use ie. the use of benzodiazepines, alcohol and cannabis to counter the effects of 
the stimulants, had also either ceased or dramatically reduced by the same time. All changes 
were most marked within the first stage of treatment when issues of motivation and 
education were the particular focus and the value of these interactions was not only supported 
by the individual target measures taken at these times but also the outcome itself only five 
weeks after clear statements of ambivalence about change and abstinence had been made in 
the focus group discussion.
310
5.1.2 Associated Mental Health Changes
The focus group discussion provided an opportunity for all participants to share the mental 
health difficulties that they had in common and were particularly related to the drugs 
misused. Depression, anxiety and paranoia were often mentioned in the context of past using 
experiences and current effects on the individual. In support of this qualitative data, 
measures taken at baseline in the single case showed significant mental health difficulties: 
particularly clinical depression and acute anxiety; mental state examination by a colleague 
supported these measures. By discharge there had been marked changes in mental health 
functioning with no clinical depression evident and dramatically reduced scores on anxiety 
measures. In line with the drug use changes, the mental health changes were most striking 
in the first and early second stages of treatment. Clearly, reduction in drug use would lead 
to a stabilisation and improvement in mental health functioning not only from a 
neurochemical perspective but also on a number of psychological dimensions eg. self esteem 
linked to the achievement of early abstinence.
There was a brief period of medical intervention at the time of early abstinence which 
coincided with the exacerbation of the mental health difficulties expected at that time ie. 
dopamine depletion, disrupted sleep pattern. This intervention played no part in the 
achievement of abstinence itself and seemed to provide symptom relief as an adjunctive 
treatment at that time.
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5.1.3 Associated Lifestyle Changes
Again, the focus group discussion provided rich and detailed data evidence of the 
deterioration of lifestyle functioning that accompanies chronic stimulant drug misuse. 
Financial hardship, loss of accommodation and employment, loss of friends and leisure 
activities and a general slump into isolation and inactivity were common experiences which 
often triggered the realisation of the extent of the problem. Such issues were discussed in 
the context of the decision to come into treatment and it seems were linked to a shift from 
precontemplation to contemplation. Such difficulties are clearly related to a number of 
aspects of a drug using lifestyle eg. the cost of financing the habit and the associated physical 
and mental health changes making daily functioning increasingly difficult. Paranoia and 
suspicion, which are effects of regular, long term stimulant misuse, would lead to an 
avoidance of interpersonal contacts and feed into the isolation of depression. The quantitative 
data again supported the focus group data with the single case highlighting striking reductions 
in social functioning, sexual health behaviour and an increase in criminal activity as drug 
misuse became more chronic; all showed marked differences between baseline and 
discharge. Risk behaviours and involvement in crime were eradicated by the second phase 
of treatment, the changes maintained until discharge. Social functioning showed marked 
change in early treatment and was much improved by discharge with scores reflecting 
ongoing housing problems at that time. Health showed steady improvement over time which 
corresponded to the maintenance of abstinence and related improvements in sleep, diet and 
general well being.
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It is clear, therefore, that the changes in drug use and associated changes in mental health 
and lifestyle functioning are in a positive direction, over time in treatment. The changes 
support each other with the most striking changes in all aspects seen in the first and early 
second phase of treatment. The correspondence of change in these three dimensions also 
reflect the psychological constructs underpinning each phase of treatment and offers good 
support for a biopsychosocial approach to treatment. It is impossible to predict the direction 
of change between these three dimensions as the many variables involved effect each other 
in numerous ways and combinations - therefore it is not possible to hypothesise that change 
in drug use precedes all other associated changes except on the aspects of functioning that 
are clearly biologically determined. It can be hypothesised, however, that given the self 
perpetuating biopsychosocial mechanisms that underpin chronic stimulant misuse, this data 
strongly supports the combination of interventions within this treatment programme and it 
could be predicted that failure to acknowledge the significant role of all these variables in the 
etiology and maintenance of difficulties might prohibit the maintenance of abstinence and 
long-term change.
5^ 2 The relationship between change and involvement in treatment
It is clear that all data must be interpreted with caution given the small sample size for the 
qualitative data and the use of the single case study for the quantitative data. Such 
considerations make the question of the contribution of treatment to changes seen, very 
difficult to answer particularly in terms of the relevance to the treatment population.
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The quantitative data does provide some support for some of the changes seen as being 
related to specific factors of treatment. This evidence is provided by the individual target 
measures which were used and were specific measures relating to the psychological construct 
underpinning treatment at the time. Each measure eg. the Readiness to Change 
Questionnaire (Rollnick et al, 1992) collected data before and after the specific intervention 
period relating to the psychological construct of the measure, ie. for the RCQ, the 
motivational phase of treatment underpinned by motivational models of behaviour change. 
In all cases there was a marked shift in pre and post intervention measures in accordance 
with and providing support for the intervention itself at that time. This data was, in turn, 
supported by the qualitative data of the focus group where the participants highlighted the 
same specific aspects of treatment as being the most useful in facilitating their change 
behaviour. There were specific references to increasing knowledge and understanding the 
drugs used, getting a real perspective and staying stopped: features key to the cognitive - 
behavioural aspects of treatment and where, during treatment, change was evident.
Key non-specific components of treatment were also raised in the focus group discussion as 
positive aspects of the programme. High frequency attendance was agreed by all to be 
necessary in terms of the containment and structure it offered to the participants who were 
feeling vulnerable and needy. The group aspect of treatment was particularly seen as a 
positive feature of the programme with participants highlighting the positive aspects of group 
functioning which again overlap with professional perspectives of such an approach. Within 
the programme itself, the ’group’ quickly reduced to two participants and, for the final half 
of the programme, one participant, so there is no possibility to hypothesise its role as a 
contributory, positive non-specific component of the programme: a post-intervention focus
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group would be the most useful way of evaluating this in the future.
It is difficult to speculate as to how far the overall changes seen during treatment, ie. drug, 
mental health and lifestyle, are specifically related to the treatment programme itself. It was 
not possible to use a matched control given the ethical aspects of withholding treatment and 
also lack of access to stimulant drug misusers. Furthermore, the generalisability of the 
results seen is limited to the single case itself and no firm conclusions about implications for 
treatment populations can be made. The striking changes seen on a number of variables 
while in treatment and the correspondence of change in terms of a) time period ie. the most 
dramatic changes for the majority of variables occurring at the time of early abstinence and 
b) the marked psychological changes seen which related to the same specific psychological 
construct underpinning treatment at that time, indicate some involvement of treatment in the 
changes seen. This is particularly striking when considering the pre-treatment, 15 years of 
chaotic and chronic stimulant drug misuse shown by the subject of the single case study and 
the fact that over that time there were numerous, failed attempts to change.
5.3 Patients’ expectations of treatment
The focus group data provided a comprehensive insight into the perspective of the service 
user. Although clearly ambivalent about the concept of abstinence and the process of 
engaging in treatment, participants appeared to be quite clear about their treatment 
expectations. The mechanisms for engaging in treatment were highlighted as key for this 
group who emphasised the need for fast access to programmes with subsequent high 
frequency attendance, structure and containment. Waiting lists were seen as incompatible
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with the psychological changes made in order to access treatment initially, ie. the shift from 
the ’comfortable’ denial of precontemplation to the psychological conflicts arising out of the 
contemplation stage of change. The issue of the change in the drug using behaviour itself 
was less clear cut with participants expectations being more definitely associated with 
understanding their use but with there being no clear statements of stopping their use. 
Again, this seemed to relate to the stage of change of the participants at the time of the group 
(ie. contemplation), where ambivalence and anxiety are marked features. Participants 
expectations of the treatment programme itself were, as discussed earlier, based around the 
more cognitive (understanding) and behavioural (relapsing and using) aspects of using 
behaviour with an emphasis on psychological interpretations of these behaviours; no 
references to the underlying biological aspects of their behaviour were made. Therefore, 
having highlighted motivational issues at the beginning of the focus group discussion when 
looking at coming into treatment, participants moved onto an explanation of change-focused 
behaviours, ie. education and relapse prevention, in line with the proposed model of the 
intervention. Taking a meta perspective on the process and direction of the discussion, it 
would seem that the participants were highlighting the psychological aspects of the 
programme and also, it seems, in the same order as the programme design, ie. motivational 
work seen as preceding change directed interventions; this provides validation of the 
proposed programme prior to beginning it and is therefore reassurance for the service 
provider. This is also seen with the positive and enthusiastic support for the inclusion of 
group interventions within the programme.
Given the interesting data provided in the pre-intervention focus group, it is unfortunate that, 
given drop outs, it was not possible to evaluate whether participants’ expectations of
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treatment were fulfilled within a post intervention focus group discussion. This would clearly 
be a priority for future research studies.
5.4 Factors influencing stimulant drug taking behaviour
The qualitative and quantitative data support the notion of a biopsychosocial approach to the 
understanding and treatment of stimulant drug misuse. In the focus group discussion, 
participants highlighted a number of aspects underpinning and maintaining their using 
behaviour, including issues of self medication, craving, depression and anxiety and short and 
long term social and lifestyle difficulties. None of these factors could be seen as mutually 
exclusive to the others and often a specific difficulty, eg. depression, could be understood 
and explained by either a biological, psychological or social formulation: eg. dopamine 
depletion, proximal or distal psychological experiences (early or recent reactive loss, for 
example) and financial difficulties, repossession etc., respectively. Clearly it is most 
probable that all factors combine and none are dependent from the others. It was interesting 
to note, however, that from a participant perspective, the emphasis was on the psychosocial 
aspects of their behaviour and a biological formulation was not highlighted. It became clear, 
as the discussion continued, that a number of key factors were emerging from the participants 
as key to their using experience, factors that showed remarkable overlap with professional 
models of stimulant using behaviours.
Motivational issues were highlighted at the outset as being key to pre-treatment behaviour and 
intentions to change it. The biopsychosocial aspects of motivational change were emphasised 
as participants highlighted a number of factors on all dimensions that combined to push them
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into a state of readiness for treatment with an acknowledgement of the extent of their 
difficulties. This state was described as less psychologically comfortable than the previous 
state of denial of problem severity , and it was clear that immediate access to the containment 
of a treatment programme was necessary. Participants were looking for an "understanding" 
and "perspective" on their behaviour and saw the opportunity to "knock heads together" in 
a group useful and helpful in terms of strengthening intention to change and also challenging 
individuals’ perspectives on their own use which may be contributing to continued using; 
such features link to the educational and decision making aspects of the early motivational 
work. The qualitative data relating to the early motivational aspects was supported by the 
single case quantitative data, where N showed marked pre and post differences in 
motivational state before and after the specific period of motivational work. During that time 
he also demonstrated an increase in knowledge about the drugs used (gaining understanding). 
It was at the end of this time that N first became abstinent.
Abstinence was a state highlighted in the focus group discussion that was easy to achieve but 
not to maintain: highlighting a second key factor in stimulant using behaviour, relapse. 
Relapse prevention was also seen as being about understanding entrenched patterns of using 
behaviour in order to "stay stopped". It was also clearly stated that relapse prevention was 
about not developing alternative or substitute addictions, ie. acknowledging the need for clear 
functional analyses of the using behaviour and the significance of such behaviour in the 
lifestyle of the user: thus underscoring the use of relapse prevention interventions in 
combination with lifestyle interventions. Again this supported professional models of 
treatment and was supported by the quantitative data. N successfully maintained abstinence 
from week five to the end of treatment and showed associated lifestyle changes.
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As highlighted at the beginning of this discussion, all these factors and the changes seen, 
although separated in time by phases of treatment, were not mutually exclusive or linear in 
progress. It appears, however, that the biopsychosocial factors of stimulant drug using 
behaviour, in particular motivation, relapse and lifestyle issues, are those regarded, by both 
service providers and service users alike, as key in the etiology, maintenance and treatment 
of the stimulant drug misuser. Furthermore, specific and structured interventions targeting 
these factors in a stepwise and sequential programme, showed good outcome on all these 
variables.
5.5 Limitations of the data
The data presented has a number of limitations which must be considered before discussing 
the implications for treatment.
5.5.1 The sample
The initial sample size was small and the predictive power of group outcomes would have 
been poor. A particular feature of this study was a high rate of attrition, with more than half 
the sample failing to complete treatment. This rate is high but it is not inconsistent with 
other published reports of outpatient CBT interventions with stimulant misusers (eg. Rawson 
et al, 1986). Nevertheless, drop outs were substantial and suggests that only some stimulant 
misusers may be successfully treated with the purely psychological, abstinence based 
approach described in this report. Other groups of users may require medication and/or a 
brief period of hospitalisation before starting outpatient therapy. Given that retention in
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treatment tends to be related to better long term outcome (Wells et al, 1994), then clearly 
approaches that can retain clients in treatment hold promise. Since much of drop out is in 
at the beginning of treatment, approaches that respond quickly to clients’ initiatives in 
seeking treatment and that capitalise on clients’ current motivation towards behaviour change 
will be important. Recent research indicates that higher severity stimulant misusers with 
clinical depression are significantly more likely to remain in treatment programmes with 
abstinence orientated, relapse prevention based programmes, whereas the lower severity user 
remains in programmes offering a medication based intervention (Carroll et al, 1994). The 
two clients who engaged in treatment and, in particular, N who completed the programme 
with good outcomes on a number of dimensions, were both longer history misusers with 
more chronic and entrenched daily patterns of using. It might be that the drop outs at the 
beginning of treatment who were all lower severity misusers, are showing the same pattern 
as the sample in the Carroll et al study and that it appears that relapse prevention retains both 
higher severity and depressed users in treatment. Clearly such conclusions must be made 
with caution given the small numbers involved, however this effect could suggest that 
stimulant misusers with more intense involvement with the drugs may benefit from the 
additional structure, intensity and didactic content of relapse prevention which focuses 
specifically on reducing access to drugs and the avoidance and subsequent management of 
high risk situations for relapse, while low intensity approaches may be effective for the less 
severe users.
It is also useful to consider factors that may account for drop out. Motivation and readiness 
for change may play a significant role and indeed, as discussed in section 4.1, the drop outs 
did present with behaviours that might have may illustrative of ambivalence, eg. talking little
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in the focus group, erratic attendance etc. However some other factors may also have been 
important for specific clients who dropped out. M was the only female client and the mother 
of two small children and her drop out may highlight the importance of gender specific 
issues. A mix of genders or single gender groups may be more appropriate for meeting the 
specific needs of clients; women with children may find the high frequency attendance 
difficult and crèche facilities may need to be organised for them. The length of the 
programme may have also been a factor contributing to dropout, as in the case of DE who 
achieved a number of significant goals within the first half of the programme (ie. abstinence 
and rehousing) and then dropped out. Clearly the follow up of drop outs is necessary to 
clarify these issues and the experience of this pilot should encourage a consideration of such 
factors for future programmes.
5.5.2 The single case data
The presentation of a single case has advantages in terms of retaining detail important to 
consider in the early stages of treatment design and evaluation; the collapsing of group data 
would mean much of this detail becomes lost. Obviously, however, the conclusions that can 
be drawn from a single case are limited in terms of the treatment population as a whole. N 
was an intelligent individual with a high severity stimulant problem: do the outcomes indicate 
that this intervention is most likely to be efficacious for individuals with a similar profile 
or stimulant users more generally? It is not possible to answer this question without further 
research which will be discussed later. The limitation of no matched control has been 
discussed previously and would also need to be addressed in future research. For N, the 
long term outcome from treatment is also not addressed as there has been no follow up
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period included in this report. Prognosis might be predicted as good given the huge pre/post 
treatment changes made and also the length of abstinence shown while in treatment given an 
early achievement of this state. Follow up data would allow an insight into the long term 
effects of treatment and also whether changes made and maintained while in treatment were 
not due to attending the programme itself.
5.5.3 The Focus Group
Interpretation of the focus group data may have been bias by the fact that the analyst was 
also the designer and main coordinator of the treatment programme. The involvement of the 
moderator throughout the analysis and interpretation of the raw data may have reduced this 
to some degree. The loss of the post treatment focus group meant that it was not possible 
to evaluate participants’ evaluations of treatment after involvement in the programme and 
clearly such data would have enhanced the evaluation of the programme.
5.6 Implications for the treatment of stimulant drug misusers
Cognitive - behavioural therapy approaches within a structured, abstinence orientated 
treatment programme have shown good outcome with a single case of a chronic, long term 
clinically depressed poly - stimulant user. Significant changes over time in treatment were 
linked to biological, psychological and social aspects of functioning with abstinence from all 
stimulant drugs achieved at an early stage in treatment and maintained over time until 
discharge from the programme. The results were striking given the history of chronic use 
and numerous failed attempts to stop. Furthermore a group discussion among a sample of
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stimulant users with a diversity of demographic and using profiles, highlighted that the 
programme content and structure matched the clients own perceptions of the most appropriate 
and helpful treatment models for their difficulties. Such results from a newly designed and 
pilot run programme indicate that such a model of treatment should be refined and further 
developed for such a population with the continued inclusion of a strong evaluation 
component which builds on the issues raised in this study. For the development of such 
programmes a number of issues would need to be addressed based on the experience of this 
pilot.
A critical issue facing all service providers is one of the access to treatment populations and 
the retention of them in treatment. Stimulant misusers do not present to drug dependency 
units in the same way that opiate misusers do. This is reflected in the difficulties of 
recruitment for this study and would need to be addressed. Local and national data of the 
prevalence of stimulant drug misuse indicates that there is a growing number of misusers 
who may be in need of advice or treatment. There are indications that Genito-Urinary 
Medicine (G.U.M.) clinics see a higher number of stimulant misusers presenting with sexual 
health needs and targeted interventions aimed at increasing the awareness of services for such 
users in these settings may be most appropriate. This study has lead to a prioritisation of this 
issue within the Camden and Islington Drugs Services, and the bid found in the clinical 
dossier of this PsychD folio, which relates to the development of services for stimulant 
misusers, is for the development of a new, half time clinical psychology post created for the 
specific purpose of working within a G.U.M. service with stimulant misusers; the bid has 
been successful and the post starts in September 1995. A further point of access may be in 
the community in places were these drugs are most likely to be used, eg. in clubs, at raves
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etc. Community outreach models may be usefully developed and Camden and Islington 
drugs services have recently successfully bid for money to develop outreach, community 
based workshops for stimulant misusers with a voluntary, street-based drugs project.
The key factor associated with access is one of retention^ digdm a significant issue for this 
study. Retention may be linked to motivational states but also a number of other variables, 
including: length of time in treatment, frequency of attendance, type of treatment offered (ie. 
prescribing vs. non-prescribing; advice vs. treatment, etc.), gender specific issues, the 
influence of the waiting list, the drug profile of the client ie. stimulant only vs. polydrug 
misusers, feelings of safety and the confidentiality of treatment for individuals experiencing 
anxiety and paranoia relating to the drugs used, etc. Such issues, either individually or in 
combination, may have been significantly associated with the drop-out’s seen in this study 
and future research needs to address the complexity of this phenomenon. What this issue 
also highlights is the fact that stimulant drug misusers are clearly not a homogenous 
population and their heterogeneity must be reflected in a diversity of treatment availability.
Addressing the treatment needs of the stimulant misuser clearly has resource implicatiom. 
The programme itself requires high levels of commitment and availability by service 
providers. The emerging diversity of treatment needs of this heterogenous population will 
require a broad-based and flexible approach over a variety of interventions. The issues of 
access indicate that service providers need to allocate resources to address this issue in other 
settings, outreach interventions etc. Furthermore, issues of immediate access to treatment 
highlight the need for ongoing, rolling programmes with regular intake times. The 
combination of variables involved in the etiology and maintenance of stimulant using
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difficulties, within a broadly biopsychosocial perspective, also highlights the multi­
disciplinary approach necessary and thus the involvement and support of a range of staff 
members. Given the limited resources already available in drugs services, clearly such issues 
need to be given serious consideration when planning services for a new population with 
some unique and specific treatment needs. Needs assessment and population profiling may 
allow for a prioritisation of service development within existing resources.
5.7 Research Implications
5.7.1 The research tools
Increasingly, researchers are recognising the benefits of combining qualitative and 
quantitative procedures, resulting in greater methodological mixes that, it could be argued, 
strengthen the research design. Focus groups being used at the same time as quantitative 
procedures allows for triangulation, ie. the researcher utilising two or more different research 
methods to address the same issue to confirm findings and to obtain both breadth and depth 
of information. The quantitative data provides some support for the predictive validity of 
the qualitative data with the outcome of the single case and the specific changes made 
relating to the psychological constructs of the programme supporting the aspects of treatment 
that were highlighted as being most helpful for change from the participants’ view point.
The focus group also had a beneficial effect on the bonding of the group providing a safe 
atmosphere where participants were able to share common experiences and anxieties prior 
to the onset of the treatment programme. The use of three levels of measurement: global,
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target and process, was useful particularly within the context of the single case study. The 
efficacy of specific interventions was more clearly analysed given the combination of 
measures at particular phases of treatment and relating to specific psychological constructs 
of those intervention times.
5.7.2 Recommendations for future research
The implications for treatment highlighted by the data indicate the important role of ongoing 
research and service evaluation. While there are clearly a number of limitations to the data 
in terms of its applicability to the treatment population in general, the results are promising 
and highlight the potential for significant change while in a cognitive-behavioural, abstinence 
orientated treatment programme. The use of the target measures before and after each 
specific psychological intervention and the marked pre - post changes shown on such 
dimensions, provides further support for the programme and the use of cognitive behavioural 
interventions, in particular motivational, educational, lifestyle and relapse prevention 
strategies. Given these promising preliminary results in the face of the difficulties inherent 
in the design and evaluation of new programmes for new treatment populations, it would 
clearly be useful to investigate such interventions further. A group study, as initially 
intended for this pilot programme, should be attempted and larger samples used. Matched 
controls should be included, however the ethical implications of this need to be addressed. 
A post intervention focus group would be an interesting and useful measure of patients’ 
experiences of the programme and all future research should be designed with the inclusion 
of such qualitative measures given the richness of data that they provide. Further interesting 
studies would be in the investigation of some of the more specific issues raised in this study:
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the differences in treatment outcome by severity of use; a comparison of programmes of 
differing lengths with matched samples in each; comparing and contrasting the efficacy of 
such abstinence orientated interventions with populations of poly drug misusers who may be 
on prescriptions for the treatment of their opiate or benzodiazepine use: ie. the effect of 
mixed models of intervention on outcome; and an investigation of models for matching 
patient variables with the appropriate intensity of treatment in order to maximise both 
treatment outcome and cost effectiveness.
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6.0 CONCLUSIONS
i) Stimulant misusers are a heterogenous population and patient characteristics, eg. 
severity of use, may influence treatment seeking, retention and effects.
ii) Cognitive behavioural therapy outpatient interventions using a biopsychosocial 
approach and specific strategies of motivational, educational, relapse prevention and 
lifestyle interventions show good outcomes on a number of biological, psychological 
and social dimensions for a chronic, longterm stimulant drug misuser.
iii) Target measures suggest that the motivational, educational, lifestyle and relapse 
prevention interventions facilitated change in each related area and contributed, to 
some degree, to the overall marked changes seen between baseline and end of 
treatment.
iv) Prior to treatment, participant focus group disussion highlighted that there was a 
striking overlap between professional and lay models of treatment indicating that the 
proposed model provided the structure, content and containment seen by the service 
users as key to their treatment needs.
v) Accessing treatment populations and retaining them in treatment are priority issues 
for service providers. A creative and flexible approach is needed in the development 
of future treatment programmes to include outreach and community based work with 
such populations. The complex relationship between treatment retention and outcome
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needs to be explored as more impaired misusers may be differentially retained in 
some forms of treatment.
vi) The extensive resource implications of providing a comprehensive range of services 
for stimulant drug misusers, indicates that community needs assessment and 
population profiling are important initial exercises for service providers managing 
limited resources.
vii) The creative use of outcome measures with the combination of qualitative and 
quantitative measures provides a broader and more detailed perspective on the needs 
of the service user and the efficacy of treatment.
viii) Future service development must include ongoing evaluation. Priorities for further 
research are: a group study, as initially intended for this pilot programme, with the 
use of larger samples and the inclusion of matched controls. Future research needs 
to explore patient treatment -matching and the development of specialised treatments 
for clinical distinct subgroups of stimulant misusers.
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7.0 APPENDICES
A. The Process of Change Model (Prochaska and DiClemente, 1986)
B. Questionnaires used;
(i) The Opiate Treatment Index (Darke et al, 1992)
(ii) The Halikas-Crosby Drug Impairment Rating Scale for Cocaine (Halikas et al, 
1991)
(iii)^ -^  The Severity of Dependence Scale (Gossop et al, 1992)
(iv) The Beck Depression Inventory (Beck et al, 1961)
(v) The Readiness to Change Questionnaire (Rollnick et al, 1992)
(vi) The Inventory of Drinking Situations (Annis et al, 1982b)
(vii) The Situational Confidence Questionnaire (Annis et al, 1982c)
C. The Focus Group
(i) The Interview Schedule
(ii) Transcript of the Focus Group
D. Knowledge Intervention
Stimulant drug knowledge: the multiple-choice quiz
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The process of change
Contemplation: 
Weighing up pros 
and cons of 
changing.
Premature 
way out
Decision:
To change drug use 
or to continue as 
before.
Precontempiation:
Client sees  no problem 
but others disapprove.
Relapse:
Return to previous
Active changes: 
Putting decision 
into practice.
Maintenance:
Actively maintaining
/
pattern of drug use. change.
OPTIMAL RECOVERY 
Change consolidated
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Study No.______
Centre No. _
Date of Interview. 
Interviewer __
Initial / Follow-up
OPIATE TREATMENT INDEX 
(OTI)
Copyright © National Drug and Alcohol Research Centre. 1990
SECTIO N I: D E M O G R A PH IC S/TR EA TM EN T HISTORY
1. Date of Birth / /
2. Sex:
Fem ale  ........1 Male  ..................... 2
3. How would you describe your ethnic group of origin? (Please circle the
appropriate number below)
01 White
02 White European
03 Black Caribbean
04 Black African
05 Black Other (please specify
06 Indian
07 Pakistan
08 Bangladeshi
09 Chinese
10 Irish
11 Greek/Greek Cypriot
12 Turkish/Turkish Cypriot
13 Filipino
14 Eritrean
15 Somali
16 Mixed Parentage
17 Arab
18 Other (please specify..........    )
4. How many times have you previously been in treatment?
5. What sort of treatments have you previously been in?
No previous treatment 0 
Methadone 1
Detoxification 2
Drug Free Counselling 3 
Therapeutic Community 4 
Narcotics Anonymous 5
SECTION n : DRUG USE
First, I’m going to ask you some questions on your use of drugs. 1 11 emphasise again that
the information you give me is completely confidential.
NB: For all categories, if the subject responds that their last use of the drug was more 
than a month ago, score zero for that category. Do not include use o n  day o f interview.
Heroin
Now I’m going to ask you some questions about heroin (smack, hammer, horse, scag).
1. On what day did you last use heroin?  _______
2. How many hits/smokes/snorts did you have on that day? — -----
3. On which day before that did you use heroin? _
4. And how many hits/smokes did you have on-that day?-------- _
5. And when was the day before that?   ....
(ql= ,q2= ,tl= ,t2= ) Q
Other Opiates
These questions are about your use of opiates other than heroin (e.g. street
methadone/done,'morphine, pethidine, codeine).
6. On what day did you last use opiates other than heroin? (do not include legally 
obtained methadone) _ _ _ _ _
7. How many pills, doses etc. (üd you have on that day?---------
8. On which day before that did you use opiates other than heroin?-----------
9. And how many pills, doses etc. ctid you have on that day? -------—
10. And when was the day before that? -----------
(ql= ,q2= ,tl= ,t2= ) Q
'I'lA
Alcohol - Weekly Drink Diary
These questions are about your use of alcohol.
11. On what day did you last drink alcohol?
12. On which day before that did you drink alcohol?
13. & 14. For both days, please fill in the diary below:
TIME OF 
DRINiONG
NO. OF 
UNITS/PINTS/ 
SINGLES/GLASSES 
OF WINE ETC.
TYPE OF 
ALCOHOL
MONEY SPENT
DAY ONE
DAY TWO
15. And when was the day before that?
NB: 1 unit = half pint ordinary beer 
single measure of vermouth 
single measure of spirits 
1 glass of wine 
1 small glass of sherry
1 + units = 1 standard canned lager
2 + units = 1 strong canned lager
4 + units = 1 extra strong canned lager
Cannabis
These questions are about your use of marijuana (dope, grass, hash, pot).
16. On what day did you last use marijuana ?  ----------
17. How many joints, bongs, etc. did you have on that day;
18. On which day before that did you use marijuana? -----
19. And how many joints, bongs, etc. did you have on that day?
20. And when was the day before that?  --------
(ql= ,q2= ,tl= ,t2= )
Amphetamines
These questions are about your use of amphetamines (speed).
21. On what day did you last use amphetamines?  -------------
22. How many tablets, snorts, hits etc. did you have on that day?
23. On which day before that did you use amphetamines? --------
24. And how many tablets, snorts, hits, etc., did you have on that day? —
25. And when was the day before that? ----------
(ql= ,q2= ,tl= ,t2= ) Q
Cocaine
These questions are about your use of cocaine (coke, snow, crack).
26. On what day did you last use cocaine? --------------
27. How many snorts, hits, smokes etc. did you have on that day? ---------
28. On which day before that did you use cocaine? ----------
29. And how many snorts, hits, smokes etc. did you have on that day? —
30. And when was the day before that?  ----------
(ql= ,q2= ,tl= ,t2= ) ^
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Tranquillise! a
These questions are about your use of tranquillisers (e.g. Serapax, Rohypnol, Mogadon, 
Valium).
31. On what day did you last use tranquillisers? --------------
32. How many pills did you have on that day? -------------_
33. On which day before that did you use tranquillisers? ---------_
34. And how many pills did you have on that day? ______
35. And when was the day before that? _______
(ql= ,q2= ,tl= ,t2= ) Q
Barbiturates
t
These questions are about your use of barbiturates (e.g. Nembutal, Seconal).
36. On what day did you last use barbiturates? _________
37. How many pills did you have on that day? _________
38. On which day before that did you use barbiturates?  __:-----
39. And how many pills did you have on that day? ----------
40. And when was the day before that? _______
(ql= ,q2= ,tl= ,t2= ) Q
Hallucinogens
These questions are about your use of hallucinogens (e.g. LSD/acid, ecstasy, magic magic 
mushrooms).
41. On what day did you last use hallucinogens? _________
42. How many tabs, pills, etc. did you have on that day?
43. On which day before that did you use hallucinogens?
44. And how many tabs, pills, etc. did you have on that day? --------—
45. And when was the day before that? _______
(ql= ,q2= ,tl= ,t2= ) Q
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Inhalants
These questions are about your use of inhalants (e.g. amyl ricrite/rush, glue, laughing gas, 
aerosols, petrol).
46. On what day did you last use inhalants? _____ ___
(do not include asthma sprays)
47. How many sniffs did you have on that day'l _________
48. On which day before that did you use inhalants?
49. And how many sniffs did you have on that day?
50. And when was the day before that? _ _ _ _ _
(ql= ,q2= ,tl= »t2= )
Tobacco
Finally, these questions arc about your use of cigarettes.
51. On what day did you last use tobacco? _______
52. How many cigarettes did you have on that day? __
53. On which day before that did you use tobacco? ___
54. And how many cigarettes did you have on that day?
55. And when was the day before that?  _____
(ql= ,q2= ,tl= ,t2= )
General Comments On Drug Use
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nRTin USE SUMMARY
STIMULANT USE 
TOTAL
POLY-DRUG USE 
TOTAL
POLY-DRUG USE
OPIATES TRANQUILLISERS
ALCOHOL BARBITURATES
CANNABIS HALLUCINOGENS
AMPHETAMINES INHALANTS
COCAINE TOBACCO
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SECTION n i:  INJECTING AND SEXUAL PRACTICES
These questions are about the way you use drugs, and your recent sexual behaviour. I 
emphasise again that any information that you give me is completely confidential.
DRUG USE
1. How many times have you hit up (i.e. injected any drugs) in the last month? 
(please circle)
Hasn’t hit u p ..................................  0
Once a week or le s s ...................... 1
More than once a week ............... 2
(but less than once a day)
Once a day ............ ..................... 3
2-3 times a d a y .............................  4
More than 3 times a da ............... 5
If subject hasn’t injected in the last month, score zero for the Drug Use section, and go to 
question 7.
2. How many times in the last month have you used a needle after someone else 
had already used it?
No times .......................................  0
One time ............... ...................  I
Two times ............................. .. 2
3-5 times ....................................... 3
6-10 times ...................................  • 4
More than 10 t im es ...................... 5
3. How many different people have used a needle before you in the last month?
to
None  .............................  0
One person....................................  1
Two people....................................  2
3-5 people .................................... 3
6-10 people ...................... 4
More than 10 p e o p le ...................  5
4. How many times in the last month has someone used a needle after you have 
used it?
No times ....................................... 0
One time ....................................... 1
Two times  ..........................  2
3-5 times ....................................... 3
6-10 times ....................................  4
More than 10 t im es .....................  5
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5. How often, in the last month, have you cleaned needles before re-using them ? 
(please circle)
Doesn’t re-use  .............................  0
Every t i m e .............................  1
O f te n .............................    2
Sometimes  .................  3
Rarely  .................   4
N ever..............................................  5
6. Before using needles again, how often in the last month did you use bleach to 
clean them? (please circle)
Doesn’t re-use .  ...........................  0
Every t im e ..................................... 1
O f te n .............................................. . 2
Sometimes .....................    3
Rarely ............................................  4
N ever............................................... 5
Drug Use Sub-total
SEXUAL BEHAVIOUR
7. How many people, including clients, have you had sex with in the last month?
N o n e ..............................................  0
One person  ......................  1
Two people..................................... 2
3-5 people ..................................... 3
6-10 people  .............................  4
More than 10 people .................... 5
If no sex in the last month, score zero for Sexual Behaviour section, and go to 
Section IV.
8. How often have you used condoms when having sex with your regular partner(s) 
in the last month? (please circle)
No reg. partner/No penetrative sex 0
Every t im e .................................  1
Often  ..................................... 2
Sometimes ................................. . . 3
Rarely ............................................  4
N ever..........................................  5
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9. How often did you use condoms when you had sex with casual partners in the 
last month? (please circle)
No cas. partners/No penetrative sex 0
Every time  ...............................  ^
O fte n ............................. ................
Sometimes ....................................
Rarely ............................................
N ever..............................................
10. How often have you used condoms when you have been paid for sex in the last 
month? (please circle)
No paid sex/No penetrative sex . . 0
Every t im e   .....................  ^
O fte n ..........................................  ^
Sometimes ..............................  ^
R a re ly   .............................
N ever..............................................
11. How many times did you have anal sex in the last month?
No times .  ............................    ®
One time .......................................
Two times ...................... ..............
3-5 times ...................... •  ..........
6-10 times ....................................
More than 10 t im e s ........................ ^
Sexual Behaviour Sub-total
TOTAL SCORE
(Drug Use Sub total + Sexual Behaviour Sub-total)
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SECTION IV: SOCIAL FUNCTIONING
These next few questions concern the social aspects of your life (things like jobs, friends, 
etc).
1. How many different places have you lived in over the last six months?
O n e ...........................  0
Two  .................  1
Three  .......... 2
Four .......... ..............  3
Five or more . . . . .  4
2. How much of the last six months have you been unemployed?
All of the time . . . .  4 
Most of the time . . .  3 
Half of the time . . .  2 
Some of the time . . 1 
None of the time . . .  0
3. How many different full-time jobs have you had in the last six months?
O n e...........................  0
Two ........................  1
Three......................... 2
Four or more .......... 3
N o n e ........................  4
4. How often in the last six months have you had conflict with your relatives?
Very o fte n ............... 4
O ften........................  3
Sometimes............... 2
R arely......................  1
Never ......................  0
N/A
5. How often in the last six months have you had conflict with your partner(s)?
Very o fte n ............... 4
Often  ......................  3
Sometimes............... 2
R arely...................... 1
Never ...................... 0
N/A
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6. How often in the last six months have you had conflict with your friends?
Very o f te n ............... 4
O ften........................  3
Sometimes . . . . . . .  2
R arely................. 1
Never ...................... 0
N/A
7. About how many close friends would you estimate that you have? (INCLUDE 
PARTNER)
N o n e ........................  4
O n e ................. .. 3
Two ........................  2
Three........................  1
Four or more .......... 0
8. When you are having problems, are you satisfied with the support you get from 
your friends?
Very satisfied  0
Satisfied...................  1
Reasonably OK . . . .  2
Not satisfied  3
Very unsatisfied . . .  4 
N/A
9. About how often do you see your friends?
Very o fte n ............... 0
Often  ...................... 1
Sometimes............... 2
R arely...................... 3
Never ...................... 4
N/A
10. How many of the people you hang around with now have you known for more 
than six months?
N o n e ........................  4
Less than h a lf  3
About a h a lf   2
More than half . . . .  1
All of them ............  0
N/A
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heroin?
11. How much of the last six months have you been living with anyone who uses
All of the time . 
Most of the time 
Half of the time 
Some of the time 
None of the time
12. How many of the people you hang around with now are users? (INCLUDE 
PARTNER)
N o n e .................... 4
Less than half . . . 3
About a half . . . . ?
More than half . . . . 1
All of them . . . . 0
SOCIAL TOTAL
Genera! Comments on Social Functioning
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SECTION V: CRIME
In this section I am interested in any crimes that you may have committed. Any 
information that you give here is completely confidential.
Property Crime
First, I am going to ask you some questions on property crime. By property crime I mean 
things such as break and enter, robbery without violence, shoplifting, stealing a 
prescription pad, stealing a car, or receiving stolen goods. I am interested in the number 
of times that you committed a property crime, not the number of times you ve been 
caught. (RECORD TYPE OF CRIME COMMITTED)
1. How often, on average, during the last month have you committed a property 
crime? (READ OPTIONS)
No property crim e................................. 0
Less than once a w eek.......................... 1
Once a week ............................  2
More than once a w e e k  ............3
(but less than daily)
D a ily .....................................................
Tick type of crimes committed:
Break & enter  Stolen car —  Robbery —
Receiving stolen goods  Shoplifting —__------- Other----
Stolen prescription pad  (specify-----------------J
Dealings s s s a e s :- -
2. How often, on average, during the last month have you sold drugs to someone?
No drug dealin g................  ^
Less than once a w eek.......................... 1
Once a week ........................................ ^
More than once a w e e k ....................... 3
(but less than daily)
Daily   ..................................................^
Tick type of drugs dealt:
Heroin___
Marijuana___
Cocaine___
Speed___
Hallucinogens
Barbiturates
Tranquillisers
Other
(specify
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Fraud
Now I am going to ask y3u some questions about fraud scams. By fraud I mean things 
such as forging cheques, forging prescriptions, social security scams, or using someone 
else’s credit card. I am interested in the number of times that you’ve committed fraud, 
not the number of times that you’ve been caught. (RECORD TYPE OF CRIME 
COMMITTED)
3. How often, on average, during the last month have you committed a fraud?
No fraud ................................................0
Less than once a week  .................1
Once a week .........................................2
More than once a week  .............. 3
(but less than daily)
D a ily ....................................................... 4
Tick type of fraud committed:
Forging cheques  Credit card___
Forging prescriptions  Social security___
Other ___
(specify _______ _ J
Crimes Involving Violence
Finally, I am going to ask you some questions about crimes involving violence. By 
crimes involving violence I mean things such as using violence in a robbery, armed 
robbery, assault, rape, etc. I am interested in the number of times that you’ve committed 
a crime involving violence, not the number of times that you’ve been caught.
(RECORD TYPE OF CRIME COMMITTED)
4. How often, on average, during the last month have you committed a crime 
involving violence?
No violent crim e....................................0
Less than once a w eek.......................... 1
Once a week ........................................ 2
More than once a w e e k ........................3
(but less than daily)
D a ily ....................................................... 4
Tick types of violent crime:
Assault  Murder___
Violent robbery  Manslaughter___
Armed robbery  Rape____
Other___
(specify_______  )
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Current Convictions
1. Are you currently facing charges? Yes / No
CRIME TOTAL
General Comments on Crime
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SECTION VI: HEALTH
These questions are about your health. I am going to read out a list of health problems.
Please answer ‘Yes’ if you have had any of these problems over the last month.
General
Yes
1. Fatigue /  energy loss —
2. Poor appetite ----
3. Weight loss /  underweight ----
4. Trouble sleeping - —
5. Fever —
6. Night sweats ----
7. Swollen glands ----
8. Jaundice ----
9. Bleeding easily ----
10. Bruising easily ----
11. Teeth problems —
12. Eye /  Vision troubles ----
13. Ear /  Hearing troubles —
14. Cuts needing stitches ----
Yes
Total
Injection Related Problems
1. Overdose —
2. Abscesses /  Infections ----
3. Dirty hit (made feel sick) ----
4. Prominent scarring/bruising —
5. Difficulty injecting ----
Total
Cardio/Respiratory
Yes
1. Persistent cough —
2. Coughing up phlegm —
3. Coughing up blood —
4. Wheezing —
5. Sore throat —
6. Shortness of breath —
7. Chest pains —
8. Heart flutters/racing .—
9. Swollen ankles —
Total
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Genitourinary
Yes
1. Painful urination
2. Loss of sex urge
3. Discharge from 
penis/vagina
4. Rash on or around 
penis/vagina
Gynaecological
(WOMEN ONLY) (in the last few months)
Total
Yes
1. Irregular period
2. Miscarriage
Total
Musculo-skeletal
Yes
1. Joint pains/stiffness
2. Broken bones
3. Muscle pain
Total
Neurological Yes
1. Headaches —
2. Blackouts —
4. Tremors (shakes) —
5. Numbness / Tingling —
6. Dizziness — ■
7. Fits /  seizures —
8. Difficulty walking —
9. Head injury —
10. Forgetting things ----
Total
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Gastrointestinal
Yes
1. Nausea
2. Vomiting
3. Stomach pains
4. Constipation
5. Diarrhoea
Total
HEALTH TOTAL
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SECTION Vn: PSYCHOLOGICAL ADJUSTMENT 
GENERAL HEALTH QUESTIONNAIRE
Please read this carefully:
I should like to know if you have had any medical complaints, and how your health has been in general over 
the past few weeks. Please answer ALL the questions on the following pages simply by circling the answer 
that you think most nearly applies to you. Remember that we want to know about present and recent 
complaints, not those that you had in the past
HAVE YOU RECENTLY:
1. Been feeling well 
and in good health?
2. Been feeling in 
need of a pick 
me up?
3. Been feeling run 
down and out of 
sorts?
4. Felt that you are
iU?
5. Been getting any 
pains in your head?
6. Been getting a 
feeling of tightness 
or pressure in your 
head?
7. Been having hot 
or cold spells?
8. Lost much sleep 
over worry?
9. Had difficulty 
in staying asleep 
once you are off?
10. Felt constantly 
under strain?
11. Been getting edgy 
and bad tempered?
12. Been getting 
scared or panicky 
for no good reason?
Better 
than usual
Not 
at all
Not 
at all
Not 
at all
Not 
at all
Not 
at all
Not 
at all
Not 
at all
Not 
at all
Not 
at all
Not 
at all
Not 
at all
Same 
as usual
Worse 
than usual
Much worse 
than usual
No more 
than usual
Rather more 
than usual
Much more 
than usual
No more 
than usual
Rather more 
than usual
Much more 
than usual
No more 
than usual
Rather more 
than usual
Much more 
than usual
No more 
than usual
Rather more 
than usual
Much more 
than usual
No more 
than usual
Rather more 
than usual
Much more 
than usual
No more 
than usual
Rather more 
than usual
Much more 
than usual
No more 
than usual
Rather more 
than usual
Much more 
than usual
No more 
than usual
Rather more 
than usual
Much more 
than usual
No more 
than usual
Rather more 
than usual
Much more 
than usual
No more 
than usual
Rather more 
than usual
Much more 
than usual
No more 
than usual
Rather more 
than usual
Much more 
than usual
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13. Found everything 
getting on top of 
you?
14. Been feeling 
nervous and strung 
up all the time?
15. Been managing 
to keep busy and 
occupied?
16. Been taking 
longer over the 
things you do?
17. Felt on the 
whole you were 
doing things well?
18. Been satisfied 
with the way you’ve 
carried out your 
task?
Not 
at all
Not 
at all
More so 
than usual
Quicker 
than usual
Better 
than usual
More
satisfied
No more 
than usual
No more 
than usual
Same 
as usual
Same 
as usual
About 
the same
About 
the same
Rather more 
than usual
Rather more 
than usual
Rather less 
than usual
Longer 
than usual
Less well 
than usual
Less
than usual
Much more 
than usual
Much more 
than usual
Much less 
than usual
Much longer 
than usual
Much 
less well
Much less 
satisfied
19. Felt that you 
are playing a 
use All part in 
things?
20. Felt capable of 
making decisions 
about things?
21. Been able 
to enjoy your 
normal day to 
day activities?
22. Been thinking 
of yourself as a 
worthless person?
23. Felt that life 
is entirely 
hopeless?
24. Felt that life
is not worth living?
25. Thought of the 
possibility that 
you might do away 
with yourself?
More so 
than usual
More so 
than usual
More so 
than usual
Not 
at all
Not 
at all
Not 
at all
Definitely
not
Same 
as usual
Same 
as usual
Same 
as usual
No more 
than usual
No more 
than usual
No more 
than usual
I don't 
think so
Less useful 
than usual
Less so 
than usual
Less so 
than usual
Rather more 
than usual
Rather more 
than usual
Rather more 
than usual
Has crossed 
my mind
Much less 
useful
Much less 
capable
Much less 
than usual
Much more 
than usual
Much more 
than usual
Much more 
than usual
Definitely
have
353
26. Found at times 
that you couldn’t 
do anything because 
your nerves were so 
bad?
Not 
at ail
No more 
than usual
Rather more 
than usual
Much more 
than usual
27. Found yourself 
wishing you were 
dead and away from 
it all?
Not 
at all
No more 
than usual
Rather more 
than usual
Much more 
than usual
28. Found that the 
idea of talcing your 
own life kept coming 
into your mind?
Definitely
not
I don’t 
think so
Has crossed 
my mind
Definitely
has
GHQ SUMMARY DATA
A B C D TOTAL
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OPIATE TREATMENT INDEX - SCORESHEET
Drug Use HIV Risk Social Crime Health GHQ
Initial
F/Up
DRUG USE
Initial F/Up
Heroin
Other Opiates
Alcohol
Cannabis
Amphetamines
Cocaine
Tranquillisers
Barbiturates
Hallucinogens
Inhalants
Tobacco
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sn UNIVERSITY OF MINNESOTA D ep artm en t of P sy c h ia try  S u b s ta n c e  A b u se  D iso rd e r P ro g ram Halikas-Crosby Drug Impairment Rating Scale for Cocaine
itudy No.
R ater in itials
Patien t No. 
Patien t Initials
Visit N um ber
Date
E a tin g  Habit.»
0 Eats at least two regular meals per day
1 Eats at least one regular meal daily
2 Misses most m eals/Snack eatlng/Eats sporadically
3 Skips eating for entire day(s)
L o ss  of W eight  (Self-reported)
0 Stable weight/increasing weight
1 Minimal weight loss (1-5 lbs.)
2 Moderate weighty Jo ss  (6-10 lbs.)
3 Substantial weight loss (11 lbs. or more)
S leep in g  Habil»
0 No difficultles/Average 6-9 hours sleep
1 Minor difficulties (e.g.. difficulty falling asleep, 
waking up early) or Average 5-6 hours sleep or 
Average 10-12 hours sleep
2 Moderate difficulties (e.g.. awake at night, sleeping 
during the day) o£ Average 3-4 hours sleep or 
Average 13-15 hours sleep
3 Severe difficulties (e.g.. sleeps for short periods, 
skips sleeping for entire day) fii Average 2 or less 
hours sleep 2£ Average16 or more hours sleep
B athing H abits
0 Bathes or showers regularly (at least 3x/wk)
1 Bathes or showers occasionally (1-2x/wk)
2 Bathes or showers infrequently/not at all (< Ix/wk)
i . C lo th in g
0 Changes clothing & undergarments daily or 
virtually daily (6 or more times/wk)
1 Changes clothing & undergarments often (2-5 x/wk)
2 Changes clothing and undergarments Infrequently or 
not at all (less than twice/wk)
5 . R e c re a tio n  /  L eisure A ctlv itle»
(Not including drug use)
0 Spends some/most free time on hobbies & recr.
1 Spends no time on hobbies & recr./Some interest
2 Spends no time on hobbies & recr./No interest
I l le g a l A ç tlv itlf i»
0 No illegal activities
1 Participates in illegal activities rarely or 
occasionally (1-2x/wk)
2 Participates in illegal activities regularly 
(3 -5 x /w k )
3 Participates in illegal activities daily or virtually 
daily (6 or more/wk)
C onflic ts W ith O th ers  (Fights, argum ents, etc.
0 No conflicts with others
1 Infrequent conflicts with others (1-2x/wk)
2 Frequent conflicts with others (3 or more x/wk)
A lcohol U se
0 No alcohol use/Occaslonal alcohol use (1-2x/wk) 
without Intoxication
1 Regular alcohol use (3-5 days/wk) o£ Occasional 
intoxication (1-2 days/wk)
2 Daily or virtually dally alcohol use (6-7 days/wk)
Regular intoxication (3 or more days/wk)
1 0 .  o th er  Illicit Drug U se
0 No other drug use
1 Occasional use of other illicit drugs (1 -2x/wk)
2 Frequent use of other illicit drugs (3-Sx/wk)
3 Daily or virtually dally use of other drugs 
(6 -7 x /w k )
11 . C o ca in e  U se
0 No cocaine use
1 Occasional cocaine use (1-2 days/wk)
2 Frequent cocaine use (3-5 days/wk)
3 Dally/vlrtually dally cocaine use (6-7 days/wk)
1 2 .  Ability to  Stop  when U sing C ocain e
0 Always/No cocaine use
1 Most of the time (>75%)
2 Some of the time (25%-75%)
3 Never/Rarely (<25%)
UNIVERSITY OF MINNESOTA 
D epartm ent o f Psychiatry  
S u b sta n c e  A b u se D isorder Program
Halikas-Crosby 
Drug impairment Rating 
Scale for Cocaine
>tudy No.
Rater Initials
Patient No. 
Patient initials
Visit Number
Date
I  3 .  P re o c c u p a t io n  w ith  C p c e lp e
0 No thoughts of cocaine
1 Only passing thoughts of cocaine
2 Persistent thoughts of cocaine without feeling 
overwhelmed by these thoughts
3 Overwhelming thoughts of cocaine
14 .  C o c a in e  U se  o r  W ithdraw al In te rfe re s  
W ith O th e r  A c tiv it ie s
0 Never
1 O ccasionally (1-2x/wk)
2 Regularly (3-5x/wk)
3 Daily or virtually daily (6-7x/wk)
I S . D Iahonest a b o u t C o ca in e  U se w ith 
Fam ily /  F rien d s  (U se?/A m ount?/$$$)
0 None
1 Infrequently (1-2x/wk)
2 O ccasionally (3-5x/wk)
3 Frequently (>5x/wk)
16 .  A sso c ia tio n  w ith  Known D rug U agrs
0 Never associates with known drug users
1 Occasionally associates with known drug users 
(1 -2 x /w k )
2 Regularly associates with known drug users 
(3 -5 x /w k )
3 Associates with known drug users daily or 
virtually dally (> 5x/wk)
1 7 .  A v o id an ce  of S itu a t io n s  Invo lv ing  D rug s
0 Frequently (> 5x/wk)
1 O ccasionally (3-5x/wk)
2 Infrequently (l-2x/w k)
3 Never/Not at all
0 Expresses normal or increased sexual drive
1 Reports mildly diminished sexual drive
2 Reports moderately diminished sexual drive
3 Expresses no sexual drive whatsoever/Repulsed 
by the thought of sexual activity
1 9  . Paranoid  S y m p to m s
0 No reported suspiciousness
1 Mildly suspicious of others
2 Moderately suspicious of others
3 Extremely suspiclous/Delusions of persecution
2 0 .  I r r i t a b i l i t y
0 None
1 Mild
2 Moderate
3 Severe/Incapacitating
2 1 .  A n x l s t .v
0 None
1 Mild
2 Moderate
3 Severe/Incapacitating
2 2 .  Fatigue /  Lack of Energy
0 None
1 Mild
2 Moderate
3 Severe/Incapacitating
2 3 .  D ep ressed  Mood
0 No reports of depressed mood
1 Reports of depressed mood only on 
questioning
2 Spontaneous verbal reports of depressed 
mood
3 Feelings of depression communicated both 
verbally and nonverbally
2 4 .  Optimism About the Future
0 Certain or virtually certain that "things will 
improve"
1 Hopeful that "things will improve"
2 Uncertain about future
3 Feels that future Is hopeless
2 5 S e l f - E s t e e m
0 Feels good about self
1 Feels disappointed with self
2 Feels like he/she let self and others down
3 Feels completely worthless
Total Score:
S E V E R I T Y  O F  D E P E N D E N C E  S C A L E
Name:
Date:
Please think o f your drug use during a typical recent period o f using when you answer 
these questions.
Please answer by circling one response only.
1. Did you think that your drug use was out of control?
Never Sometimes Often
or almost never
Always 
or nearly always
2. Did the prospect of missing a dose make you veiy anxious or worried?
Never 
or almost never
Sometimes Often Always 
or nearly always
3. Did you worry about your drug use?
Never 
or almost never
Sometimes Often Always 
or nearly always
4. Did you wish you could stop?
Never 
or almost never
Sometimes Often Always 
or nearly always
S. How difficult would you find it to stop or go without using drugs?
Impossible Very
Difficult
Quite
Difficult
Not
Difficult
Thank you very much for your help.
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VBECK INVENTORY
Name. Date.
On this questionnaire are groups of statements. Please read each group of statements carefully. Then pick 
out the one statement in each group which best describes the way you have been feeling the p a s t  w e e k ,  
IN C L U D IN G  TODAY! Circle the number beside the statement you picked. If several statements in the group 
seem to apply equally well, circle each one. Be sure to read all the statements In each group before 
making your choice.
0  I do not feel sad.
1 I feel sad.
2 I am sad all the time and I can't snap out of it.
3 I am so sad or unhappy that I can't stand it.
0  I am not particularly discouraged about the future.
1 I feel discouraged about the future.
2 I feel I have nothing to look forward to.
3 I feel that the future is hopeless and that things cannot
improve.
0 I do not feel like a failure.
1 I feel I have failed more than the average person.
2 As I look back on my life, all I can see is a lot of failures.
3 I feel I am a complete failure as a person.
0  I get as much satisfaction out of things as I used to.
1 I don't enjoy things the way I used to.
2 I don't get real satisfaction out of anything anymore.
3 I am dissatisfied or bored with everything.
0  I don't feel particularly guilty
1 I feel guilty a good pan of the time.
2 I feel quite guilty most of the time.
3 1 feel guilty all of the time.
6 0
1
2 
3
7 0 
I
I don't feel I am being punished.
I feel I may be punished.
I expect to be punished.
I feel I am being punished.
I don't feel disappointed in myself. 
I am disappointed in myself 
I am disgusted with myself.
I hate myself.
8 0  I don't feel I am any worse than anybody else
1 I am cntical of myself for my weaknesses or mistakes
2 I blame myself all the time for my faults.
3 I blame myself for everything bad that happens.
9 0 I don't have any thoughts of killing myself.
1 I have thoughts of killing myself, but I would not carry 
them out.
2 I would like to kill myself
3 I would kill myself if I had the chance.
10
I I
I don't cry any more than usual.
I cry more now than I used to.
I cry all the time now.
1 used to be able to cry. but now I can't cry even though I 
want to.
I am no more irritated now than I ever am.
I get annoyed or irritated more easily than I used to.
1 feel irritated all the time now.
I don't get irritated at all by the things that used to irritate 
me.
12 0 I have not lost interest in other people.
1 I am less interested in other p e t^ le  than I used to be.
2 I have lost most of my interest in other people.
3 I have lost all o f my interest in other people.
13 0 I make decisions about as well as I ever could.
1 I put off making decisions more than I used to.
2 I have greater difficulty in making decisions than before.
3 I can 't make decisions at all anymore.
14 0 I don 't feel I look any worse than I usM to.
1 I am worried that I am looking old or unattractive.
2 I feel that there are permanent changes in my appearance 
that make me look unanractive.
3 I believe that 1 look ugly.
15 0  I can work about as well as before.
1 It takes an extra effort to  get started at doing something.
2 1 have to push myself very hard to  do anything.
3 I can 't do any work at all.
l é  0 I can sleep as well as usual.
1 I d o n t sleep as well as I used to.
2 1 wake up 1-2 hours earlier than usual and find it hard to get 
back to sleep.
3 1 wake up several hours earlier than I used to and cannot get 
back to sleep.
17 0 1 don't get more tired than usual.
1 I get tired more easily than I used to.
2 1 get tired from doing almost anything.
3 1 am too tired to do anything.
18 0 My appetite is no worse than usual.
1 My appetite is not as good as it used to be.
2 My appetite is much worse now.
3 1 have no appetite «  all anymore.
19 0 1 haven't lost much weight, if  any. lately.
1 I have lost more than 5 pounds. I am purposely trying to lose weight
2 1 have lost more than 10 pounds, by eating less. % s . .. No---------
3 I have lost more than IS pounds.
20 0 I am no more worried about my health than usual.
1 I am worried about physical problems such as aches and 
pains: or upset stomach; off&onstipation.
2 1 am very worried about physical problems and it Is hard to 
think of much else.
3 I am so worried about my physical problems that I cannot 
think about anything else.
21 0 1 have not noticed any recent change in my interest in sea
1 1 am less interested in sex than 1 used to be.
2 I am much less interested in sex now.
3 I have lost interest in sex completely.
Kenrothiction without author's express written consent is not permitted. Additional copies and/or permission to use this scale may be obtained 
Irom: CENTER FOR COGNITIVE THERAPY. Room 602. 133 South 36th Street. Philadelphia. PA 19104
DIMS.#, AW r  a«ck. MD
r e a d in e s s  t o  c h a n g e  q u e s t io n n a ir e
Subject Name Date
The following questionnaire is designed to identify how you personally feel about youf using r%ht iu»w ’ 
read each of the quesuons below carefully, and then decide whether you agree or duagree with the staiemeiits.
Please circle the answer of your choice to each question.
1 = Strongly Disagree
2 = Disagree
3 = Unsure
4 = Agree
5 = Strongly Agree
Your answers are completely private and confidential.
1. I don’t think I use too much.
2. I am trying to use less than I 
used to.
3. I enjoy my using, but sometimes 
I use too much.
4. Sometimes I think I should cut 
down on my using.
5. It’s a waste of time thinking 
about my using.
6. I have just recently changed 
my using habits.
7. Anyone can tallcabout wanting 
to do something about using, 
but I am actually doing 
something about i t
8. I am at the stage where I 
should think about using less 
drugs.
9. My using is a problem 
sometimes.
10. There is no need for me to think 
about changing my using.
11. I am actually changing my using 
habits right now.
12. Using less drugs would be 
pointless for me.
Official
Use Only
/P
/A
/C
1C
/P
/A
/A
1C
1C
fP
/A
/P
INVENTORY OF DRUG TAKING
lAME:
)ATE:
.isted below are a number of situations or events in which people TAKE DRUGS.
Lead each item carefully, and answer in terms of your DRUG TAKING over the past year.
If you "NEVER" TOOK DRUGS in that situation, circle "1"
If you "RARELY" TOOK DRUGS in that situation, circle "2"
If you "FREQUENTLY" TOOK DRUGS in that situation, circle "3"
If you "ALMOST ALWAYS" TOOK DRUGS in that situation, circle "4"
Never
When I had an argument with a friend
When I was depressed about things 
in general
When I felt that things were going to 
work out well for me at last
When I felt shaky and sick
When I would decide to test my willpower 
by showing that I really could stop after 
one FIX
When good friends would drop by and I 
would be full of good feelings
When I would see people using or talking 
about drugs on TV
When I felt uneasy in the presence of 
someone
I TOOK DRUGS
Rarely Frequently Almost
Always
I TOOK DRUGS
Never Rarely Frequently A lm ost
A lw ays
8 .
9.
21.
When someone criticised me
When I would be invited to someone s 
home and they would offer me drugs
When I would have trouble sleeping
When I wanted to heighten my sexual 
enjoyment
When I would be given the drug of my 
choice free of charge
When I was enjoying myself
When I would be in a social situation 
in which I had always been high in 
the past
When 1 would become sad at the 
memory of something that had 
happened
When 1 would start to believe that 
drugs were no longer a problem for me
When other people around me made me 
tense
When I would be out with friends and 
they would stop by a dealers for their
supply
When 1 would begin to think how 
satisfying a fix would be
When 1 wanted to feel closer to 
someone 1 liked
4
4
4 7
I TOOK DRUGS
Never Rarelv Frequently Almost
Always
2. When someone in the same room was 
using drugs
3. When I felt that there was nowhere 
left to turn
4. When I felt that I had let myself 
down
5. When I felt sexually rejected
6. When I was bored
7. When I was unable to express my 
feelings to someone
8. When other people treated me 
fairly
9. When 1 would remember how good 
it felt
10. When 1 felt rejected by friends
11. When 1 felt confident and relaxed
12. When 1 would see something that 
reminded me of drugs
13. When 1 would begin to feel fed up 
with life
H. When 1 was troubled and 1 wanted
to think more clearly
35. When 1 was lonely
36. When 1 would convince myself that
1 was a new person now and could
take drugs occasionally.
4
4
I TOOK DRUGS
Never Rarely Frequently Almost
Always
7. When I was feeling on top ot the 
world
U When I would pass by an ex dealer’s 
house or chemist
9. When I would be in a situation in 
which I was in the habit of taking 
drugs
[). When I felt drowsy and wanted to 
stay alert
1. When I was tired
2. When I was in physical pain
3. When I would feel confident that 
1 could handle one fix
4. When someone close to me was 
suffering
5. When 1 would start thinking that
I would never know my limits with 
drugs unless 1 tested them
16. When 1 would be out with my friends
’on the town’ and wanted to increase 
my enjoyment
M. When 1 would unexpectedly find drugs 
in the house
48. When 1 was having a good conversation 
with someone and wanted to recount 
some really good stories
49. When 1 would be offered drugs and 
would feel awkward about refusing
4
4
4
I TOOK DRUGS
Never Rarely Frequently Almost
Always
When other people didn’t seem to 
like me
When I felt nauseous
When I felt unsure that I could 
measure up to other people’s 
expectations
When I felt under a lot of pressure
When I would wonder about my self 
control over drugs and would feel 
like having some to try it out
When nothing I did seemed right to me
When other people interfered with my 
plans
When I would start thinking that I 
was finally cured and could handle 
drugs
When everything was going well
When I felt no one really cared 
what happened to me
When I would be at a party and 
other people would be using drugs
When I felt unsure of myself and 
wanted to function better
When pressure would build up at 
work because of the demands of my 
supervisor
3 6 5
I TOOK DRUGS
Never Rarely Frequently Almost
A iways
i3. When I couldn’t seem to do things I 
tried to do
:4. When I was afraid that things weren't 
going to work out
)5. When I felt satisfied with something 
I had done
)6. When I felt jealous over something 
someone had done
)1. When I would pass by an ex-suppliers 
or chemist
)8. When I felt empty inside
)9. If I were at a party and the people
with me bought drugs
70. When I felt exhausted
71. When everything was going badly
for me
72. When I wanted to celebrate with 
a friend
73. When someone would pressure me to 
’be a good sport’ and have some 
drugs
74. When I would start to feel guilty 
about something
75. When 1 felt jumpy and physically 
tense
76. When 1 was angry at the way things 
had turned out
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I TOOK DRUGS
Never Rarely Frequently Almost
Alwavs
n . When I would feel under a lot of
pressure from family members at home 1
8^. When something good would happen
and I would feel like celebrating 1
'9. When I feeling content with my life 1
50. When I would start thinking that
I wasn’t really hooked on drugs 1
11. When I would stan to think that
just one fix could cause no harm 1
52. When I would be having fun with 
friends and wanted to increase our 
enjoyment 1
53. When I felt confused about what I
should do 1
54. When I would meet a friend and 
he/she would suggest that we use
together 1
55. When I would want to celebrate 
special occasions like Christmas
or birthdays 1
56. When I had a headache 1
57. When 1 was not getting along
well with others at work 1
58. When 1 would be enjoying myself
at a party and wanted to feel even
better 1
89. When 1 would suddenly have an urge
for a fix 1
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1 TOOK DRUGS
Neve.* Rarely Frequently Almost
Alwavs
When I would think of the chances 
I had missed in life
When I wanted to prove to myself 
that I could take a few drugs without 
becoming re-addicted
When there were fights at home
When having a good time with friends 
and felt that drugs would make it 
even more enjoyable
When there were problems with people 
at work
When I would be relaxed with a good 
friend and wanted to have a good time
When my dealer offers me drugs
When I felt happy at the memory of 
something that had happened
When my stomach felt like it was 
tied in knots
When I felt that I needed courage 
to face up to someone
00. When I felt that someone was trying 
to control me and I wanted to feel 
more independent
SITUATIONAL CONFIDENCE QUESTIONNAIRE
AME:
ATE:
isted below are a number of situation or event in which people take drugs.
nagine yourself as you are right now in each of these situations. Indicate on the scale provided how 
)nfident you are that you would be able to resist the urge to take drugs .n that situation.
ircle 100 if you are 100% confident right now that you could resist the urge to take drugs; 80 if you arc
3% confident; 60 if you are 60% confident. If you are more unconfident than conlldent, circle 40 lo 
idicate that you are only 40% confident that you could resist the urge to take drugs; 20 for 20% confident; 
if you ahve no confidence at all about that situation.
I WOULD BE ABLE TO RESIST THE URGE TO TAKE DRUGS
NOT AT ALL VERY
CONFIDENT CONFIDENT
When 1 had an argument with a friend 0 20 40 60 80 1(K)
0 20 40 60 80 1(K)
When 1 was depressed about things 
in general
When 1 felt that things were going to
work out well for me at last 0 20 40 60 80 1(H)
When 1 felt shaky and sick 0 20 40 60 80 l(K)
When 1 would decide to test my willpower 
by showing that I really could stop after
one FIX 0 20 40 60 80 KK)
When good friends would drop by and 1
would be full of good feelings 0 20 40 60 80 KK)
When 1 would see people using or talking 
about drugs on TV
When 1 felt uneasy in the presence of 
someone
0 20 40 60 80 KK)
0 20 40 60 80 KK)
14.
I WOULD BE ABLE TO RESIST THE URGE TO TAKE DRl (iS
NOT AT ALL VERY
CONFIDENT CONFIDENT
9. When someone criticised me 0 20 40 60 80 KM)
10. When I would be invited to someone's
home and they would offer me drugs 0 20 40 60 80 KM)
11. When I would have trouble sleeping 0 20 40 60 80 KM)
0 20 40 60 80 KM)
12. When I wanted to heighten my sexual 
enjoyment
13. When I would be given the drug of my
choice free of charge 0 20 40 60 80 KM)
When I was enjoying myself 0 20 40 60 80 KM)
15. When I would be in a social situation 
in which 1 had always been high in 
the past
16. When 1 would become sad at the 
memory of something that had 
happened
17. When 1 would start to believe that 
drugs were no longer a problem for me
18. When other people around me made me 
tense
19. When 1 would be out with friends and 
they would stop by a dealers for their 
supply
20. When 1 would begin to think how 
satisfying a fix would be
21. When 1 wanted to feel closer to 
someone I liked
0 20 40 60 80 KM)
0 20 40 60 80 KM)
0 20 40 60 80 KM)
0 20 40 60 80 KM)
0 20 40 60 80 KK)
0 20 40 60 80 KK)
0 20 40 60 80 KK)
I WOULD BE ABLE TO RESIST THE URGE TO TAKE DRI GS
NOT AT ALL 
CONFIDENT
VERY
CONFIDENT
12. When someone in the same room was 
using drugs 0 20 40 60 80 KK) 7
1
3. When I felt that there was nowhere 
left to turn 0 20 40 60 80 KM) 1
4. When I felt that I had let myself 
down 0 20 40 60 80 KK) 1
5. When I felt sexually rejected 0 20 40 60 80 KM) 6
6. When I was bored 0 20 40 60 80 KM) 1
7. When I was unable to express my 
feelings to someone 0 20 40 60 80 KK) 6
8. When other people treated me 
fairly 0 20 40 60 80 KK) 6
9. When I would remember how good 
it felt 0 20 40 60 80 KK) 5
0. When I felt rejected by friends 0 20 40 60 80 KK) 6
1. When I felt confident and relaxed 0 20 40 60 80 KK) 3
2. When I would see something that 
reminded me of drugs 0 20 40 60 80 KK) 5
3. When I would begin to feel fed up 
with life 0 20 40 60 80 KK) 1
4. When I was troubled and I wanted 
to think more clearly 0 20 40 60 80 100 1
15. When I was lonely 0 20 40 60 80 100 1
16. When 1 would convince myself that 
1 was a new person now and could 
take drugs occasionally. 0 20 40 60 80 KK) 4
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I WOULD BE ABLE TO RESIST THE URGE TO TAKE DRUGS
NOT AT ALL 
CONFIDENT
VERY
CONFIDENT
37. When I was feeling on top of the 
world 0 20 40 60 80 KK)
3
38. When I would pass by an ex dealer’s 
house or chemist 0 20 40 60 80 KM) 5
39. When I would be in a situation in 
which I was in the habit of taking 
drugs 0 20 40 60 80 KM) 5
40. When I felt drowsy and wanted to 
stay alert 0 20 40 60 80 KM)
41. When I was tired 0 20 40 60 80 KM) i
1
42. When I was in physical pain 0 20 40 60 80 KM) I
1
43. When I would feel confident that 
1 could handle one fix 0 20 40 60 80 KM) 4
44. When someone close to me was 
suffering 0 20 40 60 80 100 6
45. When 1 would start thinking that 
1 would never know my limits with 
drugs unless 1 tested them 0 20 40 60 80 KK)
46. When 1 would be out with my friends 
’on the town’ and wanted to increase 
my enjoyment 0 20 40 60 80 KK) 8
47. When 1 would unexpectedly find drugs 
in the house 0 20 40 60 80 KK) 5
48. When 1 was having a good conversation 
with someone and wanted to recount 
some really good stories 0 20 40 60 80 KK) 8
49. When 1 would be offered drugs and 
would feel awkward about refusing 0 20 40 60 80 KK) 1
I WOULD BE ABLE TO RESIST THE URGE TO TAKE DRUGS
NOT AT ALL VERY
CONFIDENT CONFIDENT
!0. When other people didn’t seem to
like me 0 20 40 60 80 KK)
il. When I felt nauseous 0 20 40 60 80 KK)
>2. When I felt unsure that I could
measure up to other people’s
expectations 0 20 40 60 80 KK)
13. When I felt under a lot of pressure 0 20 40 60 80 KK)
14. When I would wonder about my self 
control over drugs and would feel
like having some to try it out 0 20 40 60 80 KK)
15. When nothing I did seemed right to me 0 20 40 60 80 KK)
16. When other people interfered with my
plans 0 20 40 60 80 100
>7. When I would start thinking that I
was finally cured and could handle
drugs 0 20 40 60 80 KK)
)8. When everything was going well 0 20 40 60 80 KK)
)9. When I felt no one really cared
what happened to me 0 20 40 60 80 KK)
30. When I would be at a party and
other people would be using drugs 0 20 40 60 80 KK)
31. When I felt unsure of myself and
wanted to function better 0 20 40 60 80 100
62. When pressure would build up at
work because of the demands of my 
supervisor 0 20 40 60 80 KK)
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I WOULD BE ABLE TO RESIST THE URGE TO TAKE DRUGS
NOT AT ALL VERY
CONFIDENT CONFIDENT
63. When I couldn’t seem to do things I 
tried to do
64. When I was afraid that things weren’t 
going to work out
65. When I felt satisfied with something 
I had done
66. When I felt jealous over something 
someone had done
67. When I would pass by an ex-suppliers 
or chemist "
68. When I felt empty inside
69. If I were at a party and the people 
with me bought drugs
70. When I felt exhausted
71. When everything was going badly
for me
72. When I wanted to celebrate with 
a friend
73. When someone would pressure me to 
’be a good sport’ and have some 
drugs
74. When I would start to feel guilty 
about something
75. When I felt jumpy and physically 
tense
76. When I was angry at the way things 
had turned out
0 20 40 60 80 HH)
0 20 40 60 80 KK)
0 20 40 60 80 KK)
0 20 40 60 80 KK)
0 20 40 60 80 KK) I 5
0 20 40 60 80 KK)
0 20 40 60 80 100
0 20 40 60 80 KK)
0 20 40 60 80 KK)
0 20 40 60 80 KK)
0 20 40 60 80 100
0 20 40 60 80 100
0 20 40 60 80 100
0 20 40 60 80 100
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I WOULD BE ABLE TO RESIST THE URGE TO TAKE DRUGS
NOT AT ALL 
CONFIDENT
VERY
CONFIDENT
7. When I would feel under a lot of
pressure from family members at home
When something good would happen 
and I would feel like celebrating
). When I feeling content with my life
). When I would start thinking that
I wasn’t really hooked on drugs
L When I would start to think that 
just one fix could cause no harm
I. When I would be having fun with 
friends and wanted to increase our 
enjoyment
U When I felt confused about what I 
should do
U When I would meet a friend and 
he/she would suggest that we use 
together
5. When I would want to celebrate 
special occasions like Christmas 
or birthdays
5. When I had a headache
7. When I was not getting along 
well with others at woik
8. When I would be enjoying myself 
at a party and wanted to feel even 
better
9. When I would suddenly have an urge 
for a fix
0 20 40 60 80 KK)
0 20 40 60 80 KK)
0 20 40 60 80 KK)
0 20 40 60 80 KK)
0 20 40 60 80 KK)
0 20 40 60 80 100
0 20 40 60 80 KK)
0 20 40 60 80 KK)
0 20 40 60 80 KK)
0 20 40 60 80 KK)
0 20 40 60 80 UK)
0 20 40 60 80 100
0 20 40 60 80 100
375
I WOULD BE ABLE TO RESIST THE URGE TO TAKE DRUGS
NOT AT ALL VERY
CONFIDENT CONFIDENT
93. When having a good time with friends 
and felt that drugs would make it
94. When there were problems with people
at work 0 20 40 60 80 HW)
95. When I would be relaxed with a good
friend and wanted to have a good time 0 20 40 60 80 HK)
96. When my dealer offers me drugs 0 20 40 60 80 KK)
97. When I felt happy at the memory of
something that had happened 0 20 40 60 80 UK)
98. When my stomach felt like it was
tied in knots 0 20 40 60 80 100
99. When I felt that I needed courage
to face up to someone 0 20 40 60 80 HK)
100. When I felt that someone was trying 
to control me and I wanted to feel
more independent 0 20 40 60 80 100
90. When I would think of the chances j
I had missed in life 0 20 40 60 80 100 î
91. When 1 wanted to prove to myself * 
that I could take a few drugs without
becoming re-addicted 0 20 40 60 80 KK) 4
92. When there were fights at home 0 20 40 60 80 KK) 6 .
even more enjoyable 0 20 40 60 80 KK) , S
i
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ANNIS QUESTIONNAIRE - SCORE/PROFILE SHEET
NAME: DATE:
S C A L E I D S S C Q
NO TITLE NO
ITEMS
CATEGORY
SCORE
PROBLEM
INDEX
STRENGTH OF 
EXPECTANCIES
1 Unpleasant
em otions
20
2 P hysical
discom fort
10
3 P leasant em otions 10
4 T esting control 
over drugs
10
5 Urges/Tem ptation  
to  take drugs
10
6 C onflict w ith  
others
20
7 P ressure from  
others to  take  
drugs
10
8 P leasant tim es  
w ith  others
10
SCORING = Problem = Category Score - N ,100 
Index Maximum Score - N
- Strength of expectancies = Sum of confidence ratings across items
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C A T E G O RY H I E R A R C H I E S
IDS S Ç J >
PRE-TREATMENT EVALUATION GROUP: INTERVIEW SCHEDULE
Facilitator: Dr. Jane Gibbon, Clinical Psychologist 
Date: Tuesday 6 September 1994 (Time: TBA)
Themes:
1. The Process of Change:
* issues of control
* belief systems
* abstinence vs. controlled use
2. Components of treatment
* models of treatment
* goal directed vs. insight orientated approaches
3. The treatment programme
* experiences of the service to date
* hopes and fears
* the concept of abstinence
Sequence of Questions
1. Introduction to the group
explain purpose of group including role of the facilitator 
give consent form for groups to be taped 
explain issues of confidentiality
2. Group discussion
a) what brought you into treatment
b) why have treatment at this stage of your drug use
c) what are your expectations of treatment (positive and negative)
d) what are your hopes and fears - including being in group, i.e. group
dynamics/interaction
e) what is your impression of the service so far
f) how do you feel that this is an abstinence oriented programme vs. controlled use
g) how do you envisage that you will achieve abstinence (belief systems around 
abstinence: examining constructs i.e. willpower; religion; cognitive control etc.)
i) final statement - summary
3. Notes to facilitator
What do you fed, NOT what is your opinion 
What am I leaving out?
What do I need to ask to know more?
Open questions: •Describe...
•Tell me about...
•What features...
Probes: •Explain further?
•Give an example?
•Anything else?
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FOCUS GROUP 1 - 4TH OCTOBER 1994
START TIME: 3.00 P.M.
END TIME: 4.15 P.M.
FACILITATOR: DR. JANE GIBBONS
GROUP: NICK
DEE
DORION
DAVID
MAXINE
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Jane: "Introduction - we could start with, um, what prompted all of you to
come here today, I'm quite interested in what prompted you to come
for treatment, so maybe we could start talking about that."
Dee: "What today?"
Jane: "Yeah."
Dee: "'Cos we have to come today to meet everybody basically" (laughter among
group)
Nick: "No, what you mean why we went in for treatment?"
Jane: "Yeah."
Nick: "I, well I personally went in because I was a successful photographer, um, for
about six years, and then, just started off taking a little bit of coke and ended
up taking about 5 grams a day every day, and...I lost it...and I lost my career, 
and I didn't know why I didn't want to go back to doing photography, and for 
about three years now I've just been doing just about enough to survive and 
signing on and whatever...and a few months ago I lost my girlfriend, well I 
didn't lose my girlfriend she left me" (laughs and group laughter) "and um... 
we got back together again and, I know that the reason was because she was
382
really upset that I wasn't fulfilling my potential, um, you know she found it 
disturbing that I could be a successful photographer and wasn't doing it, and 
we tried to figure out why.... and the reality is that I'm terrified of earning 
money because I know, now without any money I'm still doing 2 or 3 grams 
of coke per week, but when I earn money again, unless I've actually got rid of 
this compulsion of taking cocaine and 'E's then I'm gonna be straight back in 
it but in a much bigger way. When I split up with her, I think part of coming 
on the course and facing up to things was in order to maybe get her back, but 
I've in the meantime having split up for proper, um. I've decide to carry on 
with it because it's what I need to do. I was worried at the start that I was 
doing it for the wrong reasons I was doing it in order to impress her but in fact 
now having split up with her completely I know that I'm doing it for me."
Dee: "I'm kind of the same, similar to Nick, I can't fulfill my potential I've been a
successful musician up until about three years ago, but my problem slightly 
differs because I was doing just as much as then I am now but the difference 
is now I'm not enjoying it, and I'm starting to get slippery you know? It's the 
first time I've really felt unhealthy, I haven't really had any problems. I've been 
sailing right through every buzz I've had, so, now it's kind of like it ain't 
doing what it used to do to me."
Nick: "You're almost doing it, I feel I'm almost doing it to punish myself. When
I take coke now, the cocaine buzz....well one, I have to get rid of the cocaine
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as soon as I can, there's no stopping, you know if I go out and I get a couple 
of grams it's gone in an hour because all I wanna do is get rid of it because 
I wanna actually stop taking it and I actually get no pleasure out of it except 
seeing it gone. There is no pleasure factor to it."
Dee: "Yeah, that's right."
Nick: "All it does is immediately bring on all of the bad memories and bad feelings
I have about myself for having blown it"
Jane: "What about the other people in the group, it sounds like you're talking about
things like compulsion and realty not enjoying the drug that you're taking 
anymore. Is that similar for other people in the group?"
David: "It's just like a habit isn't it, you just wanna keep doing it...you're not getting
the same thing out of it."
Nick: "Also I think if we were enjoying it we wouldn't be here."
Dee: "Exactly, that's why I wasn't here before. It wasn't a case ...I had no
problems.... if someone wants to come up to me and say I've got a problem 
with drugs, it would be like whoa, slow down, you're off your cloud man, I'm 
having a good one...but I'm not any more, so."
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Jane: "Maxine, you kind of said "mm" when they talked about not enjoying it."
Maxine: "I'd like to get rid of it...I just want to get rid of it, you know."
David: "You don't know how much you need it until you try and get off it. That's
when you know....before I used to say I could easily kick it, then when I tried 
to give it up, then I couldn't do it. And it was costing me so much money a 
week...a day I mean."
Jane: "So I mean you know some of you have talked about the process..it sounds 
like it took quite a long time for you to think about coming in to treatment, 
is that the same for everyone in the group, or was there any one thing that 
made you think'Oh, I need to go and get help'?"
Dee: "No it didn't take me a long time to think it, the minute I thought it I came 
down here, I never thought about it before, it never crossed my mind to come 
to one of these places."
Nick: "And for me it was the minute I realised that what was stopping me from 
working...before that I blamed it on all sorts of other things like being insecure 
and...not being talented..."
(At this point a man mumbles something but it is inaudible on the tape.)
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Jane: "What about other people, I mean how did you get to here about the
programme?"
David: "From the doctor's...I went to the doctor...! think I took so much during that
week I just felt shit, really bad, I thought 'I've had enough it, let's go and do 
something about it' and I stopped for a full week...then after that week on 
Friday I'd go out with me mates and then after two beers sitting in the pub 
they'd say 'heres a line, there's a line' I'd say no to to the first couple then after 
that I just got back on it. I've give up a couple of times but it's only lasted a 
couple of days."
Nick: "It's not even the drug itself it's the actual process of taking the drug, you
know it's the process of going and seeing your dealer and actually chopping 
it up, it's not just a physical thing with the drug.."
David: "That's right, yeah, yeah."
Dee: "Yeah, that's right, you've got it and that's a buzz in itself."
Nick: "And for me when I was bad at it, I mean I don't take that much at the
moment because I've restricted myself financially so I can't do it, but um,
when I was bad, my whole day, I mean I was still working as a photographer
but my whole day, from the moment I got up was geared up to where I was
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gonna get my coke from that day, the best quality for the least price...and 
that..that was what my day was about....that and taking it and staying up all 
night."
(Knock on the door - Tanya: "Excuse me, sorry. Dorion s here.")
Jane: "Okay, so a new person's just entered the room so we're just going to" (the
tape goes a bit funny at this point) "so what we were talking about, we were 
just having a discussion about people had, um, accessed the programme and 
why they'd decided to come for treatment now and people were talking about, 
really the fact that they were no longer enjoying their drug-taking and felt that 
for various reasons it was interfering with their lives so much that they felt that 
they wanted to come for treatment. Yeah? Does anyone else want to say any 
more about that and what we were talking about before?"
Nick: "Um, I think I realised...when I realised just how dependant I was on
drugs....um, my mum had given me £5,000 at the beginning of the year to set
up my business...again...and, um, I started blowing it quite heavily on coke
again, and I decided to go to Thailand to sort my head out for three months 
and the first day I was in Bangkok I got arrested, um, for, um, well I thought 
I'd bought some coke but infact I'd bought some heroin...and I was puking my 
guts up for sixteen hours after one line of this stuff, and Mr. Dickhead took 
it back to the dealer to try and get my money back, and I got arrested and I
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spent three months in Thailand on the run without a passport or anything....and
that really sort of brought it home to me, you know, just how silly it was to
be so dependant on it....on a stimulant drug."
Jane: "Okay, is there anything you want to add to the discussion at this point?"
Dorian: "Not really."
Jane: "Okay, right. I mean I guess it would be really interesting for me to know 
what your expectations of the treatment is, I mean what do people hope to get 
from coming on the course?"
David: "Well, to get off the drugs."
Dee: "Yeah, to stop using them, I think that's pretty obvious really."
Maxine: "Or just control it or something."
Dorian: "I'd like to understand it."
Maxine: "I'm tired you know."
Dee: "Maybe just to get some perspective on ..on our...."
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Nick: "Yeah, maybe to be able to use drugs recreationly again, as opposed to it being 
an addiction...! mean that's not a goal because to do that I think you're saying 
'I still want to be an addict'but..."
Maxine: "I know but if you put yourself back and say right I want to come out of here
and not use it, that's a load of bollocks really mmt?"
Nick: "Yeah, I agree."
Maxine: "I've done it so many times and it doesn't work, you know what I mean so...."
Jane: "Shall we just stick with that because that's quite an interesting idea, I mean 
people seem to be saying different things, that some people come in because 
they want to give up, whereas other people are saying that...."
Dorian: "Yeah, but sub-consciously you're saying I want to give up' but mentally and
physically where your body's already been in that cycle, you've gone through 
that cycle, like sometimes if you take the drug you think 'Well God what am 
I doing, this is a waste of time' you know? I mean 'what's it doing for me, I 
feel like shit', at the time yeah it's alright, then you feel like shit, then you 
might be able to go two or three days without it, but then...as long as you're 
away from the drug...that seems alright....but then when you...with me, because 
of the industry I work in...like every day I go through it's just there and like
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there's nothing I can do about it apart from leave that industry and look for 
other work, and I'm not really compatible for any other work than what I do 
already....and, I find that, like sometimes 1 say, like, I get so pissed off 
because if I'm working...because of the hours I work, I work like nights, 
because I do all the clubs and that, and...:it's, all because you're always in that 
circle, it's always there and people always offering you, and sometimes your 
guard goes down and once you start, it tends to..it's continuous, until you're out 
of it...like, if I'm not working for three or four days then there's no problem..as 
soon as I go back in there, it's like the guard you put up to protect yourself 
against it just...just falls again, and it's like, catch 22, you say right, well if I 
leave the job I can look for another job, but it's not the time to leave that job 
because there's nothing else there that's gonna cover my expenses, my 
bills....and my living expenses as a whole, you know...so it's...I've come here 
really to understand, one, what's the attraction to the drug and why, like, not 
because you can't say 'No' because you can say 'No'...."
Nick: "No, you can't, well I can't.."
Dorian: "Well I can say no, because I've sat in a room and people are smoking and
they've offered me and I've gone 'No', even dope, because...."
Jane: "Sorry to interrupt you, I think that's a really interesting idea, you know that
you can say no or you can't say no, I mean what do other people in the
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group.
Nick: "I personally want to be in a position where I can say no because at the 
moment I can't say no, if there's cocaine there I cannot say no to it, I wanna 
stick my nose in it, and take it."
Jane: "And you're saying that if the drug's there then it's really difficult to say no to 
it."
Dorian: "Yeah, yeah."
Nick: "You'd still wanna be in your business wouldn't you? If drugs weren't 
there....that's what you're trying to do, so it's a shame to have to give up your 
career for drugs... you know, I wanna be successful photographer again but I 
can't because I'm addicted to drugs. The drugs are always gonna be in that 
business, and the same in your business, and your business."
David: "There everywhere aren't they."
Nick: "Yeah..."
Dorian: "It's more available now than it was, say, ten years ago .... I mean, like it used
to be just ffeebasing and now people are saying it's crack, it's just the same
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as what they had in the sixties, freebaseing and Charlie, but it's like a more 
commercial thing now because anyone can get it, and I find myself.....now it's 
not so much the, that drug you get addicted to it's what it's mixed with that's 
more the body addiction. I mean if you had straight cocaine then .... well then 
as soon as it's mixed with something, then that's the mixture..."
Nick: "No no, I think you're avoiding the issue, I think you're addicted to cocaine, 
but I don't..."
Dorian: "No no. I'm not saying..."
Nick: 'It's okay to be addicted, but it's addictive it's as simple as that ."
Jane: "But I guess, I mean what I'm interested in..."
Dorian: "Each of us are in a different position, different stages of..."
Maxine: "Because you're dealing with things and you feel paranoid ... if it was clean
and like...then you wouldn't get that addiction you get."
Nick: "I find the reason you're paranoid is because you're taking too much of it..."
Maxine: "Yeah, Okay. "
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Dee: "Well yeah, I mean ten years ago, if I was burning like rock of Charlie in a
pipe which is proper basing, Fd still have the same anxiety at the end of the 
night ... Fd still be thinking 'where's the next pipe coming from?'...you know 
what I mean? As it gets to a certain point of enjoying myself then Fd get to 
a point where Fm thinking I'm not enjoying it anymore, that was then, that
was ten years ago, if Fm making a rock now it's crap, it's the same thing you
know, once you start coming down off that, it's no distinction between that 
buzz for me, it's still the same...it's like greed and nasty..."
Nick: "Gluttony."
Dee: "Yeah."
Jane: "We've started off talking about whether it was possible to say to No to the
drug, you know, if it's in front of you..."
David: "I can't say no, you can't say no can you?"
Jane: "I mean what do people think about that, I mean this whole idea of...."
Dee: "I think you've got to want to say no, haven't you? If you want to say no
you've got to say no, haven't you, if you're hungry and someone puts food in 
front of you you're gonna lap it up, if someone puts a bit of Charlie in front
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of you and you've got a habit....! don't think, you know, it doesn't come....if 
everyone....in an ideal world we could split ourselves into two people and one 
says 'look you're not doing anymore'....but it doesn't work like that, does it?
I dunno, it may be different for different addictions..."
Nick: "I think also that we're all involved socially in. with people who use drugs all
the time...and...I don't want to change my group of friends, you know, I still 
want to be with all those people but I just don't wanna be taking dope, I don't 
wanna care whether they're taking dmgs or not, but I personally don't want to 
be taking drugs."
Jane: "The word 'addiction' is quite interesting as well, I wonder if people could just
talk a little bit about what they mean when they use the word 'addiction', 
because I think people often use it in a very different way, and the word's come 
up a bit in the discussion and I think..."
Dee: "Addiction for me means I wake up in the morning and I can't do anything
until I've had my spliff. I've got to have a few spliffs and then I'm alright to 
deal with people, then by, what, the afternoon I start thinking about I might go 
and have a beer and...you know what I mean...have a toot or whatever, by the 
evening I meet up with a bunch of people and we're going to go out and there's 
nothing else to do but going out on a buzz ... that's addiction...I'm defining it 
for myself. Obviously until you start coming down, everything's much better
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when you're doing i t  everything's normal when you're doing it, everything's
right."
Nick: "I think for me, addiction means when the most important thing to you is
the drugs tl\at you're taking, more important than your relationships, more 
important than your work .... that's how I define that I'm addictive."
Jane: "What about other people in the group, I mean I think you used the word
addiction, am I right?"
Dorian: "Yeah, but the thing is, with myself it's like, I only indulge it at the night
because during the day I mean I get up and I'm doing my work, 'cos I do a job
during the day as w ell and I don't bother 'cos ..... I find ... when most if
I'm depressed or....I use it as an excuse... use dmgs as an excuse to maybe, I
dunno like another cloak.... like putting on another coat...you know... like
where I'm hurting inside like you got no-one who can understand you or you 
think people...like you're doing so much for people and then no-one's taking 
any interest in you ... and when you do say something and they act as if your 
stupid, you know, and it's really trying to get someone to understand you, so 
you indulge in the coke to sort of like suppress..."
Nick: "Hide that feeling..."
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Dorian: "...yeah, hide that feeling .... but then when people do see you they see you
with drugs and they say 'ah, what's wrong with you, you're on drugs' and this... 
but instead of finding out why you've resorted to the drugs..."
Dee: "Yeah, they just pass you off..."
Dorian: "...they just pass you off, and then you get more involved because that's...it's
easier to deal with that than to deal with, um..."
Nick: "Emotional problems causing you to be addictive in the first place, yeah."
Dorian: "...and it's basically when this realisation hits you think to yourself, I mean
it goes on for a period and you keep lying to yourself saying 'oh, there's 
nothing..' and then realisation hits you something like God, you look around 
you, you see what's happening and then you take a look at yourself and you 
think 'this is not me' you know? And you're trying to, you're in a constant 
battle with yourself trying to understand why you're doing this, alright it's nice 
for a little while, but then it becomes boring, it just becomes something you 
do "
Dee: "Yeah, and then it's the same as when you're straight except you're not 
anywhere anymore, neither situations, straight or stoned .. you're not getting 
away from it anymore."
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Dorian: "I mean basically you start acting different towards people, you think you're
like as you was before.... but that's basically when they first start noticing you, 
because you start acting like you won't talk to people, like because you feel 
a certain way, if you don't feel like talking to someone, you just don't talk, and 
then they start saying to you 'you're ignorant, what's the matter?'.."
Dee: "Unsociable and that...."
Dorian: "... unsociable..and you they put you in a category where you think well all I
do, is I don't want to talk to people, if I don't feel like to talking to anyone 
then I won't talk. I'm not obligated to talk to anyone ... and where you get 
pushed then the drug's a substitute to suppress what you're feeling, because I 
mean basically like me, sometimes I don't .... like telling...like I've told say, 
something... and I don't like to explain myself because I don't think there's 
no need to explain, and then you get push, push, push, push, push, by people 
around you, they all want explanations, they want to know why this, why this, 
why this, you can't ...well, me, I can't say, well this is the reason, and the 
reason basically is you ... and., but that's in a sense blaming other people for 
what you ...you've done, but it's ...there is a link between the two, you know 
...people you're around, people you see every day, the way people are towards 
you, and there's a link with drugs, it's easier to deal with the drug than it is 
easier to deal with people today, I find, but I know it's not a good thing 
but...."
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Jane: "So, you're talking, what I'm hearing you saying is that you're talking about
drugs as a way of suppressing emotions, yeah?"
Dorian: "Mmm, yeah."
Nick: "A way of not dealing with it, avoiding them."
Jane: "What do other people in the group think about that?" (Pause)
David: "I don't know."
Jane: "Is that something you've heard before or you've thought about yourself, or. 
do you think that's different than to that?"
David: "I've got a mate that does 'E's....'' (Inaudible)
Dorian: "It's an escape really, but..."
Dee: "Yeah, you just bypass everything don't you?"
Dorian: "...yeah, then you come back to reality and you go 'oh shit here we g o '... it's
like a wicked circle... but I mean if you get a better understanding about the 
drug and how to deal with basically yourself as an individual, and basically
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you put the drug down and you put -yourself down and you say well, it's easy 
to go without them because this routs is just stress, grief, whatever, and even 
if you go through that stress, grief, whatever the drug's still gonna be there, it's 
not goima go away, but it's for you to make it go away."
Jane: "So that brings us back really nicely to thinking about what people are
expecting from the programme and it sounds like you're saying you want to 
understand a bit more about your drug taking and a bit more about yourself, 
yeah?"
Dee: "Yeah, just like get a bit of a perspective, I mean same with any problem,
if you get any rational person it doesn't matter whether they're a user or not 
you can give them a problem, any problem, and give them sufficient amount 
of information to solve the problem then everyone will have a better chance 
of doing it...so I think that's what I'm here for to get some perspective I mean 
'cos I mean at the end of the day you've got to help yourself anyway."
Jane: "Right...what about other people, do you think that having a greater
understanding is something you're looking for from the course?"
David: "I just want to try, I just want to have a go, have some help to give it up, I just
want to stop."
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Jane: "I wonder if any of you, I mean you may not, but I wonder if any of you have 
any idea what that information would be or what do you think is going to 
help."
David: "Well I've got no questions, it's my first time. I mean it's the first time I'm
here."
Jane: "Right...so for you..."
Nick: "It's like a magical mystery tour to most of us at the moment because none 
of us know what's going to happen, you know, we all know that were on this 
course because we all want to give up drugs, but none of us, w e l l  I personally 
haven't got any idea w hat...."
Dee: "Can we get it cheaper?" (laughs)
Nick: (laughs) "..I was hoping to get it on prescription!"
Jane: "Right, well obviously you don't know what's going to be happening on the 
programme,"
David: "Well I ain't had nothing told to me yet."
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Jane: but I wondered if, you know, when you were coming for treatment if any 
of you had any ideas about what you might be looking for, about what mgt 
be helpful."
Dorian: "I mean me, personally. I'm just looking for a better understanding, cos if I
understand something to the fullest.... then it makes it easier for me to deal 
with because, like for me, if you see a heroin addict and like, you see the way 
they are the way they carry on, you can mirror yourself - if you take any form 
of drugs - you can mirror yourself with that person, well I don't want to be 
in that situation, and the easy way not to be in that situation is not to take that
particular drug, you know I mean cocaine. I've only been using like, for two
years, and that's since basically I got into jungle, 'cos I do a lot of jungle raves 
and that is just drugs..."
Dee: "Predominately yeah?"
Dorian: "...it's just there... and ... it was by accident really, it was just through smoking
a couple of spliffs that... and then it progressed from there, like I've said to 
myself 'what's happening, what's going on?' because I mean I've used cocaine, 
snorted casually before, and it hasn't been a problem, the problem stemmed 
when, as I said, free basing.... it's like because I've done things that I would 
never of done before.... to freebase, you know, and I'm thinking, well the only 
person I'm hurting is myself at the end of the day.."
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Jane: "So what you seem to be saying is that you're doing something that doesn't 
make sense to you..."
Dorian: "yeah..."
Jane: "...and you want to have more of an understanding.."
Dorian: "... yeah, if I can understand it then I can deal with it... and perhaps it's not
understanding it, it's nice....."
Jane: "...but again that's an interesting idea - do people think that you need to 
be able to understand in order to stop it? I mean do you think in order to stop 
taking drugs you've got to understand why you're doing it?"
Dee: "No, I mean I've probably got the willpower to turn round and say I'm not
going to do blah, blah, blah, anymore, but it's what comes with it what's 
stopping. .. what I haven't got a clue about, you know and I'd rather know what 
that's gonna be about. I'd rather know the obstacles I'm gonna have to 
approach. You know stopping is... it's staying stopped, you know? That's the
thing you've got to have a certain amount of information to know what's
going on or just going to charge off aren't you again, with a new set of 
problems.'"'
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Dorian: "Yeah, but that's where I think this understanding the drug and understanding
yourself... it's all part of the same package, it's like following a circle, you 
understand the drug, then you understand what the drug's doing to you, then 
you have to understand what you have to do to stop one being two, two being 
three, etc, etc.."
Dee: "Yeah, that's what I'm saying, you could stop and you might end up being a
patient at Friem Barnet's or something within a week, if you didn't know what's
. -, going on."
Nick: "The other thing I...the other reason I want to give up drugs is because I find
myself more and more involved in criminality.... um, not actually going out and 
robbing people or mugging people or robbing banks or whatever just general 
day to day - I found that over the years, because I was always doing 
something illegal, I always had cocaine or a spliff or 'E's on me, um, I accepted 
the fact that I was involved in a criminal lifestyle and as my finances got worse 
I found that I'd become more involved in it and like I don't think about the fact 
that I drive a car - well I do - but I don't question the fact that I drive a car
without insurance and tax, now ten years ago I would never have done that,
you know what I mean, because if I couldn't afford to insure my car I wouldn't 
drive my car; nowadays I don't give it a second thought and I want to not be 
a criminal anymore, I don't want to be in that sort of dangerous environment 
all the time. I don't want to be afraid of fucking policemen when they walk
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past me going down the road."
Jane: "So, am I right in thinking that everyone here is working towards not taking 
drugs anymore, is that what you're expecting from the programme?
Maxine: "Yeah."
David: "I think that's what I'm looking for."
Nick: "I can't say that; I hope to be able to say that in three months time but at the 
moment I can't say I don't ever want to take drugs again."
Jane: "Because it's quite interesting you know, I wonder, I mean people seem to 
be quite clear about what they want, what they're wanting, and quite clear 
about where they are at the moment; I mean do you, do people think, you 
know I mean I'm just curious, do people think you're ever completely sure 
about what you want or do you think people kind of go up and down in terms 
of where they're at?"
David: "Well the reason why I want to be out of it be truthful, say I spent £150 a day 
on Charlie I could of given that to my kids, not to some dealer, you know it's 
either the Charlie or the money; you know, why give it to him when I could 
give it to my kids, or could give it to my mum or my dad or something like
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that, instead of putting it up my nose."
Nick: "Or spend it on you..."
Dee: "You're more important."
Nick: "...you know just think you warrant having "
David: "I don't feel guilty about spending it on me, but I don't think I can feel guilty
not spending it on my kids, so that's what I think; I'd rather spend it on them."
Jane: "Okay, maybe we should move on, I think we've hammered that question to
death. I guess I'd be interested to know at this point if you have any worries 
or particular fears about the programme..."
Nick: "My fears about the.... um, one, there seems to have been a very long time in
the assessment period leading up to this course, that's one thing, because it got 
put back a couple of times and whatever, um, that's bothered me, because
having made the decision aU I want to do is get on with it you know, um....I've
forgotten the question!"
Jane: "Well let's just stick with that at the moment because it has been quite a long
time getting on to the programme, is that what bothers other people, or..."
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Dorian: "It did me because I committed myself to doing something, and I actually did
stop, when I started the programme I thought I'll just stop, and I did, and then 
it went wrong I felt let down because I was ready to go and I'd mentally 
prepared myself...and then...I just went on a binge 'cos I thought....
Nick: "That's the thing, when you know you're gonna give up all you want to do is 
take as much as you can before you give up, continually I do that."
Jane: "So is that what other people did?"
Nick: The difference is I don't wanna give up now I wanna give up in six months, 
but you know what I mean, I know I'm gonna have to...."
(Lots of voices at this point)
Jane: "Sorry can we just have one person..."
David: "Well when I come on a Thursday, on the Sunday night I stop the drugs
until the Thursday...and when I come here, come all the way down here, and 
....that time you ain't here....we had to make another appointment for next week, 
and you think oh fiick it, after all that time, you come here and you're let 
down, I went straight back out and bought some more Charlie and..."
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Jane: "Right., what about you, did you have a similar..."
Maxine: "No it wasn't long for me 'cos like.... I haven't been here that long, I have been
coming here that long, so.....only about the last one and a half months, so it 
hasn't been long?'
Jane: "But everyone else it sounds like you made the decision to come so you 
stopped taking the stuff and then you went on a binge when you found out 
you couldn't start straight away."
Dorian: "I felt let down, because, you've .you've come..it's enough to commit yourself
to come to one of these places and say okay. I've got a problem and I need to 
get it sorted so I need help, so you come to experts, but then, when they make 
a decision with you.... like if you can't go to them at the time that's been pre­
arranged, and then it goes on and on and on, the longer the period in between 
what you were supposed to do what you were supposed to do and the gap in 
between, it's like, where do you turn to....."
Nick: "Exactly, an hour isn't long enough every week for me personally, I need to 
talk longer than that."
Jane: "So has that initial kind of problem getting started made any of you think twice 
about coming or feel that that's likely to happen again or feel unsure about
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things?"
Dorian: "No, because the group's started, and all I was waiting for ... it's alright here
talking to your key worker and then going away from here yeah, because you 
can... because you tend to vent things you wouldn't with anyone else because 
they're totally separated from your life... and your surroundings, you know and, 
you see you can talk.. I felt I could talk more freely but, it's when like, you ve 
said, this is my timetable, okay.... because you've got that person in your comer 
it gives me a bit more initiative to...well I can say no...it's when you're getting 
let down by that side..... really it's like you've gone for the last resort... it's 
like....you know...and then he's there sitting in the comer calling you: Charlie 
I'm here, rock's on there....you know....it's like, you look that way it's there, you 
look that way it's there, but as I say, having that person in your comer you 
know you can...if it's getting to that stage, you can go to that person there, to 
help you get through aU that, because people outside, they don't understand, 
unless you've been on the dmg you don't understand - what you're going 
through, what you're feeling; you know, even though you're saying No, I don't 
want that, and you want some but, you've got to have a certain amount of self 
discipline and before you lose all that completely; I mean if you do lose it 
completely that's it, you know, I find I've still got...I can say No, but it get's 
harder and harder because of the environment, because it's around and you 
smell it, every time you walk through the club and you smell it, and....''
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Nick: "Some people get in that environment and don't..."
Dorian: "There's not many people I know..."
Nick: "No, but they're fucking lucky the ones that do...I tell you. I'm so envious of 
people..."
Dee: "Yeah, but are they, you know? I've talked to people at places, you know non­
users and stuff, and I've just come to the conclusion that they are...and they're 
just pot-heads; I've spoken to thousands of them, they've sat there and talked 
to me for like an hour and I've been sitting there out of me brain and all of a 
sudden I've just thought, hang on a minute, what's this prick talking about, 
what's he going on about, do you know what I mean? He's got to be on one 
to be talking like that..."
Dorian: "...your normal punter, you know, even from the management, people who are
running the place, if they're not alcoholics, they're spliff heads or they're coke 
heads, that's is... from the very top it comes, right down to your punter that 
walks in the door, you know....and very rarely you meet a person, well in my 
opinion, that don't indulge in any sort of drugs."
Jane: "Can we just stick with your, you know, any criticisms you may have about 
the programme, I mean you've talked about a feeling of being let down, it
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sounds like it was quite strong for all of you."
Dee: "No, not me, no, because I got into this quite fast, it was few weeks before I
actually started."
Jane: "So would I be right in thinking that you would say that fast access into the
programme is important?"
Dorian: "Yeah."
Nick: "Yeah, once you've made that decision..."
Dee: "Yeah, definitely, because for me it made it really easy to talk to Tanya a few
times and then coming straight into it here."
Jane: "Would you say that was an important part of the treatment programme?"
Dorian: "Yeah, I would."
Nick: "I would as well."
Dee: "I couldn't say because I haven't experienced waiting."
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Jane: "Okay, any other thoughts about...I mean what about being in a group and
being part of a group with other people, what do people feel about that?
Nick: "I think personally, that being in a group's really good, much better than on an
individual basis, because I find on an individual basis you become incredibly 
self indulgent and self pitying..."
Dee: "And deceptive..."
Nick: "...Yeah, and I think somehow, if there's a group...if you're being analysed by,
I presume, I mean when you say something I kind of analyse what you're 
saying and look that little bit deeper, and if you've got other people looking 
at you, you're going to be more thoughtful about what you're actually 
saying...you might also be more guarded about what you're saying, but for me 
personally it stops the fantasy going on."
Jane: "Right, how's that for other people."
Dee: "Yeah, I think the thought of a group is good for me because...it's like, it's the
one thing you're not going to get anywhere, I mean if you're using, you're not 
going to go into a pub, club, anywhere, where you're going to find someone 
in a comer that knows what he or she is talking about, dmgs, and they're not
using them, but they're prepared to sit and talk to you for an hour, so you can
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get you're head round it....you're not gonna find that anywhere else are you? 
You know, I mean maybe that's something that I'm longing for anyway, to 
belong to something that...''
Nick: "To know that you're not completely isolated..."
Dee: "....as he was talking a minute ago, a lot of what he was saying was not exactly 
what I was thinking, but made me think about something else you know? And 
it's good to just knock heads together."
Dorian: "Another thing is like, I don't think any of us have got anything in common
apart from the drug that we use, and all our lives will be different, like we 
know different people, but coming together as individuals is like, binding, like 
combining what we're going through together to reach our common 
denominator, which is to wipe out the drug taking....My hope is like to 
understand you, to understand you, to understand you, to understand you, 'cos 
we're all at different stages..."
Nick: "And to give and receive support from each other...."
Dorian: "....and we're all here for different reasons, so, if one's at a worse stage than
another person, one's at a lesser stage, it'll be easier for that person, I think, to 
deal with what they're going through because they're getting it first hand from
412
somebody who's a bit further up the ladder than the other, you see."
Jane: "So what you seem to be saying is that there's something supportive about 
being with other people who have taken drugs. "
Dorian: "Yeah, you might not know it, but there is, just by us sitting here just talking."
Jane: "And also if people are at different stages they might be able to use their 
experience to help you, is that what you're saying? Do other people think the 
same, or do you think, oh god. I'm in a group of people and I'd rather be on 
my own? What do other people think?"
David: "Everybody knows what we're talking about don't they? Like if I was in a pub
taking a spliff or taking Charlie "
Nick: "I think it's also nice to be with a group of people who aren't praising drugs, 
because everybody else I know still takes drugs regularly - well not every 
body, but the people who do - and are still really happy to be taking drugs all 
the time and therefore you feel incredibly, um...um... disturbed about not being 
able to take drugs happily, do you know what I mean, and I personally feel 
incredibly isolated, the more my dmg habit came on, the more isolated I 
became, and so you find there are fewer and fewer people you can actually talk 
to about it."
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David: "Jane I've gotta go."
Jane: "Okay, fine thanks very much. I'll see you in six months time."
(Everyone says goodbye and he leaves the room - time -  3.40 p.m.)
Jane: "I suppose, I mean maybe, there's a danger, something, you know maybe 
slightly dangerous about being in a group, in that you might be more tempted 
to take dmgs, or....you know, if there's other people...."
Dorian: "I mean. I'm in groups all the time, and I mean, it's....I think it's down to the
individual...at the end of the day... where I've been vulnerable, where I've got 
to the stage where I've got to have it all the time so I don't know, whereas I 
can understand where you're coming from, because I have seen people like 
that, in the club business. I've seen it already, but...I've had no choice because 
of my work. I've had to say No sometimes, because if we're doing a 
promotion, someone comes along with Charlie, I can't afford to do it because 
of the responsibility I've got. I'd say well, put me some here and 111 have it 
later on, but at that time I can say no, but what I mean to say, I don't mean, 
'No I don't want the dmg', I mean there's particular times when I say No I don't 
want it, I'd rather have it when I finish work, then it's my time, so if I'm idiot, 
if I'm stupid, then...ifs not gonna affect what I'm doing, or my work, because 
sometimes when I'm depressed, someone says 'Yeah, go on have a bit of
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Charlie, have a nose and you'll be all smiley face..', but then I'm still feeling 
depressed, even though I might be showing outside, inside I'm still fighting 
with myself, it's like, you know. I've still got to tackle the problem when I 
come off the drug, and because I'm feeling like shit because I'm on the drug, 
it makes me ten times worse than what it was before, if I just went and dealt 
with it. So that's why I say. I'd like to understand the drug, and all it's 
contents, what it does, stages people go through, what it does to your body, 
and...maybe - I'm not saying it will be - maybe it'll be more of a deterrent to... 
I mean I used to take 'E's like nobody's business, and all of a sudden my friend 
died on 'E's, and I just went...I don't want to know. ..I mean, since then, maybe 
I've had a half, but I...I haven't done what I used to, I used to do it bang, bang, 
bang, bang, bang, six or seven 'E's, you know, going from Thursday to 
Thursday, when I used to go to raves, it used to be just raves, it's not so bad 
now 'cos raves are mostlt at the weekend, I used to go from Thursday to 
Thursday right the way through, and we used to be out of our heads just on 
'E's, and until something severe happens, like jolted me, I mean it was someone 
close, it was like, I don't want to know, you know....I mean I take coke and I 
smoke spliffs, I mean I've been smoking spliff for God knows how 
long...and...to be honest I don't think I'm gonna stop smoking spliffs....but it's 
the powder, that I can see...before it gets any better it's gonna get worse, and 
I can see because of the environment, I mean especially with this Jungle...and 
you're meeting these people...and most of them it's just like, coke, it's just coke, 
and...it's like... being able to maybe control myself when I'm around that stuff.
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when Fm in that environment, where Fve got some control, before I lose it
entirely like I need to understand it more to understand myself, you know,
so I can say...because like, a couple of years ago, I used to say to people, Fd 
say No, Fd just smoke a spliff, and then certain things, F went through a bad, 
really bad stage, and someone said, here have a puff on this, and it was nice, 
yeah my problems went away and I didn't have to worry it just went into a 
void....and then, I woke up and it was like, God, what's happening? You know, 
and that's why Fm here now, to stop, before it goes any further...to try..."
Jane: "So it seems, because we were talking about, you know, what it would be like 
being in a group and whether people found that supportive, and you seem to 
be saying, that yeah being in a group is really going to help, but actually in the 
end it's about me and it's about the individual doing something...."
Dorian: "Well yeah that's what it is at the end of the day, it's about you, and because...!
can't kick his habit for him .."
Nick: "Exactly, yeah..."
Dorian: "....and he can't kick it for me, no matter what he says or what I say, it's still
down to that individual..."
Dee: "Yeah, but it's just nice to know that someone else has stood up and said, I
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want to sort something out..."
Dorian: "..Yeah, you all want the same thing, yeah...."
Dee: "....do you know what I mean, it's like when you wai a kid outside the
headmasters office, if there was a few of you there, you'd just wait for your 
whack, if you was on your own it'd be like, what?! I don't need all this!"
Nick: "Once we've actually got into the programme and some people have actually
given up, it would be good to actually see that they have managed to give up, 
you know, and therefore maybe I can..."
Jane: "Mm, so people can be an example..."
Dee: "Yeah because there's also an issue, that is, there's so many people out there
doing fucking stuff and they've been doing it just as long as me, but they
haven't got a problem, and I want to know why...."
Nick: "Didn't we all see people like that? When I - forget the coke for a bit - I got
into 'E's in '88 and I've been doing 'E's every weekend ever since, and I saw 
people go completely psychotic, you know, completely paranoid and lose it 
completely, and I thought you poor bastard, thank God that doesn't happen to 
me, and then suddenly six years along the line. I've realised, fuck it has
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happened to me, you know, I have become that person I was feeling sorry for 
before...and you know, that was a shock to me, because I never thought it 
would actually get me like that.... even though for seven...ten years before that, 
rd been a cocaine addict and I was really proud when I gave up cocaine, but 
all I did was give up cocaine and get into 'E's..."
Dorian: "Just substitute it for something else."
Dee: "Yeah, I mean for me, the 'E' situation, I mean. I've stopped going so mad on 
the 'E's because I mean like ten years ago it looked like whisky-a-go-go and 
you used to pay 25 quid for one, and you was out of your box and..you knew 
it...."
(First side of tape ends.)
Dorian: "...each individual's saying their little piece, I mean, some things people say
might seem like a load of garbage, but...it's...certain things within what that 
person's saying "
Dee: "It's triggering little switches..."
Dorian: ".... it's triggering little switches inside different people, because I m ean a
lot of talking, is a lot bullshit....but....sometimes that's what you need to get out
418
what you're really trying to say, and for each individual, something within that 
sentence or what that person says, means something....the rest of it might be 
just garbage but one thing, that one little thing, if that one little thing can 
trigger something off, then, I feel it's worth it."
Jane: "And you think that's more likely to happen if you're in a group of people than
if you just had an individual..."
Dorian: "Yeah, because at the end of the day we're all being honest with ourselves,
saying look, we have got a problem, whether you feel you're addicted to it or
if you feel you're not, we've all got a problem, the problem is the powder, and
we want to try and deal with it, or at least be able to control it instead of it 
controlling us."
Jane: "Any other fears or worries about the programme at the moment, or comments
about the service so far."
Nick: "I'm a bit worried about the confidentiality of it I must admit. It frightens me,
because I don't believe. .."
Dee: "Yeah, that's my worry..."
Nick: ".... the National Health Service, I do not believe has a secure record
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on...medical records, they get out...and you wait..."
Dee: "Yeah, and that thing on t.v. last night, I was shitting my pants...that thing last
night on hospitals..."
Nick: "...yeah, absolutely. World in Action..."
Dee: "... the World in Action team went into a load of hospitals and medical
centres with little cameras on them, and they got into files and into drug 
cabinets and they got into where the babies were....I mean if you can walk into 
a place and take a baby...do you know what I mean, that's the one thing I'm 
worried about..."
Nick: "I mean we all know how guttural the press is, you know, and we're admitting
to crimes, some of us are admitting to dealing, it's all there in the bloody 
records, it is a bit frightening; for me personally, it would be a bit better if it 
were totally anonymous, if we were all just working - 1 mean not just us when 
it's just us and it isn't being recorded - but if we worked on the first letter of 
our name or something, but right from the start so that we don't have to sign 
these forms, so that nobody right from the start knows who we are, you 
know..."
Dorian: "I mean, as they was saying, if something gets out, like my job, because of
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certain people that I work for ...and...it will affect me, because if they get note 
of this then Fm sacked...because what they don't know doesn't hurt them, 
because I don't take that to work with me, you know...but... it can affect my 
future by people getting hold of them because of the people I know."
Jane: ''So what's the fear, that written information is going to leave this building or...
Dorian: "No, it's just being identified...really... I mean I could sit here and talk to you
all day, but as long as no-one knows who I am, then what I say they can't put 
a name to that voice, I suppose like if they were really technical they could do 
it, like through voice analysis and that, but...the fear is..places like these 
hospitals are so easily accessible to...like ...aliens I will call them, who are just 
digging for information looking...they might see me with some certain person 
and then follow me, and they'd see me come in here then someone comes in..."
Nick: "Well I'll give you another scenario; you get a junkie out needing a fix who
breaks in the window looking for methadone or whatever drugs are here, and 
they go through the office and they rummage around the office and, you know, 
maybe chuck some files out the window or something... .you know, I don't think 
there's this conspiracy of someone out to get us, it's that thing of a hap-hazard 
event, and you know someone finding the file and phoning this person up and 
saying 'We found this file outside this drug centre' and then suddenly 
everything's, you know, in public demand..."
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Dee: "Plus, on top of that, I think you've got to realise - well I'm talking about 
myself, I don't know about anyone else - but once you're using, you become 
very secretive and you got, you know...I like having the door shut and, you 
know, something like this, it's just ....it's obviously frightening.''
Jane: "Is that a concern for you as well, the confidentiality?"
Maxine: "Um....not really....well yeah..."
Jane: "...but it's not something ...I mean do people think about it quite a lot, does it 
occupy your...."
Dorian: "I mean I do, because of the work I do and the people I'm working with...I
mean I'm not saying they don't take it because I don't know, but because I'm 
involved with them....if someone got hold of certain information, it would only 
be used against me because, I know like, maybe a celebrity, and the security 
man may be supplying celebrities...that's... I mean people are scornful, and
because the word 'dmgs' is there, then they can say anything...you know, if
they found out that I take dmgs myself they could say well..you know... and 
where does that leave me? It puts me back to where I don't want to be, 
because where I am now. I'm furthering myself. I'm getting better, and...I mean, 
to be totally honest, I didn't think I had problem as such; it was only because 
my whole lifestyle was changing, that I decided that part of it had to change
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as well. That's why I said to you, I can say No, as such, you know, I can put 
it down and have it later, you know, it won't be 'Oh it's there. I've got to have 
it there', you know I can discipline myself, I  can see, because...I've seen, being 
within that circle I've seen how it does affect ... I don't want to get to the 
certain stage where people are, where I can't say no, you know, that's the 
reason I came here to...not so I don't use it completely, because I know if I'm 
with the programme, I can talk to them, and understand them, then it builds 
my resistance and my confidence. Just by having people there, being 
supportive to what I want, and saying if I can be supportive to what someone 
else wants, 111 give them as much support as I can. 111 do what I can, 
you know?"
Jane: "I've just got one more question and then I'd just like to ask you if there's
anymore you want to say, which means we may run a little bit over four 
o'clock, is that alright with people? I mean if the programme is geared towards 
abstinence, it is thinking about getting people off drugs, about stopping. What 
are peoples thoughts about that, in terms of how do you think it's possible to 
stop taking drugs, I mean I know we've talked a bit about this before, but is 
it to do with willpower or...anybody's thoughts about that?"
Dorian: "It's just weird, because drugs, from drink to cigarettes to hard drugs, it's part
of your lifestyle, it's part of everyone's lifestyle, it's just there...and...I find, if 
someone says No to me. I'd say Yeah, and I'd do the opposite, I mean like.
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cigarettes, I've smoked cigarettes but I don't as much because it's legal, same 
with drink, like, if cannabis was legal then I wouldn't puff as much as I 
do...because it's illegal, it's like, a lot of things I do it because the law says one 
thing, and yet they're doing it themselves but they're saying I can't do it, and 
so I'm defying by what I'm doing. I'm defying. I'm... .saying I'm doing what 
I want to do, you know, even though it may be wrong, it's down to myself,
because everything else you do you're under a microscope seriously, drug
taking is the only thing you can have a little bit of privacy, because you get 
it and you go away; everything else you're under a microscope, everything you 
do..."
Jane: "That's interesting, and you were saying about some sort of control..."
Dee; "Yeah, some sort of control. We are told, I mean in this country especially,
we're told what hours we can drink - one of England's favourite past times is 
that we're all boozers - we're told when we can drink, what time we can finish 
drinking, you know, and we're told how much cigarettes we can bring home, 
I mean, ffon every single little thing like that, that's got to be an element, that's 
got to be a part of it, I mean when you go and buy drugs there's nobody who 
is sitting there saying, 'No,no,no you're not buying three grams today, take one'; 
it doesn't happen, it's you're environment, you're in control of it completely."
Jane: "Yet somewhere that flips to being out of control and the drug becomes...."
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Dee: "Yeah, you just end up losing, I end up losing my perspective."
Nick: "If you're saying that at the end of six months the idea is abstinence of drugs,
does that include alcohol?"
Jane: "To be honest, I really don't know, because..."
Nick: "That's very honest!"
(Laughter in the group)
Nick: "Because I can't envisage a situation where I will never take any sort of drug
again; I can't see that, I really can't, and if that's the aim, then I'm gonna, it's 
gonna fail. Because I can't see that, I really can't."
Jane: "Well when I say abstinence I'm talking I'm talking about stimulant drugs and
I think obviously you need to discuss with Tanya and Luke, because they're 
the people running the programme, what their thoughts are about other drugs, 
I mean I'm purely at the moment thinking about stimulant drugs."
Dee: "Because, I mean, if all of us walk out of here anyway, let's just say we all
end up walking out of here like robots, at the end of six months knowing that 
we're never going to touch anything again, that causes another whole heap of
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problems because there's still other people out there than can go out and do it 
and don't seem to have a problem; my problem personally is if I do a little bit 
then I'm going to do loads, and I'll keep on doing it, you know, I can't 
understand this abstinence, but if I'm going to totally stop doing everything , 
where am I going to be?"
Jane: "No, I'm not saying that, I think what I'm saying is as far as I understand the
treatment programme is about helping you to stop taking drugs, stop taking the 
drugs that you're having problems with....and I guess what I was interested 
to hear was your thoughts about that, which you've talked about..."
Nick: "But it also has...I think it also has to deal with the problems - not just the
problem of taking drugs - the problems with why you're taking drugs, because 
the trouble is if you cure yourself of taking A, B, and C, at the end of the 
day youll turn to D, E, and F, if you haven't solved the original problems in 
the first place, that make you want to take it in the first place."
Jnne: "So again we're coming back - correct me if I'm wrong - we seem to be
coming back to the idea that in order to stop doing what you're doing you need 
to actually think about why you're doing it m the first place."
(At this point Maxine leaves - time = 4.05 p.m.)
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Jane: "Any other thoughts about stopping drugs or controlling drugs that you'd like 
to just say to the..."
Dorian: "I find myself....if I go out of London, then I haven't got a problem with
drugs,"
Nick: "Absolutely."
Dorian:.......... "....  like I've gone to Torquay for 2-3 weeks at a time, and drugs haven't
entered my mind...alright, I have a spliff, I have a drink, and I don't class that 
as being anything really....but the powder, the minute I'm in London it's bang, 
bang, bang; North, East, South and West....it's just.....you walk here it's there, 
you walk there it's there, but the minute I go out of London, I'm not even 
thinking about....maybe the first day, but then when you're involved in doing 
what you're doing, you're enjoying yourself, you're relaxing, it's not a problem, 
but as soon as you come back to London., .it's like back in London, I want 
them..."
Nick: "I don't find drugs a problem when I can't get hold of them, that doesn't bother 
me; if I can't get hold of them then I don't take drugs. The trouble is I can 
always get hold of them."
Dee; "Yeah, I always seem to come up with something like a contingency; when I'm
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going away out of London, I'll take it with me... just because of the fear of, 
the thought of me being somewhere....getting them feelings and not being able 
to have it. I'd just come straight back to get it. And even when I've gone 
abroad. I've risked myself...I was in Florence airport a little while ago in Italy, 
with the dogs on me and I don't know how I didn't get the search, you know, 
the dogs were pushing me up against the waU, you know, I had grass and stuff, 
and coke and 'E's, and I was thinking here we go, this is it. Midnight Express 
for me...and I was shitting myself but once I was there for a while, once I was 
in Italy I thought Jesus Christ!"
Nick: "If you can iihagine being six thousand miles away right, I was supposed to
be going on holiday with my girlfriend - she got a job at the last minute and 
couldn't come - so suddenly I found myself in Bangkok on my own right, and 
I've travelled all over Europe and all over America, but suddenly I found 
myself in a place where I didn't understand a word of the language, I didn't 
know what the shops sold, and I knew I knew I was leaving Bangkok the next 
day to fly down to the islands, and instead of thinking 'I'll go and have a 
couple of jars and go and chill out in my hotel room', I thought 'No, I've got 
to have drugs. I've got to have drugs. I'll go and buy some grass', and I went 
and bought some grass and I got set up in this trap and I ended up buying 
some - what I thought was coke and turned out to be smack - and I had a 
policeman shooting a fucking gun at me in the middle of Bangkok, you know, 
and that's terrifying....just because that was the only way I could think of
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dealing with that anxiety...was to take drugs."
Jane: "So, again, coming back to , you seem to be talking about two different things
- anxiety about not having the drug so you go to all lengths..."
Nick: "Not only about not having drug, just general life anxiety and the way of
dealing with it is to get the drug."
Jane: "Right, so again, it's coming back to this idea that some people use drugs as
a way of controlling their emotions. Okay, I'm aware that we've run out 
of thne; is their anything that we haven't covered or that's really important or 
that you'd like to say just as a kind of final, you know...anything?''
Dorian: "Not really, it's just that I know there's no guarantee that being here will solve
the problem. I'm not saying it won't help, but I mean..... it's down to me as 
an individual; this is just like another sort of stepping stone, but in my comer 
to fight what I'm trying to fight...it's like another arm to pull you away... at 
least when I'm thinking about the drugs I think I'll have you lot in mind at the 
same time, knowing that I'm on the course and everyone else wiU sort of like 
pop up, it won't be...like before I didn't have anything to worry about, but in 
a sense it's having a responsibility to each other as well, because we're all here 
to help each other..."
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Nick: "Can I just ask a question? Are we all in relationships? Is that a major part
of our lives and is that more important than our dmg taking? Because for me, 
what I've found is that when my relationships start to go wrong, my drug habit 
increases a lot until it's completely destroyed and then I start a new relationship 
and the drug habit is low, and as things go wrong in that relationship, bang..the 
drug intake goes up each time, you know what I mean?"
Dee: "Yeah, I know what you're saying, you start using your partner as a ....as
everything is going on...."
Nick: "As a barometer...."
Dee: "....as a barometer yeah, so you can judge by..."
Dorian: "Instead of judging yourself you can judge by...."
Dee: "...yeah, and in the end you end up getting all these prejudices and you start
hijacking peoples lives with these prejudices and stuff... that's all the sort of 
stuff I can't wait to get rid of. That's why I really want some perspective, like 
Dorion was saying, it's good that we're all here because you can listen to what 
other people are saying and think either one, that hasn't happened to me yet, 
or two, it has happened and I remember dealing with it, so he must be right, 
he's on the right lines you know."
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Dorion: "It's like before I was on drugs....I used to have a puff and everything was fine,
but as soon as that started, as he said with relationships - it's good that you 
mentioned it - I find that...instead of...as an excuse before I used to blame her, 
because..."
Nick: "She's treated you like a bitch so I'm gonna go out and get cocaine, I know she 
doesn't like me taking drugs so I'm gonna fucking do it, because she's done 
something wrong with me..."
Dorion: "....using her as an excuse, using her as a scapegoat, but she's not, because
she...it was my girlfriend that got me here, she said to me 'Go to the 
clinic'...she's in a better position to see what's happening with me than myself 
because she's got to live with me, and she said to me the way I've changed, I 
started shouting and just...not losing it, but really getting irritated...."
Nick: "Irrational, emotional outbursts...."
Dorion: ".....yeah, exactly, and where she can see all of that so she's saying 'You need
to get help' I'm going 'No,no it's alright. Ill go and see someone', so I've gone 
and saw someone else who's on the gear and then I've sat down and started 
doing it with them, and I've gone 'No this is wrong', so I need to go somewhere 
that's totally independent....she says go and see the doctor, and I said no way 
am I going to see my doctor because what is he going to think of me. So she
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found this place and she said to me 'Go/ so I've said alright, 'For you I'll go'... 
I went..the first conversation, it wasn't bullshit I was hearing, and I thought 
there's someone here who's really got my interest at heart, so I cam back - I've 
missed a few appointments because of work, but I came back - and it was 
like...to come on this course itself, even after last week it was like, because I 
was let down before, and the course was supposed to start a little while ago 
I was like in two minds about whether I should come, whether it was worth 
it or not, and the I got another job looking after someone on a Wednesday, 
so I had to go and say to them, can't I go on another date because like I'm 
booked up Wednesday so...to show that I've committed myself to the course 
I've rearranged with that person to take the Thursday, so they've had to change 
their calendar to suit me, but I haven't told them why. I've just said Tve got 
to go on a course and it's important to me', and so therefore...and by the fact 
of knowing that there's someone else apart from these, even though you haven't 
told them for the right reason, they're still considering you as an individual and 
are willing to break they're calendar to help you, then that's more supporting 
and more the reason why I'm willing to fight more to give it up, than just to 
lay back and let it happen.''
Jane: "In a way that period of time has shown to you that you really are committed
to it."
Dorion: "Yeah, because of what I've done in order to get on the course, I mean I've said
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like Fridays and Wednesdays are no good to me, but it's no good to everybody 
else on the course if we're not willing to commit ourselves to each other and 
to the course and there's no point us being here at all."
Nick: "The fiinny thing is that it just shows how much of a problem we all do have,
in that we've all committed ourselves to something that we don't know anything 
about, you know what I mean? Even though we don't know anything about, 
well I personally don't have a clue what you're gonna tell me when I walk in 
here tomorrow, but we've all committed ourselves to it so therefore we 
obviously we all have a problem that needs to be sorted out."
Jane: "That seems like a good place to end, yeah?"
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T H F . S T I M U L A N T  Q U IZ
NAME: DATE:
MULTIPLE CHOICE (choose one of the listed  answers)
Which of the following is a 
stimulant (upper)?
a.
b.
c.
d.
Heroin
Valium
CJocaine
Tobacco
Which of the following is a 
stimulant?
a. Alcohol
b. Amphetamine
c. Cannabis
d. LSD
Which of the following is a 
stimulant?
a. Oodeine
b. Coffee
c PCP
d. Amyl nitrite
Long term use of stimulants will:
a. Keep the user continuously
W
b Exhaust the user
c. Create long term energy 
supplies
d. Control paranoia
What effect do stimulants have on 
the circulatory system?
a. They tighten blood vessels
b. They relax blood vessels
c. They thin the blood
d. They thicken the blood
6. Which is NOT an effect of casual
stimulant use?
a. Increased blood pressure
b. Confidence
c. Extra energy
d. Muscular relaxation
7. Which of the following is NOT an
effect of long term use of stronger 
stimulants?
a. Blood vessel dilation
b. Talkativeness
c. Irritability
d. Insomnia
8. Snorting cocaine is also called:
a. Cocaine bromide
b. CJocaine sulphide
c. Cocaine hydrochloride
d. Cocaine amphetamine
9. Which is NOT a method of using
cocaine?
a. Smoked in a pipe
b. Injected in a  vein
c. Eaten in brownies
d. Absorbed by the gums
10. If cocaine is injected, it will take 
how long for the rush to occur?
a. 15-30 seconds
b. 1-3 minutes
c. 5-10 minutes
d 3-7 seconds
11. Which is NOT a slang name for 
cocaine?
a.
b.
c.
d.
Coke
Snow
Crack
Smack
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12. If cocaine is snorted (tooting, 
horning, blowing) how long does it 
take for the effects to begin?
a. 7-10 seconds
b. 15-30 seconds
c. 3-5 minutes
d. 10-30 minutes
13. Initially, the major effects of 
cocaine are:
a. Euphoria
b. Increase confidence
c. Rapid heart rate
d. All of the above
14. Disruption of dopamine release 
caused by excess cocaine use can 
cause:
a. Paranoia
b. Acrophobia
c. Hives
d. Pinpoint pupils
15. A megor difference between the 
e f f e c t s  o f  c o c a in e  a n d  
amphetamines is:
a. The stimulation
b. The paranoia
c. The cost
d. The rapid heart rate
16. A msjor difference between the 
e f f e c t s  o f c o c a in e  a n d  
amphetamines is:
a. The duration of effects
b. T he in c re a s e  blood 
pressure
c. The illegality
d. The release of epinephrine
17. The cocaine crash is:
a. When a user starts falling 
dow n fro m  m u sc le  
exhaustion caused by 
cocaine use
b. When long term cocaine 
use depletes nervous
18.
19.
20.
21.
system chemicals from the 
system
c. When excess cocaine use 
causes hallucinations
d. When excess cocaine use 
causes agitation and 
violence
An overdose from cocaine can
cause:
a.
b.
c.
Convulsions 
Respiratory depression 
Over-stimulation of the 
heart
All of the above
Which is a reason for compulsive 
use of cocaine?
a. Price
b. Safety of use
c. Avoidance of the crash
d. To control heroin use
Crack is:
a. Cocaine hydrochloride
b. Freebase cocaine
c. Cocaine sulphate
d. Amphetamine mixed with 
snorting cocaine
If cocaine is to be smoked, an 
essential property is:
a.
b.
c.
d.
Larger crystals than  
snorting cocaine 
W h ite  c o lo u r  a f te r  
formulation 
A water pipe
A lower melting point than 
snorting cocaine
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22. Cheap basing means:
a. Using a cheaper cut of 
cocaine
b. Using baking soda to make 
crack
c. Making a drug that can be 
smoked in any kind of pipe
d. Selling crack in smaller 
amounts
23. The major reason that crack 
cocaine usually causes more 
intense reactions than snorting 
cocaine is:
29. True or false: Cocaine causes
physical and mental effects that 
do not occur normally.
30. True or false: There are two basic
ways to make smokable cocaine.
31. True or false: The most frequent
type of overdose with crack
cocaine causes rapid heartbeat 
Emd hyperventilation.
32. True or false: The main reason for
the popularity of crack cocaine is 
media hype.
a. The fact that it is smoked, 
not snorted
b. It is always purer than 
snorting cocaine
c. It is cheaper
d. It usually has some
amphetamine mixed with 
it
24. One of the reasons crack cocaine 
has become popular is:
a. The fear of AIDS since
crack is smoked
b. Crack cocaine is cheaper 
on a gram for gram basis 
than snorting cocaine
c. Crack cocaine has fewer
impurities than freebase 
cocaine
d. I t ’s c h e a p e r  t h a n
methamphetamines
True or False
25 True or false: Uppers stimulate
the central nervous system.
26 True or false: Uppers force the
release of energy chemicals.
27 True or false: Uppers create free
energy for the body.
28. True or false: Excess, long term
use of cocaine causes depression.
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ANSWERS
MULTIPLE CHOICE
1. c. Cocaine
2. b. Amphetamines
3. b. Coffee
4. b. Exhausts the user
5. a. They tighten (constrict) 
blood vessels
6. d. Muscular relaxation
7. a. Blood vessel dilation
8. c. Cocaine hydrochloride
9. c. Eaten in brownies
10. a. 15-30 seconds
11. d. Smack
12. c. 3-5 minutes
13. d. All of the above
14. a. Paranoia
15. c. The cost
16. a. Duration of effects
17. b. Depletes nervous system 
chemicals (eg: epinephrine)
18. d. All of the above
19. c. Avoidance of the crash
20. b. Freebase cocaine
21. d. Lower melting point
22. b. Using baking soda
23. a. It is smoked
24. a. The fear of AIDS
TRUE OR FALSE
25. True
26. True
27. False
28. True
29. False
30. True
31. True
32. False
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